<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceutics</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceutics</journal-id><journal-id journal-id-type="publisher-id">pharmaceutics</journal-id><journal-title-group><journal-title>Pharmaceutics</journal-title></journal-title-group><issn pub-type="epub">1999-4923</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9505985</article-id><article-id pub-id-type="doi">10.3390/pharmaceutics14091837</article-id><article-id pub-id-type="publisher-id">pharmaceutics-14-01837</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>How to Completely Squeeze a Fungus&#x02014;Advanced Genome Mining Tools for Novel Bioactive Substances</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2330-3106</contrib-id><name><surname>Sch&#x000fc;ller</surname><given-names>Andreas</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8738-2106</contrib-id><name><surname>Studt-Reinhold</surname><given-names>Lena</given-names></name></contrib><contrib contrib-type="author"><name><surname>Strauss</surname><given-names>Joseph</given-names></name><xref rid="c1-pharmaceutics-14-01837" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Casteleijn</surname><given-names>Marco G.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Popa</surname><given-names>Mircea Ioan</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pharmaceutics-14-01837">Institute of Microbial Genetics, Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences Vienna, A-3430 Tulln/Donau, Austria</aff><author-notes><corresp id="c1-pharmaceutics-14-01837"><label>*</label>Correspondence: <email>joseph.strauss@boku.ac.at</email></corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>8</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2022</year></pub-date><volume>14</volume><issue>9</issue><elocation-id>1837</elocation-id><history><date date-type="received"><day>29</day><month>7</month><year>2022</year></date><date date-type="accepted"><day>29</day><month>8</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 by the authors.</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Fungal species have the capability of producing an overwhelming diversity of bioactive substances that can have beneficial but also detrimental effects on human health. These so-called secondary metabolites naturally serve as antimicrobial &#x0201c;weapon systems&#x0201d;, signaling molecules or developmental effectors for fungi and hence are produced only under very specific environmental conditions or stages in their life cycle. However, as these complex conditions are difficult or even impossible to mimic in laboratory settings, only a small fraction of the true chemical diversity of fungi is known so far. This also implies that a large space for potentially new pharmaceuticals remains unexplored. We here present an overview on current developments in advanced methods that can be used to explore this chemical space. We focus on genetic and genomic methods, how to detect genes that harbor the blueprints for the production of these compounds (i.e., biosynthetic gene clusters, BGCs), and ways to activate these silent chromosomal regions. We provide an in-depth view of the chromatin-level regulation of BGCs and of the potential to use the CRISPR/Cas technology as an activation tool.</p></abstract><kwd-group><kwd>genome mining</kwd><kwd>secondary metabolism</kwd><kwd>BGC prediction</kwd><kwd>BGC activation</kwd><kwd>OSMAC</kwd><kwd>chromatin</kwd><kwd>CRISPR/Cas</kwd><kwd>dCas</kwd><kwd>cluster activation</kwd><kwd>filamentous fungi</kwd></kwd-group><funding-group><award-group><funding-source>NFB Lower Austria Science Fund</funding-source><award-id>LS19-009</award-id></award-group><award-group><funding-source>FWF Austrian Science Fund</funding-source><award-id>P32790</award-id></award-group><funding-statement>Open access funding provided by Austrian Science Fund (FWF). Work was funded by grant LS19-009 &#x0201c;TASSMATA&#x0201d; from the NFB Lower Austria Science Fund and grant P32790 &#x0201c;ChroCosm&#x0201d; from the FWF Austrian Science Fund to J.S. </funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmaceutics-14-01837"><title>1. Introduction</title><sec id="sec1dot1-pharmaceutics-14-01837"><title>1.1. Fungal Secondary Metabolites as Biopharmaceuticals of Tomorrow</title><p>Bacteria, plants, and filamentous fungi are capable of producing many chemically diverse bioactive substances, referred to as natural products or secondary metabolites (SMs) [<xref rid="B1-pharmaceutics-14-01837" ref-type="bibr">1</xref>]. Probably the most prominent of these fungal bioactive compounds is penicillin from <italic toggle="yes">Penicillium rubens</italic>, discovered by Alexander Fleming in 1929 [<xref rid="B2-pharmaceutics-14-01837" ref-type="bibr">2</xref>,<xref rid="B3-pharmaceutics-14-01837" ref-type="bibr">3</xref>] which initiated the &#x0201c;antibiotic revolution&#x0201d; that lead to a major paradigm shift in the treatment of patients [<xref rid="B4-pharmaceutics-14-01837" ref-type="bibr">4</xref>]. Many fungi and their SMs made it into pharmaceutical application, such as cyclosporin from <italic toggle="yes">Tolypocladium inflatum</italic> which is used as an immunosuppressant [<xref rid="B5-pharmaceutics-14-01837" ref-type="bibr">5</xref>,<xref rid="B6-pharmaceutics-14-01837" ref-type="bibr">6</xref>], or lovastatin as a treatment for coronary heart diseases produced by <italic toggle="yes">Aspergillus terreus</italic> [<xref rid="B7-pharmaceutics-14-01837" ref-type="bibr">7</xref>]. Other fields of application for microbial-derived natural products are the food industry (e.g., soy sauce, sake, and miso by <italic toggle="yes">Aspergillus oryzae</italic> or citric acid by <italic toggle="yes">Aspergillus niger</italic> [<xref rid="B8-pharmaceutics-14-01837" ref-type="bibr">8</xref>]), the agricultural sector (biocontrol agents [<xref rid="B9-pharmaceutics-14-01837" ref-type="bibr">9</xref>,<xref rid="B10-pharmaceutics-14-01837" ref-type="bibr">10</xref>,<xref rid="B11-pharmaceutics-14-01837" ref-type="bibr">11</xref>], growth hormones [<xref rid="B12-pharmaceutics-14-01837" ref-type="bibr">12</xref>]) and many others [<xref rid="B13-pharmaceutics-14-01837" ref-type="bibr">13</xref>,<xref rid="B14-pharmaceutics-14-01837" ref-type="bibr">14</xref>,<xref rid="B15-pharmaceutics-14-01837" ref-type="bibr">15</xref>,<xref rid="B16-pharmaceutics-14-01837" ref-type="bibr">16</xref>]. The ever-rising demand due to the emergence of multi-resistant pathogens and resistant cancer types underscores the importance of mining new bioactive substances from fungal sources [<xref rid="B17-pharmaceutics-14-01837" ref-type="bibr">17</xref>].</p><p>SMs are per definition not essential for growth but may provide selective advantages for the producing organism upon specific environmental challenges: e.g., pH stress (acids and alkaline substances [<xref rid="B18-pharmaceutics-14-01837" ref-type="bibr">18</xref>]), temperature stress (regulators of membrane fluidity [<xref rid="B19-pharmaceutics-14-01837" ref-type="bibr">19</xref>]), oxidative stress (antioxidants [<xref rid="B20-pharmaceutics-14-01837" ref-type="bibr">20</xref>]), UV protection (pigments [<xref rid="B21-pharmaceutics-14-01837" ref-type="bibr">21</xref>]), microbial warfare (antimicrobials [<xref rid="B22-pharmaceutics-14-01837" ref-type="bibr">22</xref>]), communication (e.g., quorum sensing via homoserine lactones [<xref rid="B23-pharmaceutics-14-01837" ref-type="bibr">23</xref>]), pathogenicity and host-infection (effectors or virulence factors [<xref rid="B24-pharmaceutics-14-01837" ref-type="bibr">24</xref>,<xref rid="B25-pharmaceutics-14-01837" ref-type="bibr">25</xref>]), support of ion uptake (sideophore production for iron acquisition [<xref rid="B26-pharmaceutics-14-01837" ref-type="bibr">26</xref>]). As versatile as these functions are, as diverse are the chemical properties of such natural products. Not surprisingly, most of them are only produced under defined environmental or developmental conditions implying a complex regulation at the molecular level [<xref rid="B27-pharmaceutics-14-01837" ref-type="bibr">27</xref>].</p><p>The blueprints for such bioactive substances are stored in biosynthetic genes that are, in most cases, physically linked in fungal genomes and together with genes for regulators and transporters sometimes constitute very large BGCs [<xref rid="B28-pharmaceutics-14-01837" ref-type="bibr">28</xref>,<xref rid="B29-pharmaceutics-14-01837" ref-type="bibr">29</xref>]. These BGCs are silenced by default through heterochromatic structures at the chromosomal level, but once activated by the specific signal, they work similar to an orchestrated factory to produce the cluster-specific compound. Bioinformatic tools have been developed that predict fungal BGCs based on whole-genome sequence data and these predictions show that so far sequenced fungi harbor between ~15 and 50 BGCs, but up to more than 80 BGCs have also been predicted in some genomes [<xref rid="B28-pharmaceutics-14-01837" ref-type="bibr">28</xref>,<xref rid="B30-pharmaceutics-14-01837" ref-type="bibr">30</xref>]. However, as outlined above, most of them are transcriptionally silent under standard laboratory conditions and hence the majority of associated natural products are not known [<xref rid="B27-pharmaceutics-14-01837" ref-type="bibr">27</xref>]. </p></sec><sec id="sec1dot2-pharmaceutics-14-01837"><title>1.2. Genomic Organization and Evolution of BGCs</title><p>Depending on the so-called backbone or key enzyme(s) involved in the biosynthesis, SMs are categorized according to the chemical families. They belong to e.g., polyketides, non-ribosomal peptides, terpenes and alkaloids or prenylated tryptophan derivates. Accordingly, they are synthesized by polyketide synthases (PKSs; further divided into highly reducing (HR-PKS) and non-reducing (NR-PKS)), non-ribosomal peptide synthetases (NRPSs), terpene cyclases (TCs) and dimethylallyltryptophan synthases (DMATSs) or hybrids of them [<xref rid="B28-pharmaceutics-14-01837" ref-type="bibr">28</xref>,<xref rid="B29-pharmaceutics-14-01837" ref-type="bibr">29</xref>]. </p><p>Next to the backbone enzyme-encoding gene(s) BGCs often harbor genes involved in self-resistance against a potentially toxic SM produced by the BGC, transport of precursors, intermediates, or the resulting compound [<xref rid="B31-pharmaceutics-14-01837" ref-type="bibr">31</xref>,<xref rid="B32-pharmaceutics-14-01837" ref-type="bibr">32</xref>], transcriptional activation of the biosynthetic genes, and often so-called tailoring or decorating enzymes that modify the structure of the chemical scaffold compound released by the backbone enzyme (e.g., P450 monooxygenases, methyltransferases, hydroxylases, epimerases, etc. [<xref rid="B29-pharmaceutics-14-01837" ref-type="bibr">29</xref>]). </p><p>A few exceptions exist that deviate from this standard configuration. For example, in <italic toggle="yes">Fusarium graminearum</italic>, polyketide synthase PKS8 was shown to be a stand-alone gene that is responsible for the synthesis of gibepyrone A [<xref rid="B33-pharmaceutics-14-01837" ref-type="bibr">33</xref>], while the kojic acid BGC from <italic toggle="yes">Aspergillus oryzae</italic> does not have a backbone enzyme-encoding gene at all [<xref rid="B34-pharmaceutics-14-01837" ref-type="bibr">34</xref>]. In other cases, the formation of superclusters was observed which encode for several independently synthesized biosynthetic products [<xref rid="B35-pharmaceutics-14-01837" ref-type="bibr">35</xref>]. The opposite was also observed, where several BGCs or genes from distinct genomic locations communicate with each other to synthesize one product [<xref rid="B36-pharmaceutics-14-01837" ref-type="bibr">36</xref>].</p><p>Fungi exhibit a very diversified and specialized chemical repertoire. The diversification of BGCs increases with the phylogenetic distance [<xref rid="B37-pharmaceutics-14-01837" ref-type="bibr">37</xref>,<xref rid="B38-pharmaceutics-14-01837" ref-type="bibr">38</xref>] but in some cases, it can even be observed within the same or closely related species, which was shown for <italic toggle="yes">Aspergillus fumigatus</italic> [<xref rid="B39-pharmaceutics-14-01837" ref-type="bibr">39</xref>,<xref rid="B40-pharmaceutics-14-01837" ref-type="bibr">40</xref>], <italic toggle="yes">Aspergillus niger</italic> [<xref rid="B41-pharmaceutics-14-01837" ref-type="bibr">41</xref>] as well as between <italic toggle="yes">A. oryzae</italic> and its close relative <italic toggle="yes">Aspergillus flavus</italic> [<xref rid="B42-pharmaceutics-14-01837" ref-type="bibr">42</xref>]. Constant interactions with other microorganisms and environmental conditions promote the intra and interspecies diversification process by exerting positive or negative selective pressure on BGCs in that specific ecosystem. If a BGC is non-essential or not beneficial in a certain microenvironment it is likely to acquire deleterious mutations or even gene loss over time [<xref rid="B43-pharmaceutics-14-01837" ref-type="bibr">43</xref>]. A comparison of isolates from the same species but separated microenvironments revealed the emergence of different ecotypes as observed during population genetics studies on <italic toggle="yes">Streptomyces</italic> [<xref rid="B44-pharmaceutics-14-01837" ref-type="bibr">44</xref>] and <italic toggle="yes">Umbilicaria pustulata</italic> [<xref rid="B45-pharmaceutics-14-01837" ref-type="bibr">45</xref>].</p><p>BGCs are differently affected by evolution compared to the rest of the genome. They are located outside of so-called syntenic blocks, i.e., their position within the genome, and the BGC itself is less conserved than the rest of the genome [<xref rid="B46-pharmaceutics-14-01837" ref-type="bibr">46</xref>,<xref rid="B47-pharmaceutics-14-01837" ref-type="bibr">47</xref>]. In support of this, many BGCs were found to be enriched in sub-telomeric regions which are known to be hotspots for recombination [<xref rid="B48-pharmaceutics-14-01837" ref-type="bibr">48</xref>]. This was shown in <italic toggle="yes">Sclerotinia sclerotium</italic> [<xref rid="B49-pharmaceutics-14-01837" ref-type="bibr">49</xref>], <italic toggle="yes">Magnaporthe oryzae</italic> [<xref rid="B50-pharmaceutics-14-01837" ref-type="bibr">50</xref>,<xref rid="B51-pharmaceutics-14-01837" ref-type="bibr">51</xref>], <italic toggle="yes">A. fumigatus</italic> [<xref rid="B52-pharmaceutics-14-01837" ref-type="bibr">52</xref>], and <italic toggle="yes">Zymoseptoria tritici</italic> [<xref rid="B53-pharmaceutics-14-01837" ref-type="bibr">53</xref>].</p><p>From an evolutionary perspective, the ability to quickly adapt to new environmental challenges is fundamental for the survival of an organism. In the case of fungi and other microbes, this means that they can adapt and change their metabolomic arsenal fast enough to properly compete against other microbes or environmental changes. This implies that the relevant genomic regions and hence the genes situated in these regions (i.e., BGCs) experience regular mutations (single nucleotide polymorphisms (SNPs) such as missense, nonsense, frameshift, or gain/loss of function) and genomic rearrangements as for instance gene duplications, gene or BGC loss, BGC rearrangements, pseudogenization events and also the acquisition of genetic material via horizontal gene transfer [<xref rid="B43-pharmaceutics-14-01837" ref-type="bibr">43</xref>]. Organisms that acquire beneficial mutations will surpass others that experience disadvantageous ones whereby the environmental context decides if a certain mutation is beneficial or not. Microbial competition is not only about having the &#x0201c;best weaponry&#x0201d; but also about defense, resource efficiency, and denying beneficial effects to competitors. This not only implies gain of function or the <italic toggle="yes">de novo</italic> assembly of a BGC but also reductive genomic evolution which led to the &#x0201c;Black Queen Hypothesis&#x0201d; (BQH) [<xref rid="B54-pharmaceutics-14-01837" ref-type="bibr">54</xref>]. The BQH considers that selective pressure can lead to the loss of a gene or function if that gene is dispensable (which makes it more energy efficient not to have it), or if the gene product would give a competitor more benefits than the producing organism itself.</p><p>For the artificial activation of silent BGCs in a laboratory context, this means that some of the BGCs will carry deleterious mutations or even miss whole genes that would be necessary for the biosynthesis of the BGC product. In these cases, solely transcriptional activation will not suffice. Close examination of the BGC of interest can already unveil if genes carry a premature stop codon or if homologous BGCs indicate missing genes or frameshift mutations. A possible workaround in these scenarios is the exchange of single genes by their homologs or the genetic repair of a nonsense mutation as performed by Burkhardt et al. with the STC5 gene in <italic toggle="yes">Fusarium fujikuroi</italic> [<xref rid="B55-pharmaceutics-14-01837" ref-type="bibr">55</xref>].</p><p>Multiple genomic, inter-species, and environmental factors contribute to this elevated diversification and evolution of BGCs. The occurrence of mutations and genomic rearrangements depend on many exogenous (e.g., radiation, heat, chemicals, environmental conditions, &#x02026;) and endogenous factors (e.g., errors in DNA damage repair, or active transposable elements). As stated above, BGCs and pathogenicity-related genes are often in polymorphic regions that are prone to such events (e.g., sub-telomeric regions). Transposable elements (TEs) play an important role during evolution and also in the de novo assembly of BGCs. In <italic toggle="yes">Verticillium dahliae</italic> it was found that BGC and pathogenicity-related genes are often located close to transposable elements [<xref rid="B56-pharmaceutics-14-01837" ref-type="bibr">56</xref>]. In a comparative study within <italic toggle="yes">Aspergillus fumigatus</italic> isolates, horizontally transferred BGCs, BGC idiomorphs (i.e., different BGCs in the same genomic location), and BGCs that are present in different genomic locations within the same or closely related species) are often flanked by TEs [<xref rid="B39-pharmaceutics-14-01837" ref-type="bibr">39</xref>]. Similar findings were also found between <italic toggle="yes">A. oryzae</italic> and <italic toggle="yes">A flavus</italic> where two strain isolates had different BGCs in the same genomic locus [<xref rid="B42-pharmaceutics-14-01837" ref-type="bibr">42</xref>] or in the case of several <italic toggle="yes">Botrytis</italic> species where the BOT BGC, involved in botrydial biosynthesis, was present at four different genomic locations across seven examined species [<xref rid="B57-pharmaceutics-14-01837" ref-type="bibr">57</xref>,<xref rid="B58-pharmaceutics-14-01837" ref-type="bibr">58</xref>]. When analyzing BGC genes and TE co-occurrence in <italic toggle="yes">Sclerotinia,</italic> they found that the overall co-occurrence of BGC genes and TEs is not significantly enhanced. Upon closer examination, however, it became evident that a subset of BGC genes, which is enriched in key-enzyme encoding genes, is co-occurrent with TEs and that genes in this subset often derive from recent gene duplication events [<xref rid="B49-pharmaceutics-14-01837" ref-type="bibr">49</xref>]. BGC genes near TEs, therefore, were found less conserved than BGC genes more distal to the TE. All these findings point towards a TE-dependent heterogeneous evolution of BGCs (i.e., genes near TEs have an increased &#x0201c;evolutionary speed&#x0201d;). In the case of BGC prediction, TEs are, to our knowledge, not yet a considered factor, although it seems that these motives could very likely be good indicators for the presence of a BGC. Furthermore, TEs are probably also important factors for the de novo assembly of BGCs. </p><p>De novo assembly is hypothesized to be a two-step process. The first step starts with the framework establishment of the new metabolic pathway [<xref rid="B59-pharmaceutics-14-01837" ref-type="bibr">59</xref>]. Often, this is accomplished by horizontal gene transfer, as shown for the sterigmatocystin cluster from <italic toggle="yes">A. nidulans</italic> to <italic toggle="yes">Podospora</italic> [<xref rid="B60-pharmaceutics-14-01837" ref-type="bibr">60</xref>], or the transfer of the bikaverin BGC from <italic toggle="yes">Fusarium</italic> to <italic toggle="yes">Botrytis</italic> [<xref rid="B61-pharmaceutics-14-01837" ref-type="bibr">61</xref>] and many others [<xref rid="B59-pharmaceutics-14-01837" ref-type="bibr">59</xref>,<xref rid="B62-pharmaceutics-14-01837" ref-type="bibr">62</xref>,<xref rid="B63-pharmaceutics-14-01837" ref-type="bibr">63</xref>,<xref rid="B64-pharmaceutics-14-01837" ref-type="bibr">64</xref>,<xref rid="B65-pharmaceutics-14-01837" ref-type="bibr">65</xref>,<xref rid="B66-pharmaceutics-14-01837" ref-type="bibr">66</xref>]). Other mechanisms involve the recruitment of host genes or gene duplication events (e.g., fatty acid synthase as ancestor of PKS enzymes [<xref rid="B67-pharmaceutics-14-01837" ref-type="bibr">67</xref>]). In a second step, the BGC is clustered by genomic rearrangements. Sometimes, however, it also happens that two separate BGCs, which are not physically linked, are responsible for the biosynthesis of one compound (i.e., cluster crosstalk) [<xref rid="B36-pharmaceutics-14-01837" ref-type="bibr">36</xref>] or that superclusters (e.g., fumagillin/pseurotin cluster from <italic toggle="yes">Aspergillus fumigatus</italic> [<xref rid="B35-pharmaceutics-14-01837" ref-type="bibr">35</xref>]) are formed. Cluster crosstalk could be observed with the trichothecene supercluster of <italic toggle="yes">F. graminearum</italic> which consists of a 12 gene BGC and a separated 2 gene BGC plus one single gene at three different genomic loci [<xref rid="B68-pharmaceutics-14-01837" ref-type="bibr">68</xref>].</p><p>All in all, the genomic comparative studies from <italic toggle="yes">A. fumigatus</italic> [<xref rid="B39-pharmaceutics-14-01837" ref-type="bibr">39</xref>], <italic toggle="yes">A. flavus</italic> and <italic toggle="yes">A. oryzae</italic> [<xref rid="B42-pharmaceutics-14-01837" ref-type="bibr">42</xref>], <italic toggle="yes">S. sclerotiorum</italic> [<xref rid="B49-pharmaceutics-14-01837" ref-type="bibr">49</xref>], <italic toggle="yes">V. dahlia</italic> [<xref rid="B56-pharmaceutics-14-01837" ref-type="bibr">56</xref>], and also the reviews from Lind et al. [<xref rid="B39-pharmaceutics-14-01837" ref-type="bibr">39</xref>] and Rokas et al. [<xref rid="B43-pharmaceutics-14-01837" ref-type="bibr">43</xref>] give very good insights into the evolution of BGCs and especially the role of TEs as one of their driving forces.</p><p>The fact that this evolutionarily driven arms-race is not only apparent between closely related species but also between different ecotypes of the same species illustrates that BGCs are evolving at a fast pace. This highlights that the research pool of fungal genera and species must be expanded to increase the chance of finding novel natural products in the future. However, most of the current research is focused on mining BGCs in only a few but very well-described genera, the so-called model organisms.</p><p>In this review, we highlight the concepts and technical possibilities on how to decrypt the secondary metabolome of a given (filamentous) fungus by efficiently deploying targeted and untargeted BGC-activation methods in synergy with genome mining. Special attention will be paid to more recent strategies involving the chromatin regulation of BGCs and the new possibilities currently emerging by the combination of CRISPR/Cas technology and transcriptional activators, global regulators, or chromatin-modifying enzymes.</p></sec></sec><sec id="sec2-pharmaceutics-14-01837"><title>2. Deciphering the Genomic Potential of Fungal Genomes for Secondary Metabolites </title><p><underline>In silico-prediction of BGCs</underline> within the genome of the target fungus gives important information about the (theoretical) chemical potential of a fungus. This is not only important for deciding if a species is a promising candidate for novel bioactive compounds but is also a prerequisite for linking those compounds to a specific cluster and also for targeted BGC activation. Bioinformatic analyses of high-quality genome sequences and transcriptome datasets are becoming cornerstones to explore the theoretical chemical diversity of SMs in a given species. Those resources are routinely used today for gene annotation [<xref rid="B69-pharmaceutics-14-01837" ref-type="bibr">69</xref>], BGC prediction [<xref rid="B70-pharmaceutics-14-01837" ref-type="bibr">70</xref>], cluster phylogeny [<xref rid="B28-pharmaceutics-14-01837" ref-type="bibr">28</xref>,<xref rid="B71-pharmaceutics-14-01837" ref-type="bibr">71</xref>,<xref rid="B72-pharmaceutics-14-01837" ref-type="bibr">72</xref>], prediction of the metabolite structure and bioactivity [<xref rid="B73-pharmaceutics-14-01837" ref-type="bibr">73</xref>], drug target predictions [<xref rid="B74-pharmaceutics-14-01837" ref-type="bibr">74</xref>,<xref rid="B75-pharmaceutics-14-01837" ref-type="bibr">75</xref>] and also dereplication [<xref rid="B76-pharmaceutics-14-01837" ref-type="bibr">76</xref>]. As outlined in <xref rid="sec1dot2-pharmaceutics-14-01837" ref-type="sec">Section 1.2</xref>, there are many different data types and sources that can be utilized for the prediction of BGCs. In the following paragraph, we will describe the basic principle and the developmental cycle of BGC prediction tools. </p><p><xref rid="pharmaceutics-14-01837-f001" ref-type="fig">Figure 1</xref> illustrates the workflow of genome mining-assisted BGC prediction and revelation. It comprises the crucial steps that are necessary for the prediction and verification of a BGC and its corresponding metabolite. It also shows the pitfalls which can easily remain unnoticed but significantly impact the reliability of the prediction.</p><sec><title>BGC Prediction Methods</title><p>The majority of BGC prediction tools can be classified into either high-confidence/low-novelty (rule-based) or low-confidence/high-novelty (rule-independent) [<xref rid="B70-pharmaceutics-14-01837" ref-type="bibr">70</xref>,<xref rid="B77-pharmaceutics-14-01837" ref-type="bibr">77</xref>]. </p><p><underline>High-confidence/low novelty methods</underline> reliably detect BGCs that are closely related to already verified cluster types (i.e., PKS; NRPS, etc.) by scanning the genome for their specific signatures (genes, gene types, genomic arrangement, etc.). These signatures are retrieved from experimentally verified data that links the compound to the respective BGC, which are then implemented into the algorithm. The prediction tool antiSMASH [<xref rid="B78-pharmaceutics-14-01837" ref-type="bibr">78</xref>] is a very well-established and regularly updated platform that also integrates many other published algorithms. It can be used for fungal, plant, and bacterial genomes and contains methods for finding canonical and also novel BGCs. During the prediction of known BGC types, the procedure often starts with an initial screen for <underline>backbone enzyme-encoding genes</underline> which serve as anchor-point for further analysis of the region. In a second step, the cluster borders are determined by scanning the area around this anchor point for the presence of other BGC-related genes [<xref rid="B78-pharmaceutics-14-01837" ref-type="bibr">78</xref>,<xref rid="B79-pharmaceutics-14-01837" ref-type="bibr">79</xref>]. This means, however, that high-confidence/low-novelty (rule-based) methods can only detect BGCs that share similarities with already discovered and described cluster types</p><p>In contrast to this, <underline>low-confidence/high-novelty (rule-independent methods)</underline> pursue the aim of detecting BGCs of a novel yet unknown type that does not follow currently known patterns (gene types, arrangement, etc.). There are multiple strategies for finding new BGC types that use various experimental and -omics data for this purpose. </p><p><underline>MIPS-CG</underline>, for example, utilizes an algorithm that does not rely on the use of backbone genes as BGC-anchor points as some BGCs were shown to lack these (e.g., kojic acid BGC). Instead, to identify these non-canonical BGCs, MIPS-CG performs pairwise genome comparisons between different fungal species and removes <underline>syntenic blocks</underline>, because BGCs are often not located in such regions. Following the assumption that BGCs follow a basic common structure (similar gene functions) MIPS-CG scans for clustered genes that follow this pattern [<xref rid="B47-pharmaceutics-14-01837" ref-type="bibr">47</xref>]. </p><p>The <underline>EvoMining</underline> algorithm uses a <underline>phylogenomic</underline> approach to detect BGCs. It is based on three evolutionary concepts. First, those new enzymatic functions evolve by retaining the reaction mechanism of the enzyme but changing substrate specificity. Second, the evolution of metabolic pathways can lead to the deployment of existing enzyme families that perform new functions (e.g., fatty acid synthases as the ancestor of PKSs) and third, that BGCs have their origin in central metabolism [<xref rid="B71-pharmaceutics-14-01837" ref-type="bibr">71</xref>,<xref rid="B80-pharmaceutics-14-01837" ref-type="bibr">80</xref>].</p><p>AntiSMASH version 4 introduced the <underline>Clusterfinder</underline> algorithm which converts a genome into a string of <underline>Pfam domains</underline> (i.e., protein family domains). Subsequently, BGCs are annotated where stretches with a significant amount of BGC-related Pfam domains occur [<xref rid="B81-pharmaceutics-14-01837" ref-type="bibr">81</xref>,<xref rid="B82-pharmaceutics-14-01837" ref-type="bibr">82</xref>]. </p><p>The <underline>ARTS</underline> algorithm (Antibiotic Resistant Target Seeker), although currently supporting only bacterial genomes, is a tool for specifically finding BGCs that encode for an antibiotic. When bacteria produce an antibiotic substance, they can either detoxify and shuttle the compound out of the cell or express a <underline>resistant homolog</underline> of the gene that is targeted by the antibiotic. The resistance pathway is exploited by ARTS. The algorithm compares the genome to a reference genome and looks for duplicate housekeeping genes in the genome. These resistant homologs often are inside the same BGC. Furthermore, the cluster is often acquired by horizontal gene transfer (HGT). With the combination of BGC prediction via antiSMASH, gene duplicate screening and the comparison of the <underline>phylogeny</underline> of core gene trees of the organism and the cluster genes, ARTS can predict clusters that are highly likely to be responsible for the biosynthesis of an antibiotic [<xref rid="B83-pharmaceutics-14-01837" ref-type="bibr">83</xref>,<xref rid="B84-pharmaceutics-14-01837" ref-type="bibr">84</xref>]. The <underline>FRIGG</underline> pipeline pursues a similar approach but can be used for fungal genomes [<xref rid="B85-pharmaceutics-14-01837" ref-type="bibr">85</xref>]. </p><p><underline>Middas-M</underline> follows the hypothesis that BGCs can be found where an array of genes is coregulated. They combine <underline>transcriptomic data</underline> of several culture conditions with genomic data to predict BGCs [<xref rid="B86-pharmaceutics-14-01837" ref-type="bibr">86</xref>]. This method will, however, only catch BGCs that actually can be activated under laboratory conditions. </p><p>Algorithms use various curated but also non-curated data sources for their calculation of BGC genes. These data repositories can basically hold any kind of information about BGCs (e.g., gene information, genomic arrangement, related species, protein information, educts and products, transcriptional information, phylogenetics, environmental information, etc.). Curated data sources contain fewer data entries, but the reliability and quality of these entries are often pristine, non-redundant, and experimentally backed which leads to more reliable predictions. Non-curated data sources basically hold all the information that is available (e.g., Genbank). This means that the algorithm has to process and filter a lot of data of various quality and actuality (e.g., low-quality sequencing data and annotation, experimentally not verified predictions, etc.). Depending on the popularity of the examined genus this also can lead to many redundancies that might contain flawed information. All in all, non-curated sources contain more, but less reliable data which can reduce the quality and reliability of the prediction.</p><p>It should be mentioned that, as the experimental information about a novel BGC type increases, it will subsequently pass over from the rule-independent (high novelty/low confidence) to the rule-based (low novelty/ high confidence) prediction methods. This developmental process of prediction tools will undoubtedly lead to the discovery of yet unknown BGCs in already known and well-described species; however, it is strongly dependent on high-quality and accurate experimental data, provided by laboratories. The elucidation of novel BGC types and their genomic signatures, plus their proper deposit in data repositories (e.g., MiBiG, NP-atlas 2.0, GNPS, etc.) will significantly improve BGC predictions in the future. For more detailed information about genome mining and predictive tools, please consult the review of Blin and coworkers from 2019 [<xref rid="B70-pharmaceutics-14-01837" ref-type="bibr">70</xref>].</p><p><xref rid="pharmaceutics-14-01837-t001" ref-type="table">Table 1</xref> lists many of the actual databases and BGC prediction tools. They are ordered according to their last update (Status: March 2022), and also summarizes their characteristics.</p></sec></sec><sec id="sec3-pharmaceutics-14-01837"><title>3. Activation of Microbial BGCs via Environmental Triggers</title><p>In the past decades, many strategies have been developed to shed light on this &#x0201c;dark matter&#x0201d; in fungal genomes and thereby unlock the chemical wealth residing within the fungal kingdom. In the pre-genomics era approaches predominantly sought to induce SM biosynthesis by mimicking environmental triggers. Genome sequencing and bioinformatic analyses for BGC predictions were developed later on and did not only reveal that filamentous fungi possess far more BGCs than anticipated, but also opened opportunities for a more targeted activation of single BGCs. </p><p>We are now at a point where the combination of technological possibilities, abundance of available methods, and the already substantial amount of collected data makes it possible to expand the research to novel yet not well described fungal species. There is no &#x0201c;one for all&#x0201d;-approach that is superior to other strategies, but available methods should rather be used in a complementary and context-dependent manner.</p><sec id="sec3dot1-pharmaceutics-14-01837"><title>3.1. Mimicking Natural Habitats and Stress Conditions</title><p>Fungal SMs serve different purposes during the life cycle of a fungal colony and accordingly, their production profiles somehow mirror these environmental or developmental conditions. Therefore, one of the approaches to trigger the production of new SMs is to impose challenging, sometimes stressful growth conditions on the fungal cells. Indeed, testing different cultivation conditions and imposing environmental stress has proven to be a very effective way of triggering the production of otherwise absent secondary metabolites. This approach was termed &#x0201c;One Strain-Many Compounds&#x0201d; (OSMAC) [<xref rid="B115-pharmaceutics-14-01837" ref-type="bibr">115</xref>,<xref rid="B116-pharmaceutics-14-01837" ref-type="bibr">116</xref>] and is very useful for assessing which BGCs can be induced within a laboratory environment and which need more laborsome methods such as genetic manipulation for their activation. Especially in the case of less-studied fungi that are in the process of being established for laboratory work, different cultivation conditions also give insights into the fungal physiology and suitable media and parameters for their cultivation. </p><p>In some instances, it was shown that the fungus reacted as expected to the applied conditions. For example, UV light exposure can trigger the production of UV protectants [<xref rid="B117-pharmaceutics-14-01837" ref-type="bibr">117</xref>], while oxidative stress can lead to the production of antioxidants [<xref rid="B118-pharmaceutics-14-01837" ref-type="bibr">118</xref>]. It was also shown that <italic toggle="yes">A. terreus</italic> produces the pathogenesis-related SM terrain when fungal culture conditions mimic the environment of the plant or rhizosphere, which is associated with nitrogen starvation, iron shortage, and the presence of methionine [<xref rid="B119-pharmaceutics-14-01837" ref-type="bibr">119</xref>]. </p><p>Environmental stimuli are generally processed via <underline>global regulators</underline>. The purpose of global regulators is to coordinate the expression of an array of genes that ensure a resource-efficient response that is suited to the environmental circumstances [<xref rid="B120-pharmaceutics-14-01837" ref-type="bibr">120</xref>,<xref rid="B121-pharmaceutics-14-01837" ref-type="bibr">121</xref>]. Therefore, instead of mimicking such stimuli via media and cultivation conditions, the genetic engineering of global regulators (i.e., deletion, overexpression, knockdown, mutation) is also a successful way of triggering the activation of BGCs. This, however, can also lead to phenotypical abnormalities such as aberrant sexual and asexual cycle and growth defects [<xref rid="B122-pharmaceutics-14-01837" ref-type="bibr">122</xref>,<xref rid="B123-pharmaceutics-14-01837" ref-type="bibr">123</xref>] which could be linked to the intertwined character of many global regulatory networks [<xref rid="B29-pharmaceutics-14-01837" ref-type="bibr">29</xref>]. </p><p>The most thoroughly researched environmental signals that are connected to the production of fungal metabolites are nutrient availability and light regulation. </p><p>The type and concentration of the available <underline>nitrogen source</underline> also greatly impacts secondary metabolism, as shown for some well-established model organisms from the genus <italic toggle="yes">Fusarium</italic> [<xref rid="B124-pharmaceutics-14-01837" ref-type="bibr">124</xref>,<xref rid="B125-pharmaceutics-14-01837" ref-type="bibr">125</xref>,<xref rid="B126-pharmaceutics-14-01837" ref-type="bibr">126</xref>,<xref rid="B127-pharmaceutics-14-01837" ref-type="bibr">127</xref>] and <italic toggle="yes">Aspergillus</italic> [<xref rid="B128-pharmaceutics-14-01837" ref-type="bibr">128</xref>]. The major GATA transcription factor AreA, AreB, and Nmr are global regulators of nitrogen-dependent genes and pathways in filamentous fungi. In <italic toggle="yes">F. fujikuroi</italic>, deletion of <italic toggle="yes">AREA</italic> and <italic toggle="yes">AREB</italic> led to differential regulation of many known but also yet cryptic BGCs [<xref rid="B127-pharmaceutics-14-01837" ref-type="bibr">127</xref>]. In <italic toggle="yes">F. graminearum</italic>, AreA is required for the production of deoxynivalenol (DON), zearalenone, and fusarielin H [<xref rid="B129-pharmaceutics-14-01837" ref-type="bibr">129</xref>]. Similar results were obtained in <italic toggle="yes">Acremonium chrysogenum</italic> where the deletion of <italic toggle="yes">areA</italic> led to the reduction of cephalosporin [<xref rid="B130-pharmaceutics-14-01837" ref-type="bibr">130</xref>] and in <italic toggle="yes">Fusarium oxysporum</italic> where AreA is necessary for the synthesis of beauvericin and ferricrocin [<xref rid="B131-pharmaceutics-14-01837" ref-type="bibr">131</xref>].</p><p><underline>Light</underline> is also an important natural regulator of growth, development/conidiation and biosynthesis of natural products in fungi [<xref rid="B132-pharmaceutics-14-01837" ref-type="bibr">132</xref>,<xref rid="B133-pharmaceutics-14-01837" ref-type="bibr">133</xref>,<xref rid="B134-pharmaceutics-14-01837" ref-type="bibr">134</xref>,<xref rid="B135-pharmaceutics-14-01837" ref-type="bibr">135</xref>,<xref rid="B136-pharmaceutics-14-01837" ref-type="bibr">136</xref>]. Genetic manipulation of components of the fungal-specific light regulator velvet complex showed its involvement in many developmental and also biosynthetic processes [<xref rid="B137-pharmaceutics-14-01837" ref-type="bibr">137</xref>,<xref rid="B138-pharmaceutics-14-01837" ref-type="bibr">138</xref>,<xref rid="B139-pharmaceutics-14-01837" ref-type="bibr">139</xref>,<xref rid="B140-pharmaceutics-14-01837" ref-type="bibr">140</xref>,<xref rid="B141-pharmaceutics-14-01837" ref-type="bibr">141</xref>]. It consists of velvet-like proteins like, VelA, VelB and most importantly, the methyltransferase LaeA. Deletion of <italic toggle="yes">laeA</italic> in <italic toggle="yes">A. nidulans</italic>, resulted in the abolishment of the production of sterigmatocystin, penicillin, and lovastatin while overexpression of <italic toggle="yes">laeA</italic> led to increased lovastatin and penicillin production [<xref rid="B142-pharmaceutics-14-01837" ref-type="bibr">142</xref>]. Similarly, LaeA was also found to be a positive regulator of secondary metabolism in <italic toggle="yes">Valsa mali</italic> [<xref rid="B143-pharmaceutics-14-01837" ref-type="bibr">143</xref>], <italic toggle="yes">Aspergillus ochraceus</italic> [<xref rid="B136-pharmaceutics-14-01837" ref-type="bibr">136</xref>], <italic toggle="yes">Penicillium expansum</italic> [<xref rid="B144-pharmaceutics-14-01837" ref-type="bibr">144</xref>], <italic toggle="yes">Chaetomium globosum</italic> [<xref rid="B145-pharmaceutics-14-01837" ref-type="bibr">145</xref>], <italic toggle="yes">Fusarium verticillioides</italic> [<xref rid="B146-pharmaceutics-14-01837" ref-type="bibr">146</xref>] <italic toggle="yes">and F. fujikuroi</italic> [<xref rid="B147-pharmaceutics-14-01837" ref-type="bibr">147</xref>]. Therefore, LaeA seems to have a conserved role of a positive regulator of BGCs in many filamentous fungi which makes it a promising target for overexpression studies. </p><p>Other variables influencing SM levels are the <underline>pH value</underline> of the growth medium [<xref rid="B148-pharmaceutics-14-01837" ref-type="bibr">148</xref>,<xref rid="B149-pharmaceutics-14-01837" ref-type="bibr">149</xref>,<xref rid="B150-pharmaceutics-14-01837" ref-type="bibr">150</xref>,<xref rid="B151-pharmaceutics-14-01837" ref-type="bibr">151</xref>,<xref rid="B152-pharmaceutics-14-01837" ref-type="bibr">152</xref>,<xref rid="B153-pharmaceutics-14-01837" ref-type="bibr">153</xref>], an effect mainly mediated by the transcription factor (TF) PacC [<xref rid="B154-pharmaceutics-14-01837" ref-type="bibr">154</xref>,<xref rid="B155-pharmaceutics-14-01837" ref-type="bibr">155</xref>,<xref rid="B156-pharmaceutics-14-01837" ref-type="bibr">156</xref>], <underline>temperature stress</underline> [<xref rid="B118-pharmaceutics-14-01837" ref-type="bibr">118</xref>,<xref rid="B157-pharmaceutics-14-01837" ref-type="bibr">157</xref>,<xref rid="B158-pharmaceutics-14-01837" ref-type="bibr">158</xref>], <underline>osmotic stress,</underline> and <underline>salinity</underline> [<xref rid="B159-pharmaceutics-14-01837" ref-type="bibr">159</xref>,<xref rid="B160-pharmaceutics-14-01837" ref-type="bibr">160</xref>,<xref rid="B161-pharmaceutics-14-01837" ref-type="bibr">161</xref>,<xref rid="B162-pharmaceutics-14-01837" ref-type="bibr">162</xref>], or <underline>metals and trace elements</underline> [<xref rid="B163-pharmaceutics-14-01837" ref-type="bibr">163</xref>,<xref rid="B164-pharmaceutics-14-01837" ref-type="bibr">164</xref>,<xref rid="B165-pharmaceutics-14-01837" ref-type="bibr">165</xref>,<xref rid="B166-pharmaceutics-14-01837" ref-type="bibr">166</xref>]. The concentration and quality of the available <underline>carbon source</underline> can also be a critical parameter [<xref rid="B135-pharmaceutics-14-01837" ref-type="bibr">135</xref>,<xref rid="B167-pharmaceutics-14-01837" ref-type="bibr">167</xref>,<xref rid="B168-pharmaceutics-14-01837" ref-type="bibr">168</xref>] for SM production which is mediated by the carbon catabolite repressor CreA [<xref rid="B122-pharmaceutics-14-01837" ref-type="bibr">122</xref>]. For <underline>oxidative stress</underline> [<xref rid="B118-pharmaceutics-14-01837" ref-type="bibr">118</xref>,<xref rid="B123-pharmaceutics-14-01837" ref-type="bibr">123</xref>,<xref rid="B169-pharmaceutics-14-01837" ref-type="bibr">169</xref>,<xref rid="B170-pharmaceutics-14-01837" ref-type="bibr">170</xref>,<xref rid="B171-pharmaceutics-14-01837" ref-type="bibr">171</xref>] Skn7 [<xref rid="B172-pharmaceutics-14-01837" ref-type="bibr">172</xref>] and ApyapA/AoyapA (Aflatoxin production) are known response regulators [<xref rid="B173-pharmaceutics-14-01837" ref-type="bibr">173</xref>,<xref rid="B174-pharmaceutics-14-01837" ref-type="bibr">174</xref>]. There are general repressors such as McrA, but the conditions for its activity remain unknown [<xref rid="B175-pharmaceutics-14-01837" ref-type="bibr">175</xref>] or Nsd1(CsM1/Ltf1) which is involved in sexual development and conidiation in <italic toggle="yes">A. nidulans</italic> and other fungi [<xref rid="B176-pharmaceutics-14-01837" ref-type="bibr">176</xref>]. </p><p>Apart from media composition, the type of <underline>cultivation condition</underline> also can play a pivotal role in the physiology of the fungus and thus potentially influence the production of secondary metabolites. Differences in the metabolomic profiles could be observed when comparing submerse and solid cultivation [<xref rid="B177-pharmaceutics-14-01837" ref-type="bibr">177</xref>,<xref rid="B178-pharmaceutics-14-01837" ref-type="bibr">178</xref>], as well as between agitated or static fermentation [<xref rid="B179-pharmaceutics-14-01837" ref-type="bibr">179</xref>]. The addition of a polymeric growth support to a submersed culture also had profound influences on growth and metabolite biosynthesis [<xref rid="B180-pharmaceutics-14-01837" ref-type="bibr">180</xref>].</p><p><xref rid="pharmaceutics-14-01837-t002" ref-type="table">Table 2</xref> provides an overview on methods and examples where they have been used to successfully induce BGCs by mimicking natural triggers or by genetic manipulation of global regulators.</p></sec><sec id="sec3dot2-pharmaceutics-14-01837"><title>3.2. Co-Cultivation</title><p>During co-cultivation [<xref rid="B116-pharmaceutics-14-01837" ref-type="bibr">116</xref>,<xref rid="B211-pharmaceutics-14-01837" ref-type="bibr">211</xref>,<xref rid="B212-pharmaceutics-14-01837" ref-type="bibr">212</xref>], microorganisms are brought into an interactive environment with the aim to mimic natural competition that can also trigger the production of SMs. There are several possible setups for co-cultivation. One approach uses (random) pairwise co-cultivation of strains [<xref rid="B213-pharmaceutics-14-01837" ref-type="bibr">213</xref>] (<xref rid="pharmaceutics-14-01837-t003" ref-type="table">Table 3</xref>; Setup 1). A second approach tests a strain collection against certain microorganisms of interest, such as (antibiotic-resistant) pathogens [<xref rid="B214-pharmaceutics-14-01837" ref-type="bibr">214</xref>,<xref rid="B215-pharmaceutics-14-01837" ref-type="bibr">215</xref>] (<xref rid="pharmaceutics-14-01837-t003" ref-type="table">Table 3</xref>; Setup 2). A third approach cultivates strains together with the (sterile-filtrated or extracted) culture supernatants of other microorganisms. The latter approach can be necessary if cultivation or media requirements of the individual species are not compatible for simultaneous cultivation or if the mechanisms of the induction of SMs (e.g., physical interaction or presence of a compound) is being investigated [<xref rid="B216-pharmaceutics-14-01837" ref-type="bibr">216</xref>] (<xref rid="pharmaceutics-14-01837-t003" ref-type="table">Table 3</xref>; Setup 3). This latter strategy was just recently chosen in our laboratory resulting in the identification of the signaling molecule, that triggers the fungal response in the interaction between the bacterium <italic toggle="yes">Streptomyces rapamycinicus</italic> and the filamentous ascomycete <italic toggle="yes">A. nidulans</italic> [<xref rid="B184-pharmaceutics-14-01837" ref-type="bibr">184</xref>]. Another fruitful concept is the co-cultivation of a fungus with a bacteriophage (i.e., infection) which led to the production of a novel SM [<xref rid="B217-pharmaceutics-14-01837" ref-type="bibr">217</xref>]. Co-cultivation can be very challenging due to the sheer endless combinatorial numbers of specimens and cultivation parameters that have to fit both organisms. However, if the co-cultivation approach is already well established, it can be a very powerful and rewarding tool. <xref rid="pharmaceutics-14-01837-t003" ref-type="table">Table 3</xref> lists publications that successfully applied co-cultivation approaches for the activation of BGCs. </p></sec><sec id="sec3dot3-pharmaceutics-14-01837"><title>3.3. Conclusions of Initial Assessment</title><p>OSMAC approaches, paired with metabolome analysis, transcriptome analysis, and bioinformatic methods can already create an extensive map of the secondary metabolome that is produced in a laboratory environment. To discriminate already known compounds from putatively new compounds, exact masses of the new compounds are compared to masses from already described compounds. This can be performed in the lab by screening against a library of SM standards [<xref rid="B234-pharmaceutics-14-01837" ref-type="bibr">234</xref>] or by applying bioinformatic tools such as PRISM 4 [<xref rid="B235-pharmaceutics-14-01837" ref-type="bibr">235</xref>] or DEREPLICATOR+ [<xref rid="B76-pharmaceutics-14-01837" ref-type="bibr">76</xref>]. </p><p>After this initial assessment, the remaining cryptic BGCs can then be targeted by molecular biology methods for releasing the full bioactive potential of the target organism.</p></sec></sec><sec id="sec4-pharmaceutics-14-01837"><title>4. BGC Activation Using Molecular Biology Tools: The Way to Fully Exploit the Genome for Novel Bioactive Substances </title><p>Applying molecular biology tools for genetic engineering enables the alteration of regulatory mechanisms at the genomic or epigenetic layer. This way, cryptic BGCs not transcribed under any tested laboratory condition can be activated in the native host by the manipulation of global regulators, pathway-specific regulators, chromatin modifiers, or by disruption of a repressive signaling pathway. Furthermore, if the fungus is not amenable to any approach that requires genetic transformation, the whole BGC may be transferred to and expressed in another organism (i.e., heterologous expression). There are <underline>untargeted methods</underline> that result in a global metabolomic and transcriptional response (e.g., deletion of global repressor or overexpression of global activator) and there are <underline>targeted methods</underline>, that aim to activate only a specific BGC by manipulating regulatory elements of the BGC (e.g., overexpression of pathway-specific transcription factor (TF)). The advantage of targeted methods is that changes in the metabolome can be much more easily linked to the BGC under study. <xref rid="pharmaceutics-14-01837-f002" ref-type="fig">Figure 2</xref> illustrates the molecular genetic methods for the activation of silent BGCs. </p><sec id="sec4dot1-pharmaceutics-14-01837"><title>4.1. Overexpression of a Pathway Specific Transcription Factor or Whole BGC</title><p>By overexpression of a pathway-specific TF, the whole cluster may be upregulated. This strategy was shown to be successful in increasing the production of aflatoxin in <italic toggle="yes">A. flavus</italic> [<xref rid="B236-pharmaceutics-14-01837" ref-type="bibr">236</xref>] and also led to the discovery of aspyridone [<xref rid="B237-pharmaceutics-14-01837" ref-type="bibr">237</xref>], and asperfuranone in <italic toggle="yes">A. nidulans</italic> [<xref rid="B238-pharmaceutics-14-01837" ref-type="bibr">238</xref>] or trichosetin in <italic toggle="yes">F. fujikuroi</italic> [<xref rid="B239-pharmaceutics-14-01837" ref-type="bibr">239</xref>]. Further examples can be retrieved from <xref rid="pharmaceutics-14-01837-t004" ref-type="table">Table 4</xref>.</p><p>Bioinformatic analyses revealed that in the case of the genus <italic toggle="yes">Aspergillus</italic> 50% to up to 70% of the BGCs contain a <underline>pathway-specific TF</underline> [<xref rid="B240-pharmaceutics-14-01837" ref-type="bibr">240</xref>,<xref rid="B241-pharmaceutics-14-01837" ref-type="bibr">241</xref>]. Co-expression studies under different conditions in <italic toggle="yes">Aspergillus niger,</italic> however, provided evidence that eight of 45 BGCs that contain a TF, show no co-expression between the BGC-synthetic genes and the TF, which indicates that they are not affiliated with the BGC and hence, overexpression would not lead to its activation [<xref rid="B242-pharmaceutics-14-01837" ref-type="bibr">242</xref>]. This hypothesis is supported by a publication where overexpression of the pathway-specific TF failed in 15 of 18 cases in <italic toggle="yes">A. nidulans</italic> [<xref rid="B243-pharmaceutics-14-01837" ref-type="bibr">243</xref>]. This approach also fails if the TF needs to get post-translationally activated, as it is the case with AflR, the pathway-specific TF of the sterigmatocystin cluster of <italic toggle="yes">A. nidulans,</italic> which is inactivated by the presence of glucose [<xref rid="B244-pharmaceutics-14-01837" ref-type="bibr">244</xref>] and activated by the RimO kinase in response to glucose starvation, as recently discovered in our laboratory [<xref rid="B245-pharmaceutics-14-01837" ref-type="bibr">245</xref>]. Another possibility could be a necessary interaction between the BGC-specific TF and another factor or natural inducer to unfold the full activation potential. In this scenario, the overexpression of just the TF might not have any effect on the clustered genes [<xref rid="B246-pharmaceutics-14-01837" ref-type="bibr">246</xref>]. A possible way to circumvent this was shown in the (+)-asperlin cluster in <italic toggle="yes">A. nidulans</italic>. The modular composition of many TFs (activator domain, DNA-binding domain) made it possible to fuse the DNA-binding domain of the asperlin BGC-specific TF (AlnR) with the trans-activator domain of another TF (afoA). This way, the overexpression of this hybrid TF led to the discovery of the antibiotic (+)-asperlin [<xref rid="B246-pharmaceutics-14-01837" ref-type="bibr">246</xref>].</p><p>In the case of clusters that do not have a TF, <underline>serial promoter replacements</underline> of all BGC-specific genes can be conducted. This approach has been successful in the activation of several uncharacterized BGCs in <italic toggle="yes">A. nidulans</italic>, finally shown to be responsible for the expression of the Ivo gene cluster producing a new pigment [<xref rid="B247-pharmaceutics-14-01837" ref-type="bibr">247</xref>], or for the discovery of the new proteasome inhibitor fellutamide B [<xref rid="B248-pharmaceutics-14-01837" ref-type="bibr">248</xref>], and chicorine [<xref rid="B243-pharmaceutics-14-01837" ref-type="bibr">243</xref>]. The idea was also tested in other species and <xref rid="pharmaceutics-14-01837-t004" ref-type="table">Table 4</xref> summarizes some of the successful attempts in the published literature. However, it is clear that exchanging many promoters in a multi-gene BGC can be quite cumbersome and may not always lead to successful transformation events, especially when the BGC under investigation is located in heterochromatic regions. </p></sec><sec id="sec4dot2-pharmaceutics-14-01837"><title>4.2. Heterologous Expression</title><p>In the case that none of the aforementioned methods worked out or the studied species is not amenable to transformation or does not yield stable transformants, heterologous expression in a model host can be a powerful tool for the activation of unknown BGCs. For this method, single protein domains or genes or a whole BGC are introduced into a well-known production host. For the expression of single domains or genes, bacterial hosts such as <italic toggle="yes">Escherichia coli</italic> are often sufficient [<xref rid="B272-pharmaceutics-14-01837" ref-type="bibr">272</xref>,<xref rid="B273-pharmaceutics-14-01837" ref-type="bibr">273</xref>]. For larger genes or small clusters, many (engineered) yeast overexpression hosts such as <italic toggle="yes">Saccharomyces cerevisiae</italic>, <italic toggle="yes">Hansenula polymorpha</italic> or <italic toggle="yes">Pichia pastoris</italic> exist [<xref rid="B274-pharmaceutics-14-01837" ref-type="bibr">274</xref>,<xref rid="B275-pharmaceutics-14-01837" ref-type="bibr">275</xref>].</p><p>If the expression scaffold of the donor organism (promoters, terminators, codon usage, splicing, etc.) is however not suited for the host there are two other possibilities. The regulatory elements of a BGC can be exchanged by host-specific ones, or the BGC can be heterologously expressed in a host that is closely related to the donor organism [<xref rid="B274-pharmaceutics-14-01837" ref-type="bibr">274</xref>]. There are already engineered fungal hosts (low metabolite background, removal of proteases) that are readily deployed such as <italic toggle="yes">A. oryzae</italic> [<xref rid="B276-pharmaceutics-14-01837" ref-type="bibr">276</xref>], <italic toggle="yes">A. nidulans</italic> [<xref rid="B277-pharmaceutics-14-01837" ref-type="bibr">277</xref>] <italic toggle="yes">A. niger</italic> [<xref rid="B278-pharmaceutics-14-01837" ref-type="bibr">278</xref>], but also <italic toggle="yes">F. grameniarum</italic> [<xref rid="B279-pharmaceutics-14-01837" ref-type="bibr">279</xref>,<xref rid="B280-pharmaceutics-14-01837" ref-type="bibr">280</xref>] and <italic toggle="yes">Penicillium</italic> strains [<xref rid="B281-pharmaceutics-14-01837" ref-type="bibr">281</xref>,<xref rid="B282-pharmaceutics-14-01837" ref-type="bibr">282</xref>] are emerging as expression platforms. Heterologous expression is often used when high yields of a certain SM are important (i.e., industrial application) but specifically for the activation of silent fungal BGCs, systems such as FAC-MS [<xref rid="B283-pharmaceutics-14-01837" ref-type="bibr">283</xref>,<xref rid="B284-pharmaceutics-14-01837" ref-type="bibr">284</xref>], HeX [<xref rid="B285-pharmaceutics-14-01837" ref-type="bibr">285</xref>] or CoIN [<xref rid="B286-pharmaceutics-14-01837" ref-type="bibr">286</xref>] have been developed. <xref rid="pharmaceutics-14-01837-t005" ref-type="table">Table 5</xref> lists publications that used heterologous expression for the activation of silent BGCs.</p><sec id="sec4dot2dot1-pharmaceutics-14-01837"><title>4.2.1. Fungal Artificial Chromosomes (FAC-MS) [<xref rid="B283-pharmaceutics-14-01837" ref-type="bibr">283</xref>,<xref rid="B284-pharmaceutics-14-01837" ref-type="bibr">284</xref>]</title><p>During the FAC-MS approach, the donors&#x02019; DNA is sheared and random chromosomal parts (up to 300 kb) which eventually contain a whole BGC are cloned into fungal artificial chromosomes (FACs). These FACs are then transformed into the host organism (e.g., <italic toggle="yes">A nidulans</italic>). This already led to the identification of 15 new metabolites from a library of 56 FACs each containing one unknown BGC from <italic toggle="yes">A. aculeatus, A. terreus</italic> or <italic toggle="yes">A. wentii</italic> in the heterologous expression host <italic toggle="yes">A. nidulans.</italic> It also resulted in the elucidation of the biosynthetic pathway of acu-dioxomorpholine from <italic toggle="yes">A. aculeatus</italic> [<xref rid="B283-pharmaceutics-14-01837" ref-type="bibr">283</xref>,<xref rid="B284-pharmaceutics-14-01837" ref-type="bibr">284</xref>,<xref rid="B287-pharmaceutics-14-01837" ref-type="bibr">287</xref>]. As long as the expression host can utilize the AMA1-region and the donors&#x02019; genomic information, the FAC-MS approach is a viable option for BGC mining.</p></sec><sec id="sec4dot2dot2-pharmaceutics-14-01837"><title>4.2.2. CoIN [<xref rid="B286-pharmaceutics-14-01837" ref-type="bibr">286</xref>]</title><p>This approach uses the <italic toggle="yes">A. nidulans</italic> regulatory matrix (TFs and their downstream promoters) of the sterigmatocystin cluster in combination with the <italic toggle="yes">niiA</italic>/<italic toggle="yes">niAD</italic> promoter. In this system, the TF-encoding genes <italic toggle="yes">aflR</italic> and its cofactor <italic toggle="yes">aflS</italic> are put under the control of the bi-directional promoter of the <italic toggle="yes">niiA/niaD</italic> genes coding for nitrate- and nitrite reductase, respectively, in <italic toggle="yes">A. nidulans</italic>. The genes of the BGC of interest are put under the control of the eight sterigmatocystin promoters that are regulated by AflR/AflS. This way, the orchestrated expression of up to eight genes of an unknown BGC without reusing a single promoter sequence can be accomplished by the growth of nitrate as the sole N-source leading to a high induction of the TFs.</p></sec><sec id="sec4dot2dot3-pharmaceutics-14-01837"><title>4.2.3. Single Promoter BGC Expression [<xref rid="B296-pharmaceutics-14-01837" ref-type="bibr">296</xref>]</title><p>Hoefgen and coworkers utilized the 2A peptide of the picornavirus to enable the transcription and translation of a whole BGC with only one promoter and one terminator. The 2A peptide auto-cleaves itself after translation without leading to the disassembly of ribosomes. This way, several genes can be co-expressed with the use of only a single promoter. The cloning of the construct however can be difficult and laborious and the transcript levels of the genes will stay equal and cannot be individually regulated.</p></sec><sec id="sec4dot2dot4-pharmaceutics-14-01837"><title>4.2.4. Hex [<xref rid="B285-pharmaceutics-14-01837" ref-type="bibr">285</xref>]</title><p>With the Hex approach, it is possible to express whole fungal BGCs in an engineered strain of <italic toggle="yes">Saccharomyces cerevisiae</italic>. New promoter sequences that are coregulated with p<sub>ADH2</sub> (called Hex-promoters) have been utilized to enable cloning via a high throughput DNA assembly strategy by homologous recombination into 2 &#x000b5; vectors. Genome mining assisted the selection of novel BCGs and subsequent cloning into yeast plasmids with an upper limit of seven genes per plasmid (maximum of two plasmids per clone). Expression is followed by untargeted metabolomics and LC-MS and NMR for structural elucidation of putatively novel compounds. For proof of concept, 41 investigated BGCs (from ascomycete and basidiomycete species) resulted in the detection of 22 new compounds.</p></sec></sec></sec><sec id="sec5-pharmaceutics-14-01837"><title>5. Chromatin: An Important Layer of (BGC) Gene Regulation</title><p>While previously mentioned methods have already led to the discovery of many bioactive substances of fungal origin, many BGCs may still resist discovery with these approaches. Therefore, another strategy would be the manipulation of epigenetic and chromatin-based regulation of BGCs. Until recently, this could only be accomplished by the manipulation of global chromatin remodelers, however, as the general knowledge of this level of regulation increases, engineering of programmable chromatin regulators becomes feasible. The emergence of CRISPR/Cas-based methods, moreover, opens up new opportunities for <underline>activating BGCs by locus-specific modification of histones</underline>. These new approaches would not only make it possible to activate BGCs where other methods failed but have the potential of giving many new insights into the histone code of gene regulation. The next sections concentrate on the regulation of BGC expression via chromatin and histone modifications and describe also the current state of locus-specific chromatin modifications for the activation of secondary metabolites. After that, we will review the role of a CRISPR/Cas as a carrier for targeted BGC activation via locus-specific chromatin modification.</p><p>In eukaryotes, genomic DNA wraps around histone protein octamers (~146 bp DNA/nucleosome) to form nucleosome chains (i.e., chromatin) [<xref rid="B298-pharmaceutics-14-01837" ref-type="bibr">298</xref>,<xref rid="B299-pharmaceutics-14-01837" ref-type="bibr">299</xref>]. Each nucleosome consists of an octamer constituted of two of the four core histone proteins H2A, H2B, H3 and H4 with sometimes iso-forms (e.g., H2AZ, CENH3, H4.2, H4v) of the histones being incorporated into the nucleosome for the specific cellular processes (e.g., DNA repair, etc.) [<xref rid="B300-pharmaceutics-14-01837" ref-type="bibr">300</xref>]. Histones, especially H3 and H4, can carry post-translational modifications (or histone marks) on specific amino acid residues, that are read and translated by so-called reader proteins. Depending on the histone marks, chromatin structure is either loosely packed and open for transcription or very compact which hinders access to the DNA and therefore transcription. Furthermore, chromatin reader proteins can also recruit other proteins such as TFs or components of the transcriptional machinery. This way, genes can be either packaged into a very tight polymer of nucleosomes that is transcriptionally silent, called heterochromatin, or into a more relaxed form of packaging, called euchromatin, that allows proteins to interact with the underlying DNA (i.e., TFs, transcriptional machinery, etc.) [<xref rid="B301-pharmaceutics-14-01837" ref-type="bibr">301</xref>].</p><sec id="sec5dot1-pharmaceutics-14-01837"><title>5.1. Heterochromatin</title><p>The DNA within heterochromatic regions is not freely accessible for transcriptional activation. Pioneering factors however are capable of binding to condensed chromatin and subsequently recruit TFs or chromatin remodelers. This way, heterochromatin can be reversed to a more open and accessible state which promotes the binding and interaction of TFs or other reader/writer/eraser proteins and subsequently can result in gene activation [<xref rid="B302-pharmaceutics-14-01837" ref-type="bibr">302</xref>,<xref rid="B303-pharmaceutics-14-01837" ref-type="bibr">303</xref>]. In general, there are two pathways to form heterochromatic regions within the genome which are conserved in most eukaryotes i.e., constitutive and facultative heterochromatin. Both chromatin states are associated with distinct histone methylation marks.</p><sec id="sec5dot1dot1-pharmaceutics-14-01837"><title>5.1.1. Constitutive Heterochromatin via H3K9 Methylation and Clr4/HP1</title><p>Methylation of H3K9 is a hallmark of constitutive heterochromatin. <underline>H3K9me3</underline> is established by the histone methyl-transferase KMT1 (ClrD in <italic toggle="yes">A. nidulans, Schizosaccharomyces pombe</italic> Clr4 homolog) [<xref rid="B304-pharmaceutics-14-01837" ref-type="bibr">304</xref>] and the heterochromatin protein 1 (HP1, <italic toggle="yes">A. nidulans</italic> homolog HepA) which is a reader protein for this mark [<xref rid="B305-pharmaceutics-14-01837" ref-type="bibr">305</xref>]. In some fungi, it was shown that the DNA methyltransferase (e.g., Dim-2 in <italic toggle="yes">Neurospora crassa</italic>) is subsequently recruited for further silencing of the region [<xref rid="B306-pharmaceutics-14-01837" ref-type="bibr">306</xref>]. In the case of fungi, the term &#x0201c;constitutive&#x0201d; may be misleading as it was shown that <italic toggle="yes">A. nidulans</italic> can activate its sterigmatocystin cluster that contains hallmarks of constitutive heterochromatin (i.e., H3K9me3, HepA occupancy). Our lab showed that under inducing conditions in the wild type (nutrient starvation), H3K9me3 peaks are depleted from the ST BGC, and dissociation of HepA and increase of acetylation levels in the BGC occur, and these events are correlated with transcriptional activation of the cluster [<xref rid="B305-pharmaceutics-14-01837" ref-type="bibr">305</xref>]. A similar observation was made in <italic toggle="yes">Epichloe festucae</italic> where BGCs that are silent in axenic culture, had H3K9me3 marks, but during plant infection, the H3K9me3 marks were reduced and the BGCs were activated [<xref rid="B307-pharmaceutics-14-01837" ref-type="bibr">307</xref>]. In contrast, however, the phytopathogenic fungus <italic toggle="yes">F. fujikuroi</italic> does not have any detectable H3K9me3-enriched areas inside BGCs. In <italic toggle="yes">F. fujikuroi</italic>, these marks are generally in pericentric and centromeric regions and sometimes in transposon-rich regions with few or no annotated genes [<xref rid="B125-pharmaceutics-14-01837" ref-type="bibr">125</xref>]. In <italic toggle="yes">Fusarium mangiferae,</italic> deletion of the <italic toggle="yes">clrD</italic> homolog <italic toggle="yes">FmKMT1</italic> led to increased production of beauvericin biosynthesis while fusapyrone biosynthesis was nearly abolished [<xref rid="B308-pharmaceutics-14-01837" ref-type="bibr">308</xref>]. These examples suggest that heterochromatin via H3K9 methylation is differently involved in BGC silencing depending on the fungal species and the BGC in question. This pathway may be especially important in fungal species such as aspergilli, which lacks the molecular machinery for the establishment of H3K27me3 (PRC2 complex) associated with facultative heterochromatin in other fungi [<xref rid="B309-pharmaceutics-14-01837" ref-type="bibr">309</xref>,<xref rid="B310-pharmaceutics-14-01837" ref-type="bibr">310</xref>,<xref rid="B311-pharmaceutics-14-01837" ref-type="bibr">311</xref>]. Thus, it is currently unknown if and how facultative heterochromatin is established in these genera that do not possess PRC2 homologs.</p></sec><sec id="sec5dot1dot2-pharmaceutics-14-01837"><title>5.1.2. Facultative Heterochromatin via H3K27me3 and Polycomb Repressive Complex II (PRC2)</title><p>The second pathway for heterochromatin formation is mediated by the polycomb repressive complex II and marked by the histone modification <underline>H3K27me3</underline> [<xref rid="B307-pharmaceutics-14-01837" ref-type="bibr">307</xref>,<xref rid="B312-pharmaceutics-14-01837" ref-type="bibr">312</xref>,<xref rid="B313-pharmaceutics-14-01837" ref-type="bibr">313</xref>]. This form of heterochromatin is generally regarded as facultative as it can be conditionally restructured into euchromatin, hence promoting the transcription of underlying genes (e.g., regulation of developmental genes in drosophila) [<xref rid="B314-pharmaceutics-14-01837" ref-type="bibr">314</xref>]. Some genera such as <italic toggle="yes">Aspergillus and Penicillium</italic> [<xref rid="B309-pharmaceutics-14-01837" ref-type="bibr">309</xref>], <italic toggle="yes">Ustilago</italic> [<xref rid="B310-pharmaceutics-14-01837" ref-type="bibr">310</xref>], and some yeasts [<xref rid="B311-pharmaceutics-14-01837" ref-type="bibr">311</xref>] however are devoid of these chromatin marks. In fungi such as <italic toggle="yes">F. graminearum</italic> [<xref rid="B312-pharmaceutics-14-01837" ref-type="bibr">312</xref>] and <italic toggle="yes">F. fujikuroi</italic> [<xref rid="B315-pharmaceutics-14-01837" ref-type="bibr">315</xref>] many BGCs are located in H3K27me3 regions and knockdown or knockout of the methyltransferase-encoding gene <italic toggle="yes">KMT6</italic> of the PRC2 led to de-repression of several BGCs. More interestingly, formerly H3K27me3 regions are acetylated in <italic toggle="yes">KMT6</italic> knock-down strains as shown for the beauvericin BGC in <italic toggle="yes">F. fujikuroi</italic> [<xref rid="B315-pharmaceutics-14-01837" ref-type="bibr">315</xref>]. Similar effects were observed for <italic toggle="yes">Verticillium dahliae</italic> where lack of Set7, the PRC2 methyl transferase, led to the induction of 839 genes of which 75% are within H3K27me3 domains in the wild type. Furthermore, many genes that are upregulated <italic toggle="yes">in planta</italic> are also located within these domains [<xref rid="B316-pharmaceutics-14-01837" ref-type="bibr">316</xref>]. In the case of <italic toggle="yes">N. crassa</italic>, H3K27me3 marks are distributed throughout the genome but especially in the sub-telomeric regions where it was shown that a short DNA telomere repeat (i.e., (TTAGGG)<sub>17</sub>) can trigger the establishment of large domains of H3K27me2/3 [<xref rid="B317-pharmaceutics-14-01837" ref-type="bibr">317</xref>]. In <italic toggle="yes">N. crassa</italic> facultative heterochromatin covers around 7% of the genome containing 1000 silent genes [<xref rid="B313-pharmaceutics-14-01837" ref-type="bibr">313</xref>]. In <italic toggle="yes">Magnaporthe oryzae</italic>, 50% of TEs and many plant infection-related genes, which are suppressed in axenic culture, are covered by H3K27me3 [<xref rid="B318-pharmaceutics-14-01837" ref-type="bibr">318</xref>].</p><p>These examples show the versatile nature of gene regulation by H3K27me3 and H3K9me3 in different fungal genera which still needs more research that elucidates the mechanism and chronological order of the (de)-repression process.</p><p>Accumulating evidence in mammals [<xref rid="B319-pharmaceutics-14-01837" ref-type="bibr">319</xref>] and also in fungi (e.g., <italic toggle="yes">N. crassa</italic> [<xref rid="B317-pharmaceutics-14-01837" ref-type="bibr">317</xref>]) suggest that there exist DNA motifs that trigger specific histone modifications. In humans and mouse, over 350 of such motifs have been found and linked to different histone modifications such as H3K4me1, H3K4me2, H3K4me3, H3K27ac, H3K27me3, H3K9me3, H3K9ac, and H3K36me3. Genetic manipulations of these motifs were successful in reducing H3K27 acetylation at a chosen locus [<xref rid="B319-pharmaceutics-14-01837" ref-type="bibr">319</xref>]. If this is also applicable to filamentous fungi, especially H3K27me3 and H3K9me3 it would be a promising approach for relieving heterochromatic structures around silent BGCs.</p><p><xref rid="pharmaceutics-14-01837-t006" ref-type="table">Table 6</xref> lists various approaches that lead to the production of SMs by interfering with chromatin active enzymes (via chemicals or via molecular biology methods such as overexpression, deletion, or knockdown).</p></sec></sec><sec id="sec5dot2-pharmaceutics-14-01837"><title>5.2. Euchromatin</title><p>While heterochromatic regions suppress the transcription of underlying genes, euchromatin promotes gene expression. It is characterized by highly accessible DNA (i.e., low nucleosome density) and is often marked by histone acetylation and H3K4 trimethylation. Histone acetylation is regarded as an active mark and is established by histone acetyl transferases (HATs) [<xref rid="B347-pharmaceutics-14-01837" ref-type="bibr">347</xref>]. Usually, they are part of protein complexes such as the Saga/Ada (HAT: GcnE) or the NuA4 complex (HAT: EsaA) [<xref rid="B348-pharmaceutics-14-01837" ref-type="bibr">348</xref>]. Removal of acetylation marks is performed by histone deacetylases (HDACs) which often mediate transcriptional repression [<xref rid="B324-pharmaceutics-14-01837" ref-type="bibr">324</xref>]. Some of these HDACs were shown to act on the genome-wide level and are involved in developmental and metabolic processes (e.g., HosA in <italic toggle="yes">A. flavus</italic> [<xref rid="B349-pharmaceutics-14-01837" ref-type="bibr">349</xref>], HosB and HstA in <italic toggle="yes">A. nidulans</italic> [<xref rid="B350-pharmaceutics-14-01837" ref-type="bibr">350</xref>]) while others are active in specific regions (i.e., Sir2 in <italic toggle="yes">Candida albicans</italic> in subtelomeric regions [<xref rid="B351-pharmaceutics-14-01837" ref-type="bibr">351</xref>], HdaA regulates two telomer proximal but not distal clusters in <italic toggle="yes">A. nidulans</italic> [<xref rid="B350-pharmaceutics-14-01837" ref-type="bibr">350</xref>]). These findings suggest that some HDACs have a location or even cluster-specific activity. Demethylation by HDACs can be inhibited by HDAC inhibitors. Because these chemicals often inactivate multiple HDACs simultaneously, their application results in a genome-wide increase in acetylation and de-regulation of thousands of genes [<xref rid="B352-pharmaceutics-14-01837" ref-type="bibr">352</xref>]. For references concerning the inhibition or deletion of HDACs for activation of silent BGCs please consult <xref rid="pharmaceutics-14-01837-t006" ref-type="table">Table 6</xref>.</p><sec id="sec5dot2dot1-pharmaceutics-14-01837"><title>5.2.1. Methylation of Histone 3 Lysin 4</title><p>H3K4me1/2/3 is probably one of the most discussed and controversial histone modifications in terms of gene transcription and activation. It is established by the COMPASS complex with Set1 as the catalytic subunit [<xref rid="B353-pharmaceutics-14-01837" ref-type="bibr">353</xref>]. H3K4me3 is reversed by lysine demethylases such as KdmB in <italic toggle="yes">A. nidulans</italic> [<xref rid="B354-pharmaceutics-14-01837" ref-type="bibr">354</xref>,<xref rid="B355-pharmaceutics-14-01837" ref-type="bibr">355</xref>] or Kdm5 in <italic toggle="yes">F. graminearum</italic> [<xref rid="B355-pharmaceutics-14-01837" ref-type="bibr">355</xref>]. This modification was initially thought to have a transcriptionally promoting character. Recent studies in mice, however, suggest that H3K4me3 is not necessary for transcription but instead prevents silencing of the region by PRC2 or DNA methylation [<xref rid="B356-pharmaceutics-14-01837" ref-type="bibr">356</xref>]. This would explain several contradictory observations such as the underrepresentation of H3K4me3 in active clusters in several fungal species such as <italic toggle="yes">A. nidulans</italic> [<xref rid="B354-pharmaceutics-14-01837" ref-type="bibr">354</xref>], <italic toggle="yes">F. fujikuroi</italic> [<xref rid="B125-pharmaceutics-14-01837" ref-type="bibr">125</xref>] and <italic toggle="yes">F. graminearum</italic> [<xref rid="B312-pharmaceutics-14-01837" ref-type="bibr">312</xref>] or the partial upregulation of BGCs after abolished H3K4me3 due to deletion of subunits of the COMPASS complex (e.g., <italic toggle="yes">cclA</italic>, <italic toggle="yes">sppA</italic>, <italic toggle="yes">setA</italic>). This was observed in many species such as <italic toggle="yes">A. nidulans</italic> (monodictyphenone, desacetylaustin, dehydroaustinol, citreorosein, emodic acid, 2-OH, 2-aminoemodin, emodin, and the polyketides F9775A and F9775B) [<xref rid="B357-pharmaceutics-14-01837" ref-type="bibr">357</xref>,<xref rid="B358-pharmaceutics-14-01837" ref-type="bibr">358</xref>], <italic toggle="yes">A. fumigatus</italic> (gliotoxin) [<xref rid="B359-pharmaceutics-14-01837" ref-type="bibr">359</xref>], <italic toggle="yes">F. fujikuroi</italic> (BIK, FUS) [<xref rid="B360-pharmaceutics-14-01837" ref-type="bibr">360</xref>], <italic toggle="yes">F. graminearum</italic> (ZON, fusarins) [<xref rid="B360-pharmaceutics-14-01837" ref-type="bibr">360</xref>]. But also downregulation of BGCs in <italic toggle="yes">A. nidulans</italic> (Penicillin G, Sterigmatocystin) [<xref rid="B355-pharmaceutics-14-01837" ref-type="bibr">355</xref>], <italic toggle="yes">F. fujikuroi</italic> (gibberellic acid) [<xref rid="B360-pharmaceutics-14-01837" ref-type="bibr">360</xref>] and <italic toggle="yes">F. graminearum</italic> (deoxynivalenol) [<xref rid="B360-pharmaceutics-14-01837" ref-type="bibr">360</xref>] was observed in these mutants. Further puzzling results came from knockout experiments of the H3K4 demethylase (i.e., <italic toggle="yes">kdmB</italic>) in <italic toggle="yes">A. nidulans</italic> by our laboratory. It led to a 20% increase of global H3K4me3 but 90% of all annotated genes that are connected to secondary metabolism were downregulated. Sterigmatocystin and orsellinic acid biosynthesis were reduced while products of the monodictyphenone pathway were increased (i.e., 2,&#x003c9;-dihydroxyemodin, &#x003c9;-hydroxyemodin, 2-hydroxyemodin, emodin) [<xref rid="B354-pharmaceutics-14-01837" ref-type="bibr">354</xref>]. Following this observation, the role of KdmB as inducer of SM clusters goes beyond its function as H3K4m3 demethylase and several indirect effects on general SM regulators may account for the observed phenotype of <italic toggle="yes">kdmB</italic> deletion or overexpression. For example, one could assume that, due to the downregulation of the majority of secondary metabolism genes, the precursor pool may have been increased which may have led to a better turnover by the same amounts of enzymes from the mdp pathway, resulting in higher quantities of mpd-related metabolites [<xref rid="B354-pharmaceutics-14-01837" ref-type="bibr">354</xref>]. Similar results were found in <italic toggle="yes">F. fujukuroi</italic> [<xref rid="B337-pharmaceutics-14-01837" ref-type="bibr">337</xref>] and <italic toggle="yes">F. graminearum</italic> [<xref rid="B355-pharmaceutics-14-01837" ref-type="bibr">355</xref>] but most interestingly, in the case of Kdm5 in <italic toggle="yes">F. graminearum</italic>, we found that many SMs are regulated by Kdm5 in a demethylase-independent role (regulation by a catalytically inactive variant of Kdm5) [<xref rid="B355-pharmaceutics-14-01837" ref-type="bibr">355</xref>].</p><p>Taken together, results that try to link H3K4me3 and active transcription often result in complex and sometimes contradictory results. The role of H3K4me3 as protection against silencing would explain why this mark often but not always is correlated with transcriptional activation. Further insight into the local role of H3K4 trimethylation would be important to evaluate its role in the induction and transcription of silent BGCs.</p></sec><sec id="sec5dot2dot2-pharmaceutics-14-01837"><title>5.2.2. H4K12 Acetylation</title><p>In <italic toggle="yes">A. nidulans</italic>, the H4K12 acetyltransferase EsaA is essential for viability and also involved in the up-regulation of three of four examined BGCs. EsaA overexpression led to depletion of the H4 nucleosome at investigated loci and increased expression levels of BGCs. In the case of the cryptic <italic toggle="yes">ORS</italic> cluster, increased acetylation and nucleosome depletion occurred, but the BGC was not activated. It was suggested by the authors that EsaA and H4K12 acetylation could be responsible for histone depletion at promoter regions so that other effectors such as TFs can access the locus and recruit the transcriptional machinery [<xref rid="B361-pharmaceutics-14-01837" ref-type="bibr">361</xref>].</p><p>Similar findings were published by Roze et al. in <italic toggle="yes">A. parasiticus</italic> where they detected an increase of overall H4 acetylation in the aflatoxin BGC promoters followed by <italic toggle="yes">aflR</italic> binding and transcription [<xref rid="B362-pharmaceutics-14-01837" ref-type="bibr">362</xref>].</p></sec><sec id="sec5dot2dot3-pharmaceutics-14-01837"><title>5.2.3. H3K9 Acetylation/H3K14 Acetylation</title><p>H3K9 acetylation, which is the mark counteracting silencing by H3K9me3, is enriched in transcriptionally active promoters, sometimes enriched especially in BGCs. In <italic toggle="yes">F. fujikuroi</italic> it was seen that the overall correlation between genome-wide H3K9ac and transcription is weak but that in the case of BGCs the correlation is very strong, suggesting that H3K9ac has important roles in the production of SMs [<xref rid="B125-pharmaceutics-14-01837" ref-type="bibr">125</xref>]. In the case of the fusarin C BGC, H3K9 acetylation was significantly enriched across the whole BGC when grown under inducing conditions [<xref rid="B363-pharmaceutics-14-01837" ref-type="bibr">363</xref>]. Another study showed that deletion of the histone deacetylase FfHda1 in <italic toggle="yes">F. fujikuroi</italic> also results in increased levels of H3K9ac in gene promoters and increased transcriptional activity. This even resulted in the activation of the bikaverin cluster under repressive conditions [<xref rid="B364-pharmaceutics-14-01837" ref-type="bibr">364</xref>].</p><p>The most intensively studied HAT GcnE, which is part of the SAGA/Ada complex, was shown to be responsible for the acetylation of H3K9 and H3K14 in <italic toggle="yes">A. nidulans</italic>, and additionally H3K18 and H3K27 in <italic toggle="yes">F. graminearum</italic> [<xref rid="B365-pharmaceutics-14-01837" ref-type="bibr">365</xref>] and H3K4, H3K9, H3K18 and H3K27 in <italic toggle="yes">F. fujikuroi</italic> [<xref rid="B366-pharmaceutics-14-01837" ref-type="bibr">366</xref>]. In the case of several BGCs in <italic toggle="yes">A. nidulans</italic> (orsellinic acid, sterigmatocystin, penicillin, terrequinone) GcnE is necessary for activation. While H3K14 acetylation was not enriched within clusters, H3K9 acetylation was only applied in BGCs (only sterigmatocystin and <italic toggle="yes">ORS</italic> clusters were examined for H3K9ac). While genes outside the cluster showed no signs of differential expression, all BGCs that were expressed in the wild type showed abolished transcription in the <italic toggle="yes">gcnE</italic> deletion mutant [<xref rid="B367-pharmaceutics-14-01837" ref-type="bibr">367</xref>,<xref rid="B368-pharmaceutics-14-01837" ref-type="bibr">368</xref>]. The acetylation pattern around active genes showed a strong correlation between the increase of H3K9ac around the TSS and transcription while in the case of H3K14ac, the correlation was rather weak. Upon acetylation, the H3 density around the TSS was reduced which suggests that at least one of these marks could be involved in nucleosome depletion around the TSS [<xref rid="B367-pharmaceutics-14-01837" ref-type="bibr">367</xref>].</p><p>Recently the fungal-specific HAT Rtt109, which is responsible for H3K9 and/ or H3K56 acetylation (DNA damage repair), was described in <italic toggle="yes">A. flavus</italic>, <italic toggle="yes">Beauveria bassiana</italic> and <italic toggle="yes">F. graminearum</italic> [<xref rid="B369-pharmaceutics-14-01837" ref-type="bibr">369</xref>]. Deletion in <italic toggle="yes">A. flavus</italic> led to the removal of both H3K9 and H3K56 acetylation which resulted in impaired growth and virulence, vulnerability to DNA damage stress and also to the abolished expression of genes of the aflatoxin cluster, further promoting H3K9 acetylation as an important mark for gene transcription [<xref rid="B370-pharmaceutics-14-01837" ref-type="bibr">370</xref>].</p></sec><sec id="sec5dot2dot4-pharmaceutics-14-01837"><title>5.2.4. H3K27 Acetylation</title><p>H3K27 acetylation is the counteracting mark of the silencing H3K27me3 modification. During chromatin accessibility studies in <italic toggle="yes">Neurospora crassa</italic>, it was found that H3K27 acetylation is one of the most predictive histone marks of open chromatin [<xref rid="B371-pharmaceutics-14-01837" ref-type="bibr">371</xref>]. As already mentioned it was shown in <italic toggle="yes">F. fujikuroi</italic> [<xref rid="B335-pharmaceutics-14-01837" ref-type="bibr">335</xref>] and <italic toggle="yes">M. oryzae</italic> [<xref rid="B318-pharmaceutics-14-01837" ref-type="bibr">318</xref>] that H3K27ac spreads to regions previously marked by H3K27me3 if components of the PRC2 complex are deleted. This often resulted in transcriptional activation. Loss of H3K27ac on the other hand did not result in transcriptional inactivation. This suggests that H3K27ac is not necessary for active transcription but plays a role in gene activation/accessibility of previously silenced genes. It seems that H3K27 acetylation by the SAGA complex (i.e., GcnE) is one of the mechanisms that can revert silencing by the PRC2 machinery. The exchange mechanism itself and the involvement of other histone acetylations (by GcnE) in the transcriptional activation is however not fully understood yet.</p></sec></sec><sec id="sec5dot3-pharmaceutics-14-01837"><title>5.3. The Histone Code of Actively Transcribed Genes</title><p>Actively transcribed genes have a distinct chromatin signature around the promoter region, gene body, and terminator. We assessed the histone mark occupation around the start codon in all active genes of Chromosome IV of <italic toggle="yes">A. nidulans</italic>. H3K9/K14 acetylation is enriched in the promoter with the highest level at the first nucleosome after the translation start site. H3K4me3 is enriched at the first three nucleosomes downstream of the ATG and H3K36me3 spreads across the active gene body. While H3K4me3 and H3K9/K14Ac decreased towards the 3&#x02032; of the gene, H3K36me3 increased [<xref rid="B354-pharmaceutics-14-01837" ref-type="bibr">354</xref>]. Similar findings were published in <italic toggle="yes">V. dahliae</italic> [<xref rid="B316-pharmaceutics-14-01837" ref-type="bibr">316</xref>] and <italic toggle="yes">Candida albicans</italic> [<xref rid="B351-pharmaceutics-14-01837" ref-type="bibr">351</xref>]. Furthermore, it was found that transcriptional active genes correlate positively with increased acetylation within the promoter region in <italic toggle="yes">Aspergillus parasiticus</italic> [<xref rid="B362-pharmaceutics-14-01837" ref-type="bibr">362</xref>]. Noteworthy, in human cells, artificial application of H3K27 acetylation in the promoter region led to subsequent H3K4me3 and transcription while the deployment of H3K4me3 did not result in increased acetylation or transcription [<xref rid="B372-pharmaceutics-14-01837" ref-type="bibr">372</xref>].</p></sec><sec id="sec5dot4-pharmaceutics-14-01837"><title>5.4. Finding New Bioactive Compounds by Breaking the Chromatin Silencing Machinery</title><p>The production of SMs is a metabolically costly process requiring high energy input to produce the necessary reduction equivalents (NADPH) and ATP. Therefore, their biosynthesis is strictly economized. To ensure that energy is not wasted, fungi by default silence their BGCs at the level of heterochromatin formation, making these genomic regions inaccessible to the transcriptional machinery [<xref rid="B305-pharmaceutics-14-01837" ref-type="bibr">305</xref>,<xref rid="B315-pharmaceutics-14-01837" ref-type="bibr">315</xref>,<xref rid="B348-pharmaceutics-14-01837" ref-type="bibr">348</xref>]. As soon as environmental or developmental conditions demand the production of a certain beneficial SM, the chromatin-based silencing is lifted and specific activation factors start the expression of BGC genes. Experimental setups that aim for induction of fungal BGCs via chromatin modifications either delete, inhibit or overexpress chromatin active enzymes. Most common approaches in this regard are the genetic of chemical inhibition of HDACs [<xref rid="B324-pharmaceutics-14-01837" ref-type="bibr">324</xref>,<xref rid="B331-pharmaceutics-14-01837" ref-type="bibr">331</xref>,<xref rid="B335-pharmaceutics-14-01837" ref-type="bibr">335</xref>,<xref rid="B344-pharmaceutics-14-01837" ref-type="bibr">344</xref>] or inactivation of components of the silencing machinery via PRC2 [<xref rid="B307-pharmaceutics-14-01837" ref-type="bibr">307</xref>,<xref rid="B312-pharmaceutics-14-01837" ref-type="bibr">312</xref>,<xref rid="B334-pharmaceutics-14-01837" ref-type="bibr">334</xref>,<xref rid="B338-pharmaceutics-14-01837" ref-type="bibr">338</xref>] or components related to heterochromatin formation via H3K9me (e.g., Dim5/Kmt1/ClrD/HP1, &#x02026;) [<xref rid="B305-pharmaceutics-14-01837" ref-type="bibr">305</xref>,<xref rid="B307-pharmaceutics-14-01837" ref-type="bibr">307</xref>,<xref rid="B308-pharmaceutics-14-01837" ref-type="bibr">308</xref>,<xref rid="B334-pharmaceutics-14-01837" ref-type="bibr">334</xref>,<xref rid="B339-pharmaceutics-14-01837" ref-type="bibr">339</xref>].</p><p>One particular successful and easy-to-apply strategy for artificial lifting heterochromatin based silencing was the application of chemical inhibitors for HDACs that are known to be essential for most heterochromatin formation complexes. HDAC inhibitors (HDACi) lead to higher acetylation of histones, a driver for gene expression. The most rewarding results following this strategy used SAHA, butyric acid, valproic acid, nicotinamide, and trichostatin as additives to the growth medium [<xref rid="B188-pharmaceutics-14-01837" ref-type="bibr">188</xref>,<xref rid="B342-pharmaceutics-14-01837" ref-type="bibr">342</xref>]. A similar approach that often is applied together with HDACi aims for the inhibition of DNA-methyltransferases (DNMTs). DNA methylation in fungi is mostly connected to the silencing of transposable and repetitive elements [<xref rid="B373-pharmaceutics-14-01837" ref-type="bibr">373</xref>]. Inhibition or deletion of HDACs or DNMTs resulted in the discovery of nygerone A in <italic toggle="yes">A. niger</italic> [<xref rid="B119-pharmaceutics-14-01837" ref-type="bibr">119</xref>], or the production of diorcinol 3-O-&#x003b1;-D-ribofuranoside in a marine-derived isolate from <italic toggle="yes">Aspergillus</italic> sp. [<xref rid="B130-pharmaceutics-14-01837" ref-type="bibr">130</xref>] or in the induction of many silent BGCs during a screen of 162 mangrove endophytic fungi of which 72 produced bioactive substances [<xref rid="B137-pharmaceutics-14-01837" ref-type="bibr">137</xref>]. <xref rid="pharmaceutics-14-01837-t006" ref-type="table">Table 6</xref> lists publications that used the genetic or chemical interference of chromatin remodelers for the induction of silent BGCs.</p><p>There are however downsides to strategies that interfere with globally active regulators. While approaches that mimic environmental conditions result in a native regulatory response of BGCs, the disruption of global regulatory mechanisms can lead to the synthesis of cryptic compounds that emerge due to uncoordinated regulation of genes or by bio-transformation of the inhibitors [<xref rid="B332-pharmaceutics-14-01837" ref-type="bibr">332</xref>,<xref rid="B344-pharmaceutics-14-01837" ref-type="bibr">344</xref>,<xref rid="B374-pharmaceutics-14-01837" ref-type="bibr">374</xref>]. Additionally, chemical or genetic manipulation of globally active chromatin remodelers can be lethal [<xref rid="B315-pharmaceutics-14-01837" ref-type="bibr">315</xref>] or lead to phenotypically aberrant transformants (i.e., growth, morphology, conidiation, &#x02026;) [<xref rid="B308-pharmaceutics-14-01837" ref-type="bibr">308</xref>,<xref rid="B339-pharmaceutics-14-01837" ref-type="bibr">339</xref>,<xref rid="B375-pharmaceutics-14-01837" ref-type="bibr">375</xref>,<xref rid="B376-pharmaceutics-14-01837" ref-type="bibr">376</xref>,<xref rid="B377-pharmaceutics-14-01837" ref-type="bibr">377</xref>]. All these factors can result in a substantial change of the whole metabolome [<xref rid="B321-pharmaceutics-14-01837" ref-type="bibr">321</xref>,<xref rid="B346-pharmaceutics-14-01837" ref-type="bibr">346</xref>] and transcriptome [<xref rid="B326-pharmaceutics-14-01837" ref-type="bibr">326</xref>,<xref rid="B351-pharmaceutics-14-01837" ref-type="bibr">351</xref>] which makes interpretation challenging, even with software solutions that assist with the detection of degradation products or bio-transformed moieties such as BioTransformer [<xref rid="B378-pharmaceutics-14-01837" ref-type="bibr">378</xref>].</p><p>In recent years, however, CRISPR/Cas technology advanced to a point where new options for targeted local chromatin modifications are available and some have already been established in fungal species.</p></sec></sec><sec id="sec6-pharmaceutics-14-01837"><title>6. CRISPR/Cas: New Opportunities in Molecular Biology: Targeted Gene Deletion, Activation and Epigenetic Editing in Filamentous Fungi</title><p>CRISPR/Cas is a fast-advancing technology in molecular biology that is nowadays deployed in many prokaryotes and eukaryotes, illustrated by around 25,000 publications connected to &#x0201c;CRISPR&#x0201d; over the last 5 years. Its fast development in terms of genome editing but also in epigenome editing and as a tool for transcriptional activation makes it a very promising option for future application. Although CRISPR/Cas technology is widely used for gene manipulation, approaches for gene and BGC activation are just recently gaining attention in filamentous fungi. In the next section, we shortly introduce the principle of CRISPR/CAS technology and different classes and types that are available before moving to approaches that are applied in filamentous fungi and future perspectives of gene activation (i.e., CRISPRa) applications.</p><sec id="sec6dot1-pharmaceutics-14-01837"><title>6.1. Principle of CRISPR-Cas Technology</title><p>The best-known variant of CRIPSR/Cas systems is the RNA-guided nuclease Cas9 from <italic toggle="yes">Streptococcus pyrogenes</italic>, SpCas9. CRISPR/Cas is the major component of the acquired bacterial or archaeal immune system [<xref rid="B379-pharmaceutics-14-01837" ref-type="bibr">379</xref>]. It is a nuclease that inactivates foreign DNA by causing double-strand breaks at specific DNA-loci via previously acquired guide sequences.</p><p>The native lifecycle of the CRISPR/Cas adaptive immunity consists of three stages. Adaption, expression, and interference [<xref rid="B380-pharmaceutics-14-01837" ref-type="bibr">380</xref>]. Upon initial infection, invading (e.g., phage) DNA is digested by Cas proteins that recognize foreign DNA by a nucleotide sequence that does not occur in the host genome. The so-called protospacer adjacent motif or PAM. Each CRISPR/Cas system has a distinct PAM sequence. A short stretch of the DNA (i.e., protospacer) is then cleaved out and inserted into a DNA locus called CRISPR-array. In the expression phase, the whole CRISPR array with all protospacers is transcribed (i.e., pre-CRISPR RNA or pre-crRNA) and processed into mature CRISPR RNAs (i.e., crRNA). Different CRISPR/Cas variants have different procedures during this phase, either demanding a complex interplay of many Cas proteins or requiring only one multi-domain protein [<xref rid="B380-pharmaceutics-14-01837" ref-type="bibr">380</xref>]. During the interference stage, the mature crRNA or guide RNA is used as a reference pattern for the Cas nucleases to inactivate invading non-host DNAs by inducing double-strand breaks at loci that match the crRNA sequence and possess a PAM motif [<xref rid="B380-pharmaceutics-14-01837" ref-type="bibr">380</xref>].</p><p>After the discovery of CRISPR/Cas, its potential instantly attracted the interest of the scientific community. Many research groups refined this strategy over the past years to one of the most versatile tools used in modern molecular biology that has now been established in many eukaryotic organisms, including filamentous fungi [<xref rid="B381-pharmaceutics-14-01837" ref-type="bibr">381</xref>,<xref rid="B382-pharmaceutics-14-01837" ref-type="bibr">382</xref>]. New variants of the CRISPR/Cas from different bacterial sources or engineered forms evolve(d). Some are only capable of nicking the DNA or even are incapable of modifying the DNA at all (nuclease- dead Cas9, dCas9). By fusing these variants with proteins of versatile functionality, researchers created a multitude of effector proteins that can be targeted precisely throughout the genome. This opened many new possibilities for addressing research questions that go beyond genome editing, such as CRISPR/Cas mediated chromatin modification [<xref rid="B252-pharmaceutics-14-01837" ref-type="bibr">252</xref>], gene activation (CRISPRa) [<xref rid="B251-pharmaceutics-14-01837" ref-type="bibr">251</xref>,<xref rid="B253-pharmaceutics-14-01837" ref-type="bibr">253</xref>,<xref rid="B271-pharmaceutics-14-01837" ref-type="bibr">271</xref>,<xref rid="B383-pharmaceutics-14-01837" ref-type="bibr">383</xref>] or transcriptional interference (CRISPRi) [<xref rid="B384-pharmaceutics-14-01837" ref-type="bibr">384</xref>,<xref rid="B385-pharmaceutics-14-01837" ref-type="bibr">385</xref>] and locus-specific protein proximity labelling (CasID or BioID) [<xref rid="B386-pharmaceutics-14-01837" ref-type="bibr">386</xref>].</p></sec><sec id="sec6dot2-pharmaceutics-14-01837"><title>6.2. Differences between CRISPR/Cas Variants</title><p>Following Cas9, different variants of CRISPR-Cas systems have been found in nature as reviewed in detail by [<xref rid="B380-pharmaceutics-14-01837" ref-type="bibr">380</xref>]. They are divided into two classes which differ in their complexity. While class I CRISPR/Cas systems utilize many proteins for each phase of the natural defense (adaption, expression, interference), class II CRISPR/Cas systems only use 2&#x02013;3 proteins during adaption and only 1 (Type V (i.e., Cas12a) and VI) or two (Type II (i.e., Cas9)) proteins during expression and interference. The simplicity of Class II systems makes them the prevalent choice for CRISPR/Cas applications in molecular biology. Depending on the type of Cas variant, they can either target RNA molecules (Type VI) or DNA (Type II and V) molecules [<xref rid="B381-pharmaceutics-14-01837" ref-type="bibr">381</xref>]. Within Class II especially <underline>SpCas9</underline> from <italic toggle="yes">Streptococcus pyrogenes</italic> or <underline>Cas12a</underline> (i.e., Cpf1) from <italic toggle="yes">Francisella novicida, Acidaminococcus</italic> sp. or <italic toggle="yes">Lachnospiraceae bacterium</italic> (i.e., FnCas12a, AsCas12a, LbCas12a) are being deployed for molecular biology in fungi. They have important differences that make both of them viable options, depending on the application [<xref rid="B381-pharmaceutics-14-01837" ref-type="bibr">381</xref>].</p><p>Easier handling and cloning with Cas12a due to <underline>different gRNA processing</underline>. Cas9 needs the matured form of the tracrRNA and the crRNA which, in nature, anneal to produce a functional guide RNA that can then build a complex with the Cas9 protein. Genetic engineering-led, however, to the development of both crRNA and tracrRNA in one single guide RNA (sgRNA) which increased the handling comfort and efficiency [<xref rid="B387-pharmaceutics-14-01837" ref-type="bibr">387</xref>]. Nevertheless, for the proper maturation of the sgRNA, it has to be ensured that only the sgRNA without any additional nucleotides is released from the transcript which is currently accomplished by either ribozymes [<xref rid="B388-pharmaceutics-14-01837" ref-type="bibr">388</xref>] or tRNAs [<xref rid="B389-pharmaceutics-14-01837" ref-type="bibr">389</xref>] that flank the sgRNA. The sgRNA maturation via ribozymes uses an RNA polymerase II promoter and terminator together with the Hammerhead and HDV ribozymes to release the mature sgRNA [<xref rid="B388-pharmaceutics-14-01837" ref-type="bibr">388</xref>]. N&#x000f8;dvig and co-workers took this idea even further and developed a system capable of multiplexing sgRNAs utilizing the endogenous tRNA processing machinery. It consists of a cassette that uses an RNA polymerase III promoter to express sgRNAs which are flanked by tRNAs. This then results in the release of mature sgRNAs by tRNA-specific RNAse P and RNAse Z enzymes [<xref rid="B389-pharmaceutics-14-01837" ref-type="bibr">389</xref>] (<xref rid="pharmaceutics-14-01837-f003" ref-type="fig">Figure 3</xref>a). This made it possible to express multiple sgRNAs at the same time thereby increasing editing efficiency by application of several gRNAs at the same locus which in turn allows for multiple gene editing. However, the genetic scaffold that is required for proper processing and release of multiple mature sgRNAs makes the cloning and transformation process of Cas9 multiplexing systems a challenging and labor-intensive endeavour in filamentous fungi. In the case of the ribozyme approach, the repetitive expression scaffold for one gRNA sequence is around 185 nt-long [<xref rid="B388-pharmaceutics-14-01837" ref-type="bibr">388</xref>] and in the case of the tRNA-assisted approach, it spans even around 222 nts (containing 2x identical glycine tRNA) [<xref rid="B389-pharmaceutics-14-01837" ref-type="bibr">389</xref>] (<xref rid="pharmaceutics-14-01837-f003" ref-type="fig">Figure 3</xref>a).</p><p>In stark contrast to Cas9, Cas12a can directly process the U6 promoter-driven CRISPR array into the mature guide RNAs which only consists of a 19 nt-long direct repeat (DR) and a 23&#x02013;25 nt-long protospacer sequence (PS) (i.e., U6-DR-PS-DR-PS-DR-PS-, etc.) (<xref rid="pharmaceutics-14-01837-f003" ref-type="fig">Figure 3</xref>b). This greatly facilitates the cloning and application of single and multiple sgRNAs with Cas12a [<xref rid="B390-pharmaceutics-14-01837" ref-type="bibr">390</xref>,<xref rid="B391-pharmaceutics-14-01837" ref-type="bibr">391</xref>,<xref rid="B392-pharmaceutics-14-01837" ref-type="bibr">392</xref>,<xref rid="B393-pharmaceutics-14-01837" ref-type="bibr">393</xref>].</p><p><underline>The DNA cleavage pattern</underline> is different between Cas9 and Cas12a. While SpCas9 produces a blunt end cut 3 bps upstream of the NGG PAM [<xref rid="B387-pharmaceutics-14-01837" ref-type="bibr">387</xref>], Cas12a variant FnCas12a cleaves after the 23rd base on the targeted strand at the 18th base of the non-targeted strand which results in staggering cleavage sites distant from the PAM [<xref rid="B394-pharmaceutics-14-01837" ref-type="bibr">394</xref>]. In the case of Cas9, the cleavage is mediated by two nuclease domains (HNH and RuvC) [<xref rid="B395-pharmaceutics-14-01837" ref-type="bibr">395</xref>], while Cas12a only has one RuvC domain for the cleavage of both strands [<xref rid="B394-pharmaceutics-14-01837" ref-type="bibr">394</xref>].</p><p><underline>The PAM sequence</underline> of Cas9 is the short 3 nucleotide long G-rich motif NGG while Cas12a has a T-rich PAM (AsCas12a and LbCas12a: 5&#x02032;-TTTN-3&#x02032; [<xref rid="B381-pharmaceutics-14-01837" ref-type="bibr">381</xref>] or 5&#x02032;-TTTV-3&#x02032; [<xref rid="B396-pharmaceutics-14-01837" ref-type="bibr">396</xref>]; FnCas12a: 5&#x02032;-TTN-3&#x02032; [<xref rid="B394-pharmaceutics-14-01837" ref-type="bibr">394</xref>]. Other PAMs are possible, depending on the origin of Cas12a [<xref rid="B397-pharmaceutics-14-01837" ref-type="bibr">397</xref>]. There are also engineered variants that accept a broader range of PAMs which will be described in <xref rid="sec6dot5-pharmaceutics-14-01837" ref-type="sec">Section 6.5</xref>. The PAM greatly limits the loci that can be targeted because, without a present PAM, neither annealing nor cutting occurs properly.</p><p>Genetic engineering led to the development of <underline>catalytically inactive (i.e., dead or dCas) and nicking CRISPR/Cas tools.</underline> Cas9 proteins that can only nick the DNA (i.e., nCas9) [<xref rid="B398-pharmaceutics-14-01837" ref-type="bibr">398</xref>] resulted in improved single base editing efficacy [<xref rid="B399-pharmaceutics-14-01837" ref-type="bibr">399</xref>]. There are also mutant versions of Cas12a proteins although they are not yet capable of perfect nicks as they still retain some of the catalytic activity for the second strand. Merely the ratio of single and double-strand breaks is shifted in favor of the nicks [<xref rid="B400-pharmaceutics-14-01837" ref-type="bibr">400</xref>,<xref rid="B401-pharmaceutics-14-01837" ref-type="bibr">401</xref>]. In contrast to Cas9, Cas12a only has one catalytic domain that cleaves both strands which makes the engineering of nCas12a variants more complicated.</p><p>The development of catalytically inactive Cas9 and later Cas12a variants (i.e., dead or dCas9 and dCas12a) made CRISPR/Cas to a very powerful tool in molecular biology [<xref rid="B400-pharmaceutics-14-01837" ref-type="bibr">400</xref>,<xref rid="B402-pharmaceutics-14-01837" ref-type="bibr">402</xref>]. dCas proteins can be used as guidance vessels for attached proteins or protein domains. This way, CRISPR/Cas can be deployed for a multitude of applications, involving basically any protein that can be functionally fused to the N and/or C-terminal or even as a mediator of transcriptional interference (CRISPRi) by the sterical hindrance of the transcriptional machinery within a gene body or at the transcriptional start site [<xref rid="B403-pharmaceutics-14-01837" ref-type="bibr">403</xref>].</p><p>Although SpCas9 is currently the prevalent choice for gene editing and other applications, the Cas12a system has many benefits for working with filamentous fungi. The biggest advantage with regard to BGC activation is the easy deployment of multiple gRNAs as compared to SpCas9. While Cas12a can process the raw pre-crRNA transcript directly, Cas9 needs more complex cloning strategies involving features that allow for a proper release of blunt end sgRNAs (e.g., ribozymes or tRNA scaffolds). Cas12a is, therefore, much easier to handle which not only makes experiments more time efficient but also more robust as the system requires fewer components.</p><p>The second advantage for work with filamentous fungi specifically is the <underline>temperature maximum</underline>. Most filamentous fungi grow well around room temperature. SpCas9 has its catalytic maximum at 32 &#x000b0;C which can be challenging for some fungi. Cas12a, on the other hand, can be deployed at lower temperatures (i.e., 28 &#x000b0;C) which increases the efficiency in most fungal strains [<xref rid="B404-pharmaceutics-14-01837" ref-type="bibr">404</xref>].</p><p>One of the drawbacks of the CRISPR/Cas system is the requirement of the PAM motif at the target locus. The difference in PAM sequences in different variants increases the versatility and flexibility in this matter which can be very important for experiments that require specific loci, with limited PAM options, to be targeted.</p></sec><sec id="sec6dot3-pharmaceutics-14-01837"><title>6.3. Gene Editing via CRISPR/Cas</title><p>Various approaches that involve CRISPR/Cas technology have been already applied to different fungal species [<xref rid="B395-pharmaceutics-14-01837" ref-type="bibr">395</xref>]. Especially in fungal species where site-directed mutagenesis and gene editing rates by conventional methods are very low, CRISPR/Cas is a promising option [<xref rid="B405-pharmaceutics-14-01837" ref-type="bibr">405</xref>,<xref rid="B406-pharmaceutics-14-01837" ref-type="bibr">406</xref>].</p><p>To increase the editing efficiency by utilizing homologous DNA repair pathways, linear or circular double-stranded DNA with homologous regions or single-stranded DNA oligos with small homologous regions can be transformed together with the Cas construct. These then can get inserted at the Cas9 restriction site after cleavage which not only can increase the mutation rate but makes it also possible not only to mutate, but exchange the DNA sequence via homology-directed repair mechanisms (<xref rid="pharmaceutics-14-01837-f003" ref-type="fig">Figure 3</xref>c) [<xref rid="B389-pharmaceutics-14-01837" ref-type="bibr">389</xref>,<xref rid="B407-pharmaceutics-14-01837" ref-type="bibr">407</xref>].</p><p>The transformation of the CRISPR/Cas machinery and the guide RNA(s) can be performed on a single [<xref rid="B388-pharmaceutics-14-01837" ref-type="bibr">388</xref>] or multiple plasmids [<xref rid="B251-pharmaceutics-14-01837" ref-type="bibr">251</xref>], episomal plasmids by utilization of the AMA1 region of <italic toggle="yes">A. nidulans</italic> [<xref rid="B388-pharmaceutics-14-01837" ref-type="bibr">388</xref>,<xref rid="B389-pharmaceutics-14-01837" ref-type="bibr">389</xref>], by random integration into the genome [<xref rid="B408-pharmaceutics-14-01837" ref-type="bibr">408</xref>] or within a specific genomic locus [<xref rid="B251-pharmaceutics-14-01837" ref-type="bibr">251</xref>]. We recently also developed an inducible CRISPR/Cas variant in filamentous fungi that uses the human estrogen receptor [<xref rid="B251-pharmaceutics-14-01837" ref-type="bibr">251</xref>,<xref rid="B409-pharmaceutics-14-01837" ref-type="bibr">409</xref>]. Other variants utilize the Tet-ON system for induction [<xref rid="B410-pharmaceutics-14-01837" ref-type="bibr">410</xref>].</p><p>If the fungus is not amenable to stable or transient genomic transformations, mutation by CRISPR/Cas systems can also be achieved by transformation of the in vitro pre-assembled (i.e., sgRNA and Cas-protein) ribonucleotide complex (RNP) [<xref rid="B407-pharmaceutics-14-01837" ref-type="bibr">407</xref>,<xref rid="B411-pharmaceutics-14-01837" ref-type="bibr">411</xref>,<xref rid="B412-pharmaceutics-14-01837" ref-type="bibr">412</xref>]. For more information about CRISPR/CAS applications in fungi, please consult the recent review by Schuster and Kahmann [<xref rid="B413-pharmaceutics-14-01837" ref-type="bibr">413</xref>].</p></sec><sec id="sec6dot4-pharmaceutics-14-01837"><title>6.4. Gene and BGC Activation via CRISPR/dCAS Variants</title><p>Catalytically inactive Cas variants (i.e., dCas9, dCas12a) have great potential to be used for the activation of silent BGCs. When fused to a trans-activator domain it can be deployed as a programmable TF for the activation of one or multiple genes (via sgRNA multiplexing; <xref rid="pharmaceutics-14-01837-f003" ref-type="fig">Figure 3</xref>a,b) [<xref rid="B251-pharmaceutics-14-01837" ref-type="bibr">251</xref>,<xref rid="B253-pharmaceutics-14-01837" ref-type="bibr">253</xref>]. Another potent approach is the fusion of a chromatin remodeler (domain) which would provide the possibility to change histone modifications in a targeted and locus-specific manner [<xref rid="B252-pharmaceutics-14-01837" ref-type="bibr">252</xref>]. This way, BGCs that are buried within heterochromatin could be made accessible by replacing the silencing marks (i.e., H3K9me3, H3K27me3) with active marks (i.e., acetylation). <xref rid="pharmaceutics-14-01837-f004" ref-type="fig">Figure 4</xref> illustrates both dCas-mediated approaches for the activation of silent BGCs.</p><sec id="sec6dot4dot1-pharmaceutics-14-01837"><title>6.4.1. Transcriptional Regulation</title><p>The fusion of a trans-activator or trans-activating domain and a dCas protein transforms it into a programmable transcription factor that can be sent to any spot within the genome (as long as an appropriate PAM is present). This CRISPRa method was established simultaneously in the filamentous fungi <italic toggle="yes">Aspergillus nidulans</italic> for dCas9 [<xref rid="B251-pharmaceutics-14-01837" ref-type="bibr">251</xref>] and dCas12a [<xref rid="B253-pharmaceutics-14-01837" ref-type="bibr">253</xref>] and shortly after also in <italic toggle="yes">P. rubens</italic> [<xref rid="B271-pharmaceutics-14-01837" ref-type="bibr">271</xref>]. In every case, the trans-activator VPR [<xref rid="B414-pharmaceutics-14-01837" ref-type="bibr">414</xref>] was chosen as it was shown to be more effective than other known trans-activator domains. It is a tripartite activator with protein domains that were shown to interact with parts of the transcriptional machinery and also the histone acetylase complex SAGA [<xref rid="B415-pharmaceutics-14-01837" ref-type="bibr">415</xref>]. The hybrid trans-activator consists of four copies of the VP16 domain of the Herpes simplex virus, the p65 domain of the human activator NF-&#x003ba;B and the Rta domain of the Epstein-Barr virus TF. These publications tackle multiple challenges when it comes to BGC activation. Roux et al. successfully deployed dCas12a-VPR in an episomal and stable approach. They showed that the activation of a BGC can be achieved by upregulation of the pathway-specific TF but also by using guide RNA multiplexing to upregulate all genes of a BGC [<xref rid="B253-pharmaceutics-14-01837" ref-type="bibr">253</xref>]. Simultaneously, we published a nucleosome positioning map of the genome of <italic toggle="yes">A. nidulans</italic> which was used to target VPR-dCas9 into nucleosome-free regions within the promoter [<xref rid="B251-pharmaceutics-14-01837" ref-type="bibr">251</xref>]. This facilitates the binding of VPR-dCas9 as it was shown that steric hindrances such as nucleosomes or other proteins can prevent the annealing of (d)Cas proteins to their target [<xref rid="B416-pharmaceutics-14-01837" ref-type="bibr">416</xref>]. Furthermore, we deployed an inducible version of VPR-dCas9 to precisely time the activation process because some metabolites could be toxic to the host and therefore interfere with the morphology and (chemical) phenotype of the fungus if the BGC product is synthesized constitutively [<xref rid="B251-pharmaceutics-14-01837" ref-type="bibr">251</xref>].</p></sec><sec id="sec6dot4dot2-pharmaceutics-14-01837"><title>6.4.2. Targeted Chromatin Remodelling Using CRISPR/Cas</title><p>Targeted locus-specific deposition of histone marks via fusion proteins of dCas and chromatin active domains is an emerging field in molecular biology. In human cancer cells, targeted modification of H3K9me3 and H3K27ac can be accomplished by deploying a fusion protein composed of dCas9 and the H3K9 methyl-transferase KRAB (i.e., Kr&#x000fc;ppel-associated box repressor) or the histone acetyl transferase p300, respectively. In both cases, the targeting of the fusion proteins to DNA accessible sites (e.g., nucleosome-free regions, NFRs) led to the respective modification at the locus (i.e., H3K9me3 and H3K27ac). In the case of H3K9me3, it was even shown that the DNA is inaccessible after the histone mark H3K9me3 is deployed [<xref rid="B417-pharmaceutics-14-01837" ref-type="bibr">417</xref>,<xref rid="B418-pharmaceutics-14-01837" ref-type="bibr">418</xref>].</p><p>In fungi, gene activation and repression by targeting chromatin active domains via CRISPR/Cas to target loci were accomplished in <italic toggle="yes">A. niger,</italic> although the actual effect on chromatin status (i.e., histone modifications) has not been assessed [<xref rid="B252-pharmaceutics-14-01837" ref-type="bibr">252</xref>]. Li et al. hereby targeted the human acetyl transferase p300 to the promoter region of the HR-PKS-encoding gene <italic toggle="yes">FUM1</italic> and managed to activate the fumonisin cluster in <italic toggle="yes">A. niger</italic>. Furthermore, they fused endogenous proteins such as GcnE, the acetyltransferase of the SAGA complex, histone deacetylases HosA and RpdA, and the H3K9 demethylase Lde to dCas9 separately and tested its effect on the SM gene <italic toggle="yes">breF</italic>. While the fusion of the catalytic core of human p300 fused to dCas9 led to an activation of the target gene as expected, fusion proteins of dCas9 and GcnE, RpdA and HosA resulted in repression of the gene while no difference was seen with the dCas9-Lde fusion protein. While most of the results are as expected, the repression effect by dCas9-GcnE is interesting. Although the authors state that the repression of <italic toggle="yes">breF</italic> by dCas9-GcnE is expected as GcnE was shown to be a negative regulator of 12 PKSs in <italic toggle="yes">A. niger</italic>, the result is surprising to us. Upregulation of BGCs due to the deletion of a broad domain regulator-encoding gene such as <italic toggle="yes">gcnE</italic> could be due to many indirect effects, for instance if GcnE was the activator of a repressor of these BGCs. Targeting the acetyltransferase to a specific genomic location, however, should lead to higher levels of acetylation only at the specific location and, therefore, to upregulation of only the targeted gene.</p><p>In the case of the dCas9-HosA, activation of the pigmentation gene <italic toggle="yes">fwnA</italic> was observed. Again, this is theoretically consistent with literature where <italic toggle="yes">fwnA</italic> expression decreased in <italic toggle="yes">hosA</italic> deletion strains. Such as with GcnE however, comparing a local effect (i.e., deacetylation of the promoter region) with a genome-wide effect (i.e., deletion of broad domain regulator such as HosA) does not take indirect regulatory effects into account. Unfortunately, histone modifications of the targeted loci were not analyzed, so it is not clear if really a change in histone modifications is responsible for the observations. Furthermore, there could also be the possibility of host-mediated recruitment of the endogenous fusion protein (i.e., HosA, RpdA, GncE, Lde) which could interfere with the experimental setup. Using only the catalytic domain (of homologs) would be a way of circumventing this.</p><p>Histone phosphorylation is another mechanism for gene induction that is prevalent in stress response gene promoters. A fusion of dCas9 and a hyperactive variant of the human histone kinase MSK1 (i.e., dMSK1) could be targeted to promoters for gene activation by phosphorylation of H3S28 and H3S10 [<xref rid="B419-pharmaceutics-14-01837" ref-type="bibr">419</xref>]. Here, several (also non-stress response) genes were activated by targeting the promoter. When gene activation was successful, an increase in H3S10ph, H3S28ph, and H4K27ac was found. In cases where H3S10ph but not H3S28ph occurred, neither H4K27ac nor gene activation was observed. This was, however, not yet tested in fungal organisms.</p><p>In summary, the targeted deployment of histone modifications as a regulator of transcription is an emerging field in fungal research but experimental data is currently scarce. More research is needed to fully assess this strategy for the activation of silent BGCs. If successful, CRISPR/Cas-based targeted deployment of chromatin active domains will not only result in the discovery of many natural products but will also provide a lot of information about transcription and the local chromatin context.</p></sec></sec><sec id="sec6dot5-pharmaceutics-14-01837"><title>6.5. Application Relevant Information for CRISPR/Cas-Methods</title><p>Next, we want to summarize insights regarding the deployment of CRISPR/Cas methods. This is aimed at helping with the experimental planning. It will focus on the two main CAS systems that have been used for fungal research, Cas9, and Cas12a.</p><p><underline>Cas and dCas</underline> approaches have different <underline>prerequisites</underline> in regard to the target site, residence time and off-targets. When using CRISPR/Cas for gene-editing purposes, the successful outcome depends on a <underline>one-time event</underline> (the cleavage of DNA). In the case of CRISRRa or CRISPRi however the effect is determined by a <underline>continuous interaction</underline> of the fusion complex with the proteome or DNA at the target locus [<xref rid="B420-pharmaceutics-14-01837" ref-type="bibr">420</xref>,<xref rid="B421-pharmaceutics-14-01837" ref-type="bibr">421</xref>]. Concluding, a sgRNA that proved to elicit DNA mutations via CRISPR/Cas might not be of use for experiments where a long residence time is essential (e.g., CRISPRa).</p><p><underline>Off-target</underline> annealing also has different consequences depending on the application. Cas proteins can anneal to off-target sites but as long as the sgRNA does not match appropriately, no cut will occur. In the case of dCas approaches, however, this could theoretically lead to off-target effects mediated by the active domain that is fused to the dCas protein.</p><p>There are several <underline>tools that design gRNAs</underline> for different (d)Cas systems based on one or several of the following features: sequence composition, chromatin accessibility, gene expression, nucleotide position, RNA secondary structure, melting temperature, free energy, off-target possibility, and more [<xref rid="B422-pharmaceutics-14-01837" ref-type="bibr">422</xref>]. Some of them also feature different application types such as DNA cleavage, CRISPRi and CRISPRa. This is important because the sgRNA/crRNA design for mutational Cas approaches is different from those for CRISPRa approaches because they target the gene body and not promoter regions [<xref rid="B423-pharmaceutics-14-01837" ref-type="bibr">423</xref>]. Most of them are biased towards one or more organisms (mostly mammalian) or applications (e.g., mutational vs. CRISPRa). Some tools such as Cas-Designer (Cas9) [<xref rid="B424-pharmaceutics-14-01837" ref-type="bibr">424</xref>] feature a broad spectrum of genomes that are continuously updated (also by user request). CASPER (Cas9 and Cas12a) is not biased towards an organism and was specifically designed for genome editing in non-model organisms [<xref rid="B425-pharmaceutics-14-01837" ref-type="bibr">425</xref>]. Guide RNA design tools for non-model organism often calculate the gRNA efficiency based only on sequence features which can lead to reduced sgRNA performance if other, unconsidered parameters, such as nucleosome occupancy, prevents target site accessibility.</p><p>In the case of <underline>CRISPRa</underline> approaches, the <underline>location of deployment within the promoter</underline> (in plants) was shown to have a distinctly different effect on the activation of the target gene even if the sgRNAs were only as little as 50 base-pairs apart from each other [<xref rid="B426-pharmaceutics-14-01837" ref-type="bibr">426</xref>]. For more detailed information, read the following recent reviews which describe available prediction tools and guide RNA optimization [<xref rid="B422-pharmaceutics-14-01837" ref-type="bibr">422</xref>,<xref rid="B427-pharmaceutics-14-01837" ref-type="bibr">427</xref>].</p><p><underline>Cas efficiency</underline> depends on multiple factors including Cas-sgRNA complex formation and concentration, target site accessibility, residence time, and codon optimization. By codon optimization alone, Cas efficiency could be increased from 35 to 70% [<xref rid="B428-pharmaceutics-14-01837" ref-type="bibr">428</xref>].</p><p>Cas stabilizes the sgRNA, but the complex formation can be hindered by other RNAs and some divalent ions. To be functional, the Cas protein and the sgRNA/crRNA have to form a complex. Unbound sgRNAs get degraded very quickly. Upon complex formation, the Cas9 protein stabilizes the sgRNA, undergoes conformational changes, and is released from the inactive apo-state [<xref rid="B429-pharmaceutics-14-01837" ref-type="bibr">429</xref>,<xref rid="B430-pharmaceutics-14-01837" ref-type="bibr">430</xref>]. Random RNA molecules that are present in the cell also can bind unspecific to Cas9 and compete with sgRNAs which delays or prevents complex formation [<xref rid="B431-pharmaceutics-14-01837" ref-type="bibr">431</xref>]. After complex formation however, unspecific RNAs have no significant impact on the ribonucleotide stability anymore [<xref rid="B429-pharmaceutics-14-01837" ref-type="bibr">429</xref>]. It is therefore important to express the sgRNA/crRNA at high levels so that the Cas protein has a high chance of collision before another RNA molecule can interfere or the sgRNA/crRNA is degraded [<xref rid="B429-pharmaceutics-14-01837" ref-type="bibr">429</xref>]. The following publications give in-depth information about Cas9 [<xref rid="B432-pharmaceutics-14-01837" ref-type="bibr">432</xref>] and Cas12a [<xref rid="B433-pharmaceutics-14-01837" ref-type="bibr">433</xref>] kinetics.</p><p>It also is important to note that in the <underline>apo-state Cas9 can bind DNA in a non-specific manner</underline> while the protein remains catalytically inactive, so no unguided &#x0201c;rogue&#x0201d;-activity is happening under normal conditions [<xref rid="B430-pharmaceutics-14-01837" ref-type="bibr">430</xref>]. It was, however, shown that the presence of <underline>Mn<sup>2+</sup> or Co<sup>2+</sup></underline> ions can lead to unspecific DNA cleavage even without bound crRNA (Cas12a) or sgRNA (Cas9), respectively, which makes media composition potentially also an important brick in the wall of CRISPR/Cas applications [<xref rid="B434-pharmaceutics-14-01837" ref-type="bibr">434</xref>]. Processing of the pre-crRNA by Cas12a variants does not seem to be Mg<sup>2+</sup>-dependent but it was shown that in the case of LbCas12a and FnCas12a, affinity to the crRNA is dependent on <underline>Mg<sup>2+</sup></underline> ions which were found to be coordinated in the RNP complex [<xref rid="B435-pharmaceutics-14-01837" ref-type="bibr">435</xref>,<xref rid="B436-pharmaceutics-14-01837" ref-type="bibr">436</xref>]. It can be concluded that <underline>divalent ions can have a significant impact on Cas activity and specificity</underline> which should be kept in mind when deciding on culture conditions.</p><p>The determinants of the <underline>residence time</underline> of Cas at its target locus are the proper pairing with the PAM, the subsequent annealing to the seed region, the local proteome and its fluctuations (i.e., accessibility and dislocation), and the concentration of Cas-sgRNA complex [<xref rid="B421-pharmaceutics-14-01837" ref-type="bibr">421</xref>]. The impact of mutations on the annealing, residence time and cleavage efficiency also follow this order (PAM &#x0003e; seed sequence &#x0003e; PAM-distal sgRNA sequence (=5&#x02032;-end)) with the proteomic occupancy around the target locus having a varying influence [<xref rid="B429-pharmaceutics-14-01837" ref-type="bibr">429</xref>,<xref rid="B437-pharmaceutics-14-01837" ref-type="bibr">437</xref>]. The residence time is significantly shorter the less complementary the annealing sequence is which was shown in human cell lines where residence times of less than two minutes to up to more than three hours have been observed [<xref rid="B429-pharmaceutics-14-01837" ref-type="bibr">429</xref>].</p><p><underline>The proteome of the target site</underline> can prevent binding of Cas-sgRNA complex or even dislodge bound Cas. In vitro experiments confirmed that cleavage by Cas9 is nearly abolished when targeted to DNA occupied by nucleosomes. At the edges of nucleosomes or within linker regions, however, cleavage was largely unaffected. Interestingly, the position of the PAM was the essential determinant of cleavage efficiency when sequences close to the border of a nucleosome were targeted. This was verified in vitro by designing two nearly perfectly overlapping sgRNAs (shifted by four nts) but with opposite orientations. The sgRNA that had the PAM located proximal to the nucleosome showed drastically reduced cleavage efficiency compared to the sgRNA that had the PAM located distal [<xref rid="B416-pharmaceutics-14-01837" ref-type="bibr">416</xref>]. This observation was also confirmed in vivo in human cell lines [<xref rid="B438-pharmaceutics-14-01837" ref-type="bibr">438</xref>,<xref rid="B439-pharmaceutics-14-01837" ref-type="bibr">439</xref>,<xref rid="B440-pharmaceutics-14-01837" ref-type="bibr">440</xref>]. The magnitude of this effect is, however, also dependent on the strength of the interaction between nucleosome and DNA. Upon comparing two different DNA sequences that are known to have different affinities to nucleosomes, it was shown that breathing chromatin structures (fluctuations of DNA occupancy of the nucleosome) show a much higher cleaving permissiveness towards Cas9 than nucleosomes with strong interactions to DNA. Interestingly, the cleaving efficiency around the nucleosome dyad was comparably low in both cases. Furthermore, when repeating the same experiments with the addition of the chromatin remodeler SNF2H or RSC, Cas9 cleavage efficiency was significantly enhanced [<xref rid="B441-pharmaceutics-14-01837" ref-type="bibr">441</xref>].</p><p>The obstruction of CRISPR/Cas by proteins is not limited to nucleosomes. In the case of SpCas9 (<italic toggle="yes">Streptococcus pyogenes</italic>), which is known to remain bound to both DNA ends after cleavage [<xref rid="B442-pharmaceutics-14-01837" ref-type="bibr">442</xref>], RNA polymerase was able to dislodge the Cas9 protein when targeted to the template strand. This resulted in increased editing efficiency due to the release of both cleaved DNA ends and the onset of the DNA repair machinery [<xref rid="B443-pharmaceutics-14-01837" ref-type="bibr">443</xref>]. This might however only be true for SpCas9 because in the case of SaCas9 (<italic toggle="yes">Staphylococcus aureus</italic>) [<xref rid="B444-pharmaceutics-14-01837" ref-type="bibr">444</xref>] and AsCas12a (<italic toggle="yes">Acidaminococcus</italic> sp.) [<xref rid="B445-pharmaceutics-14-01837" ref-type="bibr">445</xref>] it was shown that these proteins automatically release one DNA strand some hours after the catalytic event.</p><p>Apart from the sgRNA annealing site itself, <underline>post-PAM interactions</underline> were found to be important for stable interactions between the Cas protein and the DNA. SpCas9 was not able to remain in a place of the target site when the DNA sequence 14 base pairs downstream was occupied by another protein. It was observed that this post-PAM interaction is weak in force but very crucial for Cas9 binding and cleavage [<xref rid="B446-pharmaceutics-14-01837" ref-type="bibr">446</xref>]. Displacement mediated by disturbance of the post-PAM accessibility can also happen after the association of SpCas9 to the DNA. In the case of SaCas9, the post-PAM interaction was only around seven base-pairs and had a much lesser effect than on SpCas9 [<xref rid="B446-pharmaceutics-14-01837" ref-type="bibr">446</xref>]. SaCas9, in stark contrast to SpCas9, represented a significant barrier for other proteins such as DNA-tracking motors [<xref rid="B444-pharmaceutics-14-01837" ref-type="bibr">444</xref>]. Zhang and co-workers give a nice comparison of interactions strength between SaCas9 and SpCas9 mediated by different regions across the footprint [<xref rid="B444-pharmaceutics-14-01837" ref-type="bibr">444</xref>].</p><p><underline>Methylated DNA</underline> could be cleaved without problems by Cas9 [<xref rid="B447-pharmaceutics-14-01837" ref-type="bibr">447</xref>] and also CRISPRa approaches had been successful when the target area had DNA-methylated sites [<xref rid="B442-pharmaceutics-14-01837" ref-type="bibr">442</xref>].</p><p>The examples from above show that the proteome of the target site can have a profound impact on the binding and residence time and therefore cleavage efficiency of CRISPR/Cas. Structures that statically occupy and block the DNA such as nucleosomes should be avoided when choosing a target site for CRISPR/Cas applications.</p><p><underline>Off-target annealing</underline> has different consequences, depending on the application (i.e., Cas vs. dead-Cas). Cleavage at off-target locations depends on PAM sequence and guide-RNA homology. Two major concerns about the deployment of CRISPR/Cas systems are the possibility of off-target effects (i.e., annealing to a not intended stretch of DNA) and the restriction that CRISPR/Cas systems need a specific PAM sequence for annealing. An interesting finding in case of off-target activity of Cas9 was, that the RNP complex could <underline>bind to many off-targets</underline>, even with a seed sequence complementarity of only five nts (seed: 6&#x02013;12 nts or 5 nts proximal to the PAM sequence for SpCas9 [<xref rid="B448-pharmaceutics-14-01837" ref-type="bibr">448</xref>] or FnCas12a [<xref rid="B394-pharmaceutics-14-01837" ref-type="bibr">394</xref>,<xref rid="B435-pharmaceutics-14-01837" ref-type="bibr">435</xref>] respectively). However, for proper catalytic function, a complementary gRNA of at least 17 nts was found to be necessary. In the case of Cas9, proper initial binding of the Cas9-sgRNA complex to the DNA is mainly mediated by PAM interaction and complementary forces between the DNA and the seed region of the sgRNA. In a second step, Cas9 cleaves after sufficient pairing of the 5&#x02032;-end of the guide RNA [<xref rid="B449-pharmaceutics-14-01837" ref-type="bibr">449</xref>]. This model would explain why binding of Cas9 to the target site can even occur in case of little homology between sgRNA and target site but cleavage is nevertheless impaired due to low overall homology between sgRNA and target sequence.</p><p>The <underline>PAMS</underline> and, therefore, the possible annealing/cutting sites are different for Cas9 and Cas12a and are one of the biggest limitations of these tools. As already mentioned, Cas9 has a G-rich while Cas12a variants have T-rich PAMs. To circumvent these limitations, protein engineering performed on Cas9 and Cas12a led to the development of near- PAMless [<xref rid="B450-pharmaceutics-14-01837" ref-type="bibr">450</xref>] or PAM-flexible [<xref rid="B451-pharmaceutics-14-01837" ref-type="bibr">451</xref>,<xref rid="B452-pharmaceutics-14-01837" ref-type="bibr">452</xref>,<xref rid="B453-pharmaceutics-14-01837" ref-type="bibr">453</xref>,<xref rid="B454-pharmaceutics-14-01837" ref-type="bibr">454</xref>] variants with increased off-target activity. But also high fidelity (HF) [<xref rid="B455-pharmaceutics-14-01837" ref-type="bibr">455</xref>] variants have been engineered. Even combinations of both variants exist which compensate for the increased off-target activity of near-PAM-less or PAM-flexible variants [<xref rid="B453-pharmaceutics-14-01837" ref-type="bibr">453</xref>,<xref rid="B454-pharmaceutics-14-01837" ref-type="bibr">454</xref>]. It is of importance that the sgRNA/crRNA design has to account for the flexible PAM. It <underline>must not enable the Cas protein to anneal to the gRNA expression cassette itself</underline> which could lead to cleavage or transcriptional blockage. To assess the (off-target) cleavage pattern of a specific Cas-sgRNA complex <italic toggle="yes">in vivo</italic>, the GUIDE-SEQ approach can be applied which performs an unbiased detection of CRISPR/Cas-mediated double-strand breaks (DSBs) by in vivo integration of an oligo at sites that have DSBs (i.e., on- and off-target loci) and subsequent amplification and next-generation sequencing [<xref rid="B456-pharmaceutics-14-01837" ref-type="bibr">456</xref>].</p><p>The information above should illustrate the many application forms and variants of CRISPR/Cas systems. There is not a one for all experimental strategy because the prerequisites of the experimental question determine not only the variant of CRISPR/Cas to be deployed but also the target genetic features (i.e., gene body in case of gene knockouts but promoters in case of activation via CRISPRa approaches) and their connected properties (i.e., PAM, proteomic occupancy, sequence bias) that have to be considered during gRNA design. In fungal organisms, mutational CRISPR approaches are already widely implemented. In the case of CRISPRa or targeted chromatin remodeling, however, this technology is still in its infancy but harbors great potential of the activation of BGCs and the discovery of new bioactive metabolites in the future.</p></sec></sec><sec id="sec7-pharmaceutics-14-01837"><title>7. Perspectives</title><p>Genome mining is a core component in the revelation of unknown BGCs in fungal genomes. The data sources that are used for predictions are very diverse across the platforms and include not only DNA or protein sequences but also transcript data, phylogenetic data, and more. Deploying more and more predictive parameters that are connected to BGCs and their regulation will surely promote the discovery of new BGCs in the future. Increasing insights into novel BGC types (i.e., gene types, protein domains, genomic arrangement, backbone genes, etc.) will also lead to a transition from &#x0201c;high novelty/low reliability&#x0201d; to &#x0201c;low novelty/high reliability&#x0201d; BGC prediction algorithms which, in turn, again increases their discovery rate. Approaches for the detection of novel BGC types are very diverse and will surely enable us to discover new and currently unknown BGC types in heavily researched model organisms.</p><p>The development of these tools, however, is similar to a feedback loop between prediction and experimental verification. Predictions of known BGCs largely depend on the detection of patterns from already verified BGC types and so, the provision of high-quality experimental verification data of BGCs is a crucial component of reliable predictions. Curated databases fulfill these requirements but need the regular attention of professionals in the field. The guided deposition of such data by the research group itself into curated databases will hopefully become a standard procedure within the publication process in the future. This would increase the reliability of predictions and also accelerate the discovery process of BGCs in fungal genomes and, hence, the development of novel pharmaceutics.</p><p>CRISPR/Cas technology is emerging as a new tool and already has proven to deliver new molecules by the activation of silent BGCs in a number of organisms. Its functionality as a transcriptional activator was already experimentally shown in fungi by fusing the trans-activator VPR to dCas9 and dCas12a. Heterochromatic regions, however, could get problematic because of target site accessibility and the sole deployment of trans-activator domains.</p><p>The targeted local histone modifications could represent the next step in the toolbox for the activation of silent BGCs. If it is possible to relieve heterochromatic regions of silent marks (i.e., H3K27me3, H3K9me3), the targeted and locus-specific transition to transcriptionally active euchromatin could be within reach. The choice of the right histone-modification domain, however, is still a topic that needs thorough research. Many observations that connect transcriptional activation and histone modification indicate that H3K9 acetylation (gene activation especially in the case of BGCs), deployed by Rtt109 and GcnE, and H3K27 acetylation (hallmark for open chromatin and de-repression in <italic toggle="yes">N. crassa</italic>), also deployed by GcnE, within the promoter region correlate best with gene activation across several fungal species. As there are often nucleosome-free regions in promoters, even within heterochromatin, nucleosome positioning maps assist with the choice of a proper entry point of dCas-fusion proteins. Depending on the target locus and the prevalent histone marks, additional activators (e.g., VPR) could be necessary to induce target genes. H3S28ph also seems a promising way of activating single genes but more research, especially in the fungal context is needed in this regard. Furthermore, if DNA motifs are also proven to be responsible for occurring histone marks in fungi, this would be an additional opportunity to relieve whole BGCs from heterochromatin. This way, the programmable histone modifier can be used in combination with these mutants to activate silent BGCs and reveal their biosynthetic product.</p></sec></body><back><ack><title>Acknowledgments</title><p>Thanks to Harald Berger for giving feedback and evaluating the &#x0201c;Genome Mining&#x0201d; section. Open Access Funding by the Austrian Science Fund (FWF).</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, A.S., L.S.-R. and J.S.; Writing&#x02014;original draft preparation, A.S.; writing&#x02014;review and editing, A.S., L.S.-R. and J.S.; visualization, A.S.; supervision, L.S.-R. and J.S.; funding acquisition, J.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-pharmaceutics-14-01837"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pham</surname><given-names>J.V.</given-names></name>
<name><surname>Yilma</surname><given-names>M.A.</given-names></name>
<name><surname>Feliz</surname><given-names>A.</given-names></name>
<name><surname>Majid</surname><given-names>M.T.</given-names></name>
<name><surname>Maffetone</surname><given-names>N.</given-names></name>
<name><surname>Walker</surname><given-names>J.R.</given-names></name>
<name><surname>Kim</surname><given-names>E.</given-names></name>
<name><surname>Cho</surname><given-names>H.J.</given-names></name>
<name><surname>Reynolds</surname><given-names>J.M.</given-names></name>
<name><surname>Song</surname><given-names>M.C.</given-names></name>
<etal/>
</person-group><article-title>A Review of the Microbial Production of Bioactive Natural Products and Biologics</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>1404</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.01404</pub-id><pub-id pub-id-type="pmid">31281299</pub-id></element-citation></ref><ref id="B2-pharmaceutics-14-01837"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fleming</surname><given-names>A.</given-names></name>
</person-group><article-title>On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of <italic toggle="yes">B. influenzae</italic></article-title><source>Br. J. Exp. Pathol.</source><year>1929</year><volume>10</volume><fpage>226</fpage><pub-id pub-id-type="doi">10.1093/clinids/2.1.129</pub-id></element-citation></ref><ref id="B3-pharmaceutics-14-01837"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Houbraken</surname><given-names>J.</given-names></name>
<name><surname>Frisvad</surname><given-names>J.C.</given-names></name>
<name><surname>Samson</surname><given-names>R.A.</given-names></name>
</person-group><article-title>Fleming&#x02019;s penicillin producing strain is not <italic toggle="yes">Penicillium chrysogenum</italic> but <italic toggle="yes">P. rubens</italic></article-title><source>IMA Fungus</source><year>2011</year><volume>2</volume><fpage>87</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.5598/imafungus.2011.02.01.12</pub-id><pub-id pub-id-type="pmid">22679592</pub-id></element-citation></ref><ref id="B4-pharmaceutics-14-01837"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Olsen</surname><given-names>A.</given-names></name>
</person-group><article-title>The Antibiotic Revolution</article-title><source>Kuhn&#x02019;s Philos. Sci.</source><year>2013</year><volume>17</volume><comment>Available online: <ext-link xlink:href="https://digitalcommons.providence.edu/kuhn_2013/6" ext-link-type="uri">https://digitalcommons.providence.edu/kuhn_2013/6</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2022-07-28">(accessed on 28 July 2022)</date-in-citation></element-citation></ref><ref id="B5-pharmaceutics-14-01837"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dhillion</surname><given-names>S.S.</given-names></name>
<name><surname>Svarstad</surname><given-names>H.</given-names></name>
<name><surname>Amundsen</surname><given-names>C.</given-names></name>
<name><surname>Bugge</surname><given-names>H.C.</given-names></name>
</person-group><article-title>Bioprospecting: Effects on Environment and Development</article-title><source>AMBIO A J. Hum. Environ.</source><year>2002</year><volume>31</volume><fpage>491</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1579/0044-7447-31.6.491</pub-id></element-citation></ref><ref id="B6-pharmaceutics-14-01837"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Laupacis</surname><given-names>A.</given-names></name>
<name><surname>Keown</surname><given-names>P.A.</given-names></name>
<name><surname>Ulan</surname><given-names>R.A.</given-names></name>
<name><surname>McKenzie</surname><given-names>N.</given-names></name>
<name><surname>Stiller</surname><given-names>C.R.</given-names></name>
</person-group><article-title>Cyclosporin A: A powerful immunosuppressant</article-title><source>Can. Med. Assoc. J.</source><year>1982</year><volume>126</volume><fpage>1041</fpage><lpage>1046</lpage><pub-id pub-id-type="pmid">7074504</pub-id></element-citation></ref><ref id="B7-pharmaceutics-14-01837"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moore</surname><given-names>R.N.</given-names></name>
<name><surname>Bigam</surname><given-names>G.</given-names></name>
<name><surname>Chan</surname><given-names>J.K.</given-names></name>
<name><surname>Hogg</surname><given-names>A.M.</given-names></name>
<name><surname>Nakashima</surname><given-names>T.T.</given-names></name>
<name><surname>Vederas</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Biosynthesis of the hypocholesterolemic agent mevinolin by <italic toggle="yes">Aspergillus terreus</italic>. Determination of the origin of carbon, hydrogen, and oxygen atoms by carbon-13 NMR and mass spectrometry</article-title><source>J. Am. Chem. Soc.</source><year>1985</year><volume>107</volume><fpage>3694</fpage><lpage>3701</lpage><pub-id pub-id-type="doi">10.1021/ja00298a046</pub-id></element-citation></ref><ref id="B8-pharmaceutics-14-01837"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Goldman</surname><given-names>G.H.</given-names></name>
<name><surname>Osmani</surname><given-names>S.A.</given-names></name>
</person-group><source>The Aspergilli: Genomics, Medical Aspects, Biotechnology, and Research Methods</source><publisher-name>CRC press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2007</year></element-citation></ref><ref id="B9-pharmaceutics-14-01837"><label>9.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Nakkeeran</surname><given-names>S.</given-names></name>
<name><surname>Rajamanickam</surname><given-names>S.</given-names></name>
<name><surname>Karthikeyan</surname><given-names>M.</given-names></name>
<name><surname>Mahendra</surname><given-names>K.</given-names></name>
<name><surname>Renukadevi</surname><given-names>P.</given-names></name>
<name><surname>Johnson</surname><given-names>I.</given-names></name>
</person-group><article-title>11&#x02014;Antimicrobial secondary metabolites from Trichoderma spp. as next generation fungicides</article-title><source>Biocontrol Agents and Secondary Metabolites</source><person-group person-group-type="editor">
<name><surname>Jogaiah</surname><given-names>S.</given-names></name>
</person-group><publisher-name>Woodhead Publishing</publisher-name><publisher-loc>Sawston, UK</publisher-loc><year>2021</year><fpage>257</fpage><lpage>282</lpage></element-citation></ref><ref id="B10-pharmaceutics-14-01837"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Savita</surname></name>
<name><surname>Sharma</surname><given-names>A.</given-names></name>
</person-group><article-title>Fungi as Biological Control Agents</article-title><source>Biofertilizers for Sustainable Agriculture and Environment</source><person-group person-group-type="editor">
<name><surname>Giri</surname><given-names>B.</given-names></name>
<name><surname>Prasad</surname><given-names>R.</given-names></name>
<name><surname>Wu</surname><given-names>Q.-S.</given-names></name>
<name><surname>Varma</surname><given-names>A.</given-names></name>
</person-group><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2019</year><fpage>395</fpage><lpage>411</lpage></element-citation></ref><ref id="B11-pharmaceutics-14-01837"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Segaran</surname><given-names>G.</given-names></name>
<name><surname>Sathiavelu</surname><given-names>M.</given-names></name>
</person-group><article-title>Fungal endophytes: A potent biocontrol agent and a bioactive metabolites reservoir</article-title><source>Biocatal. Agric. Biotechnol.</source><year>2019</year><volume>21</volume><fpage>101284</fpage><pub-id pub-id-type="doi">10.1016/j.bcab.2019.101284</pub-id></element-citation></ref><ref id="B12-pharmaceutics-14-01837"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>T.Q.</given-names></name>
<name><surname>Peng</surname><given-names>H.</given-names></name>
<name><surname>Zeng</surname><given-names>S.Y.</given-names></name>
<name><surname>Ji</surname><given-names>R.Y.</given-names></name>
<name><surname>Shi</surname><given-names>K.</given-names></name>
<name><surname>Huang</surname><given-names>H.</given-names></name>
<name><surname>Ji</surname><given-names>X.J.</given-names></name>
</person-group><article-title>Microbial production of plant hormones: Opportunities and challenges</article-title><source>Bioengineered</source><year>2017</year><volume>8</volume><fpage>124</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1080/21655979.2016.1212138</pub-id><pub-id pub-id-type="pmid">27459344</pub-id></element-citation></ref><ref id="B13-pharmaceutics-14-01837"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>K.</given-names></name>
<name><surname>Li</surname><given-names>X.Q.</given-names></name>
<name><surname>Zhao</surname><given-names>D.L.</given-names></name>
<name><surname>Zhang</surname><given-names>P.</given-names></name>
</person-group><article-title>Antifungal Secondary Metabolites Produced by the Fungal Endophytes: Chemical Diversity and Potential Use in the Development of Biopesticides</article-title><source>Front. Microbiol.</source><year>2021</year><volume>12</volume><fpage>689527</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.689527</pub-id><pub-id pub-id-type="pmid">34234763</pub-id></element-citation></ref><ref id="B14-pharmaceutics-14-01837"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Du</surname><given-names>F.Y.</given-names></name>
<name><surname>Li</surname><given-names>X.M.</given-names></name>
<name><surname>Sun</surname><given-names>Z.C.</given-names></name>
<name><surname>Meng</surname><given-names>L.H.</given-names></name>
<name><surname>Wang</surname><given-names>B.G.</given-names></name>
</person-group><article-title>Secondary Metabolites with Agricultural Antagonistic Potentials from Beauveria felina, a Marine-Derived Entomopathogenic Fungus</article-title><source>J. Agric. Food Chem.</source><year>2020</year><volume>68</volume><fpage>14824</fpage><lpage>14831</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.0c05696</pub-id><pub-id pub-id-type="pmid">33322905</pub-id></element-citation></ref><ref id="B15-pharmaceutics-14-01837"><label>15.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Sanchez</surname><given-names>S.</given-names></name>
<name><surname>Demain</surname><given-names>A.L.</given-names></name>
</person-group><article-title>Bioactive Products from Fungi</article-title><source>Food Bioactives: Extraction and Biotechnology Applications</source><person-group person-group-type="editor">
<name><surname>Puri</surname><given-names>M.</given-names></name>
</person-group><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2017</year><fpage>59</fpage><lpage>87</lpage></element-citation></ref><ref id="B16-pharmaceutics-14-01837"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Copetti</surname><given-names>M.V.</given-names></name>
</person-group><article-title>Fungi as industrial producers of food ingredients</article-title><source>Curr. Opin. Food Sci.</source><year>2019</year><volume>25</volume><fpage>52</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.cofs.2019.02.006</pub-id></element-citation></ref><ref id="B17-pharmaceutics-14-01837"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tacconelli</surname><given-names>E.</given-names></name>
<name><surname>Carrara</surname><given-names>E.</given-names></name>
<name><surname>Savoldi</surname><given-names>A.</given-names></name>
<name><surname>Harbarth</surname><given-names>S.</given-names></name>
<name><surname>Mendelson</surname><given-names>M.</given-names></name>
<name><surname>Monnet</surname><given-names>D.L.</given-names></name>
<name><surname>Pulcini</surname><given-names>C.</given-names></name>
<name><surname>Kahlmeter</surname><given-names>G.</given-names></name>
<name><surname>Kluytmans</surname><given-names>J.</given-names></name>
<name><surname>Carmeli</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis</article-title><source>Lancet Infect. Dis.</source><year>2018</year><volume>18</volume><fpage>318</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(17)30753-3</pub-id><pub-id pub-id-type="pmid">29276051</pub-id></element-citation></ref><ref id="B18-pharmaceutics-14-01837"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vylkova</surname><given-names>S.</given-names></name>
</person-group><article-title>Environmental pH modulation by pathogenic fungi as a strategy to conquer the host</article-title><source>PLoS Pathog.</source><year>2017</year><volume>13</volume><elocation-id>e1006149</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006149</pub-id><pub-id pub-id-type="pmid">28231317</pub-id></element-citation></ref><ref id="B19-pharmaceutics-14-01837"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Y.-N.</given-names></name>
<name><surname>Zhang</surname><given-names>T.-J.</given-names></name>
<name><surname>Lu</surname><given-names>X.-X.</given-names></name>
<name><surname>Ma</surname><given-names>B.-L.</given-names></name>
<name><surname>Ren</surname><given-names>A.</given-names></name>
<name><surname>Shi</surname><given-names>L.</given-names></name>
<name><surname>Jiang</surname><given-names>A.-L.</given-names></name>
<name><surname>Yu</surname><given-names>H.-S.</given-names></name>
<name><surname>Zhao</surname><given-names>M.-W.</given-names></name>
</person-group><article-title>Membrane fluidity is involved in the regulation of heat stress induced secondary metabolism in Ganoderma lucidum</article-title><source>Environ. Microbiol.</source><year>2017</year><volume>19</volume><fpage>1653</fpage><lpage>1668</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.13693</pub-id><pub-id pub-id-type="pmid">28198137</pub-id></element-citation></ref><ref id="B20-pharmaceutics-14-01837"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sandmann</surname><given-names>G.</given-names></name>
</person-group><article-title>Carotenoids and Their Biosynthesis in Fungi</article-title><source>Molecules</source><year>2022</year><volume>27</volume><elocation-id>1431</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27041431</pub-id><pub-id pub-id-type="pmid">35209220</pub-id></element-citation></ref><ref id="B21-pharmaceutics-14-01837"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wong</surname><given-names>H.J.</given-names></name>
<name><surname>Mohamad-Fauzi</surname><given-names>N.</given-names></name>
<name><surname>Rizman-Idid</surname><given-names>M.</given-names></name>
<name><surname>Convey</surname><given-names>P.</given-names></name>
<name><surname>Alias</surname><given-names>S.A.</given-names></name>
</person-group><article-title>Protective mechanisms and responses of micro-fungi towards ultraviolet-induced cellular damage</article-title><source>Polar Sci.</source><year>2019</year><volume>20</volume><fpage>19</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.polar.2018.10.001</pub-id></element-citation></ref><ref id="B22-pharmaceutics-14-01837"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Batey</surname><given-names>S.F.D.</given-names></name>
<name><surname>Greco</surname><given-names>C.</given-names></name>
<name><surname>Hutchings</surname><given-names>M.I.</given-names></name>
<name><surname>Wilkinson</surname><given-names>B.</given-names></name>
</person-group><article-title>Chemical warfare between fungus-growing ants and their pathogens</article-title><source>Curr. Opin. Chem. Biol.</source><year>2020</year><volume>59</volume><fpage>172</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2020.08.001</pub-id><pub-id pub-id-type="pmid">32949983</pub-id></element-citation></ref><ref id="B23-pharmaceutics-14-01837"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Preda</surname><given-names>V.G.</given-names></name>
<name><surname>S&#x00103;ndulescu</surname><given-names>O.</given-names></name>
</person-group><article-title>Communication is the key: Biofilms, quorum sensing, formation and prevention</article-title><source>Discoveries</source><year>2019</year><volume>7</volume><fpage>e100</fpage><pub-id pub-id-type="doi">10.15190/d.2019.13</pub-id><?supplied-pmid 32309618?><pub-id pub-id-type="pmid">32309618</pub-id></element-citation></ref><ref id="B24-pharmaceutics-14-01837"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Perincherry</surname><given-names>L.</given-names></name>
<name><surname>Lalak-Ka&#x00144;czugowska</surname><given-names>J.</given-names></name>
<name><surname>St&#x00119;pie&#x00144;</surname><given-names>&#x00141;.</given-names></name>
</person-group><article-title>Fusarium-Produced Mycotoxins in Plant-Pathogen Interactions</article-title><source>Toxins</source><year>2019</year><volume>11</volume><elocation-id>664</elocation-id><pub-id pub-id-type="doi">10.3390/toxins11110664</pub-id><?supplied-pmid 31739566?><pub-id pub-id-type="pmid">31739566</pub-id></element-citation></ref><ref id="B25-pharmaceutics-14-01837"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pusztahelyi</surname><given-names>T.</given-names></name>
<name><surname>Holb</surname><given-names>I.</given-names></name>
<name><surname>P&#x000f3;csi</surname><given-names>I.</given-names></name>
</person-group><article-title>Secondary metabolites in fungus-plant interactions</article-title><source>Front. Plant Sci.</source><year>2015</year><volume>6</volume><fpage>573</fpage><pub-id pub-id-type="doi">10.3389/fpls.2015.00573</pub-id><pub-id pub-id-type="pmid">26300892</pub-id></element-citation></ref><ref id="B26-pharmaceutics-14-01837"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schrettl</surname><given-names>M.</given-names></name>
<name><surname>Haas</surname><given-names>H.</given-names></name>
</person-group><article-title>Iron homeostasis&#x02014;Achilles&#x02019; heel of <italic toggle="yes">Aspergillus fumigatus</italic>?</article-title><source>Curr. Opin. Microbiol.</source><year>2011</year><volume>14</volume><fpage>400</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2011.06.002</pub-id><pub-id pub-id-type="pmid">21724450</pub-id></element-citation></ref><ref id="B27-pharmaceutics-14-01837"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haas</surname><given-names>H.</given-names></name>
</person-group><article-title>How to trigger a fungal weapon</article-title><source>eLife</source><year>2015</year><volume>4</volume><fpage>e10504</fpage><pub-id pub-id-type="doi">10.7554/eLife.10504</pub-id></element-citation></ref><ref id="B28-pharmaceutics-14-01837"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Robey</surname><given-names>M.T.</given-names></name>
<name><surname>Caesar</surname><given-names>L.K.</given-names></name>
<name><surname>Drott</surname><given-names>M.T.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<name><surname>Kelleher</surname><given-names>N.L.</given-names></name>
</person-group><article-title>An interpreted atlas of biosynthetic gene clusters from 1,000 fungal genomes</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2021</year><volume>118</volume><fpage>e2020230118</fpage><pub-id pub-id-type="doi">10.1073/pnas.2020230118</pub-id><pub-id pub-id-type="pmid">33941694</pub-id></element-citation></ref><ref id="B29-pharmaceutics-14-01837"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Fungal secondary metabolism: Regulation, function and drug discovery</article-title><source>Nat. Rev. Microbiol.</source><year>2019</year><volume>17</volume><fpage>167</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1038/s41579-018-0121-1</pub-id><pub-id pub-id-type="pmid">30531948</pub-id></element-citation></ref><ref id="B30-pharmaceutics-14-01837"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Heo</surname><given-names>Y.M.</given-names></name>
<name><surname>Oh</surname><given-names>S.-Y.</given-names></name>
<name><surname>Kim</surname><given-names>K.</given-names></name>
<name><surname>Han</surname><given-names>S.-I.</given-names></name>
<name><surname>Kwon</surname><given-names>S.L.</given-names></name>
<name><surname>Yoo</surname><given-names>Y.</given-names></name>
<name><surname>Kim</surname><given-names>D.</given-names></name>
<name><surname>Khim</surname><given-names>J.S.</given-names></name>
<name><surname>Kang</surname><given-names>S.</given-names></name>
<name><surname>Lee</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Comparative Genomics and Transcriptomics Depict Marine Algicolous Arthrinium Species as Endosymbionts That Help Regulate Oxidative Stress in Brown Algae</article-title><source>Front. Mar. Sci.</source><year>2021</year><volume>8</volume><fpage>753222</fpage><pub-id pub-id-type="doi">10.3389/fmars.2021.753222</pub-id></element-citation></ref><ref id="B31-pharmaceutics-14-01837"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mart&#x000ed;n</surname><given-names>J.F.</given-names></name>
</person-group><article-title>Transport systems, intracellular traffic of intermediates and secretion of &#x003b2;-lactam antibiotics in fungi</article-title><source>Fungal Biol. Biotechnol.</source><year>2020</year><volume>7</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1186/s40694-020-00096-y</pub-id><pub-id pub-id-type="pmid">32351700</pub-id></element-citation></ref><ref id="B32-pharmaceutics-14-01837"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Translating biosynthetic gene clusters into fungal armor and weaponry</article-title><source>Nat. Chem. Biol.</source><year>2015</year><volume>11</volume><fpage>671</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1897</pub-id><pub-id pub-id-type="pmid">26284674</pub-id></element-citation></ref><ref id="B33-pharmaceutics-14-01837"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Westphal</surname><given-names>K.R.</given-names></name>
<name><surname>Muurmann</surname><given-names>A.T.</given-names></name>
<name><surname>Paulsen</surname><given-names>I.E.</given-names></name>
<name><surname>N&#x000f8;rgaard</surname><given-names>K.T.H.</given-names></name>
<name><surname>Overgaard</surname><given-names>M.L.</given-names></name>
<name><surname>Dall</surname><given-names>S.M.</given-names></name>
<name><surname>Aalborg</surname><given-names>T.</given-names></name>
<name><surname>Wimmer</surname><given-names>R.</given-names></name>
<name><surname>S&#x000f8;rensen</surname><given-names>J.L.</given-names></name>
<name><surname>Sondergaard</surname><given-names>T.E.</given-names></name>
</person-group><article-title>Who Needs Neighbors? PKS8 Is a Stand-Alone Gene in <italic toggle="yes">Fusarium graminearum</italic> Responsible for Production of Gibepyrones and Prolipyrone B</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2232</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23092232</pub-id></element-citation></ref><ref id="B34-pharmaceutics-14-01837"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Terabayashi</surname><given-names>Y.</given-names></name>
<name><surname>Sano</surname><given-names>M.</given-names></name>
<name><surname>Yamane</surname><given-names>N.</given-names></name>
<name><surname>Marui</surname><given-names>J.</given-names></name>
<name><surname>Tamano</surname><given-names>K.</given-names></name>
<name><surname>Sagara</surname><given-names>J.</given-names></name>
<name><surname>Dohmoto</surname><given-names>M.</given-names></name>
<name><surname>Oda</surname><given-names>K.</given-names></name>
<name><surname>Ohshima</surname><given-names>E.</given-names></name>
<name><surname>Tachibana</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Identification and characterization of genes responsible for biosynthesis of kojic acid, an industrially important compound from <italic toggle="yes">Aspergillus oryzae</italic></article-title><source>Fungal Genet. Biol.</source><year>2010</year><volume>47</volume><fpage>953</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2010.08.014</pub-id><pub-id pub-id-type="pmid">20849972</pub-id></element-citation></ref><ref id="B35-pharmaceutics-14-01837"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wiemann</surname><given-names>P.</given-names></name>
<name><surname>Guo</surname><given-names>C.J.</given-names></name>
<name><surname>Palmer</surname><given-names>J.M.</given-names></name>
<name><surname>Sekonyela</surname><given-names>R.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Prototype of an intertwined secondary-metabolite supercluster</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2013</year><volume>110</volume><fpage>17065</fpage><lpage>17070</lpage><pub-id pub-id-type="doi">10.1073/pnas.1313258110</pub-id><pub-id pub-id-type="pmid">24082142</pub-id></element-citation></ref><ref id="B36-pharmaceutics-14-01837"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dai</surname><given-names>G.</given-names></name>
<name><surname>Shen</surname><given-names>Q.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Bian</surname><given-names>X.</given-names></name>
</person-group><article-title>Biosynthesis of Fungal Natural Products Involving Two Separate Pathway Crosstalk</article-title><source>J. Fungi</source><year>2022</year><volume>8</volume><elocation-id>320</elocation-id><pub-id pub-id-type="doi">10.3390/jof8030320</pub-id></element-citation></ref><ref id="B37-pharmaceutics-14-01837"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gluck-Thaler</surname><given-names>E.</given-names></name>
<name><surname>Haridas</surname><given-names>S.</given-names></name>
<name><surname>Binder</surname><given-names>M.</given-names></name>
<name><surname>Grigoriev</surname><given-names>I.V.</given-names></name>
<name><surname>Crous</surname><given-names>P.W.</given-names></name>
<name><surname>Spatafora</surname><given-names>J.W.</given-names></name>
<name><surname>Bushley</surname><given-names>K.</given-names></name>
<name><surname>Slot</surname><given-names>J.C.</given-names></name>
</person-group><article-title>The Architecture of Metabolism Maximizes Biosynthetic Diversity in the Largest Class of Fungi</article-title><source>Mol. Biol. Evol.</source><year>2020</year><volume>37</volume><fpage>2838</fpage><lpage>2856</lpage><pub-id pub-id-type="doi">10.1093/molbev/msaa122</pub-id><pub-id pub-id-type="pmid">32421770</pub-id></element-citation></ref><ref id="B38-pharmaceutics-14-01837"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Doroghazi</surname><given-names>J.R.</given-names></name>
<name><surname>Albright</surname><given-names>J.C.</given-names></name>
<name><surname>Goering</surname><given-names>A.W.</given-names></name>
<name><surname>Ju</surname><given-names>K.S.</given-names></name>
<name><surname>Haines</surname><given-names>R.R.</given-names></name>
<name><surname>Tchalukov</surname><given-names>K.A.</given-names></name>
<name><surname>Labeda</surname><given-names>D.P.</given-names></name>
<name><surname>Kelleher</surname><given-names>N.L.</given-names></name>
<name><surname>Metcalf</surname><given-names>W.W.</given-names></name>
</person-group><article-title>A roadmap for natural product discovery based on large-scale genomics and metabolomics</article-title><source>Nat. Chem. Biol.</source><year>2014</year><volume>10</volume><fpage>963</fpage><lpage>968</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1659</pub-id><pub-id pub-id-type="pmid">25262415</pub-id></element-citation></ref><ref id="B39-pharmaceutics-14-01837"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lind</surname><given-names>A.L.</given-names></name>
<name><surname>Wisecaver</surname><given-names>J.H.</given-names></name>
<name><surname>Lameiras</surname><given-names>C.</given-names></name>
<name><surname>Wiemann</surname><given-names>P.</given-names></name>
<name><surname>Palmer</surname><given-names>J.M.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<name><surname>Rodrigues</surname><given-names>F.</given-names></name>
<name><surname>Goldman</surname><given-names>G.H.</given-names></name>
<name><surname>Rokas</surname><given-names>A.</given-names></name>
</person-group><article-title>Drivers of genetic diversity in secondary metabolic gene clusters within a fungal species</article-title><source>PLOS Biol.</source><year>2017</year><volume>15</volume><elocation-id>e2003583</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2003583</pub-id><pub-id pub-id-type="pmid">29149178</pub-id></element-citation></ref><ref id="B40-pharmaceutics-14-01837"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fedorova</surname><given-names>N.D.</given-names></name>
<name><surname>Khaldi</surname><given-names>N.</given-names></name>
<name><surname>Joardar</surname><given-names>V.S.</given-names></name>
<name><surname>Maiti</surname><given-names>R.</given-names></name>
<name><surname>Amedeo</surname><given-names>P.</given-names></name>
<name><surname>Anderson</surname><given-names>M.J.</given-names></name>
<name><surname>Crabtree</surname><given-names>J.</given-names></name>
<name><surname>Silva</surname><given-names>J.C.</given-names></name>
<name><surname>Badger</surname><given-names>J.H.</given-names></name>
<name><surname>Albarraq</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Genomic Islands in the Pathogenic Filamentous Fungus <italic toggle="yes">Aspergillus fumigatus</italic></article-title><source>PLOS Genet.</source><year>2008</year><volume>4</volume><elocation-id>e1000046</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000046</pub-id><pub-id pub-id-type="pmid">18404212</pub-id></element-citation></ref><ref id="B41-pharmaceutics-14-01837"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andersen</surname><given-names>M.R.</given-names></name>
<name><surname>Salazar</surname><given-names>M.P.</given-names></name>
<name><surname>Schaap</surname><given-names>P.J.</given-names></name>
<name><surname>van de Vondervoort</surname><given-names>P.J.I.</given-names></name>
<name><surname>Culley</surname><given-names>D.</given-names></name>
<name><surname>Thykaer</surname><given-names>J.</given-names></name>
<name><surname>Frisvad</surname><given-names>J.C.</given-names></name>
<name><surname>Nielsen</surname><given-names>K.F.</given-names></name>
<name><surname>Albang</surname><given-names>R.</given-names></name>
<name><surname>Albermann</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Comparative genomics of citric-acid-producing <italic toggle="yes">Aspergillus niger</italic> ATCC 1015 versus enzyme-producing CBS 513.88</article-title><source>Genome Res.</source><year>2011</year><volume>21</volume><fpage>885</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1101/gr.112169.110</pub-id><pub-id pub-id-type="pmid">21543515</pub-id></element-citation></ref><ref id="B42-pharmaceutics-14-01837"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gibbons</surname><given-names>J.G.</given-names></name>
<name><surname>Salichos</surname><given-names>L.</given-names></name>
<name><surname>Slot</surname><given-names>J.C.</given-names></name>
<name><surname>Rinker</surname><given-names>D.C.</given-names></name>
<name><surname>McGary</surname><given-names>K.L.</given-names></name>
<name><surname>King</surname><given-names>J.G.</given-names></name>
<name><surname>Klich</surname><given-names>M.A.</given-names></name>
<name><surname>Tabb</surname><given-names>D.L.</given-names></name>
<name><surname>McDonald</surname><given-names>W.H.</given-names></name>
<name><surname>Rokas</surname><given-names>A.</given-names></name>
</person-group><article-title>The Evolutionary Imprint of Domestication on Genome Variation and Function of the Filamentous Fungus <italic toggle="yes">Aspergillus oryzae</italic></article-title><source>Curr. Biol.</source><year>2012</year><volume>22</volume><fpage>1403</fpage><lpage>1409</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2012.05.033</pub-id><pub-id pub-id-type="pmid">22795693</pub-id></element-citation></ref><ref id="B43-pharmaceutics-14-01837"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rokas</surname><given-names>A.</given-names></name>
<name><surname>Wisecaver</surname><given-names>J.H.</given-names></name>
<name><surname>Lind</surname><given-names>A.L.</given-names></name>
</person-group><article-title>The birth, evolution and death of metabolic gene clusters in fungi</article-title><source>Nat. Rev. Microbiol.</source><year>2018</year><volume>16</volume><fpage>731</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1038/s41579-018-0075-3</pub-id><pub-id pub-id-type="pmid">30194403</pub-id></element-citation></ref><ref id="B44-pharmaceutics-14-01837"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>K.</given-names></name>
<name><surname>Rong</surname><given-names>X.</given-names></name>
<name><surname>Pinto-Tom&#x000e1;s</surname><given-names>A.A.</given-names></name>
<name><surname>Fern&#x000e1;ndez-Villalobos</surname><given-names>M.</given-names></name>
<name><surname>Murillo-Cruz</surname><given-names>C.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Voordouw</surname><given-names>G.</given-names></name>
</person-group><article-title>Population Genetic Analysis of Streptomyces albidoflavus Reveals Habitat Barriers to Homologous Recombination in the Diversification of Streptomycetes</article-title><source>Appl. Environ. Microbiol.</source><year>2015</year><volume>81</volume><fpage>966</fpage><lpage>975</lpage><pub-id pub-id-type="doi">10.1128/AEM.02925-14</pub-id><pub-id pub-id-type="pmid">25416769</pub-id></element-citation></ref><ref id="B45-pharmaceutics-14-01837"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dal Grande</surname><given-names>F.</given-names></name>
<name><surname>Jamilloux</surname><given-names>V.</given-names></name>
<name><surname>Choisne</surname><given-names>N.</given-names></name>
<name><surname>Calchera</surname><given-names>A.</given-names></name>
<name><surname>Rolshausen</surname><given-names>G.</given-names></name>
<name><surname>Petersen</surname><given-names>M.</given-names></name>
<name><surname>Schulz</surname><given-names>M.</given-names></name>
<name><surname>Nilsson</surname><given-names>M.A.</given-names></name>
<name><surname>Schmitt</surname><given-names>I.</given-names></name>
</person-group><article-title>Transposable Elements in the Genome of the Lichen-Forming Fungus Umbilicaria pustulata and Their Distribution in Different Climate Zones along Elevation</article-title><source>Biology</source><year>2022</year><volume>11</volume><elocation-id>24</elocation-id><pub-id pub-id-type="doi">10.3390/biology11010024</pub-id></element-citation></ref><ref id="B46-pharmaceutics-14-01837"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Machida</surname><given-names>M.</given-names></name>
<name><surname>Asai</surname><given-names>K.</given-names></name>
<name><surname>Sano</surname><given-names>M.</given-names></name>
<name><surname>Tanaka</surname><given-names>T.</given-names></name>
<name><surname>Kumagai</surname><given-names>T.</given-names></name>
<name><surname>Terai</surname><given-names>G.</given-names></name>
<name><surname>Kusumoto</surname><given-names>K.</given-names></name>
<name><surname>Arima</surname><given-names>T.</given-names></name>
<name><surname>Akita</surname><given-names>O.</given-names></name>
<name><surname>Kashiwagi</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Genome sequencing and analysis of <italic toggle="yes">Aspergillus oryzae</italic></article-title><source>Nature</source><year>2005</year><volume>438</volume><fpage>1157</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1038/nature04300</pub-id><pub-id pub-id-type="pmid">16372010</pub-id></element-citation></ref><ref id="B47-pharmaceutics-14-01837"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takeda</surname><given-names>I.</given-names></name>
<name><surname>Umemura</surname><given-names>M.</given-names></name>
<name><surname>Koike</surname><given-names>H.</given-names></name>
<name><surname>Asai</surname><given-names>K.</given-names></name>
<name><surname>Machida</surname><given-names>M.</given-names></name>
</person-group><article-title>Motif-independent prediction of a secondary metabolism gene cluster using comparative genomics: Application to sequenced genomes of Aspergillus and ten other filamentous fungal species</article-title><source>DNA Res. Int. J. Rapid Publ. Rep. Genes Genomes</source><year>2014</year><volume>21</volume><fpage>447</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1093/dnares/dsu010</pub-id></element-citation></ref><ref id="B48-pharmaceutics-14-01837"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brown</surname><given-names>C.A.</given-names></name>
<name><surname>Murray</surname><given-names>A.W.</given-names></name>
<name><surname>Verstrepen</surname><given-names>K.J.</given-names></name>
</person-group><article-title>Rapid expansion and functional divergence of subtelomeric gene families in yeasts</article-title><source>Curr. Biol.</source><year>2010</year><volume>20</volume><fpage>895</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2010.04.027</pub-id><?supplied-pmid 20471265?><pub-id pub-id-type="pmid">20471265</pub-id></element-citation></ref><ref id="B49-pharmaceutics-14-01837"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Graham-Taylor</surname><given-names>C.</given-names></name>
<name><surname>Kamphuis</surname><given-names>L.G.</given-names></name>
<name><surname>Derbyshire</surname><given-names>M.C.</given-names></name>
</person-group><article-title>A detailed in silico analysis of secondary metabolite biosynthesis clusters in the genome of the broad host range plant pathogenic fungus Sclerotinia sclerotiorum</article-title><source>BMC Genom.</source><year>2020</year><volume>21</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-019-6424-4</pub-id><?supplied-pmid 31898475?><pub-id pub-id-type="pmid">31898475</pub-id></element-citation></ref><ref id="B50-pharmaceutics-14-01837"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rehmeyer</surname><given-names>C.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Kusaba</surname><given-names>M.</given-names></name>
<name><surname>Kim</surname><given-names>Y.-S.</given-names></name>
<name><surname>Brown</surname><given-names>D.</given-names></name>
<name><surname>Staben</surname><given-names>C.</given-names></name>
<name><surname>Dean</surname><given-names>R.</given-names></name>
<name><surname>Farman</surname><given-names>M.</given-names></name>
</person-group><article-title>Organization of chromosome ends in the rice blast fungus, <italic toggle="yes">Magnaporthe oryzae</italic></article-title><source>Nucleic Acids Res.</source><year>2006</year><volume>34</volume><fpage>4685</fpage><lpage>4701</lpage><pub-id pub-id-type="doi">10.1093/nar/gkl588</pub-id><?supplied-pmid 16963777?><pub-id pub-id-type="pmid">16963777</pub-id></element-citation></ref><ref id="B51-pharmaceutics-14-01837"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farman</surname><given-names>M.L.</given-names></name>
</person-group><article-title>Telomeres in the rice blast fungus <italic toggle="yes">Magnaporthe oryzae</italic>: The world of the end as we know it</article-title><source>FEMS Microbiol. Lett.</source><year>2007</year><volume>273</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2007.00812.x</pub-id><pub-id pub-id-type="pmid">17610516</pub-id></element-citation></ref><ref id="B52-pharmaceutics-14-01837"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McDonagh</surname><given-names>A.</given-names></name>
<name><surname>Fedorova</surname><given-names>N.D.</given-names></name>
<name><surname>Crabtree</surname><given-names>J.</given-names></name>
<name><surname>Yu</surname><given-names>Y.</given-names></name>
<name><surname>Kim</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>D.</given-names></name>
<name><surname>Loss</surname><given-names>O.</given-names></name>
<name><surname>Cairns</surname><given-names>T.</given-names></name>
<name><surname>Goldman</surname><given-names>G.</given-names></name>
<name><surname>Armstrong-James</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Sub-Telomere Directed Gene Expression during Initiation of Invasive Aspergillosis</article-title><source>PLOS Pathog.</source><year>2008</year><volume>4</volume><elocation-id>e1000154</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000154</pub-id><pub-id pub-id-type="pmid">18787699</pub-id></element-citation></ref><ref id="B53-pharmaceutics-14-01837"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cairns</surname><given-names>T.</given-names></name>
<name><surname>Meyer</surname><given-names>V.</given-names></name>
</person-group><article-title>In silico prediction and characterization of secondary metabolite biosynthetic gene clusters in the wheat pathogen Zymoseptoria tritici</article-title><source>BMC Genom.</source><year>2017</year><volume>18</volume><elocation-id>631</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-017-3969-y</pub-id></element-citation></ref><ref id="B54-pharmaceutics-14-01837"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morris</surname><given-names>J.J.</given-names></name>
<name><surname>Lenski</surname><given-names>R.E.</given-names></name>
<name><surname>Zinser</surname><given-names>E.R.</given-names></name>
</person-group><article-title>The Black Queen Hypothesis: Evolution of dependencies through adaptive gene loss</article-title><source>mBio</source><year>2012</year><volume>3</volume><pub-id pub-id-type="doi">10.1128/mBio.00036-12</pub-id></element-citation></ref><ref id="B55-pharmaceutics-14-01837"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burkhardt</surname><given-names>I.</given-names></name>
<name><surname>Siemon</surname><given-names>T.</given-names></name>
<name><surname>Henrot</surname><given-names>M.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>Rosler</surname><given-names>S.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
<name><surname>Christmann</surname><given-names>M.</given-names></name>
<name><surname>Dickschat</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Mechanistic Characterisation of Two Sesquiterpene Cyclases from the Plant Pathogenic Fungus <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>Angew. Chem. Int. Ed. Engl.</source><year>2016</year><volume>55</volume><fpage>8748</fpage><lpage>8751</lpage><pub-id pub-id-type="doi">10.1002/anie.201603782</pub-id><?supplied-pmid 27294564?><pub-id pub-id-type="pmid">27294564</pub-id></element-citation></ref><ref id="B56-pharmaceutics-14-01837"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Torres</surname><given-names>D.E.</given-names></name>
<name><surname>Thomma</surname><given-names>B.P.H.J.</given-names></name>
<name><surname>Seidl</surname><given-names>M.F.</given-names></name>
</person-group><article-title>Transposable Elements Contribute to Genome Dynamics and Gene Expression Variation in the Fungal Plant Pathogen <italic toggle="yes">Verticillium dahliae</italic></article-title><source>Genome Biol. Evol.</source><year>2021</year><volume>13</volume><fpage>evab135</fpage><pub-id pub-id-type="doi">10.1093/gbe/evab135</pub-id><?supplied-pmid 34100895?><pub-id pub-id-type="pmid">34100895</pub-id></element-citation></ref><ref id="B57-pharmaceutics-14-01837"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valero-Jim&#x000e9;nez</surname><given-names>C.A.</given-names></name>
<name><surname>Steentjes</surname><given-names>M.B.F.</given-names></name>
<name><surname>Slot</surname><given-names>J.C.</given-names></name>
<name><surname>Shi-Kunne</surname><given-names>X.</given-names></name>
<name><surname>Scholten</surname><given-names>O.E.</given-names></name>
<name><surname>van Kan</surname><given-names>J.A.L.</given-names></name>
</person-group><article-title>Dynamics in Secondary Metabolite Gene Clusters in Otherwise Highly Syntenic and Stable Genomes in the Fungal Genus Botrytis</article-title><source>Genome Biol. Evol.</source><year>2020</year><volume>12</volume><fpage>2491</fpage><lpage>2507</lpage><pub-id pub-id-type="doi">10.1093/gbe/evaa218</pub-id><pub-id pub-id-type="pmid">33283866</pub-id></element-citation></ref><ref id="B58-pharmaceutics-14-01837"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Porquier</surname><given-names>A.</given-names></name>
<name><surname>Morgant</surname><given-names>G.</given-names></name>
<name><surname>Moraga</surname><given-names>J.</given-names></name>
<name><surname>Dalmais</surname><given-names>B.</given-names></name>
<name><surname>Luyten</surname><given-names>I.</given-names></name>
<name><surname>Simon</surname><given-names>A.</given-names></name>
<name><surname>Pradier</surname><given-names>J.-M.</given-names></name>
<name><surname>Amselem</surname><given-names>J.</given-names></name>
<name><surname>Collado</surname><given-names>I.G.</given-names></name>
<name><surname>Viaud</surname><given-names>M.</given-names></name>
</person-group><article-title>The botrydial biosynthetic gene cluster of Botrytis cinerea displays a bipartite genomic structure and is positively regulated by the putative Zn(II)2Cys6 transcription factor BcBot6</article-title><source>Fungal Genet. Biol.</source><year>2016</year><volume>96</volume><fpage>33</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2016.10.003</pub-id><?supplied-pmid 27721016?><pub-id pub-id-type="pmid">27721016</pub-id></element-citation></ref><ref id="B59-pharmaceutics-14-01837"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rokas</surname><given-names>A.</given-names></name>
<name><surname>Mead</surname><given-names>M.E.</given-names></name>
<name><surname>Steenwyk</surname><given-names>J.L.</given-names></name>
<name><surname>Raja</surname><given-names>H.A.</given-names></name>
<name><surname>Oberlies</surname><given-names>N.H.</given-names></name>
</person-group><article-title>Biosynthetic gene clusters and the evolution of fungal chemodiversity</article-title><source>Nat. Prod. Rep.</source><year>2020</year><volume>37</volume><fpage>868</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1039/C9NP00045C</pub-id><pub-id pub-id-type="pmid">31898704</pub-id></element-citation></ref><ref id="B60-pharmaceutics-14-01837"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Slot</surname><given-names>J.C.</given-names></name>
<name><surname>Rokas</surname><given-names>A.</given-names></name>
</person-group><article-title>Horizontal Transfer of a Large and Highly Toxic Secondary Metabolic Gene Cluster between Fungi</article-title><source>Curr. Biol.</source><year>2011</year><volume>21</volume><fpage>134</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2010.12.020</pub-id><pub-id pub-id-type="pmid">21194949</pub-id></element-citation></ref><ref id="B61-pharmaceutics-14-01837"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>M.A.</given-names></name>
<name><surname>Rokas</surname><given-names>A.</given-names></name>
<name><surname>Slot</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Horizontal transfer and death of a fungal secondary metabolic gene cluster</article-title><source>Genome Biol. Evol.</source><year>2012</year><volume>4</volume><fpage>289</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1093/gbe/evs011</pub-id><pub-id pub-id-type="pmid">22294497</pub-id></element-citation></ref><ref id="B62-pharmaceutics-14-01837"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dhillon</surname><given-names>B.</given-names></name>
<name><surname>Feau</surname><given-names>N.</given-names></name>
<name><surname>Aerts</surname><given-names>A.L.</given-names></name>
<name><surname>Beauseigle</surname><given-names>S.</given-names></name>
<name><surname>Bernier</surname><given-names>L.</given-names></name>
<name><surname>Copeland</surname><given-names>A.</given-names></name>
<name><surname>Foster</surname><given-names>A.</given-names></name>
<name><surname>Gill</surname><given-names>N.</given-names></name>
<name><surname>Henrissat</surname><given-names>B.</given-names></name>
<name><surname>Herath</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Horizontal gene transfer and gene dosage drives adaptation to wood colonization in a tree pathogen</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2015</year><volume>112</volume><fpage>3451</fpage><lpage>3456</lpage><pub-id pub-id-type="doi">10.1073/pnas.1424293112</pub-id><pub-id pub-id-type="pmid">25733908</pub-id></element-citation></ref><ref id="B63-pharmaceutics-14-01837"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jia</surname><given-names>Q.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>K&#x000f6;llner</surname><given-names>T.G.</given-names></name>
<name><surname>Rinkel</surname><given-names>J.</given-names></name>
<name><surname>Fu</surname><given-names>J.</given-names></name>
<name><surname>Labb&#x000e9;</surname><given-names>J.</given-names></name>
<name><surname>Xiong</surname><given-names>W.</given-names></name>
<name><surname>Dickschat</surname><given-names>J.S.</given-names></name>
<name><surname>Gershenzon</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>F.</given-names></name>
</person-group><article-title>Terpene Synthase Genes Originated from Bacteria through Horizontal Gene Transfer Contribute to Terpenoid Diversity in Fungi</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>9223</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-45532-1</pub-id><pub-id pub-id-type="pmid">31239482</pub-id></element-citation></ref><ref id="B64-pharmaceutics-14-01837"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Proctor</surname><given-names>R.H.</given-names></name>
<name><surname>Van Hove</surname><given-names>F.</given-names></name>
<name><surname>Susca</surname><given-names>A.</given-names></name>
<name><surname>Stea</surname><given-names>G.</given-names></name>
<name><surname>Busman</surname><given-names>M.</given-names></name>
<name><surname>van der Lee</surname><given-names>T.</given-names></name>
<name><surname>Waalwijk</surname><given-names>C.</given-names></name>
<name><surname>Moretti</surname><given-names>A.</given-names></name>
<name><surname>Ward</surname><given-names>T.J.</given-names></name>
</person-group><article-title>Birth, death and horizontal transfer of the fumonisin biosynthetic gene cluster during the evolutionary diversification of Fusarium</article-title><source>Mol. Microbiol.</source><year>2013</year><volume>90</volume><fpage>290</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1111/mmi.12362</pub-id><pub-id pub-id-type="pmid">23937442</pub-id></element-citation></ref><ref id="B65-pharmaceutics-14-01837"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reynolds</surname><given-names>H.T.</given-names></name>
<name><surname>Vijayakumar</surname><given-names>V.</given-names></name>
<name><surname>Gluck-Thaler</surname><given-names>E.</given-names></name>
<name><surname>Korotkin</surname><given-names>H.B.</given-names></name>
<name><surname>Matheny</surname><given-names>P.B.</given-names></name>
<name><surname>Slot</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Horizontal gene cluster transfer increased hallucinogenic mushroom diversity</article-title><source>Evol. Lett.</source><year>2018</year><volume>2</volume><fpage>88</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1002/evl3.42</pub-id><pub-id pub-id-type="pmid">30283667</pub-id></element-citation></ref><ref id="B66-pharmaceutics-14-01837"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schumacher</surname><given-names>J.</given-names></name>
<name><surname>Gautier</surname><given-names>A.</given-names></name>
<name><surname>Morgant</surname><given-names>G.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>Ducrot</surname><given-names>P.-H.</given-names></name>
<name><surname>Le P&#x000ea;cheur</surname><given-names>P.</given-names></name>
<name><surname>Azeddine</surname><given-names>S.</given-names></name>
<name><surname>Fillinger</surname><given-names>S.</given-names></name>
<name><surname>Leroux</surname><given-names>P.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>A Functional Bikaverin Biosynthesis Gene Cluster in Rare Strains of Botrytis cinerea Is Positively Controlled by VELVET</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e53729</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0053729</pub-id><pub-id pub-id-type="pmid">23308280</pub-id></element-citation></ref><ref id="B67-pharmaceutics-14-01837"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kohli</surname><given-names>G.S.</given-names></name>
<name><surname>John</surname><given-names>U.</given-names></name>
<name><surname>Van Dolah</surname><given-names>F.M.</given-names></name>
<name><surname>Murray</surname><given-names>S.A.</given-names></name>
</person-group><article-title>Evolutionary distinctiveness of fatty acid and polyketide synthesis in eukaryotes</article-title><source>ISME J.</source><year>2016</year><volume>10</volume><fpage>1877</fpage><lpage>1890</lpage><pub-id pub-id-type="doi">10.1038/ismej.2015.263</pub-id><?supplied-pmid 26784357?><pub-id pub-id-type="pmid">26784357</pub-id></element-citation></ref><ref id="B68-pharmaceutics-14-01837"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alexander</surname><given-names>N.J.</given-names></name>
<name><surname>Proctor</surname><given-names>R.H.</given-names></name>
<name><surname>McCormick</surname><given-names>S.P.</given-names></name>
</person-group><article-title>Genes, gene clusters, and biosynthesis of trichothecenes and fumonisins in Fusarium</article-title><source>Toxin Rev.</source><year>2009</year><volume>28</volume><fpage>198</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1080/15569540903092142</pub-id></element-citation></ref><ref id="B69-pharmaceutics-14-01837"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Min</surname><given-names>B.</given-names></name>
<name><surname>Grigoriev</surname><given-names>I.V.</given-names></name>
<name><surname>Choi</surname><given-names>I.-G.</given-names></name>
</person-group><article-title>FunGAP: Fungal Genome Annotation Pipeline using evidence-based gene model evaluation</article-title><source>Bioinformatics</source><year>2017</year><volume>33</volume><fpage>2936</fpage><lpage>2937</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btx353</pub-id><?supplied-pmid 28582481?><pub-id pub-id-type="pmid">28582481</pub-id></element-citation></ref><ref id="B70-pharmaceutics-14-01837"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Kim</surname><given-names>H.U.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
</person-group><article-title>Recent development of antiSMASH and other computational approaches to mine secondary metabolite biosynthetic gene clusters</article-title><source>Brief Bioinform</source><year>2019</year><volume>20</volume><fpage>1103</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1093/bib/bbx146</pub-id><pub-id pub-id-type="pmid">29112695</pub-id></element-citation></ref><ref id="B71-pharmaceutics-14-01837"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cruz-Morales</surname><given-names>P.</given-names></name>
<name><surname>Kopp</surname><given-names>J.F.</given-names></name>
<name><surname>Mart&#x000ed;nez-Guerrero</surname><given-names>C.</given-names></name>
<name><surname>Y&#x000e1;&#x000f1;ez-Guerra</surname><given-names>L.A.</given-names></name>
<name><surname>Selem-Mojica</surname><given-names>N.</given-names></name>
<name><surname>Ramos-Aboites</surname><given-names>H.</given-names></name>
<name><surname>Feldmann</surname><given-names>J.</given-names></name>
<name><surname>Barona-G&#x000f3;mez</surname><given-names>F.</given-names></name>
</person-group><article-title>Phylogenomic Analysis of Natural Products Biosynthetic Gene Clusters Allows Discovery of Arseno-Organic Metabolites in Model Streptomycetes</article-title><source>Genome Biol. Evol.</source><year>2016</year><volume>8</volume><fpage>1906</fpage><lpage>1916</lpage><pub-id pub-id-type="doi">10.1093/gbe/evw125</pub-id><pub-id pub-id-type="pmid">27289100</pub-id></element-citation></ref><ref id="B72-pharmaceutics-14-01837"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vignolle</surname><given-names>G.A.</given-names></name>
<name><surname>Schaffer</surname><given-names>D.</given-names></name>
<name><surname>Zehetner</surname><given-names>L.</given-names></name>
<name><surname>Mach</surname><given-names>R.L.</given-names></name>
<name><surname>Mach-Aigner</surname><given-names>A.R.</given-names></name>
<name><surname>Derntl</surname><given-names>C.</given-names></name>
</person-group><article-title>FunOrder: A robust and semi-automated method for the identification of essential biosynthetic genes through computational molecular co-evolution</article-title><source>PLOS Comput. Biol.</source><year>2021</year><volume>17</volume><elocation-id>e1009372</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1009372</pub-id><pub-id pub-id-type="pmid">34570757</pub-id></element-citation></ref><ref id="B73-pharmaceutics-14-01837"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Walker</surname><given-names>A.S.</given-names></name>
<name><surname>Clardy</surname><given-names>J.</given-names></name>
</person-group><article-title>A Machine Learning Bioinformatics Method to Predict Biological Activity from Biosynthetic Gene Clusters</article-title><source>J. Chem. Inf. Modeling</source><year>2021</year><volume>61</volume><fpage>2560</fpage><lpage>2571</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.0c01304</pub-id></element-citation></ref><ref id="B74-pharmaceutics-14-01837"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qiang</surname><given-names>B.</given-names></name>
<name><surname>Lai</surname><given-names>J.</given-names></name>
<name><surname>Jin</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
</person-group><article-title>Target Prediction Model for Natural Products using Transfer Learning</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>4632</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22094632</pub-id><pub-id pub-id-type="pmid">33924898</pub-id></element-citation></ref><ref id="B75-pharmaceutics-14-01837"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moumbock</surname><given-names>A.F.A.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Mishra</surname><given-names>P.</given-names></name>
<name><surname>Gao</surname><given-names>M.</given-names></name>
<name><surname>G&#x000fc;nther</surname><given-names>S.</given-names></name>
</person-group><article-title>Current computational methods for predicting protein interactions of natural products</article-title><source>Comput. Struct. Biotechnol. J.</source><year>2019</year><volume>17</volume><fpage>1367</fpage><lpage>1376</lpage><pub-id pub-id-type="doi">10.1016/j.csbj.2019.08.008</pub-id><?supplied-pmid 31762960?><pub-id pub-id-type="pmid">31762960</pub-id></element-citation></ref><ref id="B76-pharmaceutics-14-01837"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohimani</surname><given-names>H.</given-names></name>
<name><surname>Gurevich</surname><given-names>A.</given-names></name>
<name><surname>Shlemov</surname><given-names>A.</given-names></name>
<name><surname>Mikheenko</surname><given-names>A.</given-names></name>
<name><surname>Korobeynikov</surname><given-names>A.</given-names></name>
<name><surname>Cao</surname><given-names>L.</given-names></name>
<name><surname>Shcherbin</surname><given-names>E.</given-names></name>
<name><surname>Nothias</surname><given-names>L.-F.</given-names></name>
<name><surname>Dorrestein</surname><given-names>P.C.</given-names></name>
<name><surname>Pevzner</surname><given-names>P.A.</given-names></name>
</person-group><article-title>Dereplication of microbial metabolites through database search of mass spectra</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>4035</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-06082-8</pub-id><?supplied-pmid 30279420?><pub-id pub-id-type="pmid">30279420</pub-id></element-citation></ref><ref id="B77-pharmaceutics-14-01837"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Fischbach</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Computational approaches to natural product discovery</article-title><source>Nat. Chem. Biol.</source><year>2015</year><volume>11</volume><fpage>639</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1884</pub-id><?supplied-pmid 26284671?><pub-id pub-id-type="pmid">26284671</pub-id></element-citation></ref><ref id="B78-pharmaceutics-14-01837"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Shaw</surname><given-names>S.</given-names></name>
<name><surname>Kloosterman</surname><given-names>A.M.</given-names></name>
<name><surname>Charlop-Powers</surname><given-names>Z.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
</person-group><article-title>antiSMASH 6.0: Improving cluster detection and comparison capabilities</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>W29</fpage><lpage>W35</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab335</pub-id><pub-id pub-id-type="pmid">33978755</pub-id></element-citation></ref><ref id="B79-pharmaceutics-14-01837"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khaldi</surname><given-names>N.</given-names></name>
<name><surname>Seifuddin</surname><given-names>F.T.</given-names></name>
<name><surname>Turner</surname><given-names>G.</given-names></name>
<name><surname>Haft</surname><given-names>D.</given-names></name>
<name><surname>Nierman</surname><given-names>W.C.</given-names></name>
<name><surname>Wolfe</surname><given-names>K.H.</given-names></name>
<name><surname>Fedorova</surname><given-names>N.D.</given-names></name>
</person-group><article-title>SMURF: Genomic mapping of fungal secondary metabolite clusters</article-title><source>Fungal Genet. Biol.</source><year>2010</year><volume>47</volume><fpage>736</fpage><lpage>741</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2010.06.003</pub-id><pub-id pub-id-type="pmid">20554054</pub-id></element-citation></ref><ref id="B80-pharmaceutics-14-01837"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>S&#x000e9;lem-Mojica</surname><given-names>N.</given-names></name>
<name><surname>Aguilar</surname><given-names>C.</given-names></name>
<name><surname>Guti&#x000e9;rrez-Garc&#x000ed;a</surname><given-names>K.</given-names></name>
<name><surname>Mart&#x000ed;nez-Guerrero</surname><given-names>C.E.</given-names></name>
<name><surname>Barona-G&#x000f3;mez</surname><given-names>F.</given-names></name>
</person-group><article-title>EvoMining reveals the origin and fate of natural product biosynthetic enzymes</article-title><source>Microb. Genom.</source><year>2019</year><volume>5</volume><fpage>e000260</fpage><pub-id pub-id-type="doi">10.1099/mgen.0.000260</pub-id></element-citation></ref><ref id="B81-pharmaceutics-14-01837"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Wolf</surname><given-names>T.</given-names></name>
<name><surname>Chevrette</surname><given-names>M.G.</given-names></name>
<name><surname>Lu</surname><given-names>X.</given-names></name>
<name><surname>Schwalen</surname><given-names>C.J.</given-names></name>
<name><surname>Kautsar</surname><given-names>S.A.</given-names></name>
<name><surname>Suarez Duran</surname><given-names>H.G.</given-names></name>
<name><surname>de los Santos</surname><given-names>E.L.C.</given-names></name>
<name><surname>Kim</surname><given-names>H.U.</given-names></name>
<name><surname>Nave</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>antiSMASH 4.0&#x02014;improvements in chemistry prediction and gene cluster boundary identification</article-title><source>Nucleic Acids Res.</source><year>2017</year><volume>45</volume><fpage>W36</fpage><lpage>W41</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx319</pub-id><pub-id pub-id-type="pmid">28460038</pub-id></element-citation></ref><ref id="B82-pharmaceutics-14-01837"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cimermancic</surname><given-names>P.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Claesen</surname><given-names>J.</given-names></name>
<name><surname>Kurita</surname><given-names>K.</given-names></name>
<name><surname>Wieland Brown</surname><given-names>L.C.</given-names></name>
<name><surname>Mavrommatis</surname><given-names>K.</given-names></name>
<name><surname>Pati</surname><given-names>A.</given-names></name>
<name><surname>Godfrey</surname><given-names>P.A.</given-names></name>
<name><surname>Koehrsen</surname><given-names>M.</given-names></name>
<name><surname>Clardy</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters</article-title><source>Cell</source><year>2014</year><volume>158</volume><fpage>412</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.06.034</pub-id><pub-id pub-id-type="pmid">25036635</pub-id></element-citation></ref><ref id="B83-pharmaceutics-14-01837"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mungan</surname><given-names>M.D.</given-names></name>
<name><surname>Alanjary</surname><given-names>M.</given-names></name>
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Ziemert</surname><given-names>N.</given-names></name>
</person-group><article-title>ARTS 2.0: Feature updates and expansion of the Antibiotic Resistant Target Seeker for comparative genome mining</article-title><source>Nucleic Acids Res.</source><year>2020</year><volume>48</volume><fpage>W546</fpage><lpage>W552</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa374</pub-id><pub-id pub-id-type="pmid">32427317</pub-id></element-citation></ref><ref id="B84-pharmaceutics-14-01837"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alanjary</surname><given-names>M.</given-names></name>
<name><surname>Kronmiller</surname><given-names>B.</given-names></name>
<name><surname>Adamek</surname><given-names>M.</given-names></name>
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Huson</surname><given-names>D.</given-names></name>
<name><surname>Philmus</surname><given-names>B.</given-names></name>
<name><surname>Ziemert</surname><given-names>N.</given-names></name>
</person-group><article-title>The Antibiotic Resistant Target Seeker (ARTS), an exploration engine for antibiotic cluster prioritization and novel drug target discovery</article-title><source>Nucleic Acids Res.</source><year>2017</year><volume>45</volume><fpage>W42</fpage><lpage>W48</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx360</pub-id><pub-id pub-id-type="pmid">28472505</pub-id></element-citation></ref><ref id="B85-pharmaceutics-14-01837"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kj&#x000e6;rb&#x000f8;lling</surname><given-names>I.</given-names></name>
<name><surname>Vesth</surname><given-names>T.</given-names></name>
<name><surname>Andersen</surname><given-names>M.R.</given-names></name>
<name><surname>Sessions</surname><given-names>P.F.D.</given-names></name>
</person-group><article-title>Resistance Gene-Directed Genome Mining of 50 Aspergillus Species</article-title><source>mSystems</source><year>2019</year><volume>4</volume><fpage>e00085-19</fpage><pub-id pub-id-type="doi">10.1128/mSystems.00085-19</pub-id><pub-id pub-id-type="pmid">31098395</pub-id></element-citation></ref><ref id="B86-pharmaceutics-14-01837"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Umemura</surname><given-names>M.</given-names></name>
<name><surname>Koike</surname><given-names>H.</given-names></name>
<name><surname>Nagano</surname><given-names>N.</given-names></name>
<name><surname>Ishii</surname><given-names>T.</given-names></name>
<name><surname>Kawano</surname><given-names>J.</given-names></name>
<name><surname>Yamane</surname><given-names>N.</given-names></name>
<name><surname>Kozone</surname><given-names>I.</given-names></name>
<name><surname>Horimoto</surname><given-names>K.</given-names></name>
<name><surname>Shin-ya</surname><given-names>K.</given-names></name>
<name><surname>Asai</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>MIDDAS-M: Motif-Independent De Novo Detection of Secondary Metabolite Gene Clusters through the Integration of Genome Sequencing and Transcriptome Data</article-title><source>PLoS ONE</source><year>2014</year><volume>8</volume><elocation-id>e84028</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0084028</pub-id><?supplied-pmid 24391870?><pub-id pub-id-type="pmid">24391870</pub-id></element-citation></ref><ref id="B87-pharmaceutics-14-01837"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harrison</surname><given-names>P.W.</given-names></name>
<name><surname>Ahamed</surname><given-names>A.</given-names></name>
<name><surname>Aslam</surname><given-names>R.</given-names></name>
<name><surname>Alako</surname><given-names>B.T.F.</given-names></name>
<name><surname>Burgin</surname><given-names>J.</given-names></name>
<name><surname>Buso</surname><given-names>N.</given-names></name>
<name><surname>Courtot</surname><given-names>M.</given-names></name>
<name><surname>Fan</surname><given-names>J.</given-names></name>
<name><surname>Gupta</surname><given-names>D.</given-names></name>
<name><surname>Haseeb</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>The European Nucleotide Archive in 2020</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>D82</fpage><lpage>D85</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1028</pub-id><?supplied-pmid 33175160?><pub-id pub-id-type="pmid">33175160</pub-id></element-citation></ref><ref id="B88-pharmaceutics-14-01837"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kanz</surname><given-names>C.</given-names></name>
<name><surname>Aldebert</surname><given-names>P.</given-names></name>
<name><surname>Althorpe</surname><given-names>N.</given-names></name>
<name><surname>Baker</surname><given-names>W.</given-names></name>
<name><surname>Baldwin</surname><given-names>A.</given-names></name>
<name><surname>Bates</surname><given-names>K.</given-names></name>
<name><surname>Browne</surname><given-names>P.</given-names></name>
<name><surname>van den Broek</surname><given-names>A.</given-names></name>
<name><surname>Castro</surname><given-names>M.</given-names></name>
<name><surname>Cochrane</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>The EMBL Nucleotide Sequence Database</article-title><source>Nucleic Acids Res.</source><year>2005</year><volume>33</volume><fpage>D29</fpage><lpage>D33</lpage><pub-id pub-id-type="doi">10.1093/nar/gki098</pub-id><?supplied-pmid 15608199?><pub-id pub-id-type="pmid">15608199</pub-id></element-citation></ref><ref id="B89-pharmaceutics-14-01837"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Benson</surname><given-names>D.A.</given-names></name>
<name><surname>Cavanaugh</surname><given-names>M.</given-names></name>
<name><surname>Clark</surname><given-names>K.</given-names></name>
<name><surname>Karsch-Mizrachi</surname><given-names>I.</given-names></name>
<name><surname>Lipman</surname><given-names>D.J.</given-names></name>
<name><surname>Ostell</surname><given-names>J.</given-names></name>
<name><surname>Sayers</surname><given-names>E.W.</given-names></name>
</person-group><article-title>GenBank</article-title><source>Nucleic Acids Res.</source><year>2012</year><volume>41</volume><fpage>D36</fpage><lpage>D42</lpage><pub-id pub-id-type="doi">10.1093/nar/gks1195</pub-id><?supplied-pmid 23193287?><pub-id pub-id-type="pmid">23193287</pub-id></element-citation></ref><ref id="B90-pharmaceutics-14-01837"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>M.</given-names></name>
<name><surname>Carver</surname><given-names>J.J.</given-names></name>
<name><surname>Phelan</surname><given-names>V.V.</given-names></name>
<name><surname>Sanchez</surname><given-names>L.M.</given-names></name>
<name><surname>Garg</surname><given-names>N.</given-names></name>
<name><surname>Peng</surname><given-names>Y.</given-names></name>
<name><surname>Nguyen</surname><given-names>D.D.</given-names></name>
<name><surname>Watrous</surname><given-names>J.</given-names></name>
<name><surname>Kapono</surname><given-names>C.A.</given-names></name>
<name><surname>Luzzatto-Knaan</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking</article-title><source>Nat. Biotechnol.</source><year>2016</year><volume>34</volume><fpage>828</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1038/nbt.3597</pub-id><pub-id pub-id-type="pmid">27504778</pub-id></element-citation></ref><ref id="B91-pharmaceutics-14-01837"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van Santen</surname><given-names>J.A.</given-names></name>
<name><surname>Poynton</surname><given-names>E.F.</given-names></name>
<name><surname>Iskakova</surname><given-names>D.</given-names></name>
<name><surname>McMann</surname><given-names>E.</given-names></name>
<name><surname>Alsup</surname><given-names>T.A.</given-names></name>
<name><surname>Clark</surname><given-names>T.N.</given-names></name>
<name><surname>Fergusson</surname><given-names>C.H.</given-names></name>
<name><surname>Fewer</surname><given-names>D.P.</given-names></name>
<name><surname>Hughes</surname><given-names>A.H.</given-names></name>
<name><surname>McCadden</surname><given-names>C.A.</given-names></name>
<etal/>
</person-group><article-title>The Natural Products Atlas 2.0: A database of microbially-derived natural products</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>50</volume><fpage>D1317</fpage><lpage>D1323</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab941</pub-id></element-citation></ref><ref id="B92-pharmaceutics-14-01837"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haft</surname><given-names>D.H.</given-names></name>
<name><surname>Selengut</surname><given-names>J.D.</given-names></name>
<name><surname>Richter</surname><given-names>R.A.</given-names></name>
<name><surname>Harkins</surname><given-names>D.</given-names></name>
<name><surname>Basu</surname><given-names>M.K.</given-names></name>
<name><surname>Beck</surname><given-names>E.</given-names></name>
</person-group><article-title>TIGRFAMs and Genome Properties in 2013</article-title><source>Nucleic Acids Res.</source><year>2012</year><volume>41</volume><fpage>D387</fpage><lpage>D395</lpage><pub-id pub-id-type="doi">10.1093/nar/gks1234</pub-id><pub-id pub-id-type="pmid">23197656</pub-id></element-citation></ref><ref id="B93-pharmaceutics-14-01837"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Finn</surname><given-names>R.D.</given-names></name>
<name><surname>Tate</surname><given-names>J.</given-names></name>
<name><surname>Mistry</surname><given-names>J.</given-names></name>
<name><surname>Coggill</surname><given-names>P.C.</given-names></name>
<name><surname>Sammut</surname><given-names>S.J.</given-names></name>
<name><surname>Hotz</surname><given-names>H.-R.</given-names></name>
<name><surname>Ceric</surname><given-names>G.</given-names></name>
<name><surname>Forslund</surname><given-names>K.</given-names></name>
<name><surname>Eddy</surname><given-names>S.R.</given-names></name>
<name><surname>Sonnhammer</surname><given-names>E.L.L.</given-names></name>
<etal/>
</person-group><article-title>The Pfam protein families database</article-title><source>Nucleic Acids Res.</source><year>2008</year><volume>36</volume><fpage>D281</fpage><lpage>D288</lpage><pub-id pub-id-type="doi">10.1093/nar/gkm960</pub-id><pub-id pub-id-type="pmid">18039703</pub-id></element-citation></ref><ref id="B94-pharmaceutics-14-01837"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eddy</surname><given-names>S.R.</given-names></name>
</person-group><article-title>Accelerated Profile HMM Searches</article-title><source>PLOS Comput. Biol.</source><year>2011</year><volume>7</volume><elocation-id>e1002195</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002195</pub-id><pub-id pub-id-type="pmid">22039361</pub-id></element-citation></ref><ref id="B95-pharmaceutics-14-01837"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Almeida</surname><given-names>H.</given-names></name>
<name><surname>Palys</surname><given-names>S.</given-names></name>
<name><surname>Tsang</surname><given-names>A.</given-names></name>
<name><surname>Diallo</surname><given-names>A.B.</given-names></name>
</person-group><article-title>TOUCAN: A framework for fungal biosynthetic gene cluster discovery</article-title><source>NAR Genom. Bioinform.</source><year>2020</year><volume>2</volume><fpage>lqaa098</fpage><pub-id pub-id-type="doi">10.1093/nargab/lqaa098</pub-id><?supplied-pmid 33575642?><pub-id pub-id-type="pmid">33575642</pub-id></element-citation></ref><ref id="B96-pharmaceutics-14-01837"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Shaw</surname><given-names>S.</given-names></name>
<name><surname>Kautsar</surname><given-names>S.A.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
</person-group><article-title>The antiSMASH database version 3: Increased taxonomic coverage and new query features for modular enzymes</article-title><source>Nucleic Acids Res.</source><year>2020</year><volume>49</volume><fpage>D639</fpage><lpage>D643</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa978</pub-id><?supplied-pmid 33152079?><pub-id pub-id-type="pmid">33152079</pub-id></element-citation></ref><ref id="B97-pharmaceutics-14-01837"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Flissi</surname><given-names>A.</given-names></name>
<name><surname>Ricart</surname><given-names>E.</given-names></name>
<name><surname>Campart</surname><given-names>C.</given-names></name>
<name><surname>Chevalier</surname><given-names>M.</given-names></name>
<name><surname>Dufresne</surname><given-names>Y.</given-names></name>
<name><surname>Michalik</surname><given-names>J.</given-names></name>
<name><surname>Jacques</surname><given-names>P.</given-names></name>
<name><surname>Flahaut</surname><given-names>C.</given-names></name>
<name><surname>Lisacek</surname><given-names>F.</given-names></name>
<name><surname>Lecl&#x000e8;re</surname><given-names>V.</given-names></name>
<etal/>
</person-group><article-title>Norine: Update of the nonribosomal peptide resource</article-title><source>Nucleic Acids Res.</source><year>2019</year><volume>48</volume><fpage>D465</fpage><lpage>D469</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz1000</pub-id></element-citation></ref><ref id="B98-pharmaceutics-14-01837"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Navarro-Mu&#x000f1;oz</surname><given-names>J.C.</given-names></name>
<name><surname>Selem-Mojica</surname><given-names>N.</given-names></name>
<name><surname>Mullowney</surname><given-names>M.W.</given-names></name>
<name><surname>Kautsar</surname><given-names>S.A.</given-names></name>
<name><surname>Tryon</surname><given-names>J.H.</given-names></name>
<name><surname>Parkinson</surname><given-names>E.I.</given-names></name>
<name><surname>De Los Santos</surname><given-names>E.L.C.</given-names></name>
<name><surname>Yeong</surname><given-names>M.</given-names></name>
<name><surname>Cruz-Morales</surname><given-names>P.</given-names></name>
<name><surname>Abubucker</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>A computational framework to explore large-scale biosynthetic diversity</article-title><source>Nat. Chem. Biol.</source><year>2020</year><volume>16</volume><fpage>60</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/s41589-019-0400-9</pub-id><?supplied-pmid 31768033?><pub-id pub-id-type="pmid">31768033</pub-id></element-citation></ref><ref id="B99-pharmaceutics-14-01837"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kautsar</surname><given-names>S.A.</given-names></name>
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Shaw</surname><given-names>S.</given-names></name>
<name><surname>Navarro-Mu&#x000f1;oz</surname><given-names>J.C.</given-names></name>
<name><surname>Terlouw</surname><given-names>B.R.</given-names></name>
<name><surname>van der Hooft</surname><given-names>J.J.J.</given-names></name>
<name><surname>van Santen</surname><given-names>J.A.</given-names></name>
<name><surname>Tracanna</surname><given-names>V.</given-names></name>
<name><surname>Suarez Duran</surname><given-names>H.G.</given-names></name>
<name><surname>Pascal Andreu</surname><given-names>V.</given-names></name>
<etal/>
</person-group><article-title>MIBiG 2.0: A repository for biosynthetic gene clusters of known function</article-title><source>Nucleic Acids Res.</source><year>2019</year><volume>48</volume><fpage>D454</fpage><lpage>D458</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz882</pub-id></element-citation></ref><ref id="B100-pharmaceutics-14-01837"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Palaniappan</surname><given-names>K.</given-names></name>
<name><surname>Chen</surname><given-names>I.-M.A.</given-names></name>
<name><surname>Chu</surname><given-names>K.</given-names></name>
<name><surname>Ratner</surname><given-names>A.</given-names></name>
<name><surname>Seshadri</surname><given-names>R.</given-names></name>
<name><surname>Kyrpides</surname><given-names>N.C.</given-names></name>
<name><surname>Ivanova</surname><given-names>N.N.</given-names></name>
<name><surname>Mouncey</surname><given-names>N.J.</given-names></name>
</person-group><article-title>IMG-ABC v.5.0: An update to the IMG/Atlas of Biosynthetic Gene Clusters Knowledgebase</article-title><source>Nucleic Acids Res.</source><year>2019</year><volume>48</volume><fpage>D422</fpage><lpage>D430</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz932</pub-id></element-citation></ref><ref id="B101-pharmaceutics-14-01837"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hannigan</surname><given-names>G.D.</given-names></name>
<name><surname>Prihoda</surname><given-names>D.</given-names></name>
<name><surname>Palicka</surname><given-names>A.</given-names></name>
<name><surname>Soukup</surname><given-names>J.</given-names></name>
<name><surname>Klempir</surname><given-names>O.</given-names></name>
<name><surname>Rampula</surname><given-names>L.</given-names></name>
<name><surname>Durcak</surname><given-names>J.</given-names></name>
<name><surname>Wurst</surname><given-names>M.</given-names></name>
<name><surname>Kotowski</surname><given-names>J.</given-names></name>
<name><surname>Chang</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>A deep learning genome-mining strategy for biosynthetic gene cluster prediction</article-title><source>Nucleic Acids Res.</source><year>2019</year><volume>47</volume><fpage>e110</fpage><pub-id pub-id-type="doi">10.1093/nar/gkz654</pub-id><pub-id pub-id-type="pmid">31400112</pub-id></element-citation></ref><ref id="B102-pharmaceutics-14-01837"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Agrawal</surname><given-names>P.</given-names></name>
<name><surname>Khater</surname><given-names>S.</given-names></name>
<name><surname>Gupta</surname><given-names>M.</given-names></name>
<name><surname>Sain</surname><given-names>N.</given-names></name>
<name><surname>Mohanty</surname><given-names>D.</given-names></name>
</person-group><article-title>RiPPMiner: A bioinformatics resource for deciphering chemical structures of RiPPs based on prediction of cleavage and cross-links</article-title><source>Nucleic Acids Res.</source><year>2017</year><volume>45</volume><fpage>W80</fpage><lpage>W88</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx408</pub-id><pub-id pub-id-type="pmid">28499008</pub-id></element-citation></ref><ref id="B103-pharmaceutics-14-01837"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khater</surname><given-names>S.</given-names></name>
<name><surname>Gupta</surname><given-names>M.</given-names></name>
<name><surname>Agrawal</surname><given-names>P.</given-names></name>
<name><surname>Sain</surname><given-names>N.</given-names></name>
<name><surname>Prava</surname><given-names>J.</given-names></name>
<name><surname>Gupta</surname><given-names>P.</given-names></name>
<name><surname>Grover</surname><given-names>M.</given-names></name>
<name><surname>Kumar</surname><given-names>N.</given-names></name>
<name><surname>Mohanty</surname><given-names>D.</given-names></name>
</person-group><article-title>SBSPKSv2: Structure-based sequence analysis of polyketide synthases and non-ribosomal peptide synthetases</article-title><source>Nucleic Acids Res.</source><year>2017</year><volume>45</volume><fpage>W72</fpage><lpage>W79</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx344</pub-id><pub-id pub-id-type="pmid">28460065</pub-id></element-citation></ref><ref id="B104-pharmaceutics-14-01837"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anand</surname><given-names>S.</given-names></name>
<name><surname>Prasad</surname><given-names>M.V.R.</given-names></name>
<name><surname>Yadav</surname><given-names>G.</given-names></name>
<name><surname>Kumar</surname><given-names>N.</given-names></name>
<name><surname>Shehara</surname><given-names>J.</given-names></name>
<name><surname>Ansari</surname><given-names>M.Z.</given-names></name>
<name><surname>Mohanty</surname><given-names>D.</given-names></name>
</person-group><article-title>SBSPKS: Structure based sequence analysis of polyketide synthases</article-title><source>Nucleic Acids Res.</source><year>2010</year><volume>38</volume><fpage>W487</fpage><lpage>W496</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq340</pub-id><pub-id pub-id-type="pmid">20444870</pub-id></element-citation></ref><ref id="B105-pharmaceutics-14-01837"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zierep</surname><given-names>P.F.</given-names></name>
<name><surname>Padilla</surname><given-names>N.</given-names></name>
<name><surname>Yonchev</surname><given-names>D.G.</given-names></name>
<name><surname>Telukunta</surname><given-names>K.K.</given-names></name>
<name><surname>Klementz</surname><given-names>D.</given-names></name>
<name><surname>G&#x000fc;nther</surname><given-names>S.</given-names></name>
</person-group><article-title>SeMPI: A genome-based secondary metabolite prediction and identification web server</article-title><source>Nucleic Acids Res.</source><year>2017</year><volume>45</volume><fpage>W64</fpage><lpage>W71</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx289</pub-id><?supplied-pmid 28453782?><pub-id pub-id-type="pmid">28453782</pub-id></element-citation></ref><ref id="B106-pharmaceutics-14-01837"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wolf</surname><given-names>T.</given-names></name>
<name><surname>Shelest</surname><given-names>V.</given-names></name>
<name><surname>Nath</surname><given-names>N.</given-names></name>
<name><surname>Shelest</surname><given-names>E.</given-names></name>
</person-group><article-title>CASSIS and SMIPS: Promoter-based prediction of secondary metabolite gene clusters in eukaryotic genomes</article-title><source>Bioinformatics</source><year>2015</year><volume>32</volume><fpage>1138</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv713</pub-id><pub-id pub-id-type="pmid">26656005</pub-id></element-citation></ref><ref id="B107-pharmaceutics-14-01837"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vesth</surname><given-names>T.C.</given-names></name>
<name><surname>Brandl</surname><given-names>J.</given-names></name>
<name><surname>Andersen</surname><given-names>M.R.</given-names></name>
</person-group><article-title>FunGeneClusterS: Predicting fungal gene clusters from genome and transcriptome data</article-title><source>Synth. Syst. Biotechnol.</source><year>2016</year><volume>1</volume><fpage>122</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.synbio.2016.01.002</pub-id><pub-id pub-id-type="pmid">29062935</pub-id></element-citation></ref><ref id="B108-pharmaceutics-14-01837"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andersen</surname><given-names>M.R.</given-names></name>
<name><surname>Nielsen</surname><given-names>J.B.</given-names></name>
<name><surname>Klitgaard</surname><given-names>A.</given-names></name>
<name><surname>Petersen</surname><given-names>L.M.</given-names></name>
<name><surname>Zachariasen</surname><given-names>M.</given-names></name>
<name><surname>Hansen</surname><given-names>T.J.</given-names></name>
<name><surname>Blicher</surname><given-names>L.H.</given-names></name>
<name><surname>Gotfredsen</surname><given-names>C.H.</given-names></name>
<name><surname>Larsen</surname><given-names>T.O.</given-names></name>
<name><surname>Nielsen</surname><given-names>K.F.</given-names></name>
<etal/>
</person-group><article-title>Accurate prediction of secondary metabolite gene clusters in filamentous fungi</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2013</year><volume>110</volume><fpage>E99</fpage><lpage>E107</lpage><pub-id pub-id-type="doi">10.1073/pnas.1205532110</pub-id><?supplied-pmid 23248299?><pub-id pub-id-type="pmid">23248299</pub-id></element-citation></ref><ref id="B109-pharmaceutics-14-01837"><label>109.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Bachmann</surname><given-names>B.O.</given-names></name>
<name><surname>Ravel</surname><given-names>J.</given-names></name>
</person-group><article-title>Chapter 8 Methods for In Silico Prediction of Microbial Polyketide and Nonribosomal Peptide Biosynthetic Pathways from DNA Sequence Data</article-title><source>Methods in Enzymology</source><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2009</year><volume>Volume 458</volume><fpage>181</fpage><lpage>217</lpage></element-citation></ref><ref id="B110-pharmaceutics-14-01837"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Johnston</surname><given-names>C.W.</given-names></name>
<name><surname>Skinnider</surname><given-names>M.A.</given-names></name>
<name><surname>Wyatt</surname><given-names>M.A.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Ranieri</surname><given-names>M.R.M.</given-names></name>
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>Zechel</surname><given-names>D.L.</given-names></name>
<name><surname>Ma</surname><given-names>B.</given-names></name>
<name><surname>Magarvey</surname><given-names>N.A.</given-names></name>
</person-group><article-title>An automated Genomes-to-Natural Products platform (GNP) for the discovery of modular natural products</article-title><source>Nat. Commun.</source><year>2015</year><volume>6</volume><fpage>8421</fpage><pub-id pub-id-type="doi">10.1038/ncomms9421</pub-id><?supplied-pmid 26412281?><pub-id pub-id-type="pmid">26412281</pub-id></element-citation></ref><ref id="B111-pharmaceutics-14-01837"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dufresne</surname><given-names>Y.</given-names></name>
<name><surname>No&#x000e9;</surname><given-names>L.</given-names></name>
<name><surname>Lecl&#x000e8;re</surname><given-names>V.</given-names></name>
<name><surname>Pupin</surname><given-names>M.</given-names></name>
</person-group><article-title>Smiles2Monomers: A link between chemical and biological structures for polymers</article-title><source>J. Cheminform.</source><year>2015</year><volume>7</volume><fpage>62</fpage><pub-id pub-id-type="doi">10.1186/s13321-015-0111-5</pub-id><pub-id pub-id-type="pmid">26715946</pub-id></element-citation></ref><ref id="B112-pharmaceutics-14-01837"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Conway</surname><given-names>K.R.</given-names></name>
<name><surname>Boddy</surname><given-names>C.N.</given-names></name>
</person-group><article-title>ClusterMine360: A database of microbial PKS/NRPS biosynthesis</article-title><source>Nucleic Acids Res.</source><year>2012</year><volume>41</volume><fpage>D402</fpage><lpage>D407</lpage><pub-id pub-id-type="doi">10.1093/nar/gks993</pub-id><pub-id pub-id-type="pmid">23104377</pub-id></element-citation></ref><ref id="B113-pharmaceutics-14-01837"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>R&#x000f6;ttig</surname><given-names>M.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Rausch</surname><given-names>C.</given-names></name>
<name><surname>Kohlbacher</surname><given-names>O.</given-names></name>
</person-group><article-title>NRPSpredictor2&#x02014;A web server for predicting NRPS adenylation domain specificity</article-title><source>Nucleic Acids Res.</source><year>2011</year><volume>39</volume><fpage>W362</fpage><lpage>W367</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr323</pub-id><pub-id pub-id-type="pmid">21558170</pub-id></element-citation></ref><ref id="B114-pharmaceutics-14-01837"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Rausch</surname><given-names>C.</given-names></name>
<name><surname>Lopez</surname><given-names>P.</given-names></name>
<name><surname>Hoof</surname><given-names>I.</given-names></name>
<name><surname>Gaykova</surname><given-names>V.</given-names></name>
<name><surname>Huson</surname><given-names>D.H.</given-names></name>
<name><surname>Wohlleben</surname><given-names>W.</given-names></name>
</person-group><article-title>CLUSEAN: A computer-based framework for the automated analysis of bacterial secondary metabolite biosynthetic gene clusters</article-title><source>J. Biotechnol.</source><year>2009</year><volume>140</volume><fpage>13</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2009.01.007</pub-id><pub-id pub-id-type="pmid">19297688</pub-id></element-citation></ref><ref id="B115-pharmaceutics-14-01837"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bode</surname><given-names>H.B.</given-names></name>
<name><surname>Bethe</surname><given-names>B.</given-names></name>
<name><surname>H&#x000f6;fs</surname><given-names>R.</given-names></name>
<name><surname>Zeeck</surname><given-names>A.</given-names></name>
</person-group><article-title>Big Effects from Small Changes: Possible Ways to Explore Nature&#x02019;s Chemical Diversity</article-title><source>ChemBioChem</source><year>2002</year><volume>3</volume><fpage>619</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1002/1439-7633(20020703)3:7&#x0003c;619::AID-CBIC619&#x0003e;3.0.CO;2-9</pub-id><pub-id pub-id-type="pmid">12324995</pub-id></element-citation></ref><ref id="B116-pharmaceutics-14-01837"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Romano</surname><given-names>S.</given-names></name>
<name><surname>Jackson</surname><given-names>S.A.</given-names></name>
<name><surname>Patry</surname><given-names>S.</given-names></name>
<name><surname>Dobson</surname><given-names>A.D.W.</given-names></name>
</person-group><article-title>Extending the &#x0201c;One Strain Many Compounds&#x0201d; (OSMAC) Principle to Marine Microorganisms</article-title><source>Mar. Drugs</source><year>2018</year><volume>16</volume><elocation-id>244</elocation-id><pub-id pub-id-type="doi">10.3390/md16070244</pub-id><?supplied-pmid 30041461?><pub-id pub-id-type="pmid">30041461</pub-id></element-citation></ref><ref id="B117-pharmaceutics-14-01837"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Braga</surname><given-names>G.U.</given-names></name>
<name><surname>Rangel</surname><given-names>D.E.</given-names></name>
<name><surname>Fernandes</surname><given-names>&#x000c9;.K.</given-names></name>
<name><surname>Flint</surname><given-names>S.D.</given-names></name>
<name><surname>Roberts</surname><given-names>D.W.</given-names></name>
</person-group><article-title>Molecular and physiological effects of environmental UV radiation on fungal conidia</article-title><source>Curr. Genet.</source><year>2015</year><volume>61</volume><fpage>405</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1007/s00294-015-0483-0</pub-id><?supplied-pmid 25824285?><pub-id pub-id-type="pmid">25824285</pub-id></element-citation></ref><ref id="B118-pharmaceutics-14-01837"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tian</surname><given-names>F.</given-names></name>
<name><surname>Lee</surname><given-names>S.Y.</given-names></name>
<name><surname>Woo</surname><given-names>S.Y.</given-names></name>
<name><surname>Choi</surname><given-names>H.Y.</given-names></name>
<name><surname>Heo</surname><given-names>S.</given-names></name>
<name><surname>Nah</surname><given-names>G.</given-names></name>
<name><surname>Chun</surname><given-names>H.S.</given-names></name>
</person-group><article-title>Transcriptomic responses of <italic toggle="yes">Aspergillus flavus</italic> to temperature and oxidative stresses during aflatoxin production</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><fpage>2803</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-82488-7</pub-id><pub-id pub-id-type="pmid">33531617</pub-id></element-citation></ref><ref id="B119-pharmaceutics-14-01837"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gressler</surname><given-names>M.</given-names></name>
<name><surname>Meyer</surname><given-names>F.</given-names></name>
<name><surname>Heine</surname><given-names>D.</given-names></name>
<name><surname>Hortschansky</surname><given-names>P.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
<name><surname>Brock</surname><given-names>M.</given-names></name>
</person-group><article-title>Phytotoxin production in <italic toggle="yes">Aspergillus terreus</italic> is regulated by independent environmental signals</article-title><source>eLife</source><year>2015</year><volume>4</volume><fpage>e07861</fpage><pub-id pub-id-type="doi">10.7554/eLife.07861</pub-id><?supplied-pmid 26173180?><pub-id pub-id-type="pmid">26173180</pub-id></element-citation></ref><ref id="B120-pharmaceutics-14-01837"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iyer</surname><given-names>M.S.</given-names></name>
<name><surname>Pal</surname><given-names>A.</given-names></name>
<name><surname>Srinivasan</surname><given-names>S.</given-names></name>
<name><surname>Somvanshi</surname><given-names>P.R.</given-names></name>
<name><surname>Venkatesh</surname><given-names>K.V.</given-names></name>
</person-group><article-title>Global Transcriptional Regulators Fine-Tune the Translational and Metabolic Efficiency for Optimal Growth of <italic toggle="yes">Escherichia coli</italic></article-title><source>mSystems</source><year>2021</year><volume>6</volume><fpage>e00001-21</fpage><pub-id pub-id-type="doi">10.1128/mSystems.00001-21</pub-id><pub-id pub-id-type="pmid">33785570</pub-id></element-citation></ref><ref id="B121-pharmaceutics-14-01837"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lind</surname><given-names>A.L.</given-names></name>
<name><surname>Wisecaver</surname><given-names>J.H.</given-names></name>
<name><surname>Smith</surname><given-names>T.D.</given-names></name>
<name><surname>Feng</surname><given-names>X.</given-names></name>
<name><surname>Calvo</surname><given-names>A.M.</given-names></name>
<name><surname>Rokas</surname><given-names>A.</given-names></name>
</person-group><article-title>Examining the Evolution of the Regulatory Circuit Controlling Secondary Metabolism and Development in the Fungal Genus Aspergillus</article-title><source>PLOS Genet.</source><year>2015</year><volume>11</volume><elocation-id>e1005096</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005096</pub-id><pub-id pub-id-type="pmid">25786130</pub-id></element-citation></ref><ref id="B122-pharmaceutics-14-01837"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fasoyin</surname><given-names>O.E.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Qiu</surname><given-names>M.</given-names></name>
<name><surname>Han</surname><given-names>X.</given-names></name>
<name><surname>Chung</surname><given-names>K.R.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
</person-group><article-title>Carbon catabolite repression gene creA regulates morphology, aflatoxin biosynthesis and virulence in <italic toggle="yes">Aspergillus flavus</italic></article-title><source>Fungal Genet. Biol.</source><year>2018</year><volume>115</volume><fpage>41</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2018.04.008</pub-id><pub-id pub-id-type="pmid">29655909</pub-id></element-citation></ref><ref id="B123-pharmaceutics-14-01837"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leiter</surname><given-names>&#x000c9;.</given-names></name>
<name><surname>Emri</surname><given-names>T.</given-names></name>
<name><surname>P&#x000e1;kozdi</surname><given-names>K.</given-names></name>
<name><surname>Hornok</surname><given-names>L.</given-names></name>
<name><surname>P&#x000f3;csi</surname><given-names>I.</given-names></name>
</person-group><article-title>The impact of bZIP Atf1ortholog global regulators in fungi</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2021</year><volume>105</volume><fpage>5769</fpage><lpage>5783</lpage><pub-id pub-id-type="doi">10.1007/s00253-021-11431-7</pub-id><pub-id pub-id-type="pmid">34302199</pub-id></element-citation></ref><ref id="B124-pharmaceutics-14-01837"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pfannm&#x000fc;ller</surname><given-names>A.</given-names></name>
<name><surname>Boysen</surname><given-names>J.M.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Nitrate Assimilation in <italic toggle="yes">Fusarium fujikuroi</italic> Is Controlled by Multiple Levels of Regulation</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>381</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.00381</pub-id><pub-id pub-id-type="pmid">28352253</pub-id></element-citation></ref><ref id="B125-pharmaceutics-14-01837"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wiemann</surname><given-names>P.</given-names></name>
<name><surname>Sieber</surname><given-names>C.M.K.</given-names></name>
<name><surname>von Bargen</surname><given-names>K.W.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>Niehaus</surname><given-names>E.-M.</given-names></name>
<name><surname>Espino</surname><given-names>J.J.</given-names></name>
<name><surname>Hu&#x000df;</surname><given-names>K.</given-names></name>
<name><surname>Michielse</surname><given-names>C.B.</given-names></name>
<name><surname>Albermann</surname><given-names>S.</given-names></name>
<name><surname>Wagner</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Deciphering the Cryptic Genome: Genome-wide Analyses of the Rice Pathogen <italic toggle="yes">Fusarium fujikuroi</italic> Reveal Complex Regulation of Secondary Metabolism and Novel Metabolites</article-title><source>PLOS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003475</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003475</pub-id><pub-id pub-id-type="pmid">23825955</pub-id></element-citation></ref><ref id="B126-pharmaceutics-14-01837"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Nitrogen regulation of fungal secondary metabolism in fungi</article-title><source>Front. Microbiol.</source><year>2014</year><volume>5</volume><fpage>656</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2014.00656</pub-id><?supplied-pmid 25506342?><pub-id pub-id-type="pmid">25506342</pub-id></element-citation></ref><ref id="B127-pharmaceutics-14-01837"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pfannm&#x000fc;ller</surname><given-names>A.</given-names></name>
<name><surname>Leufken</surname><given-names>J.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>Michielse</surname><given-names>C.B.</given-names></name>
<name><surname>Sieber</surname><given-names>C.M.K.</given-names></name>
<name><surname>G&#x000fc;ldener</surname><given-names>U.</given-names></name>
<name><surname>Hawat</surname><given-names>S.</given-names></name>
<name><surname>Hippler</surname><given-names>M.</given-names></name>
<name><surname>Fufezan</surname><given-names>C.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Comparative transcriptome and proteome analysis reveals a global impact of the nitrogen regulators AreA and AreB on secondary metabolism in <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0176194</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0176194</pub-id><?supplied-pmid 28441411?><pub-id pub-id-type="pmid">28441411</pub-id></element-citation></ref><ref id="B128-pharmaceutics-14-01837"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>Sarkar</surname><given-names>A.</given-names></name>
<name><surname>Schroeckh</surname><given-names>V.</given-names></name>
<name><surname>Dahse</surname><given-names>H.-M.</given-names></name>
<name><surname>Roth</surname><given-names>M.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
<name><surname>Horn</surname><given-names>U.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
</person-group><article-title>Two Induced Fungal Polyketide Pathways Converge into Antiproliferative Spiroanthrones</article-title><source>ChemBioChem</source><year>2011</year><volume>12</volume><fpage>1836</fpage><lpage>1839</lpage><pub-id pub-id-type="doi">10.1002/cbic.201100132</pub-id><pub-id pub-id-type="pmid">21698737</pub-id></element-citation></ref><ref id="B129-pharmaceutics-14-01837"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Giese</surname><given-names>H.</given-names></name>
<name><surname>Sondergaard</surname><given-names>T.E.</given-names></name>
<name><surname>S&#x000f8;rensen</surname><given-names>J.L.</given-names></name>
</person-group><article-title>The AreA transcription factor in <italic toggle="yes">Fusarium graminearum</italic> regulates the use of some nonpreferred nitrogen sources and secondary metabolite production</article-title><source>Fungal Biol.</source><year>2013</year><volume>117</volume><fpage>814</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1016/j.funbio.2013.10.006</pub-id><pub-id pub-id-type="pmid">24295920</pub-id></element-citation></ref><ref id="B130-pharmaceutics-14-01837"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Pan</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>G.</given-names></name>
</person-group><article-title>Disruption of the nitrogen regulatory gene AcareA in Acremonium chrysogenum leads to reduction of cephalosporin production and repression of nitrogen metabolism</article-title><source>Fungal Genet. Biol.</source><year>2013</year><volume>61</volume><fpage>69</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2013.10.006</pub-id><pub-id pub-id-type="pmid">24161729</pub-id></element-citation></ref><ref id="B131-pharmaceutics-14-01837"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>L&#x000f3;pez-Berges</surname><given-names>M.S.</given-names></name>
<name><surname>Sch&#x000e4;fer</surname><given-names>K.</given-names></name>
<name><surname>Hera</surname><given-names>C.</given-names></name>
<name><surname>Di Pietro</surname><given-names>A.</given-names></name>
</person-group><article-title>Combinatorial function of velvet and AreA in transcriptional regulation of nitrate utilization and secondary metabolism</article-title><source>Fungal Genet. Biol.</source><year>2014</year><volume>62</volume><fpage>78</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2013.11.002</pub-id><?supplied-pmid 24240057?><pub-id pub-id-type="pmid">24240057</pub-id></element-citation></ref><ref id="B132-pharmaceutics-14-01837"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Akhberdi</surname><given-names>O.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Wang</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Hao</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Wei</surname><given-names>D.</given-names></name>
<name><surname>Zhu</surname><given-names>X.</given-names></name>
</person-group><article-title>Distinct Roles of Velvet Complex in the Development, Stress Tolerance, and Secondary Metabolism in Pestalotiopsis microspora, a Taxol Producer</article-title><source>Genes</source><year>2018</year><volume>9</volume><elocation-id>164</elocation-id><pub-id pub-id-type="doi">10.3390/genes9030164</pub-id></element-citation></ref><ref id="B133-pharmaceutics-14-01837"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bayram</surname><given-names>&#x000d6;.S.</given-names></name>
<name><surname>Dettmann</surname><given-names>A.</given-names></name>
<name><surname>Karahoda</surname><given-names>B.</given-names></name>
<name><surname>Moloney</surname><given-names>N.M.</given-names></name>
<name><surname>Ormsby</surname><given-names>T.</given-names></name>
<name><surname>McGowan</surname><given-names>J.</given-names></name>
<name><surname>Cea-S&#x000e1;nchez</surname><given-names>S.</given-names></name>
<name><surname>Miralles-Dur&#x000e1;n</surname><given-names>A.</given-names></name>
<name><surname>Brancini</surname><given-names>G.T.P.</given-names></name>
<name><surname>Luque</surname><given-names>E.M.</given-names></name>
<etal/>
</person-group><article-title>Control of Development, Secondary Metabolism and Light-Dependent Carotenoid Biosynthesis by the Velvet Complex of Neurospora crassa</article-title><source>Genetics</source><year>2019</year><volume>212</volume><fpage>691</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1534/genetics.119.302277</pub-id><pub-id pub-id-type="pmid">31068340</pub-id></element-citation></ref><ref id="B134-pharmaceutics-14-01837"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lan</surname><given-names>N.</given-names></name>
<name><surname>Yue</surname><given-names>Q.</given-names></name>
<name><surname>An</surname><given-names>Z.</given-names></name>
<name><surname>Bills</surname><given-names>G.F.</given-names></name>
</person-group><article-title>Apc.LaeA and Apc.VeA of the velvet complex govern secondary metabolism and morphological development in the echinocandin-producing fungus <italic toggle="yes">Aspergillus pachycristatus</italic></article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2020</year><volume>47</volume><fpage>155</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1007/s10295-019-02250-x</pub-id><pub-id pub-id-type="pmid">31758414</pub-id></element-citation></ref><ref id="B135-pharmaceutics-14-01837"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Monroy</surname><given-names>A.A.</given-names></name>
<name><surname>Stappler</surname><given-names>E.</given-names></name>
<name><surname>Schuster</surname><given-names>A.</given-names></name>
<name><surname>Sulyok</surname><given-names>M.</given-names></name>
<name><surname>Schmoll</surname><given-names>M.</given-names></name>
</person-group><article-title>A CRE1&#x02014;Regulated cluster is responsible for light dependent production of dihydrotrichotetronin in <italic toggle="yes">Trichoderma reesei</italic></article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0182530</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0182530</pub-id><pub-id pub-id-type="pmid">28809958</pub-id></element-citation></ref><ref id="B136-pharmaceutics-14-01837"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>G.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>F.</given-names></name>
<name><surname>Li</surname><given-names>E.</given-names></name>
<name><surname>Ma</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>B.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
</person-group><article-title>Requirement of LaeA, VeA, and VelB on Asexual Development, Ochratoxin A Biosynthesis, and Fungal Virulence in <italic toggle="yes">Aspergillus ochraceus</italic></article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>2759</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.02759</pub-id><?supplied-pmid 31849898?><pub-id pub-id-type="pmid">31849898</pub-id></element-citation></ref><ref id="B137-pharmaceutics-14-01837"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Amare</surname><given-names>M.G.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Molecular mechanisms of <italic toggle="yes">Aspergillus flavus</italic> secondary metabolism and development</article-title><source>Fungal Genet. Biol.</source><year>2014</year><volume>66</volume><fpage>11</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2014.02.008</pub-id><?supplied-pmid 24613992?><pub-id pub-id-type="pmid">24613992</pub-id></element-citation></ref><ref id="B138-pharmaceutics-14-01837"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bayram</surname><given-names>O.</given-names></name>
<name><surname>Krappmann</surname><given-names>S.</given-names></name>
<name><surname>Ni</surname><given-names>M.</given-names></name>
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Helmstaedt</surname><given-names>K.</given-names></name>
<name><surname>Valerius</surname><given-names>O.</given-names></name>
<name><surname>Braus-Stromeyer</surname><given-names>S.</given-names></name>
<name><surname>Kwon</surname><given-names>N.J.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<name><surname>Yu</surname><given-names>J.H.</given-names></name>
<etal/>
</person-group><article-title>VelB/VeA/LaeA complex coordinates light signal with fungal development and secondary metabolism</article-title><source>Science</source><year>2008</year><volume>320</volume><fpage>1504</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1126/science.1155888</pub-id><?supplied-pmid 18556559?><pub-id pub-id-type="pmid">18556559</pub-id></element-citation></ref><ref id="B139-pharmaceutics-14-01837"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mart&#x000ed;n</surname><given-names>J.F.</given-names></name>
</person-group><article-title>Key role of LaeA and velvet complex proteins on expression of &#x003b2;-lactam and PR-toxin genes in <italic toggle="yes">Penicillium chrysogenum</italic>: Cross-talk regulation of secondary metabolite pathways</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2017</year><volume>44</volume><fpage>525</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1007/s10295-016-1830-y</pub-id><pub-id pub-id-type="pmid">27565675</pub-id></element-citation></ref><ref id="B140-pharmaceutics-14-01837"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sarikaya-Bayram</surname><given-names>&#x000d6;.</given-names></name>
<name><surname>Palmer</surname><given-names>J.M.</given-names></name>
<name><surname>Keller</surname><given-names>N.</given-names></name>
<name><surname>Braus</surname><given-names>G.H.</given-names></name>
<name><surname>Bayram</surname><given-names>&#x000d6;.</given-names></name>
</person-group><article-title>One Juliet and four Romeos: VeA and its methyltransferases</article-title><source>Front. Microbiol.</source><year>2015</year><volume>6</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00001</pub-id><pub-id pub-id-type="pmid">25653648</pub-id></element-citation></ref><ref id="B141-pharmaceutics-14-01837"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wiemann</surname><given-names>P.</given-names></name>
<name><surname>Brown</surname><given-names>D.W.</given-names></name>
<name><surname>Kleigrewe</surname><given-names>K.</given-names></name>
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<name><surname>Humpf</surname><given-names>H.-U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>FfVel1 and FfLae1, components of a velvet-like complex in <italic toggle="yes">Fusarium fujikuroi</italic>, affect differentiation, secondary metabolism and virulence</article-title><source>Mol. Microbiol.</source><year>2010</year><volume>77</volume><fpage>972</fpage><lpage>994</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07263.x</pub-id><pub-id pub-id-type="pmid">20572938</pub-id></element-citation></ref><ref id="B142-pharmaceutics-14-01837"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>LaeA, a Regulator of Secondary Metabolism in <italic toggle="yes">Aspergillus</italic> spp.</article-title><source>Eukaryot. Cell</source><year>2004</year><volume>3</volume><fpage>527</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1128/EC.3.2.527-535.2004</pub-id><pub-id pub-id-type="pmid">15075281</pub-id></element-citation></ref><ref id="B143-pharmaceutics-14-01837"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Yin</surname><given-names>Z.</given-names></name>
<name><surname>Wu</surname><given-names>Y.</given-names></name>
<name><surname>Xu</surname><given-names>L.</given-names></name>
<name><surname>Du</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>N.</given-names></name>
<name><surname>Huang</surname><given-names>L.</given-names></name>
</person-group><article-title>LaeA Controls Virulence and Secondary Metabolism in Apple Canker Pathogen <italic toggle="yes">Valsa mali</italic></article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><fpage>581203</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.581203</pub-id><pub-id pub-id-type="pmid">33250871</pub-id></element-citation></ref><ref id="B144-pharmaceutics-14-01837"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kumar</surname><given-names>D.</given-names></name>
<name><surname>Barad</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Luo</surname><given-names>X.</given-names></name>
<name><surname>Tannous</surname><given-names>J.</given-names></name>
<name><surname>Dubey</surname><given-names>A.</given-names></name>
<name><surname>Glam Matana</surname><given-names>N.</given-names></name>
<name><surname>Tian</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>B.</given-names></name>
<name><surname>Keller</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>LaeA regulation of secondary metabolism modulates virulence in <italic toggle="yes">Penicillium expansum</italic> and is mediated by sucrose</article-title><source>Mol. Plant Pathol.</source><year>2017</year><volume>18</volume><fpage>1150</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1111/mpp.12469</pub-id><pub-id pub-id-type="pmid">27528575</pub-id></element-citation></ref><ref id="B145-pharmaceutics-14-01837"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>T.</given-names></name>
<name><surname>Wang</surname><given-names>M.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Si</surname><given-names>J.</given-names></name>
<name><surname>Song</surname><given-names>B.</given-names></name>
<name><surname>Zhou</surname><given-names>C.</given-names></name>
<name><surname>Yu</surname><given-names>M.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Ding</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Overexpression of the Global Regulator LaeA in <italic toggle="yes">Chaetomium globosum</italic> Leads to the Biosynthesis of Chaetoglobosin Z</article-title><source>J. Nat. Prod.</source><year>2016</year><volume>79</volume><fpage>2487</fpage><lpage>2494</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00333</pub-id><pub-id pub-id-type="pmid">27759375</pub-id></element-citation></ref><ref id="B146-pharmaceutics-14-01837"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Butchko</surname><given-names>R.A.E.</given-names></name>
<name><surname>Brown</surname><given-names>D.W.</given-names></name>
<name><surname>Busman</surname><given-names>M.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
<name><surname>Wiemann</surname><given-names>P.</given-names></name>
</person-group><article-title>Lae1 regulates expression of multiple secondary metabolite gene clusters in <italic toggle="yes">Fusarium verticillioides</italic></article-title><source>Fungal Genet. Biol.</source><year>2012</year><volume>49</volume><fpage>602</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2012.06.003</pub-id><?supplied-pmid 22713715?><pub-id pub-id-type="pmid">22713715</pub-id></element-citation></ref><ref id="B147-pharmaceutics-14-01837"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Niehaus</surname><given-names>E.M.</given-names></name>
<name><surname>Rindermann</surname><given-names>L.</given-names></name>
<name><surname>Janevska</surname><given-names>S.</given-names></name>
<name><surname>Munsterkotter</surname><given-names>M.</given-names></name>
<name><surname>Guldener</surname><given-names>U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Analysis of the global regulator Lae1 uncovers a connection between Lae1 and the histone acetyltransferase HAT1 in <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>Appl. Microbiol. Biotechnol.</source><year>2018</year><volume>102</volume><fpage>279</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1007/s00253-017-8590-0</pub-id><?supplied-pmid 29080998?><pub-id pub-id-type="pmid">29080998</pub-id></element-citation></ref><ref id="B148-pharmaceutics-14-01837"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barda</surname><given-names>O.</given-names></name>
<name><surname>Maor</surname><given-names>U.</given-names></name>
<name><surname>Sadhasivam</surname><given-names>S.</given-names></name>
<name><surname>Bi</surname><given-names>Y.</given-names></name>
<name><surname>Zakin</surname><given-names>V.</given-names></name>
<name><surname>Prusky</surname><given-names>D.</given-names></name>
<name><surname>Sionov</surname><given-names>E.</given-names></name>
</person-group><article-title>The pH-Responsive Transcription Factor PacC Governs Pathogenicity and Ochratoxin A Biosynthesis in <italic toggle="yes">Aspergillus carbonarius</italic></article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><fpage>210</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.00210</pub-id><?supplied-pmid 32117191?><pub-id pub-id-type="pmid">32117191</pub-id></element-citation></ref><ref id="B149-pharmaceutics-14-01837"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Luo</surname><given-names>Q.</given-names></name>
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>He</surname><given-names>X.</given-names></name>
<name><surname>Wu</surname><given-names>J.</given-names></name>
<name><surname>Kachanuban</surname><given-names>K.</given-names></name>
<name><surname>Wilaipun</surname><given-names>P.</given-names></name>
<name><surname>Zhu</surname><given-names>W.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Bioactive Metabolites from Acid-Tolerant Fungi in a Thai Mangrove Sediment</article-title><source>Front. Microbiol.</source><year>2021</year><volume>11</volume><fpage>60995</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.609952</pub-id></element-citation></ref><ref id="B150-pharmaceutics-14-01837"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<name><surname>Nesbitt</surname><given-names>C.</given-names></name>
<name><surname>Sarr</surname><given-names>B.</given-names></name>
<name><surname>Phillips</surname><given-names>T.D.</given-names></name>
<name><surname>Burow</surname><given-names>G.B.</given-names></name>
</person-group><article-title>pH Regulation of Sterigmatocystin and Aflatoxin Biosynthesis in <italic toggle="yes">Aspergillus</italic> spp.</article-title><source>Phytopathology</source><year>1997</year><volume>87</volume><fpage>643</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1094/PHYTO.1997.87.6.643</pub-id><pub-id pub-id-type="pmid">18945083</pub-id></element-citation></ref><ref id="B151-pharmaceutics-14-01837"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shah</surname><given-names>A.J.</given-names></name>
<name><surname>Tilburn</surname><given-names>J.</given-names></name>
<name><surname>Adlard</surname><given-names>M.W.</given-names></name>
<name><surname>Arst</surname><given-names>H.N.</given-names><suffix>Jr.</suffix></name>
</person-group><article-title>pH regulation of penicillin production in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>FEMS Microbiol. Lett.</source><year>1991</year><volume>61</volume><fpage>209</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.1991.tb04349.x</pub-id><pub-id pub-id-type="pmid">2037230</pub-id></element-citation></ref><ref id="B152-pharmaceutics-14-01837"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Trushina</surname><given-names>N.</given-names></name>
<name><surname>Levin</surname><given-names>M.</given-names></name>
<name><surname>Mukherjee</surname><given-names>P.K.</given-names></name>
<name><surname>Horwitz</surname><given-names>B.A.</given-names></name>
</person-group><article-title>PacC and pH&#x02013;dependent transcriptome of the mycotrophic fungus Trichoderma virens</article-title><source>BMC Genom.</source><year>2013</year><volume>14</volume><elocation-id>138</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-14-138</pub-id></element-citation></ref><ref id="B153-pharmaceutics-14-01837"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wiemann</surname><given-names>P.</given-names></name>
<name><surname>Willmann</surname><given-names>A.</given-names></name>
<name><surname>Straeten</surname><given-names>M.</given-names></name>
<name><surname>Kleigrewe</surname><given-names>K.</given-names></name>
<name><surname>Beyer</surname><given-names>M.</given-names></name>
<name><surname>Humpf</surname><given-names>H.U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Biosynthesis of the red pigment bikaverin in <italic toggle="yes">Fusarium fujikuroi</italic>: Genes, their function and regulation</article-title><source>Mol. Microbiol.</source><year>2009</year><volume>72</volume><fpage>931</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.06695.x</pub-id><pub-id pub-id-type="pmid">19400779</pub-id></element-citation></ref><ref id="B154-pharmaceutics-14-01837"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>B.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Tian</surname><given-names>S.</given-names></name>
</person-group><article-title>Function of pH-dependent transcription factor PacC in regulating development, pathogenicity, and mycotoxin biosynthesis of phytopathogenic fungi</article-title><source>FEBS J.</source><year>2022</year><volume>289</volume><fpage>1723</fpage><lpage>1730</lpage><pub-id pub-id-type="doi">10.1111/febs.15808</pub-id><pub-id pub-id-type="pmid">33751796</pub-id></element-citation></ref><ref id="B155-pharmaceutics-14-01837"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Merhej</surname><given-names>J.</given-names></name>
<name><surname>Richard-Forget</surname><given-names>F.</given-names></name>
<name><surname>Barreau</surname><given-names>C.</given-names></name>
</person-group><article-title>The pH regulatory factor Pac1 regulates Tri gene expression and trichothecene production in <italic toggle="yes">Fusarium graminearum</italic></article-title><source>Fungal Genet. Biol.</source><year>2011</year><volume>48</volume><fpage>275</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2010.11.008</pub-id><pub-id pub-id-type="pmid">21126599</pub-id></element-citation></ref><ref id="B156-pharmaceutics-14-01837"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tilburn</surname><given-names>J.</given-names></name>
<name><surname>Sarkar</surname><given-names>S.</given-names></name>
<name><surname>Widdick</surname><given-names>D.A.</given-names></name>
<name><surname>Espeso</surname><given-names>E.A.</given-names></name>
<name><surname>Orejas</surname><given-names>M.</given-names></name>
<name><surname>Mungroo</surname><given-names>J.</given-names></name>
<name><surname>Pe&#x000f1;alva</surname><given-names>M.A.</given-names></name>
<name><surname>Arst</surname><given-names>H.N.</given-names><suffix>Jr.</suffix></name>
</person-group><article-title>The Aspergillus PacC zinc finger transcription factor mediates regulation of both acid- and alkaline-expressed genes by ambient pH</article-title><source>Embo j.</source><year>1995</year><volume>14</volume><fpage>779</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1995.tb07056.x</pub-id><pub-id pub-id-type="pmid">7882981</pub-id></element-citation></ref><ref id="B157-pharmaceutics-14-01837"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lind</surname><given-names>A.L.</given-names></name>
<name><surname>Smith</surname><given-names>T.D.</given-names></name>
<name><surname>Saterlee</surname><given-names>T.</given-names></name>
<name><surname>Calvo</surname><given-names>A.M.</given-names></name>
<name><surname>Rokas</surname><given-names>A.</given-names></name>
</person-group><article-title>Regulation of Secondary Metabolism by the Velvet Complex Is Temperature-Responsive in Aspergillus</article-title><source>G3</source><year>2016</year><volume>6</volume><fpage>4023</fpage><lpage>4033</lpage><pub-id pub-id-type="doi">10.1534/g3.116.033084</pub-id><pub-id pub-id-type="pmid">27694115</pub-id></element-citation></ref><ref id="B158-pharmaceutics-14-01837"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yogabaanu</surname><given-names>U.</given-names></name>
<name><surname>Weber</surname><given-names>J.-F.F.</given-names></name>
<name><surname>Convey</surname><given-names>P.</given-names></name>
<name><surname>Rizman-Idid</surname><given-names>M.</given-names></name>
<name><surname>Alias</surname><given-names>S.A.</given-names></name>
</person-group><article-title>Antimicrobial properties and the influence of temperature on secondary metabolite production in cold environment soil fungi</article-title><source>Polar Sci.</source><year>2017</year><volume>14</volume><fpage>60</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.polar.2017.09.005</pub-id></element-citation></ref><ref id="B159-pharmaceutics-14-01837"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Overy</surname><given-names>D.</given-names></name>
<name><surname>Correa</surname><given-names>H.</given-names></name>
<name><surname>Roullier</surname><given-names>C.</given-names></name>
<name><surname>Chi</surname><given-names>W.-C.</given-names></name>
<name><surname>Pang</surname><given-names>K.-L.</given-names></name>
<name><surname>Rateb</surname><given-names>M.</given-names></name>
<name><surname>Ebel</surname><given-names>R.</given-names></name>
<name><surname>Shang</surname><given-names>Z.</given-names></name>
<name><surname>Capon</surname><given-names>R.</given-names></name>
<name><surname>Bills</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Does Osmotic Stress Affect Natural Product Expression in Fungi?</article-title><source>Mar. Drugs</source><year>2017</year><volume>15</volume><elocation-id>254</elocation-id><pub-id pub-id-type="doi">10.3390/md15080254</pub-id><?supplied-pmid 28805714?><pub-id pub-id-type="pmid">28805714</pub-id></element-citation></ref><ref id="B160-pharmaceutics-14-01837"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>J.</given-names></name>
<name><surname>Lu</surname><given-names>C.</given-names></name>
<name><surname>Qian</surname><given-names>X.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Zheng</surname><given-names>Z.</given-names></name>
<name><surname>Shen</surname><given-names>Y.</given-names></name>
</person-group><article-title>Effect of salinity on the growth, biological activity and secondary metabolites of some marine fungi</article-title><source>Acta Oceanol. Sin.</source><year>2011</year><volume>30</volume><fpage>118</fpage><pub-id pub-id-type="doi">10.1007/s13131-011-0126-3</pub-id></element-citation></ref><ref id="B161-pharmaceutics-14-01837"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sarri</surname><given-names>E.</given-names></name>
<name><surname>Termentzi</surname><given-names>A.</given-names></name>
<name><surname>Abraham</surname><given-names>E.M.</given-names></name>
<name><surname>Papadopoulos</surname><given-names>G.K.</given-names></name>
<name><surname>Baira</surname><given-names>E.</given-names></name>
<name><surname>Machera</surname><given-names>K.</given-names></name>
<name><surname>Loukas</surname><given-names>V.</given-names></name>
<name><surname>Komaitis</surname><given-names>F.</given-names></name>
<name><surname>Tani</surname><given-names>E.</given-names></name>
</person-group><article-title>Salinity Stress Alters the Secondary Metabolic Profile of M. sativa, M. arborea and Their Hybrid (Alborea)</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>4882</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22094882</pub-id><?supplied-pmid 34063053?><pub-id pub-id-type="pmid">34063053</pub-id></element-citation></ref><ref id="B162-pharmaceutics-14-01837"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Lu</surname><given-names>Z.</given-names></name>
<name><surname>Sun</surname><given-names>K.</given-names></name>
<name><surname>Zhu</surname><given-names>W.</given-names></name>
</person-group><article-title>Effects of High Salt Stress on Secondary Metabolite Production in the Marine-Derived Fungus Spicaria elegans</article-title><source>Mar. Drugs</source><year>2011</year><volume>9</volume><fpage>535</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.3390/md9040535</pub-id><?supplied-pmid 21731548?><pub-id pub-id-type="pmid">21731548</pub-id></element-citation></ref><ref id="B163-pharmaceutics-14-01837"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fil</surname><given-names>T.P.</given-names></name>
<name><surname>Pallini</surname><given-names>H.F.</given-names></name>
<name><surname>Amaral</surname><given-names>L.D.S.</given-names></name>
<name><surname>Silva</surname><given-names>J.V.D.</given-names></name>
<name><surname>Bid&#x000f3;ia</surname><given-names>D.L.</given-names></name>
<name><surname>Peron</surname><given-names>F.</given-names></name>
<name><surname>Garcia</surname><given-names>F.P.</given-names></name>
<name><surname>Nakamura</surname><given-names>C.V.</given-names></name>
<name><surname>Rodrigues-Filho</surname><given-names>E.</given-names></name>
</person-group><article-title>Copper and Manganese Cations Alter Secondary Metabolism in the Fungus <italic toggle="yes">Penicillium brasilianum</italic></article-title><source>J. Braz. Chem. Soc.</source><year>2016</year><volume>27</volume><fpage>1444</fpage><lpage>1451</lpage><pub-id pub-id-type="doi">10.5935/0103-5053.20160163</pub-id></element-citation></ref><ref id="B164-pharmaceutics-14-01837"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scott</surname><given-names>R.E.</given-names></name>
<name><surname>Jones</surname><given-names>A.</given-names></name>
<name><surname>Lam</surname><given-names>K.S.</given-names></name>
<name><surname>Gaucher</surname><given-names>G.M.</given-names></name>
</person-group><article-title>Manganese and antibiotic biosynthesis. I. A specific manganese requirement for patulin production in <italic toggle="yes">Penicillium urticae</italic></article-title><source>Can. J. Microbiol.</source><year>1986</year><volume>32</volume><fpage>259</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1139/m86-051</pub-id><?supplied-pmid 3708444?><pub-id pub-id-type="pmid">3708444</pub-id></element-citation></ref><ref id="B165-pharmaceutics-14-01837"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wiemann</surname><given-names>P.</given-names></name>
<name><surname>Lechner</surname><given-names>B.E.</given-names></name>
<name><surname>Baccile</surname><given-names>J.A.</given-names></name>
<name><surname>Velk</surname><given-names>T.A.</given-names></name>
<name><surname>Yin</surname><given-names>W.B.</given-names></name>
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Pakala</surname><given-names>S.</given-names></name>
<name><surname>Losada</surname><given-names>L.</given-names></name>
<name><surname>Nierman</surname><given-names>W.C.</given-names></name>
<name><surname>Schroeder</surname><given-names>F.C.</given-names></name>
<etal/>
</person-group><article-title>Perturbations in small molecule synthesis uncovers an iron-responsive secondary metabolite network in <italic toggle="yes">Aspergillus fumigatus</italic></article-title><source>Front. Microbiol.</source><year>2014</year><volume>5</volume><fpage>530</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2014.00530</pub-id><?supplied-pmid 25386169?><pub-id pub-id-type="pmid">25386169</pub-id></element-citation></ref><ref id="B166-pharmaceutics-14-01837"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raffa</surname><given-names>N.</given-names></name>
<name><surname>Won</surname><given-names>T.H.</given-names></name>
<name><surname>Sukowaty</surname><given-names>A.</given-names></name>
<name><surname>Candor</surname><given-names>K.</given-names></name>
<name><surname>Cui</surname><given-names>C.</given-names></name>
<name><surname>Halder</surname><given-names>S.</given-names></name>
<name><surname>Dai</surname><given-names>M.</given-names></name>
<name><surname>Landero-Figueroa</surname><given-names>J.A.</given-names></name>
<name><surname>Schroeder</surname><given-names>F.C.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Dual-purpose isocyanides produced by <italic toggle="yes">Aspergillus fumigatus</italic> contribute to cellular copper sufficiency and exhibit antimicrobial activity</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2021</year><volume>118</volume><fpage>e2015224118</fpage><pub-id pub-id-type="doi">10.1073/pnas.2015224118</pub-id><pub-id pub-id-type="pmid">33593906</pub-id></element-citation></ref><ref id="B167-pharmaceutics-14-01837"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gressler</surname><given-names>M.</given-names></name>
<name><surname>Zaehle</surname><given-names>C.</given-names></name>
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
<name><surname>Brock</surname><given-names>M.</given-names></name>
</person-group><article-title>Multifactorial induction of an orphan PKS-NRPS gene cluster in <italic toggle="yes">Aspergillus terreus</italic></article-title><source>Chem. Biol.</source><year>2011</year><volume>18</volume><fpage>198</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2010.12.011</pub-id><?supplied-pmid 21236704?><pub-id pub-id-type="pmid">21236704</pub-id></element-citation></ref><ref id="B168-pharmaceutics-14-01837"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ruiz-Villaf&#x000e1;n</surname><given-names>B.</given-names></name>
<name><surname>Cruz-Bautista</surname><given-names>R.</given-names></name>
<name><surname>Manzo-Ruiz</surname><given-names>M.</given-names></name>
<name><surname>Passari</surname><given-names>A.K.</given-names></name>
<name><surname>Villarreal-G&#x000f3;mez</surname><given-names>K.</given-names></name>
<name><surname>Rodr&#x000ed;guez-Sanoja</surname><given-names>R.</given-names></name>
<name><surname>S&#x000e1;nchez</surname><given-names>S.</given-names></name>
</person-group><article-title>Carbon catabolite regulation of secondary metabolite formation, an old but not well-established regulatory system</article-title><source>Microb. Biotechnol.</source><year>2022</year><volume>15</volume><fpage>1058</fpage><lpage>1072</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.13791</pub-id><?supplied-pmid 33675560?><pub-id pub-id-type="pmid">33675560</pub-id></element-citation></ref><ref id="B169-pharmaceutics-14-01837"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eisendle</surname><given-names>M.</given-names></name>
<name><surname>Schrettl</surname><given-names>M.</given-names></name>
<name><surname>Kragl</surname><given-names>C.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>D.</given-names></name>
<name><surname>Illmer</surname><given-names>P.</given-names></name>
<name><surname>Haas</surname><given-names>H.</given-names></name>
</person-group><article-title>The intracellular siderophore ferricrocin is involved in iron storage, oxidative-stress resistance, germination, and sexual development in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>Eukaryot. Cell</source><year>2006</year><volume>5</volume><fpage>1596</fpage><lpage>1603</lpage><pub-id pub-id-type="doi">10.1128/EC.00057-06</pub-id><pub-id pub-id-type="pmid">17030991</pub-id></element-citation></ref><ref id="B170-pharmaceutics-14-01837"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hong</surname><given-names>S.Y.</given-names></name>
<name><surname>Roze</surname><given-names>L.V.</given-names></name>
<name><surname>Linz</surname><given-names>J.E.</given-names></name>
</person-group><article-title>Oxidative stress-related transcription factors in the regulation of secondary metabolism</article-title><source>Toxins</source><year>2013</year><volume>5</volume><fpage>683</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.3390/toxins5040683</pub-id><?supplied-pmid 23598564?><pub-id pub-id-type="pmid">23598564</pub-id></element-citation></ref><ref id="B171-pharmaceutics-14-01837"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Roze</surname><given-names>L.V.</given-names></name>
<name><surname>Chanda</surname><given-names>A.</given-names></name>
<name><surname>Wee</surname><given-names>J.</given-names></name>
<name><surname>Awad</surname><given-names>D.</given-names></name>
<name><surname>Linz</surname><given-names>J.E.</given-names></name>
</person-group><article-title>Stress-related transcription factor AtfB integrates secondary metabolism with oxidative stress response in aspergilli</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>35137</fpage><lpage>35148</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.253468</pub-id><pub-id pub-id-type="pmid">21808056</pub-id></element-citation></ref><ref id="B172-pharmaceutics-14-01837"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>F.</given-names></name>
<name><surname>Xu</surname><given-names>G.</given-names></name>
<name><surname>Geng</surname><given-names>L.</given-names></name>
<name><surname>Lu</surname><given-names>X.</given-names></name>
<name><surname>Yang</surname><given-names>K.</given-names></name>
<name><surname>Yuan</surname><given-names>J.</given-names></name>
<name><surname>Nie</surname><given-names>X.</given-names></name>
<name><surname>Zhuang</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
</person-group><article-title>The Stress Response Regulator AflSkn7 Influences Morphological Development, Stress Response, and Pathogenicity in the Fungus <italic toggle="yes">Aspergillus flavus</italic></article-title><source>Toxins</source><year>2016</year><volume>8</volume><elocation-id>202</elocation-id><pub-id pub-id-type="doi">10.3390/toxins8070202</pub-id></element-citation></ref><ref id="B173-pharmaceutics-14-01837"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reverberi</surname><given-names>M.</given-names></name>
<name><surname>Zjalic</surname><given-names>S.</given-names></name>
<name><surname>Ricelli</surname><given-names>A.</given-names></name>
<name><surname>Punelli</surname><given-names>F.</given-names></name>
<name><surname>Camera</surname><given-names>E.</given-names></name>
<name><surname>Fabbri</surname><given-names>C.</given-names></name>
<name><surname>Picardo</surname><given-names>M.</given-names></name>
<name><surname>Fanelli</surname><given-names>C.</given-names></name>
<name><surname>Fabbri</surname><given-names>A.A.</given-names></name>
</person-group><article-title>Modulation of antioxidant defense in <italic toggle="yes">Aspergillus parasiticus</italic> is involved in aflatoxin biosynthesis: A role for the ApyapA gene</article-title><source>Eukaryot. Cell</source><year>2008</year><volume>7</volume><fpage>988</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1128/EC.00228-07</pub-id><?supplied-pmid 18441122?><pub-id pub-id-type="pmid">18441122</pub-id></element-citation></ref><ref id="B174-pharmaceutics-14-01837"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reverberi</surname><given-names>M.</given-names></name>
<name><surname>Gazzetti</surname><given-names>K.</given-names></name>
<name><surname>Punelli</surname><given-names>F.</given-names></name>
<name><surname>Scarpari</surname><given-names>M.</given-names></name>
<name><surname>Zjalic</surname><given-names>S.</given-names></name>
<name><surname>Ricelli</surname><given-names>A.</given-names></name>
<name><surname>Fabbri</surname><given-names>A.A.</given-names></name>
<name><surname>Fanelli</surname><given-names>C.</given-names></name>
</person-group><article-title>Aoyap1 regulates OTA synthesis by controlling cell redox balance in <italic toggle="yes">Aspergillus ochraceus</italic></article-title><source>Appl. Microbiol. Biotechnol.</source><year>2012</year><volume>95</volume><fpage>1293</fpage><lpage>1304</lpage><pub-id pub-id-type="doi">10.1007/s00253-012-3985-4</pub-id><pub-id pub-id-type="pmid">22410746</pub-id></element-citation></ref><ref id="B175-pharmaceutics-14-01837"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oakley</surname><given-names>C.E.</given-names></name>
<name><surname>Ahuja</surname><given-names>M.</given-names></name>
<name><surname>Sun</surname><given-names>W.W.</given-names></name>
<name><surname>Entwistle</surname><given-names>R.</given-names></name>
<name><surname>Akashi</surname><given-names>T.</given-names></name>
<name><surname>Yaegashi</surname><given-names>J.</given-names></name>
<name><surname>Guo</surname><given-names>C.J.</given-names></name>
<name><surname>Cerqueira</surname><given-names>G.C.</given-names></name>
<name><surname>Russo Wortman</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.</given-names></name>
<etal/>
</person-group><article-title>Discovery of McrA, a master regulator of Aspergillus secondary metabolism</article-title><source>Mol. Microbiol.</source><year>2017</year><volume>103</volume><fpage>347</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1111/mmi.13562</pub-id><pub-id pub-id-type="pmid">27775185</pub-id></element-citation></ref><ref id="B176-pharmaceutics-14-01837"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Niehaus</surname><given-names>E.-M.</given-names></name>
<name><surname>Schumacher</surname><given-names>J.</given-names></name>
<name><surname>Burkhardt</surname><given-names>I.</given-names></name>
<name><surname>Rabe</surname><given-names>P.</given-names></name>
<name><surname>M&#x000fc;nsterk&#x000f6;tter</surname><given-names>M.</given-names></name>
<name><surname>G&#x000fc;ldener</surname><given-names>U.</given-names></name>
<name><surname>Sieber</surname><given-names>C.M.K.</given-names></name>
<name><surname>Dickschat</surname><given-names>J.S.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>The GATA-Type Transcription Factor Csm1 Regulates Conidiation and Secondary Metabolism in <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>1175</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.01175</pub-id><pub-id pub-id-type="pmid">28694801</pub-id></element-citation></ref><ref id="B177-pharmaceutics-14-01837"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H.Y.</given-names></name>
<name><surname>Heo</surname><given-names>D.Y.</given-names></name>
<name><surname>Park</surname><given-names>H.M.</given-names></name>
<name><surname>Singh</surname><given-names>D.</given-names></name>
<name><surname>Lee</surname><given-names>C.H.</given-names></name>
</person-group><article-title>Metabolomic and Transcriptomic Comparison of Solid-State and Submerged Fermentation of <italic toggle="yes">Penicillium expansum</italic> KACC 40815</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0149012</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0149012</pub-id><?supplied-pmid 26863302?><pub-id pub-id-type="pmid">26863302</pub-id></element-citation></ref><ref id="B178-pharmaceutics-14-01837"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Son</surname><given-names>S.Y.</given-names></name>
<name><surname>Lee</surname><given-names>S.</given-names></name>
<name><surname>Singh</surname><given-names>D.</given-names></name>
<name><surname>Lee</surname><given-names>N.R.</given-names></name>
<name><surname>Lee</surname><given-names>D.Y.</given-names></name>
<name><surname>Lee</surname><given-names>C.H.</given-names></name>
</person-group><article-title>Comprehensive Secondary Metabolite Profiling Toward Delineating the Solid and Submerged-State Fermentation of <italic toggle="yes">Aspergillus oryzae</italic> KCCM 12698</article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><fpage>1076</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.01076</pub-id><?supplied-pmid 29887844?><pub-id pub-id-type="pmid">29887844</pub-id></element-citation></ref><ref id="B179-pharmaceutics-14-01837"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thammajaruk</surname><given-names>N.</given-names></name>
<name><surname>Sriubolmas</surname><given-names>N.</given-names></name>
<name><surname>Israngkul</surname><given-names>D.</given-names></name>
<name><surname>Meevootisom</surname><given-names>V.</given-names></name>
<name><surname>Wiyakrutta</surname><given-names>S.</given-names></name>
</person-group><article-title>Optimization of culture conditions for mycoepoxydiene production by <italic toggle="yes">Phomopsis</italic> sp. Hant25</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2011</year><volume>38</volume><fpage>679</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1007/s10295-010-0813-7</pub-id><pub-id pub-id-type="pmid">20803051</pub-id></element-citation></ref><ref id="B180-pharmaceutics-14-01837"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bigelis</surname><given-names>R.</given-names></name>
<name><surname>He</surname><given-names>H.</given-names></name>
<name><surname>Yang</surname><given-names>H.Y.</given-names></name>
<name><surname>Chang</surname><given-names>L.-P.</given-names></name>
<name><surname>Greenstein</surname><given-names>M.</given-names></name>
</person-group><article-title>Production of fungal antibiotics using polymeric solid supports in solid-state and liquid fermentation</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2006</year><volume>33</volume><fpage>815</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1007/s10295-006-0126-z</pub-id><?supplied-pmid 16680458?><pub-id pub-id-type="pmid">16680458</pub-id></element-citation></ref><ref id="B181-pharmaceutics-14-01837"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nahlik</surname><given-names>K.</given-names></name>
<name><surname>Dumkow</surname><given-names>M.</given-names></name>
<name><surname>Bayram</surname><given-names>O.</given-names></name>
<name><surname>Helmstaedt</surname><given-names>K.</given-names></name>
<name><surname>Busch</surname><given-names>S.</given-names></name>
<name><surname>Valerius</surname><given-names>O.</given-names></name>
<name><surname>Gerke</surname><given-names>J.</given-names></name>
<name><surname>Hoppert</surname><given-names>M.</given-names></name>
<name><surname>Schwier</surname><given-names>E.</given-names></name>
<name><surname>Opitz</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>The COP9 signalosome mediates transcriptional and metabolic response to hormones, oxidative stress protection and cell wall rearrangement during fungal development</article-title><source>Mol. Microbiol.</source><year>2010</year><volume>78</volume><fpage>964</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07384.x</pub-id><?supplied-pmid 21062371?><pub-id pub-id-type="pmid">21062371</pub-id></element-citation></ref><ref id="B182-pharmaceutics-14-01837"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gerke</surname><given-names>J.</given-names></name>
<name><surname>Bayram</surname><given-names>O.</given-names></name>
<name><surname>Feussner</surname><given-names>K.</given-names></name>
<name><surname>Landesfeind</surname><given-names>M.</given-names></name>
<name><surname>Shelest</surname><given-names>E.</given-names></name>
<name><surname>Feussner</surname><given-names>I.</given-names></name>
<name><surname>Braus</surname><given-names>G.H.</given-names></name>
</person-group><article-title>Breaking the silence: Protein stabilization uncovers silenced biosynthetic gene clusters in the fungus <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2012</year><volume>78</volume><fpage>8234</fpage><lpage>8244</lpage><pub-id pub-id-type="doi">10.1128/AEM.01808-12</pub-id><?supplied-pmid 23001671?><pub-id pub-id-type="pmid">23001671</pub-id></element-citation></ref><ref id="B183-pharmaceutics-14-01837"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Szewczyk</surname><given-names>E.</given-names></name>
<name><surname>Chiang</surname><given-names>Y.M.</given-names></name>
<name><surname>Oakley</surname><given-names>C.E.</given-names></name>
<name><surname>Davidson</surname><given-names>A.D.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.</given-names></name>
<name><surname>Oakley</surname><given-names>B.R.</given-names></name>
</person-group><article-title>Identification and characterization of the asperthecin gene cluster of <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2008</year><volume>74</volume><fpage>7607</fpage><lpage>7612</lpage><pub-id pub-id-type="doi">10.1128/AEM.01743-08</pub-id><pub-id pub-id-type="pmid">18978088</pub-id></element-citation></ref><ref id="B184-pharmaceutics-14-01837"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berger</surname><given-names>H.</given-names></name>
<name><surname>Bacher</surname><given-names>M.</given-names></name>
<name><surname>Labuda</surname><given-names>R.</given-names></name>
<name><surname>Eppel</surname><given-names>I.M.</given-names></name>
<name><surname>Bayer</surname><given-names>F.</given-names></name>
<name><surname>Sulyok</surname><given-names>M.</given-names></name>
<name><surname>Gasparotto</surname><given-names>E.</given-names></name>
<name><surname>Zehetbauer</surname><given-names>F.</given-names></name>
<name><surname>Doppler</surname><given-names>M.</given-names></name>
<name><surname>Gratzl</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Polaramycin B, and not physical interaction, is the signal that rewires fungal metabolism in the Streptomyces&#x02013;Aspergillus interaction</article-title><source>Environ. Microbiol.</source><year>2022</year><pub-id pub-id-type="doi">10.1111/1462-2920.16118</pub-id></element-citation></ref><ref id="B185-pharmaceutics-14-01837"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gu</surname><given-names>Y.</given-names></name>
<name><surname>Ding</surname><given-names>P.</given-names></name>
<name><surname>Liang</surname><given-names>Z.</given-names></name>
<name><surname>Song</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Chen</surname><given-names>G.</given-names></name>
<name><surname>Li</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Activated production of silent metabolites from marine-derived fungus Penicillium citrinum</article-title><source>Fitoterapia</source><year>2018</year><volume>127</volume><fpage>207</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2018.02.012</pub-id><pub-id pub-id-type="pmid">29474977</pub-id></element-citation></ref><ref id="B186-pharmaceutics-14-01837"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gila</surname><given-names>B.C.</given-names></name>
<name><surname>Antal</surname><given-names>K.</given-names></name>
<name><surname>Birko</surname><given-names>Z.</given-names></name>
<name><surname>Keseru</surname><given-names>J.S.</given-names></name>
<name><surname>Pocsi</surname><given-names>I.</given-names></name>
<name><surname>Emri</surname><given-names>T.</given-names></name>
</person-group><article-title>Strategies Shaping the Transcription of Carbohydrate-Active Enzyme Genes in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>J. Fungi</source><year>2022</year><volume>8</volume><elocation-id>79</elocation-id><pub-id pub-id-type="doi">10.3390/jof8010079</pub-id></element-citation></ref><ref id="B187-pharmaceutics-14-01837"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>T.</given-names></name>
<name><surname>Jiang</surname><given-names>G.</given-names></name>
<name><surname>Qu</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Xiong</surname><given-names>Y.</given-names></name>
<name><surname>Jian</surname><given-names>Q.</given-names></name>
<name><surname>Wu</surname><given-names>Y.</given-names></name>
<name><surname>Duan</surname><given-names>X.</given-names></name>
<name><surname>Zhu</surname><given-names>X.</given-names></name>
<name><surname>Hu</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Comparative Transcriptome Analysis of Penicillium citrinum Cultured with Different Carbon Sources Identifies Genes Involved in Citrinin Biosynthesis</article-title><source>Toxins</source><year>2017</year><volume>9</volume><elocation-id>69</elocation-id><pub-id pub-id-type="doi">10.3390/toxins9020069</pub-id><?supplied-pmid 28230802?><pub-id pub-id-type="pmid">28230802</pub-id></element-citation></ref><ref id="B188-pharmaceutics-14-01837"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lotfy</surname><given-names>M.M.</given-names></name>
<name><surname>Sayed</surname><given-names>A.M.</given-names></name>
<name><surname>AboulMagd</surname><given-names>A.M.</given-names></name>
<name><surname>Hassan</surname><given-names>H.M.</given-names></name>
<name><surname>El Amir</surname><given-names>D.</given-names></name>
<name><surname>Abouzid</surname><given-names>S.F.</given-names></name>
<name><surname>El-Gendy</surname><given-names>A.O.</given-names></name>
<name><surname>Rateb</surname><given-names>M.E.</given-names></name>
<name><surname>Abdelmohsen</surname><given-names>U.R.</given-names></name>
<name><surname>Alhadrami</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Metabolomic profiling, biological evaluation of <italic toggle="yes">Aspergillus awamori</italic>, the river Nile-derived fungus using epigenetic and OSMAC approaches</article-title><source>RSC Adv.</source><year>2021</year><volume>11</volume><fpage>6709</fpage><lpage>6719</lpage><pub-id pub-id-type="doi">10.1039/D0RA07578G</pub-id><?supplied-pmid 35423214?><pub-id pub-id-type="pmid">35423214</pub-id></element-citation></ref><ref id="B189-pharmaceutics-14-01837"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Hoffmeister</surname><given-names>D.</given-names></name>
<name><surname>Maggio-Hall</surname><given-names>L.A.</given-names></name>
<name><surname>Murillo</surname><given-names>R.</given-names></name>
<name><surname>Glasner</surname><given-names>J.D.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Genomic mining for Aspergillus natural products</article-title><source>Chem. Biol.</source><year>2006</year><volume>13</volume><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2005.10.008</pub-id><pub-id pub-id-type="pmid">16426969</pub-id></element-citation></ref><ref id="B190-pharmaceutics-14-01837"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fountain</surname><given-names>J.C.</given-names></name>
<name><surname>Bajaj</surname><given-names>P.</given-names></name>
<name><surname>Pandey</surname><given-names>M.</given-names></name>
<name><surname>Nayak</surname><given-names>S.N.</given-names></name>
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>Kumar</surname><given-names>V.</given-names></name>
<name><surname>Jayale</surname><given-names>A.S.</given-names></name>
<name><surname>Chitikineni</surname><given-names>A.</given-names></name>
<name><surname>Zhuang</surname><given-names>W.</given-names></name>
<name><surname>Scully</surname><given-names>B.T.</given-names></name>
<etal/>
</person-group><article-title>Oxidative stress and carbon metabolism influence <italic toggle="yes">Aspergillus flavus</italic> transcriptome composition and secondary metabolite production</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>38747</fpage><pub-id pub-id-type="doi">10.1038/srep38747</pub-id><pub-id pub-id-type="pmid">27941917</pub-id></element-citation></ref><ref id="B191-pharmaceutics-14-01837"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Joffe</surname><given-names>A.Z.</given-names></name>
<name><surname>Lisker</surname><given-names>N.</given-names></name>
</person-group><article-title>Effects of light, temperature, and pH value on aflatoxin production in vitro</article-title><source>Appl. Microbiol.</source><year>1969</year><volume>18</volume><fpage>517</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1128/am.18.3.517-518.1969</pub-id><pub-id pub-id-type="pmid">5373682</pub-id></element-citation></ref><ref id="B192-pharmaceutics-14-01837"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hagiwara</surname><given-names>D.</given-names></name>
<name><surname>Sakai</surname><given-names>K.</given-names></name>
<name><surname>Suzuki</surname><given-names>S.</given-names></name>
<name><surname>Umemura</surname><given-names>M.</given-names></name>
<name><surname>Nogawa</surname><given-names>T.</given-names></name>
<name><surname>Kato</surname><given-names>N.</given-names></name>
<name><surname>Osada</surname><given-names>H.</given-names></name>
<name><surname>Watanabe</surname><given-names>A.</given-names></name>
<name><surname>Kawamoto</surname><given-names>S.</given-names></name>
<name><surname>Gonoi</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Temperature during conidiation affects stress tolerance, pigmentation, and trypacidin accumulation in the conidia of the airborne pathogen <italic toggle="yes">Aspergillus fumigatus</italic></article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0177050</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0177050</pub-id><?supplied-pmid 28486558?><pub-id pub-id-type="pmid">28486558</pub-id></element-citation></ref><ref id="B193-pharmaceutics-14-01837"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berthier</surname><given-names>E.</given-names></name>
<name><surname>Lim</surname><given-names>F.Y.</given-names></name>
<name><surname>Deng</surname><given-names>Q.</given-names></name>
<name><surname>Guo</surname><given-names>C.J.</given-names></name>
<name><surname>Kontoyiannis</surname><given-names>D.P.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.</given-names></name>
<name><surname>Rindy</surname><given-names>J.</given-names></name>
<name><surname>Beebe</surname><given-names>D.J.</given-names></name>
<name><surname>Huttenlocher</surname><given-names>A.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Low-volume toolbox for the discovery of immunosuppressive fungal secondary metabolites</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><elocation-id>e1003289</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003289</pub-id><pub-id pub-id-type="pmid">23592999</pub-id></element-citation></ref><ref id="B194-pharmaceutics-14-01837"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jyoti</surname><given-names>S.</given-names></name>
<name><surname>Singh</surname><given-names>D.P.</given-names></name>
</person-group><article-title>Production of Secondary Metabolites from Two Penicillium Strains Adapted to Different Temperature Conditions: A Study on DifferentialResponse of Fungal Strains to Temperature Stress</article-title><source>Cell. Mol. Biol.</source><year>2016</year><pub-id pub-id-type="doi">10.4172/1165-158X.1000136</pub-id></element-citation></ref><ref id="B195-pharmaceutics-14-01837"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yaegashi</surname><given-names>J.</given-names></name>
<name><surname>Praseuth</surname><given-names>M.B.</given-names></name>
<name><surname>Tyan</surname><given-names>S.W.</given-names></name>
<name><surname>Sanchez</surname><given-names>J.F.</given-names></name>
<name><surname>Entwistle</surname><given-names>R.</given-names></name>
<name><surname>Chiang</surname><given-names>Y.M.</given-names></name>
<name><surname>Oakley</surname><given-names>B.R.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.</given-names></name>
</person-group><article-title>Molecular genetic characterization of the biosynthesis cluster of a prenylated isoindolinone alkaloid aspernidine A in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>Org. Lett.</source><year>2013</year><volume>15</volume><fpage>2862</fpage><lpage>2865</lpage><pub-id pub-id-type="doi">10.1021/ol401187b</pub-id><pub-id pub-id-type="pmid">23706169</pub-id></element-citation></ref><ref id="B196-pharmaceutics-14-01837"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Michielse</surname><given-names>C.B.</given-names></name>
<name><surname>Pfannmuller</surname><given-names>A.</given-names></name>
<name><surname>Macios</surname><given-names>M.</given-names></name>
<name><surname>Rengers</surname><given-names>P.</given-names></name>
<name><surname>Dzikowska</surname><given-names>A.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>The interplay between the GATA transcription factors AreA, the global nitrogen regulator and AreB in <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>Mol. Microbiol.</source><year>2014</year><volume>91</volume><fpage>472</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1111/mmi.12472</pub-id><?supplied-pmid 24286256?><pub-id pub-id-type="pmid">24286256</pub-id></element-citation></ref><ref id="B197-pharmaceutics-14-01837"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Niehaus</surname><given-names>E.M.</given-names></name>
<name><surname>von Bargen</surname><given-names>K.W.</given-names></name>
<name><surname>Espino</surname><given-names>J.J.</given-names></name>
<name><surname>Pfannmuller</surname><given-names>A.</given-names></name>
<name><surname>Humpf</surname><given-names>H.U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Characterization of the fusaric acid gene cluster in <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>Appl. Microbiol. Biotechnol.</source><year>2014</year><volume>98</volume><fpage>1749</fpage><lpage>1762</lpage><pub-id pub-id-type="doi">10.1007/s00253-013-5453-1</pub-id><?supplied-pmid 24389666?><pub-id pub-id-type="pmid">24389666</pub-id></element-citation></ref><ref id="B198-pharmaceutics-14-01837"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H.</given-names></name>
<name><surname>Son</surname><given-names>H.</given-names></name>
<name><surname>Lee</surname><given-names>Y.-W.</given-names></name>
</person-group><article-title>Effects of light on secondary metabolism and fungal development of <italic toggle="yes">Fusarium graminearum</italic></article-title><source>J. Appl. Microbiol.</source><year>2014</year><volume>116</volume><fpage>380</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1111/jam.12381</pub-id><?supplied-pmid 24176027?><pub-id pub-id-type="pmid">24176027</pub-id></element-citation></ref><ref id="B199-pharmaceutics-14-01837"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
<name><surname>Homann</surname><given-names>V.</given-names></name>
<name><surname>Feng</surname><given-names>B.</given-names></name>
<name><surname>Marzluf</surname><given-names>G.A.</given-names></name>
</person-group><article-title>Isolation, characterization and disruption of the areA nitrogen regulatory gene of Gibberella fujikuroi</article-title><source>Mol. Genet. Genom.</source><year>1999</year><volume>261</volume><fpage>106</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1007/s004380050947</pub-id><?supplied-pmid 10071216?><pub-id pub-id-type="pmid">10071216</pub-id></element-citation></ref><ref id="B200-pharmaceutics-14-01837"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mihlan</surname><given-names>M.</given-names></name>
<name><surname>Homann</surname><given-names>V.</given-names></name>
<name><surname>Liu</surname><given-names>T.W.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>AREA directly mediates nitrogen regulation of gibberellin biosynthesis in Gibberella fujikuroi, but its activity is not affected by NMR</article-title><source>Mol. Microbiol.</source><year>2003</year><volume>47</volume><fpage>975</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03326.x</pub-id><pub-id pub-id-type="pmid">12581353</pub-id></element-citation></ref><ref id="B201-pharmaceutics-14-01837"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nazari</surname><given-names>L.</given-names></name>
<name><surname>Manstretta</surname><given-names>V.</given-names></name>
<name><surname>Rossi</surname><given-names>V.</given-names></name>
</person-group><article-title>A non-linear model for temperature-dependent sporulation and T-2 and HT-2 production of Fusarium langsethiae and Fusarium sporotrichioides</article-title><source>Fungal Biol.</source><year>2016</year><volume>120</volume><fpage>562</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1016/j.funbio.2016.01.010</pub-id><pub-id pub-id-type="pmid">27020157</pub-id></element-citation></ref><ref id="B202-pharmaceutics-14-01837"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>V.K.</given-names></name>
<name><surname>Kumar</surname><given-names>J.</given-names></name>
<name><surname>Singh</surname><given-names>D.K.</given-names></name>
<name><surname>Mishra</surname><given-names>A.</given-names></name>
<name><surname>Verma</surname><given-names>S.K.</given-names></name>
<name><surname>Gond</surname><given-names>S.K.</given-names></name>
<name><surname>Kumar</surname><given-names>A.</given-names></name>
<name><surname>Singh</surname><given-names>N.</given-names></name>
<name><surname>Kharwar</surname><given-names>R.N.</given-names></name>
</person-group><article-title>Induction of Cryptic and Bioactive Metabolites through Natural Dietary Components in an Endophytic Fungus Colletotrichum gloeosporioides (Penz.) Sacc</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>1126</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.01126</pub-id><pub-id pub-id-type="pmid">28674526</pub-id></element-citation></ref><ref id="B203-pharmaceutics-14-01837"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>Z.</given-names></name>
<name><surname>Zhu</surname><given-names>T.</given-names></name>
<name><surname>Wei</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>G.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Gu</surname><given-names>Q.</given-names></name>
</person-group><article-title>Spicochalasin A and New Aspochalasins from the Marine-Derived Fungus Spicaria elegans</article-title><source>Eur. J. Org. Chem.</source><year>2009</year><volume>2009</volume><fpage>3045</fpage><lpage>3051</lpage><pub-id pub-id-type="doi">10.1002/ejoc.200801085</pub-id></element-citation></ref><ref id="B204-pharmaceutics-14-01837"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smetanina</surname><given-names>O.F.</given-names></name>
<name><surname>Yurchenko</surname><given-names>A.N.</given-names></name>
<name><surname>Ivanets</surname><given-names>E.V.</given-names></name>
<name><surname>Kalinovsky</surname><given-names>A.I.</given-names></name>
<name><surname>Khudyakova</surname><given-names>Y.V.</given-names></name>
<name><surname>Dyshlovoy</surname><given-names>S.A.</given-names></name>
<name><surname>von Amsberg</surname><given-names>G.</given-names></name>
<name><surname>Yurchenko</surname><given-names>E.A.</given-names></name>
<name><surname>Afiyatullov</surname><given-names>S.S.</given-names></name>
</person-group><article-title>Unique prostate cancer-toxic polyketides from marine sediment-derived fungus <italic toggle="yes">Isaria felina</italic></article-title><source>J. Antibiot.</source><year>2017</year><volume>70</volume><fpage>856</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1038/ja.2017.53</pub-id></element-citation></ref><ref id="B205-pharmaceutics-14-01837"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pruss</surname><given-names>S.</given-names></name>
<name><surname>Fetzner</surname><given-names>R.</given-names></name>
<name><surname>Seither</surname><given-names>K.</given-names></name>
<name><surname>Herr</surname><given-names>A.</given-names></name>
<name><surname>Pfeiffer</surname><given-names>E.</given-names></name>
<name><surname>Metzler</surname><given-names>M.</given-names></name>
<name><surname>Lawrence</surname><given-names>C.B.</given-names></name>
<name><surname>Fischer</surname><given-names>R.</given-names></name>
</person-group><article-title>Role of the Alternaria alternata blue-light receptor LreA (white-collar 1) in spore formation and secondary metabolism</article-title><source>Appl. Environ. Microbiol.</source><year>2014</year><volume>80</volume><fpage>2582</fpage><lpage>2591</lpage><pub-id pub-id-type="doi">10.1128/AEM.00327-14</pub-id><pub-id pub-id-type="pmid">24532063</pub-id></element-citation></ref><ref id="B206-pharmaceutics-14-01837"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bazafkan</surname><given-names>H.</given-names></name>
<name><surname>Beier</surname><given-names>S.</given-names></name>
<name><surname>Stappler</surname><given-names>E.</given-names></name>
<name><surname>B&#x000f6;hmdorfer</surname><given-names>S.</given-names></name>
<name><surname>Oberlerchner</surname><given-names>J.T.</given-names></name>
<name><surname>Sulyok</surname><given-names>M.</given-names></name>
<name><surname>Schmoll</surname><given-names>M.</given-names></name>
</person-group><article-title>SUB1 has photoreceptor dependent and independent functions in sexual development and secondary metabolism in <italic toggle="yes">Trichoderma reesei</italic></article-title><source>Mol. Microbiol.</source><year>2017</year><volume>106</volume><fpage>742</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1111/mmi.13842</pub-id><?supplied-pmid 28925526?><pub-id pub-id-type="pmid">28925526</pub-id></element-citation></ref><ref id="B207-pharmaceutics-14-01837"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shang</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>X.-M.</given-names></name>
<name><surname>Li</surname><given-names>C.-S.</given-names></name>
<name><surname>Wang</surname><given-names>B.-G.</given-names></name>
</person-group><article-title>Diverse Secondary Metabolites Produced by Marine-Derived Fungus <italic toggle="yes">Nigrospora</italic> sp. MA75 on Various Culture Media</article-title><source>Chem. Biodivers.</source><year>2012</year><volume>9</volume><fpage>1338</fpage><lpage>1348</lpage><pub-id pub-id-type="doi">10.1002/cbdv.201100216</pub-id><pub-id pub-id-type="pmid">22782879</pub-id></element-citation></ref><ref id="B208-pharmaceutics-14-01837"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Siless</surname><given-names>G.E.</given-names></name>
<name><surname>Gallardo</surname><given-names>G.L.</given-names></name>
<name><surname>Rodriguez</surname><given-names>M.A.</given-names></name>
<name><surname>Rincon</surname><given-names>Y.A.</given-names></name>
<name><surname>Godeas</surname><given-names>A.M.</given-names></name>
<name><surname>Cabrera</surname><given-names>G.M.</given-names></name>
</person-group><article-title>Metabolites from the Dark Septate Endophyte <italic toggle="yes">Drechslera</italic> sp. Evaluation by LC/MS and Principal Component Analysis of Culture Extracts with Histone Deacetylase Inhibitors</article-title><source>Chem. Biodivers.</source><year>2018</year><volume>15</volume><fpage>e1800133</fpage><pub-id pub-id-type="doi">10.1002/cbdv.201800133</pub-id><?supplied-pmid 29851264?><pub-id pub-id-type="pmid">29851264</pub-id></element-citation></ref><ref id="B209-pharmaceutics-14-01837"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khan</surname><given-names>A.A.</given-names></name>
<name><surname>Bacha</surname><given-names>N.</given-names></name>
<name><surname>Ahmad</surname><given-names>B.</given-names></name>
<name><surname>Bakht</surname><given-names>J.</given-names></name>
<name><surname>Lutfullah</surname><given-names>G.</given-names></name>
<name><surname>Ali</surname><given-names>J.</given-names></name>
</person-group><article-title>Synthesis of secondary metabolites by <italic toggle="yes">Cladosporium resinae</italic> (NRL-6437) under different growth media and chemical inducers and their pharmaceutical activity</article-title><source>Pak. J. Pharm. Sci.</source><year>2017</year><volume>30</volume><fpage>1617</fpage><lpage>1624</lpage><?supplied-pmid 29084681?><pub-id pub-id-type="pmid">29084681</pub-id></element-citation></ref><ref id="B210-pharmaceutics-14-01837"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morishita</surname><given-names>Y.</given-names></name>
<name><surname>Okazaki</surname><given-names>Y.</given-names></name>
<name><surname>Luo</surname><given-names>Y.Y.</given-names></name>
<name><surname>Nunoki</surname><given-names>J.</given-names></name>
<name><surname>Taniguchi</surname><given-names>T.</given-names></name>
<name><surname>Oshima</surname><given-names>Y.</given-names></name>
<name><surname>Asai</surname><given-names>T.</given-names></name>
</person-group><article-title>Use of plant hormones to activate silent polyketide biosynthetic pathways in <italic toggle="yes">Arthrinium sacchari</italic>, a fungus isolated from a spider</article-title><source>Org. Biomol. Chem.</source><year>2019</year><volume>17</volume><fpage>780</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1039/C8OB02837K</pub-id><pub-id pub-id-type="pmid">30608107</pub-id></element-citation></ref><ref id="B211-pharmaceutics-14-01837"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Netzker</surname><given-names>T.</given-names></name>
<name><surname>Fischer</surname><given-names>J.</given-names></name>
<name><surname>Weber</surname><given-names>J.</given-names></name>
<name><surname>Mattern</surname><given-names>D.J.</given-names></name>
<name><surname>K&#x000f6;nig</surname><given-names>C.C.</given-names></name>
<name><surname>Valiante</surname><given-names>V.</given-names></name>
<name><surname>Schroeckh</surname><given-names>V.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
</person-group><article-title>Microbial communication leading to the activation of silent fungal secondary metabolite gene clusters</article-title><source>Front. Microbiol.</source><year>2015</year><volume>6</volume><fpage>299</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00299</pub-id><pub-id pub-id-type="pmid">25941517</pub-id></element-citation></ref><ref id="B212-pharmaceutics-14-01837"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tan</surname><given-names>Z.Q.</given-names></name>
<name><surname>Leow</surname><given-names>H.Y.</given-names></name>
<name><surname>Lee</surname><given-names>D.C.W.</given-names></name>
<name><surname>Karisnan</surname><given-names>K.</given-names></name>
<name><surname>Song</surname><given-names>A.A.L.</given-names></name>
<name><surname>Mai</surname><given-names>C.W.</given-names></name>
<name><surname>Yap</surname><given-names>W.S.</given-names></name>
<name><surname>Lim</surname><given-names>S.H.E.</given-names></name>
<name><surname>Lai</surname><given-names>K.S.</given-names></name>
</person-group><article-title>Co-Culture Systems for the Production of Secondary Metabolites: Current and Future Prospects</article-title><source>Open Biotechnol. J.</source><year>2019</year><volume>13</volume><fpage>18</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.2174/1874070701913010018</pub-id></element-citation></ref><ref id="B213-pharmaceutics-14-01837"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bertrand</surname><given-names>S.</given-names></name>
<name><surname>Schumpp</surname><given-names>O.</given-names></name>
<name><surname>Bohni</surname><given-names>N.</given-names></name>
<name><surname>Bujard</surname><given-names>A.</given-names></name>
<name><surname>Azzollini</surname><given-names>A.</given-names></name>
<name><surname>Monod</surname><given-names>M.</given-names></name>
<name><surname>Gindro</surname><given-names>K.</given-names></name>
<name><surname>Wolfender</surname><given-names>J.-L.</given-names></name>
</person-group><article-title>Detection of metabolite induction in fungal co-cultures on solid media by high-throughput differential ultra-high pressure liquid chromatography&#x02013;time-of-flight mass spectrometry fingerprinting</article-title><source>J. Chromatogr. A</source><year>2013</year><volume>1292</volume><fpage>219</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2013.01.098</pub-id><pub-id pub-id-type="pmid">23466199</pub-id></element-citation></ref><ref id="B214-pharmaceutics-14-01837"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>N.</given-names></name>
<name><surname>Wen</surname><given-names>Z.</given-names></name>
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>Chai</surname><given-names>Y.</given-names></name>
<name><surname>Ma</surname><given-names>Z.</given-names></name>
</person-group><article-title>Wheat microbiome bacteria can reduce virulence of a plant pathogenic fungus by altering histone acetylation</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>3429</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-05683-7</pub-id><pub-id pub-id-type="pmid">30143616</pub-id></element-citation></ref><ref id="B215-pharmaceutics-14-01837"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schroeckh</surname><given-names>V.</given-names></name>
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>N&#x000fc;tzmann</surname><given-names>H.W.</given-names></name>
<name><surname>Shelest</surname><given-names>E.</given-names></name>
<name><surname>Schmidt-Heck</surname><given-names>W.</given-names></name>
<name><surname>Schuemann</surname><given-names>J.</given-names></name>
<name><surname>Martin</surname><given-names>K.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
</person-group><article-title>Intimate bacterial-fungal interaction triggers biosynthesis of archetypal polyketides in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>14558</fpage><lpage>14563</lpage><pub-id pub-id-type="doi">10.1073/pnas.0901870106</pub-id><pub-id pub-id-type="pmid">19666480</pub-id></element-citation></ref><ref id="B216-pharmaceutics-14-01837"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cueto</surname><given-names>M.</given-names></name>
<name><surname>Jensen</surname><given-names>P.R.</given-names></name>
<name><surname>Kauffman</surname><given-names>C.</given-names></name>
<name><surname>Fenical</surname><given-names>W.</given-names></name>
<name><surname>Lobkovsky</surname><given-names>E.</given-names></name>
<name><surname>Clardy</surname><given-names>J.</given-names></name>
</person-group><article-title>Pestalone, a New Antibiotic Produced by a Marine Fungus in Response to Bacterial Challenge</article-title><source>J. Nat. Prod.</source><year>2001</year><volume>64</volume><fpage>1444</fpage><lpage>1446</lpage><pub-id pub-id-type="doi">10.1021/np0102713</pub-id><pub-id pub-id-type="pmid">11720529</pub-id></element-citation></ref><ref id="B217-pharmaceutics-14-01837"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>C.</given-names></name>
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>Jin</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
</person-group><article-title>A Novel Benzoquinone Compound Isolated from Deep-Sea Hydrothermal Vent Triggers Apoptosis of Tumor Cells</article-title><source>Mar. Drugs</source><year>2017</year><volume>15</volume><elocation-id>200</elocation-id><pub-id pub-id-type="doi">10.3390/md15070200</pub-id><?supplied-pmid 28672882?><pub-id pub-id-type="pmid">28672882</pub-id></element-citation></ref><ref id="B218-pharmaceutics-14-01837"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mandelare</surname><given-names>P.E.</given-names></name>
<name><surname>Adpressa</surname><given-names>D.A.</given-names></name>
<name><surname>Kaweesa</surname><given-names>E.N.</given-names></name>
<name><surname>Zakharov</surname><given-names>L.N.</given-names></name>
<name><surname>Loesgen</surname><given-names>S.</given-names></name>
</person-group><article-title>Coculture of Two Developmental Stages of a Marine-Derived <italic toggle="yes">Aspergillus alliaceus</italic> Results in the Production of the Cytotoxic Bianthrone Allianthrone A</article-title><source>J. Nat. Prod.</source><year>2018</year><volume>81</volume><fpage>1014</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.8b00024</pub-id><?supplied-pmid 29517220?><pub-id pub-id-type="pmid">29517220</pub-id></element-citation></ref><ref id="B219-pharmaceutics-14-01837"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>L.</given-names></name>
<name><surname>Ding</surname><given-names>W.</given-names></name>
<name><surname>Ma</surname><given-names>Z.</given-names></name>
</person-group><article-title>Induced production of cytochalasans in co-culture of marine fungus <italic toggle="yes">Aspergillus flavipes</italic> and actinomycete <italic toggle="yes">Streptomyces</italic> sp.</article-title><source>Nat. Prod. Res.</source><year>2016</year><volume>30</volume><fpage>1718</fpage><lpage>1723</lpage><pub-id pub-id-type="doi">10.1080/14786419.2015.1136910</pub-id><?supplied-pmid 26783945?><pub-id pub-id-type="pmid">26783945</pub-id></element-citation></ref><ref id="B220-pharmaceutics-14-01837"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wakefield</surname><given-names>J.</given-names></name>
<name><surname>Hassan</surname><given-names>H.M.</given-names></name>
<name><surname>Jaspars</surname><given-names>M.</given-names></name>
<name><surname>Ebel</surname><given-names>R.</given-names></name>
<name><surname>Rateb</surname><given-names>M.E.</given-names></name>
</person-group><article-title>Dual Induction of New Microbial Secondary Metabolites by Fungal Bacterial Co-cultivation</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>1284</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.01284</pub-id><pub-id pub-id-type="pmid">28744271</pub-id></element-citation></ref><ref id="B221-pharmaceutics-14-01837"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stroe</surname><given-names>M.C.</given-names></name>
<name><surname>Netzker</surname><given-names>T.</given-names></name>
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>Kruger</surname><given-names>T.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
<name><surname>Valiante</surname><given-names>V.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
</person-group><article-title>Targeted induction of a silent fungal gene cluster encoding the bacteria-specific germination inhibitor fumigermin</article-title><source>Elife</source><year>2020</year><volume>9</volume><fpage>e52541</fpage><pub-id pub-id-type="doi">10.7554/eLife.52541</pub-id><pub-id pub-id-type="pmid">32083553</pub-id></element-citation></ref><ref id="B222-pharmaceutics-14-01837"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gerke</surname><given-names>J.</given-names></name>
<name><surname>K&#x000f6;hler</surname><given-names>A.M.</given-names></name>
<name><surname>Wennrich</surname><given-names>J.-P.</given-names></name>
<name><surname>Gro&#x000df;e</surname><given-names>V.</given-names></name>
<name><surname>Shao</surname><given-names>L.</given-names></name>
<name><surname>Heinrich</surname><given-names>A.K.</given-names></name>
<name><surname>Bode</surname><given-names>H.B.</given-names></name>
<name><surname>Chen</surname><given-names>W.</given-names></name>
<name><surname>Surup</surname><given-names>F.</given-names></name>
<name><surname>Braus</surname><given-names>G.H.</given-names></name>
</person-group><article-title>Biosynthesis of Antibacterial Iron-Chelating Tropolones in <italic toggle="yes">Aspergillus nidulans</italic> as Response to Glycopeptide-Producing Streptomycetes</article-title><source>Front. Fungal Biol.</source><year>2022</year><volume>2</volume><fpage>777474</fpage><pub-id pub-id-type="doi">10.3389/ffunb.2021.777474</pub-id></element-citation></ref><ref id="B223-pharmaceutics-14-01837"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abdelwahab</surname><given-names>M.F.</given-names></name>
<name><surname>Kurt&#x000e1;n</surname><given-names>T.</given-names></name>
<name><surname>M&#x000e1;ndi</surname><given-names>A.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>W.E.G.</given-names></name>
<name><surname>Fouad</surname><given-names>M.A.</given-names></name>
<name><surname>Kamel</surname><given-names>M.S.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Ebrahim</surname><given-names>W.</given-names></name>
<name><surname>Daletos</surname><given-names>G.</given-names></name>
<name><surname>Proksch</surname><given-names>P.</given-names></name>
</person-group><article-title>Induced secondary metabolites from the endophytic fungus <italic toggle="yes">Aspergillus versicolor</italic> through bacterial co-culture and OSMAC approaches</article-title><source>Tetrahedron Lett.</source><year>2018</year><volume>59</volume><fpage>2647</fpage><lpage>2652</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2018.05.067</pub-id></element-citation></ref><ref id="B224-pharmaceutics-14-01837"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moree</surname><given-names>W.J.</given-names></name>
<name><surname>Yang</surname><given-names>J.Y.</given-names></name>
<name><surname>Zhao</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>W.-T.</given-names></name>
<name><surname>Aparicio</surname><given-names>M.</given-names></name>
<name><surname>Atencio</surname><given-names>L.</given-names></name>
<name><surname>Ballesteros</surname><given-names>J.</given-names></name>
<name><surname>S&#x000e1;nchez</surname><given-names>J.</given-names></name>
<name><surname>Gavil&#x000e1;n</surname><given-names>R.G.</given-names></name>
<name><surname>Guti&#x000e9;rrez</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Imaging Mass Spectrometry of a Coral Microbe Interaction with Fungi</article-title><source>J. Chem. Ecol.</source><year>2013</year><volume>39</volume><fpage>1045</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1007/s10886-013-0320-1</pub-id><pub-id pub-id-type="pmid">23881443</pub-id></element-citation></ref><ref id="B225-pharmaceutics-14-01837"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oh</surname><given-names>D.-C.</given-names></name>
<name><surname>Kauffman</surname><given-names>C.A.</given-names></name>
<name><surname>Jensen</surname><given-names>P.R.</given-names></name>
<name><surname>Fenical</surname><given-names>W.</given-names></name>
</person-group><article-title>Induced Production of Emericellamides A and B from the Marine-Derived Fungus Emericella sp. in Competing Co-culture</article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>515</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1021/np060381f</pub-id><pub-id pub-id-type="pmid">17323993</pub-id></element-citation></ref><ref id="B226-pharmaceutics-14-01837"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shang</surname><given-names>Z.</given-names></name>
<name><surname>Salim</surname><given-names>A.A.</given-names></name>
<name><surname>Capon</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Chaunopyran A: Co-Cultivation of Marine Mollusk-Derived Fungi Activates a Rare Class of 2-Alkenyl-Tetrahydropyran</article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>1167</fpage><lpage>1172</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00144</pub-id><?supplied-pmid 28383912?><pub-id pub-id-type="pmid">28383912</pub-id></element-citation></ref><ref id="B227-pharmaceutics-14-01837"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yao</surname><given-names>L.</given-names></name>
<name><surname>Zhu</surname><given-names>L.-P.</given-names></name>
<name><surname>Xu</surname><given-names>X.-Y.</given-names></name>
<name><surname>Tan</surname><given-names>L.-L.</given-names></name>
<name><surname>Sadilek</surname><given-names>M.</given-names></name>
<name><surname>Fan</surname><given-names>H.</given-names></name>
<name><surname>Hu</surname><given-names>B.</given-names></name>
<name><surname>Shen</surname><given-names>X.-T.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Qiao</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Discovery of novel xylosides in co-culture of basidiomycetes Trametes versicolor and Ganoderma applanatum by integrated metabolomics and bioinformatics</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>33237</fpage><pub-id pub-id-type="doi">10.1038/srep33237</pub-id><?supplied-pmid 27616058?><pub-id pub-id-type="pmid">27616058</pub-id></element-citation></ref><ref id="B228-pharmaceutics-14-01837"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oh</surname><given-names>D.-C.</given-names></name>
<name><surname>Jensen</surname><given-names>P.R.</given-names></name>
<name><surname>Kauffman</surname><given-names>C.A.</given-names></name>
<name><surname>Fenical</surname><given-names>W.</given-names></name>
</person-group><article-title>Libertellenones A&#x02013;D: Induction of cytotoxic diterpenoid biosynthesis by marine microbial competition</article-title><source>Bioorganic Med. Chem.</source><year>2005</year><volume>13</volume><fpage>5267</fpage><lpage>5273</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2005.05.068</pub-id><?supplied-pmid 15993608?><pub-id pub-id-type="pmid">15993608</pub-id></element-citation></ref><ref id="B229-pharmaceutics-14-01837"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Zhuang</surname><given-names>Y.</given-names></name>
<name><surname>Kong</surname><given-names>F.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
<name><surname>Zhu</surname><given-names>W.</given-names></name>
</person-group><article-title>Phenolic Polyketides from the Co-Cultivation of Marine-Derived Penicillium sp. WC-29-5 and Streptomyces fradiae 007</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>2079</fpage><lpage>2088</lpage><pub-id pub-id-type="doi">10.3390/md12042079</pub-id><?supplied-pmid 24714124?><pub-id pub-id-type="pmid">24714124</pub-id></element-citation></ref><ref id="B230-pharmaceutics-14-01837"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>L.</given-names></name>
<name><surname>Ding</surname><given-names>W.</given-names></name>
<name><surname>Wang</surname><given-names>Q.</given-names></name>
<name><surname>Ma</surname><given-names>Z.</given-names></name>
<name><surname>Xu</surname><given-names>X.</given-names></name>
<name><surname>Zhao</surname><given-names>X.</given-names></name>
<name><surname>Chen</surname><given-names>Z.</given-names></name>
</person-group><article-title>Induction of cryptic bioactive 2,5-diketopiperazines in fungus Penicillium sp. DT-F29 by microbial co-culture</article-title><source>Tetrahedron</source><year>2017</year><volume>73</volume><fpage>907</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2016.12.077</pub-id></element-citation></ref><ref id="B231-pharmaceutics-14-01837"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>H.</given-names></name>
<name><surname>Aktas</surname><given-names>N.</given-names></name>
<name><surname>Konuklugil</surname><given-names>B.</given-names></name>
<name><surname>M&#x000e1;ndi</surname><given-names>A.</given-names></name>
<name><surname>Daletos</surname><given-names>G.</given-names></name>
<name><surname>Lin</surname><given-names>W.</given-names></name>
<name><surname>Dai</surname><given-names>H.</given-names></name>
<name><surname>Kurt&#x000e1;n</surname><given-names>T.</given-names></name>
<name><surname>Proksch</surname><given-names>P.</given-names></name>
</person-group><article-title>A new fusarielin analogue from <italic toggle="yes">Penicillium</italic> sp. isolated from the Mediterranean sponge Ircinia oros</article-title><source>Tetrahedron Lett.</source><year>2015</year><volume>56</volume><fpage>5317</fpage><lpage>5320</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2015.07.072</pub-id></element-citation></ref><ref id="B232-pharmaceutics-14-01837"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>He</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>G.</given-names></name>
<name><surname>Che</surname><given-names>Q.</given-names></name>
<name><surname>Zhu</surname><given-names>T.</given-names></name>
<name><surname>Gu</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
</person-group><article-title>Inducing Secondary Metabolite Production by Combined Culture of <italic toggle="yes">Talaromyces aculeatus</italic> and <italic toggle="yes">Penicillium variabile</italic></article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>3167</fpage><lpage>3171</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00417</pub-id><pub-id pub-id-type="pmid">29144133</pub-id></element-citation></ref><ref id="B233-pharmaceutics-14-01837"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khalil</surname><given-names>Z.G.</given-names></name>
<name><surname>Cruz-Morales</surname><given-names>P.</given-names></name>
<name><surname>Licona-Cassani</surname><given-names>C.</given-names></name>
<name><surname>Marcellin</surname><given-names>E.</given-names></name>
<name><surname>Capon</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Inter-Kingdom beach warfare: Microbial chemical communication activates natural chemical defences</article-title><source>ISME J.</source><year>2019</year><volume>13</volume><fpage>147</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1038/s41396-018-0265-z</pub-id><pub-id pub-id-type="pmid">30116041</pub-id></element-citation></ref><ref id="B234-pharmaceutics-14-01837"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sulyok</surname><given-names>M.</given-names></name>
<name><surname>Stadler</surname><given-names>D.</given-names></name>
<name><surname>Steiner</surname><given-names>D.</given-names></name>
<name><surname>Krska</surname><given-names>R.</given-names></name>
</person-group><article-title>Validation of an LC-MS/MS-based dilute-and-shoot approach for the quantification of &#x0003e;&#x02009;500 mycotoxins and other secondary metabolites in food crops: Challenges and solutions</article-title><source>Anal. Bioanal. Chem.</source><year>2020</year><volume>412</volume><fpage>2607</fpage><lpage>2620</lpage><pub-id pub-id-type="doi">10.1007/s00216-020-02489-9</pub-id><pub-id pub-id-type="pmid">32078002</pub-id></element-citation></ref><ref id="B235-pharmaceutics-14-01837"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Skinnider</surname><given-names>M.A.</given-names></name>
<name><surname>Johnston</surname><given-names>C.W.</given-names></name>
<name><surname>Gunabalasingam</surname><given-names>M.</given-names></name>
<name><surname>Merwin</surname><given-names>N.J.</given-names></name>
<name><surname>Kieliszek</surname><given-names>A.M.</given-names></name>
<name><surname>MacLellan</surname><given-names>R.J.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Ranieri</surname><given-names>M.R.M.</given-names></name>
<name><surname>Webster</surname><given-names>A.L.H.</given-names></name>
<name><surname>Cao</surname><given-names>M.P.T.</given-names></name>
<etal/>
</person-group><article-title>Comprehensive prediction of secondary metabolite structure and biological activity from microbial genome sequences</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>6058</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-19986-1</pub-id><pub-id pub-id-type="pmid">33247171</pub-id></element-citation></ref><ref id="B236-pharmaceutics-14-01837"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Flaherty</surname><given-names>J.E.</given-names></name>
<name><surname>Payne</surname><given-names>G.A.</given-names></name>
</person-group><article-title>Overexpression of aflR Leads to Upregulation of Pathway Gene Transcription and Increased Aflatoxin Production in <italic toggle="yes">Aspergillus flavus</italic></article-title><source>Appl. Environ. Microbiol.</source><year>1997</year><volume>63</volume><fpage>3995</fpage><lpage>4000</lpage><pub-id pub-id-type="doi">10.1128/aem.63.10.3995-4000.1997</pub-id><?supplied-pmid 16535712?><pub-id pub-id-type="pmid">16535712</pub-id></element-citation></ref><ref id="B237-pharmaceutics-14-01837"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bergmann</surname><given-names>S.</given-names></name>
<name><surname>Sch&#x000fc;mann</surname><given-names>J.</given-names></name>
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>Lange</surname><given-names>C.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
</person-group><article-title>Genomics-driven discovery of PKS-NRPS hybrid metabolites from <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>Nat. Chem. Biol.</source><year>2007</year><volume>3</volume><fpage>213</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1038/nchembio869</pub-id><pub-id pub-id-type="pmid">17369821</pub-id></element-citation></ref><ref id="B238-pharmaceutics-14-01837"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chiang</surname><given-names>Y.M.</given-names></name>
<name><surname>Szewczyk</surname><given-names>E.</given-names></name>
<name><surname>Davidson</surname><given-names>A.D.</given-names></name>
<name><surname>Keller</surname><given-names>N.</given-names></name>
<name><surname>Oakley</surname><given-names>B.R.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.</given-names></name>
</person-group><article-title>A gene cluster containing two fungal polyketide synthases encodes the biosynthetic pathway for a polyketide, asperfuranone, in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>J. Am. Chem. Soc.</source><year>2009</year><volume>131</volume><fpage>2965</fpage><lpage>2970</lpage><pub-id pub-id-type="doi">10.1021/ja8088185</pub-id><?supplied-pmid 19199437?><pub-id pub-id-type="pmid">19199437</pub-id></element-citation></ref><ref id="B239-pharmaceutics-14-01837"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Janevska</surname><given-names>S.</given-names></name>
<name><surname>Arndt</surname><given-names>B.</given-names></name>
<name><surname>Baumann</surname><given-names>L.</given-names></name>
<name><surname>Apken</surname><given-names>L.H.</given-names></name>
<name><surname>Mauriz Marques</surname><given-names>L.M.</given-names></name>
<name><surname>Humpf</surname><given-names>H.U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Establishment of the Inducible Tet-On System for the Activation of the Silent Trichosetin Gene Cluster in <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>Toxins</source><year>2017</year><volume>9</volume><elocation-id>126</elocation-id><pub-id pub-id-type="doi">10.3390/toxins9040126</pub-id></element-citation></ref><ref id="B240-pharmaceutics-14-01837"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Inglis</surname><given-names>D.O.</given-names></name>
<name><surname>Binkley</surname><given-names>J.</given-names></name>
<name><surname>Skrzypek</surname><given-names>M.S.</given-names></name>
<name><surname>Arnaud</surname><given-names>M.B.</given-names></name>
<name><surname>Cerqueira</surname><given-names>G.C.</given-names></name>
<name><surname>Shah</surname><given-names>P.</given-names></name>
<name><surname>Wymore</surname><given-names>F.</given-names></name>
<name><surname>Wortman</surname><given-names>J.R.</given-names></name>
<name><surname>Sherlock</surname><given-names>G.</given-names></name>
</person-group><article-title>Comprehensive annotation of secondary metabolite biosynthetic genes and gene clusters of <italic toggle="yes">Aspergillus nidulans</italic>, <italic toggle="yes">A. fumigatus</italic>, <italic toggle="yes">A. niger</italic> and <italic toggle="yes">A. oryzae</italic></article-title><source>BMC Microbiol.</source><year>2013</year><volume>13</volume><elocation-id>91</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-13-91</pub-id><?supplied-pmid 23617571?><pub-id pub-id-type="pmid">23617571</pub-id></element-citation></ref><ref id="B241-pharmaceutics-14-01837"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>P.-K.</given-names></name>
<name><surname>Ehrlich</surname><given-names>K.C.</given-names></name>
</person-group><article-title>Genome-wide analysis of the Zn(II)2Cys6 zinc cluster-encoding gene family in <italic toggle="yes">Aspergillus flavus</italic></article-title><source>Appl. Microbiol. Biotechnol.</source><year>2013</year><volume>97</volume><fpage>4289</fpage><lpage>4300</lpage><pub-id pub-id-type="doi">10.1007/s00253-013-4865-2</pub-id><pub-id pub-id-type="pmid">23563886</pub-id></element-citation></ref><ref id="B242-pharmaceutics-14-01837"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kwon</surname><given-names>M.J.</given-names></name>
<name><surname>Steiniger</surname><given-names>C.</given-names></name>
<name><surname>Cairns</surname><given-names>T.C.</given-names></name>
<name><surname>Wisecaver</surname><given-names>J.H.</given-names></name>
<name><surname>Lind</surname><given-names>A.L.</given-names></name>
<name><surname>Pohl</surname><given-names>C.</given-names></name>
<name><surname>Regner</surname><given-names>C.</given-names></name>
<name><surname>Rokas</surname><given-names>A.</given-names></name>
<name><surname>Meyer</surname><given-names>V.</given-names></name>
<name><surname>Goldman</surname><given-names>G.H.</given-names></name>
</person-group><article-title>Beyond the Biosynthetic Gene Cluster Paradigm: Genome-Wide Coexpression Networks Connect Clustered and Unclustered Transcription Factors to Secondary Metabolic Pathways</article-title><source>Microbiol. Spectr.</source><year>2021</year><volume>9</volume><fpage>e00898-21</fpage><pub-id pub-id-type="doi">10.1128/Spectrum.00898-21</pub-id></element-citation></ref><ref id="B243-pharmaceutics-14-01837"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ahuja</surname><given-names>M.</given-names></name>
<name><surname>Chiang</surname><given-names>Y.-M.</given-names></name>
<name><surname>Chang</surname><given-names>S.-L.</given-names></name>
<name><surname>Praseuth</surname><given-names>M.B.</given-names></name>
<name><surname>Entwistle</surname><given-names>R.</given-names></name>
<name><surname>Sanchez</surname><given-names>J.F.</given-names></name>
<name><surname>Lo</surname><given-names>H.-C.</given-names></name>
<name><surname>Yeh</surname><given-names>H.-H.</given-names></name>
<name><surname>Oakley</surname><given-names>B.R.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.C.</given-names></name>
</person-group><article-title>Illuminating the Diversity of Aromatic Polyketide Synthases in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>J. Am. Chem. Soc.</source><year>2012</year><volume>134</volume><fpage>8212</fpage><lpage>8221</lpage><pub-id pub-id-type="doi">10.1021/ja3016395</pub-id><pub-id pub-id-type="pmid">22510154</pub-id></element-citation></ref><ref id="B244-pharmaceutics-14-01837"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shimizu</surname><given-names>K.</given-names></name>
<name><surname>Hicks</surname><given-names>J.K.</given-names></name>
<name><surname>Huang</surname><given-names>T.-P.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Pka, Ras and RGS Protein Interactions Regulate Activity of AflR, a Zn(II)2Cys6 Transcription Factor in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>Genetics</source><year>2003</year><volume>165</volume><fpage>1095</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1093/genetics/165.3.1095</pub-id><pub-id pub-id-type="pmid">14668367</pub-id></element-citation></ref><ref id="B245-pharmaceutics-14-01837"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zehetbauer</surname><given-names>F.</given-names></name>
<name><surname>Seidl</surname><given-names>A.</given-names></name>
<name><surname>Berger</surname><given-names>H.</given-names></name>
<name><surname>Sulyok</surname><given-names>M.</given-names></name>
<name><surname>Kastner</surname><given-names>F.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
</person-group><article-title>RimO (SrrB) is required for carbon starvation signaling and production of secondary metabolites in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>Fungal Genet. Biol.</source><year>2022</year><volume>162</volume><fpage>103726</fpage><pub-id pub-id-type="doi">10.1016/j.fgb.2022.103726</pub-id><pub-id pub-id-type="pmid">35843417</pub-id></element-citation></ref><ref id="B246-pharmaceutics-14-01837"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grau</surname><given-names>M.F.</given-names></name>
<name><surname>Entwistle</surname><given-names>R.</given-names></name>
<name><surname>Chiang</surname><given-names>Y.-M.</given-names></name>
<name><surname>Ahuja</surname><given-names>M.</given-names></name>
<name><surname>Oakley</surname><given-names>C.E.</given-names></name>
<name><surname>Akashi</surname><given-names>T.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.C.</given-names></name>
<name><surname>Todd</surname><given-names>R.B.</given-names></name>
<name><surname>Oakley</surname><given-names>B.R.</given-names></name>
</person-group><article-title>Hybrid Transcription Factor Engineering Activates the Silent Secondary Metabolite Gene Cluster for (+)-Asperlin in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>ACS Chem. Biol.</source><year>2018</year><volume>13</volume><fpage>3193</fpage><lpage>3205</lpage><pub-id pub-id-type="doi">10.1021/acschembio.8b00679</pub-id><?supplied-pmid 30339758?><pub-id pub-id-type="pmid">30339758</pub-id></element-citation></ref><ref id="B247-pharmaceutics-14-01837"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sung</surname><given-names>C.T.</given-names></name>
<name><surname>Chang</surname><given-names>S.-L.</given-names></name>
<name><surname>Entwistle</surname><given-names>R.</given-names></name>
<name><surname>Ahn</surname><given-names>G.</given-names></name>
<name><surname>Lin</surname><given-names>T.-S.</given-names></name>
<name><surname>Petrova</surname><given-names>V.</given-names></name>
<name><surname>Yeh</surname><given-names>H.-H.</given-names></name>
<name><surname>Praseuth</surname><given-names>M.B.</given-names></name>
<name><surname>Chiang</surname><given-names>Y.-M.</given-names></name>
<name><surname>Oakley</surname><given-names>B.R.</given-names></name>
<etal/>
</person-group><article-title>Overexpression of a three-gene conidial pigment biosynthetic pathway in <italic toggle="yes">Aspergillus nidulans</italic> reveals the first NRPS known to acetylate tryptophan</article-title><source>Fungal Genet. Biol.</source><year>2017</year><volume>101</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2017.01.006</pub-id><?supplied-pmid 28108400?><pub-id pub-id-type="pmid">28108400</pub-id></element-citation></ref><ref id="B248-pharmaceutics-14-01837"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yeh</surname><given-names>H.-H.</given-names></name>
<name><surname>Ahuja</surname><given-names>M.</given-names></name>
<name><surname>Chiang</surname><given-names>Y.-M.</given-names></name>
<name><surname>Oakley</surname><given-names>C.E.</given-names></name>
<name><surname>Moore</surname><given-names>S.</given-names></name>
<name><surname>Yoon</surname><given-names>O.</given-names></name>
<name><surname>Hajovsky</surname><given-names>H.</given-names></name>
<name><surname>Bok</surname><given-names>J.-W.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.C.</given-names></name>
<etal/>
</person-group><article-title>Resistance Gene-Guided Genome Mining: Serial Promoter Exchanges in <italic toggle="yes">Aspergillus nidulans</italic> Reveal the Biosynthetic Pathway for Fellutamide B, a Proteasome Inhibitor</article-title><source>ACS Chem. Biol.</source><year>2016</year><volume>11</volume><fpage>2275</fpage><lpage>2284</lpage><pub-id pub-id-type="doi">10.1021/acschembio.6b00213</pub-id><?supplied-pmid 27294372?><pub-id pub-id-type="pmid">27294372</pub-id></element-citation></ref><ref id="B249-pharmaceutics-14-01837"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baccile</surname><given-names>J.A.</given-names></name>
<name><surname>Spraker</surname><given-names>J.E.</given-names></name>
<name><surname>Le</surname><given-names>H.H.</given-names></name>
<name><surname>Brandenburger</surname><given-names>E.</given-names></name>
<name><surname>Gomez</surname><given-names>C.</given-names></name>
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Macheleidt</surname><given-names>J.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
<name><surname>Hoffmeister</surname><given-names>D.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<etal/>
</person-group><article-title>Plant-like biosynthesis of isoquinoline alkaloids in <italic toggle="yes">Aspergillus fumigatus</italic></article-title><source>Nat. Chem. Biol.</source><year>2016</year><volume>12</volume><fpage>419</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2061</pub-id><pub-id pub-id-type="pmid">27065235</pub-id></element-citation></ref><ref id="B250-pharmaceutics-14-01837"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lim</surname><given-names>F.Y.</given-names></name>
<name><surname>Won</surname><given-names>T.H.</given-names></name>
<name><surname>Raffa</surname><given-names>N.</given-names></name>
<name><surname>Baccile</surname><given-names>J.A.</given-names></name>
<name><surname>Wisecaver</surname><given-names>J.</given-names></name>
<name><surname>Rokas</surname><given-names>A.</given-names></name>
<name><surname>Schroeder</surname><given-names>F.C.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<name><surname>Goldman</surname><given-names>G.H.</given-names></name>
</person-group><article-title>Fungal Isocyanide Synthases and Xanthocillin Biosynthesis in <italic toggle="yes">Aspergillus fumigatus</italic></article-title><source>mBio</source><year>2018</year><volume>9</volume><fpage>e00785-18</fpage><pub-id pub-id-type="doi">10.1128/mBio.00785-18</pub-id><pub-id pub-id-type="pmid">29844112</pub-id></element-citation></ref><ref id="B251-pharmaceutics-14-01837"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sch&#x000fc;ller</surname><given-names>A.</given-names></name>
<name><surname>Wolansky</surname><given-names>L.</given-names></name>
<name><surname>Berger</surname><given-names>H.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>Gacek-Matthews</surname><given-names>A.</given-names></name>
<name><surname>Sulyok</surname><given-names>M.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
</person-group><article-title>A novel fungal gene regulation system based on inducible VPR-dCas9 and nucleosome map-guided sgRNA positioning</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2020</year><volume>104</volume><fpage>9801</fpage><lpage>9822</lpage><pub-id pub-id-type="doi">10.1007/s00253-020-10900-9</pub-id><pub-id pub-id-type="pmid">33006690</pub-id></element-citation></ref><ref id="B252-pharmaceutics-14-01837"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Huang</surname><given-names>L.</given-names></name>
<name><surname>Pan</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Pan</surname><given-names>L.</given-names></name>
</person-group><article-title>CRISPR/dCas9-mediated epigenetic modification reveals differential regulation of histone acetylation on <italic toggle="yes">Aspergillus niger</italic> secondary metabolite</article-title><source>Microbiol. Res.</source><year>2021</year><volume>245</volume><fpage>126694</fpage><pub-id pub-id-type="doi">10.1016/j.micres.2020.126694</pub-id><pub-id pub-id-type="pmid">33482403</pub-id></element-citation></ref><ref id="B253-pharmaceutics-14-01837"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Roux</surname><given-names>I.</given-names></name>
<name><surname>Woodcraft</surname><given-names>C.</given-names></name>
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Wolters</surname><given-names>R.</given-names></name>
<name><surname>Gilchrist</surname><given-names>C.L.M.</given-names></name>
<name><surname>Chooi</surname><given-names>Y.-H.</given-names></name>
</person-group><article-title>CRISPR-Mediated Activation of Biosynthetic Gene Clusters for Bioactive Molecule Discovery in Filamentous Fungi</article-title><source>ACS Synth. Biol.</source><year>2020</year><volume>9</volume><fpage>1843</fpage><lpage>1854</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.0c00197</pub-id><pub-id pub-id-type="pmid">32526136</pub-id></element-citation></ref><ref id="B254-pharmaceutics-14-01837"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bromann</surname><given-names>K.</given-names></name>
<name><surname>Toivari</surname><given-names>M.</given-names></name>
<name><surname>Viljanen</surname><given-names>K.</given-names></name>
<name><surname>Vuoristo</surname><given-names>A.</given-names></name>
<name><surname>Ruohonen</surname><given-names>L.</given-names></name>
<name><surname>Nakari-Set&#x000e4;l&#x000e4;</surname><given-names>T.</given-names></name>
</person-group><article-title>Identification and Characterization of a Novel Diterpene Gene Cluster in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e35450</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0035450</pub-id><pub-id pub-id-type="pmid">22506079</pub-id></element-citation></ref><ref id="B255-pharmaceutics-14-01837"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yeh</surname><given-names>H.-H.</given-names></name>
<name><surname>Chiang</surname><given-names>Y.-M.</given-names></name>
<name><surname>Entwistle</surname><given-names>R.</given-names></name>
<name><surname>Ahuja</surname><given-names>M.</given-names></name>
<name><surname>Lee</surname><given-names>K.-H.</given-names></name>
<name><surname>Bruno</surname><given-names>K.S.</given-names></name>
<name><surname>Wu</surname><given-names>T.-K.</given-names></name>
<name><surname>Oakley</surname><given-names>B.R.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.C.</given-names></name>
</person-group><article-title>Molecular genetic analysis reveals that a nonribosomal peptide synthetase-like (NRPS-like) gene in <italic toggle="yes">Aspergillus nidulans</italic> is responsible for microperfuranone biosynthesis</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2012</year><volume>96</volume><fpage>739</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1007/s00253-012-4098-9</pub-id><pub-id pub-id-type="pmid">22627757</pub-id></element-citation></ref><ref id="B256-pharmaceutics-14-01837"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ishikawa</surname><given-names>N.</given-names></name>
<name><surname>Tanaka</surname><given-names>H.</given-names></name>
<name><surname>Koyama</surname><given-names>F.</given-names></name>
<name><surname>Noguchi</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.C.</given-names></name>
<name><surname>Hotta</surname><given-names>K.</given-names></name>
<name><surname>Watanabe</surname><given-names>K.</given-names></name>
</person-group><article-title>Non-Heme Dioxygenase Catalyzes Atypical Oxidations of 6,7-Bicyclic Systems To Form the 6,6-Quinolone Core of Viridicatin-Type Fungal Alkaloids</article-title><source>Angew. Chem. Int. Ed.</source><year>2014</year><volume>53</volume><fpage>12880</fpage><lpage>12884</lpage><pub-id pub-id-type="doi">10.1002/anie.201407920</pub-id><?supplied-pmid 25251934?><pub-id pub-id-type="pmid">25251934</pub-id></element-citation></ref><ref id="B257-pharmaceutics-14-01837"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>T.S.</given-names></name>
<name><surname>Chen</surname><given-names>B.</given-names></name>
<name><surname>Chiang</surname><given-names>Y.M.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.C.</given-names></name>
</person-group><article-title>Discovery and Elucidation of the Biosynthesis of Aspernidgulenes: Novel Polyenes from <italic toggle="yes">Aspergillus nidulans</italic> by using Serial Promoter Replacement</article-title><source>Chembiochem</source><year>2019</year><volume>20</volume><fpage>329</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1002/cbic.201800486</pub-id><?supplied-pmid 30302871?><pub-id pub-id-type="pmid">30302871</pub-id></element-citation></ref><ref id="B258-pharmaceutics-14-01837"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zabala</surname><given-names>A.O.</given-names></name>
<name><surname>Xu</surname><given-names>W.</given-names></name>
<name><surname>Chooi</surname><given-names>Y.-H.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Characterization of a Silent Azaphilone Gene Cluster from <italic toggle="yes">Aspergillus niger</italic> ATCC 1015 Reveals a Hydroxylation-Mediated Pyran-Ring Formation</article-title><source>Chem. Biol.</source><year>2012</year><volume>19</volume><fpage>1049</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2012.07.004</pub-id><?supplied-pmid 22921072?><pub-id pub-id-type="pmid">22921072</pub-id></element-citation></ref><ref id="B259-pharmaceutics-14-01837"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>P.K.</given-names></name>
<name><surname>Ehrlich</surname><given-names>K.C.</given-names></name>
<name><surname>Yu</surname><given-names>J.</given-names></name>
<name><surname>Bhatnagar</surname><given-names>D.</given-names></name>
<name><surname>Cleveland</surname><given-names>T.E.</given-names></name>
</person-group><article-title>Increased expression of <italic toggle="yes">Aspergillus parasiticus</italic> aflR, encoding a sequence-specific DNA-binding protein, relieves nitrate inhibition of aflatoxin biosynthesis</article-title><source>Appl. Environ. Microbiol.</source><year>1995</year><volume>61</volume><fpage>2372</fpage><lpage>2377</lpage><pub-id pub-id-type="doi">10.1128/aem.61.6.2372-2377.1995</pub-id><pub-id pub-id-type="pmid">7793958</pub-id></element-citation></ref><ref id="B260-pharmaceutics-14-01837"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tang</surname><given-names>S.</given-names></name>
<name><surname>Men</surname><given-names>P.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Huang</surname><given-names>X.</given-names></name>
<name><surname>Lu</surname><given-names>X.</given-names></name>
</person-group><article-title>Identification of a polyketide biosynthesis gene cluster by transcriptional regulator activation in <italic toggle="yes">Aspergillus terreus</italic></article-title><source>Fungal Genet. Biol.</source><year>2022</year><volume>160</volume><fpage>103690</fpage><pub-id pub-id-type="doi">10.1016/j.fgb.2022.103690</pub-id><pub-id pub-id-type="pmid">35351612</pub-id></element-citation></ref><ref id="B261-pharmaceutics-14-01837"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dong</surname><given-names>Y.</given-names></name>
<name><surname>Cui</surname><given-names>C.B.</given-names></name>
<name><surname>Li</surname><given-names>C.W.</given-names></name>
<name><surname>Hua</surname><given-names>W.</given-names></name>
<name><surname>Wu</surname><given-names>C.J.</given-names></name>
<name><surname>Zhu</surname><given-names>T.J.</given-names></name>
<name><surname>Gu</surname><given-names>Q.Q.</given-names></name>
</person-group><article-title>Activation of dormant secondary metabolite production by introducing neomycin resistance into the deep-sea fungus, <italic toggle="yes">Aspergillus versicolor</italic> ZBY-3</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>4326</fpage><lpage>4352</lpage><pub-id pub-id-type="doi">10.3390/md12084326</pub-id><pub-id pub-id-type="pmid">25076061</pub-id></element-citation></ref><ref id="B262-pharmaceutics-14-01837"><label>262.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Niehaus</surname><given-names>E.M.</given-names></name>
<name><surname>Janevska</surname><given-names>S.</given-names></name>
<name><surname>von Bargen</surname><given-names>K.W.</given-names></name>
<name><surname>Sieber</surname><given-names>C.M.</given-names></name>
<name><surname>Harrer</surname><given-names>H.</given-names></name>
<name><surname>Humpf</surname><given-names>H.U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Apicidin F: Characterization and genetic manipulation of a new secondary metabolite gene cluster in the rice pathogen <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e103336</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0103336</pub-id><pub-id pub-id-type="pmid">25058475</pub-id></element-citation></ref><ref id="B263-pharmaceutics-14-01837"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Von Bargen</surname><given-names>K.W.</given-names></name>
<name><surname>Niehaus</surname><given-names>E.M.</given-names></name>
<name><surname>Krug</surname><given-names>I.</given-names></name>
<name><surname>Bergander</surname><given-names>K.</given-names></name>
<name><surname>Wurthwein</surname><given-names>E.U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
<name><surname>Humpf</surname><given-names>H.U.</given-names></name>
</person-group><article-title>Isolation and Structure Elucidation of Fujikurins A-D: Products of the PKS19 Gene Cluster in <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>1809</fpage><lpage>1815</lpage><pub-id pub-id-type="doi">10.1021/np5008137</pub-id><pub-id pub-id-type="pmid">26192387</pub-id></element-citation></ref><ref id="B264-pharmaceutics-14-01837"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arndt</surname><given-names>B.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>Wiemann</surname><given-names>P.</given-names></name>
<name><surname>Osmanov</surname><given-names>H.</given-names></name>
<name><surname>Kleigrewe</surname><given-names>K.</given-names></name>
<name><surname>K&#x000f6;hler</surname><given-names>J.</given-names></name>
<name><surname>Krug</surname><given-names>I.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
<name><surname>Humpf</surname><given-names>H.-U.</given-names></name>
</person-group><article-title>Genetic engineering, high resolution mass spectrometry and nuclear magnetic resonance spectroscopy elucidate the bikaverin biosynthetic pathway in <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>Fungal Genet. Biol.</source><year>2015</year><volume>84</volume><fpage>26</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2015.09.006</pub-id><pub-id pub-id-type="pmid">26382642</pub-id></element-citation></ref><ref id="B265-pharmaceutics-14-01837"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arndt</surname><given-names>B.</given-names></name>
<name><surname>Janevska</surname><given-names>S.</given-names></name>
<name><surname>Schmid</surname><given-names>R.</given-names></name>
<name><surname>Hubner</surname><given-names>F.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
<name><surname>Humpf</surname><given-names>H.U.</given-names></name>
</person-group><article-title>A Fungal N-Dimethylallyltryptophan Metabolite from <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>Chembiochem</source><year>2017</year><volume>18</volume><fpage>899</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1002/cbic.201600691</pub-id><pub-id pub-id-type="pmid">28295904</pub-id></element-citation></ref><ref id="B266-pharmaceutics-14-01837"><label>266.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sorensen</surname><given-names>J.L.</given-names></name>
<name><surname>Hansen</surname><given-names>F.T.</given-names></name>
<name><surname>Sondergaard</surname><given-names>T.E.</given-names></name>
<name><surname>Staerk</surname><given-names>D.</given-names></name>
<name><surname>Lee</surname><given-names>T.V.</given-names></name>
<name><surname>Wimmer</surname><given-names>R.</given-names></name>
<name><surname>Klitgaard</surname><given-names>L.G.</given-names></name>
<name><surname>Purup</surname><given-names>S.</given-names></name>
<name><surname>Giese</surname><given-names>H.</given-names></name>
<name><surname>Frandsen</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Production of novel fusarielins by ectopic activation of the polyketide synthase 9 cluster in <italic toggle="yes">Fusarium graminearum</italic></article-title><source>Environ. Microbiol.</source><year>2012</year><volume>14</volume><fpage>1159</fpage><lpage>1170</lpage><pub-id pub-id-type="doi">10.1111/j.1462-2920.2011.02696.x</pub-id><?supplied-pmid 22252016?><pub-id pub-id-type="pmid">22252016</pub-id></element-citation></ref><ref id="B267-pharmaceutics-14-01837"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jia</surname><given-names>L.J.</given-names></name>
<name><surname>Tang</surname><given-names>H.Y.</given-names></name>
<name><surname>Wang</surname><given-names>W.Q.</given-names></name>
<name><surname>Yuan</surname><given-names>T.L.</given-names></name>
<name><surname>Wei</surname><given-names>W.Q.</given-names></name>
<name><surname>Pang</surname><given-names>B.</given-names></name>
<name><surname>Gong</surname><given-names>X.M.</given-names></name>
<name><surname>Wang</surname><given-names>S.F.</given-names></name>
<name><surname>Li</surname><given-names>Y.J.</given-names></name>
<name><surname>Zhang</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>A linear nonribosomal octapeptide from <italic toggle="yes">Fusarium graminearum</italic> facilitates cell-to-cell invasion of wheat</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>922</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-08726-9</pub-id><?supplied-pmid 30804501?><pub-id pub-id-type="pmid">30804501</pub-id></element-citation></ref><ref id="B268-pharmaceutics-14-01837"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kakule</surname><given-names>T.B.</given-names></name>
<name><surname>Sardar</surname><given-names>D.</given-names></name>
<name><surname>Lin</surname><given-names>Z.</given-names></name>
<name><surname>Schmidt</surname><given-names>E.W.</given-names></name>
</person-group><article-title>Two related pyrrolidinedione synthetase loci in Fusarium heterosporum ATCC 74349 produce divergent metabolites</article-title><source>ACS Chem. Biol.</source><year>2013</year><volume>8</volume><fpage>1549</fpage><lpage>1557</lpage><pub-id pub-id-type="doi">10.1021/cb400159f</pub-id><?supplied-pmid 23614392?><pub-id pub-id-type="pmid">23614392</pub-id></element-citation></ref><ref id="B269-pharmaceutics-14-01837"><label>269.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Drott</surname><given-names>M.</given-names></name>
<name><surname>Greco</surname><given-names>C.</given-names></name>
<name><surname>Luciano-Rosario</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>P.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Transcription Factor Repurposing Offers Insights into Evolution of Biosynthetic Gene Cluster Regulation</article-title><source>mBio</source><year>2021</year><volume>12</volume><fpage>e0139921</fpage><pub-id pub-id-type="doi">10.1128/mBio.01399-21</pub-id><pub-id pub-id-type="pmid">34281384</pub-id></element-citation></ref><ref id="B270-pharmaceutics-14-01837"><label>270.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>N.</given-names></name>
<name><surname>Cui</surname><given-names>C.-B.</given-names></name>
<name><surname>Li</surname><given-names>C.-W.</given-names></name>
</person-group><article-title>A new cyclic dipeptide penicimutide: The activated production of cyclic dipeptides by introduction of neomycin-resistance in the marine-derived fungus Penicillium purpurogenum G59</article-title><source>Arch. Pharmacal Res.</source><year>2016</year><volume>39</volume><fpage>762</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1007/s12272-016-0751-7</pub-id></element-citation></ref><ref id="B271-pharmaceutics-14-01837"><label>271.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>M&#x000f3;zsik</surname><given-names>L.</given-names></name>
<name><surname>Hoekzema</surname><given-names>M.</given-names></name>
<name><surname>de Kok</surname><given-names>N.A.W.</given-names></name>
<name><surname>Bovenberg</surname><given-names>R.A.L.</given-names></name>
<name><surname>Nyg&#x000e5;rd</surname><given-names>Y.</given-names></name>
<name><surname>Driessen</surname><given-names>A.J.M.</given-names></name>
</person-group><article-title>CRISPR-based transcriptional activation tool for silent genes in filamentous fungi</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><fpage>1118</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-80864-3</pub-id><pub-id pub-id-type="pmid">33441979</pub-id></element-citation></ref><ref id="B272-pharmaceutics-14-01837"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>H.</given-names></name>
<name><surname>Zhan</surname><given-names>J.</given-names></name>
<name><surname>Watanabe</surname><given-names>K.</given-names></name>
<name><surname>Xie</surname><given-names>X.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
</person-group><article-title>A polyketide macrolactone synthase from the filamentous fungus <italic toggle="yes">Gibberella zeae</italic></article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2008</year><volume>105</volume><fpage>6249</fpage><lpage>6254</lpage><pub-id pub-id-type="doi">10.1073/pnas.0800657105</pub-id><pub-id pub-id-type="pmid">18427109</pub-id></element-citation></ref><ref id="B273-pharmaceutics-14-01837"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haynes</surname><given-names>S.W.</given-names></name>
<name><surname>Ames</surname><given-names>B.D.</given-names></name>
<name><surname>Gao</surname><given-names>X.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
</person-group><article-title>Unraveling Terminal C-Domain-Mediated Condensation in Fungal Biosynthesis of Imidazoindolone Metabolites</article-title><source>Biochemistry</source><year>2011</year><volume>50</volume><fpage>5668</fpage><lpage>5679</lpage><pub-id pub-id-type="doi">10.1021/bi2004922</pub-id><pub-id pub-id-type="pmid">21591693</pub-id></element-citation></ref><ref id="B274-pharmaceutics-14-01837"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meng</surname><given-names>X.</given-names></name>
<name><surname>Fang</surname><given-names>Y.</given-names></name>
<name><surname>Ding</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Jia</surname><given-names>K.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Collemare</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>W.</given-names></name>
</person-group><article-title>Developing fungal heterologous expression platforms to explore and improve the production of natural products from fungal biodiversity</article-title><source>Biotechnol. Adv.</source><year>2022</year><volume>54</volume><fpage>107866</fpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2021.107866</pub-id><pub-id pub-id-type="pmid">34780934</pub-id></element-citation></ref><ref id="B275-pharmaceutics-14-01837"><label>275.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vassaux</surname><given-names>A.</given-names></name>
<name><surname>Meunier</surname><given-names>L.</given-names></name>
<name><surname>Vandenbol</surname><given-names>M.</given-names></name>
<name><surname>Baurain</surname><given-names>D.</given-names></name>
<name><surname>Fickers</surname><given-names>P.</given-names></name>
<name><surname>Jacques</surname><given-names>P.</given-names></name>
<name><surname>Lecl&#x000e8;re</surname><given-names>V.</given-names></name>
</person-group><article-title>Nonribosomal peptides in fungal cell factories: From genome mining to optimized heterologous production</article-title><source>Biotechnol. Adv.</source><year>2019</year><volume>37</volume><fpage>107449</fpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2019.107449</pub-id><pub-id pub-id-type="pmid">31518630</pub-id></element-citation></ref><ref id="B276-pharmaceutics-14-01837"><label>276.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>C.</given-names></name>
<name><surname>Minami</surname><given-names>A.</given-names></name>
<name><surname>Ozaki</surname><given-names>T.</given-names></name>
<name><surname>Wu</surname><given-names>J.</given-names></name>
<name><surname>Kawagishi</surname><given-names>H.</given-names></name>
<name><surname>Maruyama</surname><given-names>J.-i.</given-names></name>
<name><surname>Oikawa</surname><given-names>H.</given-names></name>
</person-group><article-title>Efficient Reconstitution of Basidiomycota Diterpene Erinacine Gene Cluster in Ascomycota Host <italic toggle="yes">Aspergillus oryzae</italic> Based on Genomic DNA Sequences</article-title><source>J. Am. Chem. Soc.</source><year>2019</year><volume>141</volume><fpage>15519</fpage><lpage>15523</lpage><pub-id pub-id-type="doi">10.1021/jacs.9b08935</pub-id><?supplied-pmid 31535864?><pub-id pub-id-type="pmid">31535864</pub-id></element-citation></ref><ref id="B277-pharmaceutics-14-01837"><label>277.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Okorafor</surname><given-names>I.C.</given-names></name>
<name><surname>Chen</surname><given-names>M.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
</person-group><article-title>High-Titer Production of Olivetolic Acid and Analogs in Engineered Fungal Host using a Nonplant Biosynthetic Pathway</article-title><source>ACS Synth. Biol.</source><year>2021</year><volume>10</volume><fpage>2159</fpage><lpage>2166</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.1c00309</pub-id><?supplied-pmid 34415146?><pub-id pub-id-type="pmid">34415146</pub-id></element-citation></ref><ref id="B278-pharmaceutics-14-01837"><label>278.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boecker</surname><given-names>S.</given-names></name>
<name><surname>Gr&#x000e4;tz</surname><given-names>S.</given-names></name>
<name><surname>Kerwat</surname><given-names>D.</given-names></name>
<name><surname>Adam</surname><given-names>L.</given-names></name>
<name><surname>Schirmer</surname><given-names>D.</given-names></name>
<name><surname>Richter</surname><given-names>L.</given-names></name>
<name><surname>Sch&#x000fc;tze</surname><given-names>T.</given-names></name>
<name><surname>Petras</surname><given-names>D.</given-names></name>
<name><surname>S&#x000fc;ssmuth</surname><given-names>R.D.</given-names></name>
<name><surname>Meyer</surname><given-names>V.</given-names></name>
</person-group><article-title><italic toggle="yes">Aspergillus niger</italic> is a superior expression host for the production of bioactive fungal cyclodepsipeptides</article-title><source>Fungal Biol. Biotechnol.</source><year>2018</year><volume>5</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.1186/s40694-018-0048-3</pub-id><pub-id pub-id-type="pmid">29507740</pub-id></element-citation></ref><ref id="B279-pharmaceutics-14-01837"><label>279.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Nielsen</surname><given-names>M.R.</given-names></name>
<name><surname>S&#x000f8;rensen</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Investigating Fungal Biosynthetic Pathways using Heterologous Gene Expression: <italic toggle="yes">Fusarium</italic> sp. as a Heterologous Host</article-title><source>Engineering Natural Product Biosynthesis: Methods and Protocols</source><person-group person-group-type="editor">
<name><surname>Skellam</surname><given-names>E.</given-names></name>
</person-group><publisher-name>Springer</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2022</year><fpage>53</fpage><lpage>74</lpage></element-citation></ref><ref id="B280-pharmaceutics-14-01837"><label>280.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nielsen</surname><given-names>M.R.</given-names></name>
<name><surname>Wollenberg</surname><given-names>R.D.</given-names></name>
<name><surname>Westphal</surname><given-names>K.R.</given-names></name>
<name><surname>Sondergaard</surname><given-names>T.E.</given-names></name>
<name><surname>Wimmer</surname><given-names>R.</given-names></name>
<name><surname>Gardiner</surname><given-names>D.M.</given-names></name>
<name><surname>S&#x000f8;rensen</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Heterologous expression of intact biosynthetic gene clusters in <italic toggle="yes">Fusarium graminearum</italic></article-title><source>Fungal Genet. Biol.</source><year>2019</year><volume>132</volume><fpage>103248</fpage><pub-id pub-id-type="doi">10.1016/j.fgb.2019.103248</pub-id><pub-id pub-id-type="pmid">31279974</pub-id></element-citation></ref><ref id="B281-pharmaceutics-14-01837"><label>281.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kindinger</surname><given-names>F.</given-names></name>
<name><surname>Nies</surname><given-names>J.</given-names></name>
<name><surname>Becker</surname><given-names>A.</given-names></name>
<name><surname>Zhu</surname><given-names>T.</given-names></name>
<name><surname>Li</surname><given-names>S.-M.</given-names></name>
</person-group><article-title>Genomic Locus of a <italic toggle="yes">Penicillium crustosum</italic> Pigment as an Integration Site for Secondary Metabolite Gene Expression</article-title><source>ACS Chem. Biol.</source><year>2019</year><volume>14</volume><fpage>1227</fpage><lpage>1234</lpage><pub-id pub-id-type="doi">10.1021/acschembio.9b00164</pub-id><?supplied-pmid 31141338?><pub-id pub-id-type="pmid">31141338</pub-id></element-citation></ref><ref id="B282-pharmaceutics-14-01837"><label>282.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pohl</surname><given-names>C.</given-names></name>
<name><surname>Polli</surname><given-names>F.</given-names></name>
<name><surname>Sch&#x000fc;tze</surname><given-names>T.</given-names></name>
<name><surname>Viggiano</surname><given-names>A.</given-names></name>
<name><surname>M&#x000f3;zsik</surname><given-names>L.</given-names></name>
<name><surname>Jung</surname><given-names>S.</given-names></name>
<name><surname>de Vries</surname><given-names>M.</given-names></name>
<name><surname>Bovenberg</surname><given-names>R.A.L.</given-names></name>
<name><surname>Meyer</surname><given-names>V.</given-names></name>
<name><surname>Driessen</surname><given-names>A.J.M.</given-names></name>
</person-group><article-title>A Penicillium rubens platform strain for secondary metabolite production</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>7630</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-64893-6</pub-id><pub-id pub-id-type="pmid">32376967</pub-id></element-citation></ref><ref id="B283-pharmaceutics-14-01837"><label>283.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Ye</surname><given-names>R.</given-names></name>
<name><surname>Clevenger</surname><given-names>K.D.</given-names></name>
<name><surname>Mead</surname><given-names>D.</given-names></name>
<name><surname>Wagner</surname><given-names>M.</given-names></name>
<name><surname>Krerowicz</surname><given-names>A.</given-names></name>
<name><surname>Albright</surname><given-names>J.C.</given-names></name>
<name><surname>Goering</surname><given-names>A.W.</given-names></name>
<name><surname>Thomas</surname><given-names>P.M.</given-names></name>
<name><surname>Kelleher</surname><given-names>N.L.</given-names></name>
<etal/>
</person-group><article-title>Fungal artificial chromosomes for mining of the fungal secondary metabolome</article-title><source>BMC Genom.</source><year>2015</year><volume>16</volume><elocation-id>343</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-015-1561-x</pub-id></element-citation></ref><ref id="B284-pharmaceutics-14-01837"><label>284.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clevenger</surname><given-names>K.D.</given-names></name>
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Ye</surname><given-names>R.</given-names></name>
<name><surname>Miley</surname><given-names>G.P.</given-names></name>
<name><surname>Verdan</surname><given-names>M.H.</given-names></name>
<name><surname>Velk</surname><given-names>T.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
<name><surname>Yang</surname><given-names>K.</given-names></name>
<name><surname>Robey</surname><given-names>M.T.</given-names></name>
<name><surname>Gao</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>A scalable platform to identify fungal secondary metabolites and their gene clusters</article-title><source>Nat. Chem. Biol.</source><year>2017</year><volume>13</volume><fpage>895</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2408</pub-id><pub-id pub-id-type="pmid">28604695</pub-id></element-citation></ref><ref id="B285-pharmaceutics-14-01837"><label>285.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harvey</surname><given-names>C.J.B.</given-names></name>
<name><surname>Tang</surname><given-names>M.</given-names></name>
<name><surname>Schlecht</surname><given-names>U.</given-names></name>
<name><surname>Horecka</surname><given-names>J.</given-names></name>
<name><surname>Fischer</surname><given-names>C.R.</given-names></name>
<name><surname>Lin</surname><given-names>H.C.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Naughton</surname><given-names>B.</given-names></name>
<name><surname>Cherry</surname><given-names>J.</given-names></name>
<name><surname>Miranda</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>HEx: A heterologous expression platform for the discovery of fungal natural products</article-title><source>Sci. Adv.</source><year>2018</year><volume>4</volume><fpage>eaar5459</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aar5459</pub-id><pub-id pub-id-type="pmid">29651464</pub-id></element-citation></ref><ref id="B286-pharmaceutics-14-01837"><label>286.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wiemann</surname><given-names>P.</given-names></name>
<name><surname>Soukup</surname><given-names>A.A.</given-names></name>
<name><surname>Folz</surname><given-names>J.S.</given-names></name>
<name><surname>Wang</surname><given-names>P.M.</given-names></name>
<name><surname>Noack</surname><given-names>A.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>CoIN: Co-inducible nitrate expression system for secondary metabolites in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>Fungal Biol. Biotechnol.</source><year>2018</year><volume>5</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1186/s40694-018-0049-2</pub-id><pub-id pub-id-type="pmid">29564145</pub-id></element-citation></ref><ref id="B287-pharmaceutics-14-01837"><label>287.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Robey</surname><given-names>M.T.</given-names></name>
<name><surname>Ye</surname><given-names>R.</given-names></name>
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Clevenger</surname><given-names>K.D.</given-names></name>
<name><surname>Islam</surname><given-names>M.N.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
<name><surname>Gupta</surname><given-names>R.</given-names></name>
<name><surname>Swyers</surname><given-names>M.</given-names></name>
<name><surname>Wu</surname><given-names>E.</given-names></name>
<name><surname>Gao</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Identification of the First Diketomorpholine Biosynthetic Pathway using FAC-MS Technology</article-title><source>ACS Chem. Biol.</source><year>2018</year><volume>13</volume><fpage>1142</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1021/acschembio.8b00024</pub-id><?supplied-pmid 29631395?><pub-id pub-id-type="pmid">29631395</pub-id></element-citation></ref><ref id="B288-pharmaceutics-14-01837"><label>288.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maiya</surname><given-names>S.</given-names></name>
<name><surname>Grundmann</surname><given-names>A.</given-names></name>
<name><surname>Li</surname><given-names>S.-M.</given-names></name>
<name><surname>Turner</surname><given-names>G.</given-names></name>
</person-group><article-title>The Fumitremorgin Gene Cluster of <italic toggle="yes">Aspergillus fumigatus</italic>: Identification of a Gene Encoding Brevianamide F Synthetase</article-title><source>ChemBioChem</source><year>2006</year><volume>7</volume><fpage>1062</fpage><lpage>1069</lpage><pub-id pub-id-type="doi">10.1002/cbic.200600003</pub-id><?supplied-pmid 16755625?><pub-id pub-id-type="pmid">16755625</pub-id></element-citation></ref><ref id="B289-pharmaceutics-14-01837"><label>289.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Itoh</surname><given-names>T.</given-names></name>
<name><surname>Tokunaga</surname><given-names>K.</given-names></name>
<name><surname>Matsuda</surname><given-names>Y.</given-names></name>
<name><surname>Fujii</surname><given-names>I.</given-names></name>
<name><surname>Abe</surname><given-names>I.</given-names></name>
<name><surname>Ebizuka</surname><given-names>Y.</given-names></name>
<name><surname>Kushiro</surname><given-names>T.</given-names></name>
</person-group><article-title>Reconstitution of a fungal meroterpenoid biosynthesis reveals the involvement of a novel family of terpene cyclases</article-title><source>Nat. Chem.</source><year>2010</year><volume>2</volume><fpage>858</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1038/nchem.764</pub-id><?supplied-pmid 20861902?><pub-id pub-id-type="pmid">20861902</pub-id></element-citation></ref><ref id="B290-pharmaceutics-14-01837"><label>290.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>A.</given-names></name>
<name><surname>Fujii</surname><given-names>I.</given-names></name>
<name><surname>Sankawa</surname><given-names>U.</given-names></name>
<name><surname>Mayorga</surname><given-names>M.E.</given-names></name>
<name><surname>Timberlake</surname><given-names>W.E.</given-names></name>
<name><surname>Ebizuka</surname><given-names>Y.</given-names></name>
</person-group><article-title>Re-identification of <italic toggle="yes">Aspergillus nidulans</italic> wA gene to code for a polyketide synthase of naphthopyrone</article-title><source>Tetrahedron Lett.</source><year>1999</year><volume>40</volume><fpage>91</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(98)80027-0</pub-id></element-citation></ref><ref id="B291-pharmaceutics-14-01837"><label>291.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Caesar</surname><given-names>L.K.</given-names></name>
<name><surname>Robey</surname><given-names>M.T.</given-names></name>
<name><surname>Swyers</surname><given-names>M.</given-names></name>
<name><surname>Islam</surname><given-names>M.N.</given-names></name>
<name><surname>Ye</surname><given-names>R.</given-names></name>
<name><surname>Vagadia</surname><given-names>P.P.</given-names></name>
<name><surname>Schiltz</surname><given-names>G.E.</given-names></name>
<name><surname>Thomas</surname><given-names>P.M.</given-names></name>
<name><surname>Wu</surname><given-names>C.C.</given-names></name>
<name><surname>Kelleher</surname><given-names>N.L.</given-names></name>
<etal/>
</person-group><article-title>Heterologous Expression of the Unusual Terreazepine Biosynthetic Gene Cluster Reveals a Promising Approach for Identifying New Chemical Scaffolds</article-title><source>mBio</source><year>2020</year><volume>11</volume><pub-id pub-id-type="doi">10.1128/mBio.01691-20</pub-id></element-citation></ref><ref id="B292-pharmaceutics-14-01837"><label>292.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yuan</surname><given-names>Y.</given-names></name>
<name><surname>Cheng</surname><given-names>S.</given-names></name>
<name><surname>Bian</surname><given-names>G.</given-names></name>
<name><surname>Yan</surname><given-names>P.</given-names></name>
<name><surname>Ma</surname><given-names>Z.</given-names></name>
<name><surname>Dai</surname><given-names>W.</given-names></name>
<name><surname>Chen</surname><given-names>R.</given-names></name>
<name><surname>Fu</surname><given-names>S.</given-names></name>
<name><surname>Huang</surname><given-names>H.</given-names></name>
<name><surname>Chi</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Efficient exploration of terpenoid biosynthetic gene clusters in filamentous fungi</article-title><source>Nat. Catal.</source><year>2022</year><volume>5</volume><fpage>277</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1038/s41929-022-00762-x</pub-id></element-citation></ref><ref id="B293-pharmaceutics-14-01837"><label>293.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bian</surname><given-names>G.</given-names></name>
<name><surname>Hou</surname><given-names>A.</given-names></name>
<name><surname>Yuan</surname><given-names>Y.</given-names></name>
<name><surname>Hu</surname><given-names>B.</given-names></name>
<name><surname>Cheng</surname><given-names>S.</given-names></name>
<name><surname>Ye</surname><given-names>Z.</given-names></name>
<name><surname>Di</surname><given-names>Y.</given-names></name>
<name><surname>Deng</surname><given-names>Z.</given-names></name>
<name><surname>Liu</surname><given-names>T.</given-names></name>
</person-group><article-title>Metabolic Engineering-Based Rapid Characterization of a Sesquiterpene Cyclase and the Skeletons of Fusariumdiene and Fusagramineol from <italic toggle="yes">Fusarium graminearum</italic></article-title><source>Org. Lett.</source><year>2018</year><volume>20</volume><fpage>1626</fpage><lpage>1629</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.8b00366</pub-id><pub-id pub-id-type="pmid">29513542</pub-id></element-citation></ref><ref id="B294-pharmaceutics-14-01837"><label>294.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pedersen</surname><given-names>T.B.</given-names></name>
<name><surname>Nielsen</surname><given-names>M.R.</given-names></name>
<name><surname>Kristensen</surname><given-names>S.B.</given-names></name>
<name><surname>Spedtsberg</surname><given-names>E.M.L.</given-names></name>
<name><surname>Yasmine</surname><given-names>W.</given-names></name>
<name><surname>Matthiesen</surname><given-names>R.</given-names></name>
<name><surname>Kaniki</surname><given-names>S.E.K.</given-names></name>
<name><surname>S&#x000f8;rensen</surname><given-names>T.</given-names></name>
<name><surname>Petersen</surname><given-names>C.</given-names></name>
<name><surname>Muff</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Heterologous Expression of the Core Genes in the Complex Fusarubin Gene Cluster of Fusarium Solani</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>7601</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21207601</pub-id></element-citation></ref><ref id="B295-pharmaceutics-14-01837"><label>295.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tan</surname><given-names>D.</given-names></name>
<name><surname>Jamieson</surname><given-names>C.S.</given-names></name>
<name><surname>Ohashi</surname><given-names>M.</given-names></name>
<name><surname>Tang</surname><given-names>M.C.</given-names></name>
<name><surname>Houk</surname><given-names>K.N.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Genome-Mined Diels-Alderase Catalyzes Formation of the cis-Octahydrodecalins of Varicidin A and B</article-title><source>J. Am. Chem. Soc.</source><year>2019</year><volume>141</volume><fpage>769</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.1021/jacs.8b12010</pub-id><pub-id pub-id-type="pmid">30609896</pub-id></element-citation></ref><ref id="B296-pharmaceutics-14-01837"><label>296.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hoefgen</surname><given-names>S.</given-names></name>
<name><surname>Lin</surname><given-names>J.</given-names></name>
<name><surname>Fricke</surname><given-names>J.</given-names></name>
<name><surname>Stroe</surname><given-names>M.C.</given-names></name>
<name><surname>Mattern</surname><given-names>D.J.</given-names></name>
<name><surname>Kufs</surname><given-names>J.E.</given-names></name>
<name><surname>Hortschansky</surname><given-names>P.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
<name><surname>Hoffmeister</surname><given-names>D.</given-names></name>
<name><surname>Valiante</surname><given-names>V.</given-names></name>
</person-group><article-title>Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi</article-title><source>Metab. Eng.</source><year>2018</year><volume>48</volume><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2018.05.014</pub-id><pub-id pub-id-type="pmid">29842926</pub-id></element-citation></ref><ref id="B297-pharmaceutics-14-01837"><label>297.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yin</surname><given-names>W.B.</given-names></name>
<name><surname>Chooi</surname><given-names>Y.H.</given-names></name>
<name><surname>Smith</surname><given-names>A.R.</given-names></name>
<name><surname>Cacho</surname><given-names>R.A.</given-names></name>
<name><surname>Hu</surname><given-names>Y.</given-names></name>
<name><surname>White</surname><given-names>T.C.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Discovery of cryptic polyketide metabolites from dermatophytes using heterologous expression in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>ACS Synth. Biol.</source><year>2013</year><volume>2</volume><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1021/sb400048b</pub-id><?supplied-pmid 23758576?><pub-id pub-id-type="pmid">23758576</pub-id></element-citation></ref><ref id="B298-pharmaceutics-14-01837"><label>298.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Noll</surname><given-names>M.</given-names></name>
<name><surname>Kornberg</surname><given-names>R.D.</given-names></name>
</person-group><article-title>Action of micrococcal nuclease on chromatin and the location of histone H1</article-title><source>J. Mol. Biol.</source><year>1977</year><volume>109</volume><fpage>393</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(77)80019-3</pub-id><pub-id pub-id-type="pmid">833849</pub-id></element-citation></ref><ref id="B299-pharmaceutics-14-01837"><label>299.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Richmond</surname><given-names>T.J.</given-names></name>
<name><surname>Finch</surname><given-names>J.T.</given-names></name>
<name><surname>Rushton</surname><given-names>B.</given-names></name>
<name><surname>Rhodes</surname><given-names>D.</given-names></name>
<name><surname>Klug</surname><given-names>A.</given-names></name>
</person-group><article-title>Structure of the nucleosome core particle at 7 &#x000c5; resolution</article-title><source>Nature</source><year>1984</year><volume>311</volume><fpage>532</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1038/311532a0</pub-id><?supplied-pmid 6482966?><pub-id pub-id-type="pmid">6482966</pub-id></element-citation></ref><ref id="B300-pharmaceutics-14-01837"><label>300.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Freitag</surname><given-names>M.</given-names></name>
</person-group><article-title>5 Fungal Chromatin and Its Role in Regulation of Gene Expression</article-title><source>Fungal Genomics</source><person-group person-group-type="editor">
<name><surname>Nowrousian</surname><given-names>M.</given-names></name>
</person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2014</year><fpage>99</fpage><lpage>120</lpage></element-citation></ref><ref id="B301-pharmaceutics-14-01837"><label>301.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Buscaino</surname><given-names>A.</given-names></name>
</person-group><article-title>Chromatin-Mediated Regulation of Genome Plasticity in Human Fungal Pathogens</article-title><source>Genes</source><year>2019</year><volume>10</volume><elocation-id>855</elocation-id><pub-id pub-id-type="doi">10.3390/genes10110855</pub-id></element-citation></ref><ref id="B302-pharmaceutics-14-01837"><label>302.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mivelaz</surname><given-names>M.</given-names></name>
<name><surname>Cao</surname><given-names>A.-M.</given-names></name>
<name><surname>Kubik</surname><given-names>S.</given-names></name>
<name><surname>Zencir</surname><given-names>S.</given-names></name>
<name><surname>Hovius</surname><given-names>R.</given-names></name>
<name><surname>Boichenko</surname><given-names>I.</given-names></name>
<name><surname>Stachowicz</surname><given-names>A.M.</given-names></name>
<name><surname>Kurat</surname><given-names>C.F.</given-names></name>
<name><surname>Shore</surname><given-names>D.</given-names></name>
<name><surname>Fierz</surname><given-names>B.</given-names></name>
</person-group><article-title>Chromatin Fiber Invasion and Nucleosome Displacement by the Rap1 Transcription Factor</article-title><source>Mol. Cell</source><year>2020</year><volume>77</volume><fpage>488</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.10.025</pub-id><pub-id pub-id-type="pmid">31761495</pub-id></element-citation></ref><ref id="B303-pharmaceutics-14-01837"><label>303.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zaret</surname><given-names>K.S.</given-names></name>
</person-group><article-title>Pioneer Transcription Factors Initiating Gene Network Changes</article-title><source>Annu. Rev. Genet.</source><year>2020</year><volume>54</volume><fpage>367</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-030220-015007</pub-id><pub-id pub-id-type="pmid">32886547</pub-id></element-citation></ref><ref id="B304-pharmaceutics-14-01837"><label>304.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Allis</surname><given-names>C.D.</given-names></name>
<name><surname>Berger</surname><given-names>S.L.</given-names></name>
<name><surname>Cote</surname><given-names>J.</given-names></name>
<name><surname>Dent</surname><given-names>S.</given-names></name>
<name><surname>Jenuwien</surname><given-names>T.</given-names></name>
<name><surname>Kouzarides</surname><given-names>T.</given-names></name>
<name><surname>Pillus</surname><given-names>L.</given-names></name>
<name><surname>Reinberg</surname><given-names>D.</given-names></name>
<name><surname>Shi</surname><given-names>Y.</given-names></name>
<name><surname>Shiekhattar</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>New Nomenclature for Chromatin-Modifying Enzymes</article-title><source>Cell</source><year>2007</year><volume>131</volume><fpage>633</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.10.039</pub-id><pub-id pub-id-type="pmid">18022353</pub-id></element-citation></ref><ref id="B305-pharmaceutics-14-01837"><label>305.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reyes-Dominguez</surname><given-names>Y.</given-names></name>
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Berger</surname><given-names>H.</given-names></name>
<name><surname>Shwab</surname><given-names>E.K.</given-names></name>
<name><surname>Basheer</surname><given-names>A.</given-names></name>
<name><surname>Gallmetzer</surname><given-names>A.</given-names></name>
<name><surname>Scazzocchio</surname><given-names>C.</given-names></name>
<name><surname>Keller</surname><given-names>N.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
</person-group><article-title>Heterochromatic marks are associated with the repression of secondary metabolism clusters in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>Mol. Microbiol.</source><year>2010</year><volume>76</volume><fpage>1376</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07051.x</pub-id><pub-id pub-id-type="pmid">20132440</pub-id></element-citation></ref><ref id="B306-pharmaceutics-14-01837"><label>306.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tamaru</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>McMillen</surname><given-names>D.</given-names></name>
<name><surname>Singh</surname><given-names>P.B.</given-names></name>
<name><surname>Nakayama</surname><given-names>J.-i.</given-names></name>
<name><surname>Grewal</surname><given-names>S.I.</given-names></name>
<name><surname>Allis</surname><given-names>C.D.</given-names></name>
<name><surname>Cheng</surname><given-names>X.</given-names></name>
<name><surname>Selker</surname><given-names>E.U.</given-names></name>
</person-group><article-title>Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa</article-title><source>Nat. Genet.</source><year>2003</year><volume>34</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1038/ng1143</pub-id><pub-id pub-id-type="pmid">12679815</pub-id></element-citation></ref><ref id="B307-pharmaceutics-14-01837"><label>307.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chujo</surname><given-names>T.</given-names></name>
<name><surname>Scott</surname><given-names>B.</given-names></name>
</person-group><article-title>Histone H3K9 and H3K27 methylation regulates fungal alkaloid biosynthesis in a fungal endophyte&#x02013;plant symbiosis</article-title><source>Mol. Microbiol.</source><year>2014</year><volume>92</volume><fpage>413</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1111/mmi.12567</pub-id><pub-id pub-id-type="pmid">24571357</pub-id></element-citation></ref><ref id="B308-pharmaceutics-14-01837"><label>308.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Atanasoff-Kardjalieff</surname><given-names>A.K.</given-names></name>
<name><surname>L&#x000fc;nne</surname><given-names>F.</given-names></name>
<name><surname>Kalinina</surname><given-names>S.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
<name><surname>Humpf</surname><given-names>H.-U.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
</person-group><article-title>Biosynthesis of Fusapyrone Depends on the H3K9 Methyltransferase, FmKmt1, in <italic toggle="yes">Fusarium mangiferae</italic></article-title><source>Front. Fungal Biol.</source><year>2021</year><volume>2</volume><fpage>671796</fpage><pub-id pub-id-type="doi">10.3389/ffunb.2021.671796</pub-id></element-citation></ref><ref id="B309-pharmaceutics-14-01837"><label>309.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Noberini</surname><given-names>R.</given-names></name>
<name><surname>Bonaldi</surname><given-names>T.</given-names></name>
<name><surname>Collemare</surname><given-names>J.</given-names></name>
<name><surname>Seidl</surname><given-names>M.F.</given-names></name>
</person-group><article-title>The histone code of the fungal genus <italic toggle="yes">Aspergillus</italic> uncovered by evolutionary and proteomic analyses</article-title><source>bioRxiv</source><year>2022</year><pub-id pub-id-type="doi">10.1101/2022.01.28.477868</pub-id></element-citation></ref><ref id="B310-pharmaceutics-14-01837"><label>310.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El&#x000ed;as-Villalobos</surname><given-names>A.</given-names></name>
<name><surname>Barrales</surname><given-names>R.R.</given-names></name>
<name><surname>Ibeas</surname><given-names>J.I.</given-names></name>
</person-group><article-title>Chromatin modification factors in plant pathogenic fungi: Insights from Ustilago maydis</article-title><source>Fungal Genet. Biol.</source><year>2019</year><volume>129</volume><fpage>52</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2019.04.006</pub-id><?supplied-pmid 30980908?><pub-id pub-id-type="pmid">30980908</pub-id></element-citation></ref><ref id="B311-pharmaceutics-14-01837"><label>311.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lachner</surname><given-names>M.</given-names></name>
<name><surname>Sengupta</surname><given-names>R.</given-names></name>
<name><surname>Schotta</surname><given-names>G.</given-names></name>
<name><surname>Jenuwein</surname><given-names>T.</given-names></name>
</person-group><article-title>Trilogies of histone lysine methylation as epigenetic landmarks of the eukaryotic genome</article-title><source>Cold Spring Harb. Symp. Quant. Biol.</source><year>2004</year><volume>69</volume><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1101/sqb.2004.69.209</pub-id><pub-id pub-id-type="pmid">16117651</pub-id></element-citation></ref><ref id="B312-pharmaceutics-14-01837"><label>312.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Connolly</surname><given-names>L.R.</given-names></name>
<name><surname>Smith</surname><given-names>K.M.</given-names></name>
<name><surname>Freitag</surname><given-names>M.</given-names></name>
</person-group><article-title>The <italic toggle="yes">Fusarium graminearum</italic> histone H3 K27 methyltransferase KMT6 regulates development and expression of secondary metabolite gene clusters</article-title><source>PLoS Genet</source><year>2013</year><volume>9</volume><elocation-id>e1003916</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003916</pub-id><pub-id pub-id-type="pmid">24204317</pub-id></element-citation></ref><ref id="B313-pharmaceutics-14-01837"><label>313.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jamieson</surname><given-names>K.</given-names></name>
<name><surname>Rountree</surname><given-names>M.R.</given-names></name>
<name><surname>Lewis</surname><given-names>Z.A.</given-names></name>
<name><surname>Stajich</surname><given-names>J.E.</given-names></name>
<name><surname>Selker</surname><given-names>E.U.</given-names></name>
</person-group><article-title>Regional control of histone H3 lysine 27 methylation in Neurospora</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2013</year><volume>110</volume><fpage>6027</fpage><lpage>6032</lpage><pub-id pub-id-type="doi">10.1073/pnas.1303750110</pub-id><pub-id pub-id-type="pmid">23530226</pub-id></element-citation></ref><ref id="B314-pharmaceutics-14-01837"><label>314.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schwartz</surname><given-names>Y.B.</given-names></name>
<name><surname>Kahn</surname><given-names>T.G.</given-names></name>
<name><surname>Nix</surname><given-names>D.A.</given-names></name>
<name><surname>Li</surname><given-names>X.-Y.</given-names></name>
<name><surname>Bourgon</surname><given-names>R.</given-names></name>
<name><surname>Biggin</surname><given-names>M.</given-names></name>
<name><surname>Pirrotta</surname><given-names>V.</given-names></name>
</person-group><article-title>Genome-wide analysis of Polycomb targets in Drosophila melanogaster</article-title><source>Nat. Genet.</source><year>2006</year><volume>38</volume><fpage>700</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1038/ng1817</pub-id><pub-id pub-id-type="pmid">16732288</pub-id></element-citation></ref><ref id="B315-pharmaceutics-14-01837"><label>315.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>R&#x000f6;sler</surname><given-names>S.M.</given-names></name>
<name><surname>Burkhardt</surname><given-names>I.</given-names></name>
<name><surname>Arndt</surname><given-names>B.</given-names></name>
<name><surname>Freitag</surname><given-names>M.</given-names></name>
<name><surname>Humpf</surname><given-names>H.U.</given-names></name>
<name><surname>Dickschat</surname><given-names>J.S.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Knock-down of the methyltransferase Kmt6 relieves H3K27me3 and results in induction of cryptic and otherwise silent secondary metabolite gene clusters in <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>Environ. Microbiol.</source><year>2016</year><volume>18</volume><fpage>4037</fpage><lpage>4054</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.13427</pub-id><pub-id pub-id-type="pmid">27348741</pub-id></element-citation></ref><ref id="B316-pharmaceutics-14-01837"><label>316.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kramer</surname><given-names>H.M.</given-names></name>
<name><surname>Seidl</surname><given-names>M.F.</given-names></name>
<name><surname>Thomma</surname><given-names>B.</given-names></name>
<name><surname>Cook</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Local Rather than Global H3K27me3 Dynamics Are Associated with Differential Gene Expression in <italic toggle="yes">Verticillium dahliae</italic></article-title><source>mBio</source><year>2022</year><volume>13</volume><fpage>e0356621</fpage><pub-id pub-id-type="doi">10.1128/mbio.03566-21</pub-id></element-citation></ref><ref id="B317-pharmaceutics-14-01837"><label>317.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jamieson</surname><given-names>K.</given-names></name>
<name><surname>McNaught</surname><given-names>K.J.</given-names></name>
<name><surname>Ormsby</surname><given-names>T.</given-names></name>
<name><surname>Leggett</surname><given-names>N.A.</given-names></name>
<name><surname>Honda</surname><given-names>S.</given-names></name>
<name><surname>Selker</surname><given-names>E.U.</given-names></name>
</person-group><article-title>Telomere repeats induce domains of H3K27 methylation in Neurospora</article-title><source>eLife</source><year>2018</year><volume>7</volume><fpage>e31216</fpage><pub-id pub-id-type="doi">10.7554/eLife.31216</pub-id><pub-id pub-id-type="pmid">29297465</pub-id></element-citation></ref><ref id="B318-pharmaceutics-14-01837"><label>318.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Huang</surname><given-names>J.</given-names></name>
<name><surname>Cook</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Histone modification dynamics at H3K27 are associated with altered transcription of in planta induced genes in <italic toggle="yes">Magnaporthe oryzae</italic></article-title><source>PLOS Genet.</source><year>2021</year><volume>17</volume><elocation-id>e1009376</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1009376</pub-id><?supplied-pmid 33534835?><pub-id pub-id-type="pmid">33534835</pub-id></element-citation></ref><ref id="B319-pharmaceutics-14-01837"><label>319.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ngo</surname><given-names>V.</given-names></name>
<name><surname>Chen</surname><given-names>Z.</given-names></name>
<name><surname>Zhang</surname><given-names>K.</given-names></name>
<name><surname>Whitaker</surname><given-names>J.W.</given-names></name>
<name><surname>Wang</surname><given-names>M.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
</person-group><article-title>Epigenomic analysis reveals DNA motifs regulating histone modifications in human and mouse</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2019</year><volume>116</volume><fpage>3668</fpage><lpage>3677</lpage><pub-id pub-id-type="doi">10.1073/pnas.1813565116</pub-id><?supplied-pmid 30755522?><pub-id pub-id-type="pmid">30755522</pub-id></element-citation></ref><ref id="B320-pharmaceutics-14-01837"><label>320.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Demers</surname><given-names>D.H.</given-names></name>
<name><surname>Knestrick</surname><given-names>M.A.</given-names></name>
<name><surname>Fleeman</surname><given-names>R.</given-names></name>
<name><surname>Tawfik</surname><given-names>R.</given-names></name>
<name><surname>Azhari</surname><given-names>A.</given-names></name>
<name><surname>Souza</surname><given-names>A.</given-names></name>
<name><surname>Vesely</surname><given-names>B.</given-names></name>
<name><surname>Netherton</surname><given-names>M.</given-names></name>
<name><surname>Gupta</surname><given-names>R.</given-names></name>
<name><surname>Colon</surname><given-names>B.L.</given-names></name>
<etal/>
</person-group><article-title>Exploitation of Mangrove Endophytic Fungi for Infectious Disease Drug Discovery</article-title><source>Mar. Drugs</source><year>2018</year><volume>16</volume><elocation-id>376</elocation-id><pub-id pub-id-type="doi">10.3390/md16100376</pub-id><?supplied-pmid 30308948?><pub-id pub-id-type="pmid">30308948</pub-id></element-citation></ref><ref id="B321-pharmaceutics-14-01837"><label>321.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aldholmi</surname><given-names>M.</given-names></name>
<name><surname>Wilkinson</surname><given-names>B.</given-names></name>
<name><surname>Ganesan</surname><given-names>A.</given-names></name>
</person-group><article-title>Epigenetic modulation of secondary metabolite profiles in <italic toggle="yes">Aspergillus calidoustus</italic> and <italic toggle="yes">Aspergillus westerdijkiae</italic> through histone deacetylase (HDAC) inhibition by vorinostat</article-title><source>J. Antibiot.</source><year>2020</year><volume>73</volume><fpage>410</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1038/s41429-020-0286-5</pub-id></element-citation></ref><ref id="B322-pharmaceutics-14-01837"><label>322.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zutz</surname><given-names>C.</given-names></name>
<name><surname>Gacek</surname><given-names>A.</given-names></name>
<name><surname>Sulyok</surname><given-names>M.</given-names></name>
<name><surname>Wagner</surname><given-names>M.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
<name><surname>Rychli</surname><given-names>K.</given-names></name>
</person-group><article-title>Small Chemical Chromatin Effectors Alter Secondary Metabolite Production in <italic toggle="yes">Aspergillus clavatus</italic></article-title><source>Toxins</source><year>2013</year><volume>5</volume><fpage>1723</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.3390/toxins5101723</pub-id><pub-id pub-id-type="pmid">24105402</pub-id></element-citation></ref><ref id="B323-pharmaceutics-14-01837"><label>323.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Chiang</surname><given-names>Y.M.</given-names></name>
<name><surname>Szewczyk</surname><given-names>E.</given-names></name>
<name><surname>Reyes-Dominguez</surname><given-names>Y.</given-names></name>
<name><surname>Davidson</surname><given-names>A.D.</given-names></name>
<name><surname>Sanchez</surname><given-names>J.F.</given-names></name>
<name><surname>Lo</surname><given-names>H.C.</given-names></name>
<name><surname>Watanabe</surname><given-names>K.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
<name><surname>Oakley</surname><given-names>B.R.</given-names></name>
<etal/>
</person-group><article-title>Chromatin-level regulation of biosynthetic gene clusters</article-title><source>Nat. Chem. Biol.</source><year>2009</year><volume>5</volume><fpage>462</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1038/nchembio.177</pub-id><pub-id pub-id-type="pmid">19448638</pub-id></element-citation></ref><ref id="B324-pharmaceutics-14-01837"><label>324.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pidroni</surname><given-names>A.</given-names></name>
<name><surname>Faber</surname><given-names>B.</given-names></name>
<name><surname>Brosch</surname><given-names>G.</given-names></name>
<name><surname>Bauer</surname><given-names>I.</given-names></name>
<name><surname>Graessle</surname><given-names>S.</given-names></name>
</person-group><article-title>A Class 1 Histone Deacetylase as Major Regulator of Secondary Metabolite Production in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><fpage>2212</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.02212</pub-id><pub-id pub-id-type="pmid">30283426</pub-id></element-citation></ref><ref id="B325-pharmaceutics-14-01837"><label>325.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Henke</surname><given-names>M.T.</given-names></name>
<name><surname>Soukup</surname><given-names>A.A.</given-names></name>
<name><surname>Goering</surname><given-names>A.W.</given-names></name>
<name><surname>McClure</surname><given-names>R.A.</given-names></name>
<name><surname>Thomson</surname><given-names>R.J.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<name><surname>Kelleher</surname><given-names>N.L.</given-names></name>
</person-group><article-title>New Aspercryptins, Lipopeptide Natural Products, Revealed by HDAC Inhibition in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>ACS Chem. Biol.</source><year>2016</year><volume>11</volume><fpage>2117</fpage><lpage>2123</lpage><pub-id pub-id-type="doi">10.1021/acschembio.6b00398</pub-id><pub-id pub-id-type="pmid">27310134</pub-id></element-citation></ref><ref id="B326-pharmaceutics-14-01837"><label>326.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Albright</surname><given-names>J.C.</given-names></name>
<name><surname>Henke</surname><given-names>M.T.</given-names></name>
<name><surname>Soukup</surname><given-names>A.A.</given-names></name>
<name><surname>McClure</surname><given-names>R.A.</given-names></name>
<name><surname>Thomson</surname><given-names>R.J.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<name><surname>Kelleher</surname><given-names>N.L.</given-names></name>
</person-group><article-title>Large-Scale Metabolomics Reveals a Complex Response of <italic toggle="yes">Aspergillus nidulans</italic> to Epigenetic Perturbation</article-title><source>ACS Chem. Biol.</source><year>2015</year><volume>10</volume><fpage>1535</fpage><lpage>1541</lpage><pub-id pub-id-type="doi">10.1021/acschembio.5b00025</pub-id><pub-id pub-id-type="pmid">25815712</pub-id></element-citation></ref><ref id="B327-pharmaceutics-14-01837"><label>327.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Henrikson</surname><given-names>J.C.</given-names></name>
<name><surname>Hoover</surname><given-names>A.R.</given-names></name>
<name><surname>Joyner</surname><given-names>P.M.</given-names></name>
<name><surname>Cichewicz</surname><given-names>R.H.</given-names></name>
</person-group><article-title>A chemical epigenetics approach for engineering the in situbiosynthesis of a cryptic natural product from <italic toggle="yes">Aspergillus niger</italic></article-title><source>Org. Biomol. Chem.</source><year>2009</year><volume>7</volume><fpage>435</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1039/B819208A</pub-id><pub-id pub-id-type="pmid">19156306</pub-id></element-citation></ref><ref id="B328-pharmaceutics-14-01837"><label>328.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Yu</surname><given-names>D.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Tabudravu</surname><given-names>J.</given-names></name>
<name><surname>Deng</surname><given-names>H.</given-names></name>
<name><surname>Pan</surname><given-names>L.</given-names></name>
</person-group><article-title>Deletion of the epigenetic regulator GcnE in <italic toggle="yes">Aspergillus niger</italic> FGSC A1279 activates the production of multiple polyketide metabolites</article-title><source>Microbiol. Res.</source><year>2018</year><volume>217</volume><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2018.10.004</pub-id><?supplied-pmid 30384904?><pub-id pub-id-type="pmid">30384904</pub-id></element-citation></ref><ref id="B329-pharmaceutics-14-01837"><label>329.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Xia</surname><given-names>Z.</given-names></name>
<name><surname>Tang</surname><given-names>J.</given-names></name>
<name><surname>Wu</surname><given-names>J.</given-names></name>
<name><surname>Tong</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>M.</given-names></name>
<name><surname>Ju</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
</person-group><article-title>Identification and Biological Evaluation of Secondary Metabolites from Marine Derived Fungi-Aspergillus sp. SCSIOW3, Cultivated in the Presence of Epigenetic Modifying Agents</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>1302</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22081302</pub-id><?supplied-pmid 28777319?><pub-id pub-id-type="pmid">28777319</pub-id></element-citation></ref><ref id="B330-pharmaceutics-14-01837"><label>330.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Triastuti</surname><given-names>A.</given-names></name>
<name><surname>Vansteelandt</surname><given-names>M.</given-names></name>
<name><surname>Barakat</surname><given-names>F.</given-names></name>
<name><surname>Trinel</surname><given-names>M.</given-names></name>
<name><surname>Jargeat</surname><given-names>P.</given-names></name>
<name><surname>Fabre</surname><given-names>N.</given-names></name>
<name><surname>Amasifuen Guerra</surname><given-names>C.A.</given-names></name>
<name><surname>Mejia</surname><given-names>K.</given-names></name>
<name><surname>Valentin</surname><given-names>A.</given-names></name>
<name><surname>Haddad</surname><given-names>M.</given-names></name>
</person-group><article-title>How Histone Deacetylase Inhibitors Alter the Secondary Metabolites of Botryosphaeria mamane, an Endophytic Fungus Isolated from Bixa orellana</article-title><source>Chem. Biodivers</source><year>2019</year><volume>16</volume><fpage>e1800485</fpage><pub-id pub-id-type="doi">10.1002/cbdv.201800485</pub-id><?supplied-pmid 30636097?><pub-id pub-id-type="pmid">30636097</pub-id></element-citation></ref><ref id="B331-pharmaceutics-14-01837"><label>331.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mao</surname><given-names>X.-M.</given-names></name>
<name><surname>Xu</surname><given-names>W.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Yin</surname><given-names>W.-B.</given-names></name>
<name><surname>Chooi</surname><given-names>Y.-H.</given-names></name>
<name><surname>Li</surname><given-names>Y.-Q.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
<name><surname>Hu</surname><given-names>Y.</given-names></name>
</person-group><article-title>Epigenetic Genome Mining of an Endophytic Fungus Leads to the Pleiotropic Biosynthesis of Natural Products</article-title><source>Angew. Chem. Int. Ed.</source><year>2015</year><volume>54</volume><fpage>7592</fpage><lpage>7596</lpage><pub-id pub-id-type="doi">10.1002/anie.201502452</pub-id></element-citation></ref><ref id="B332-pharmaceutics-14-01837"><label>332.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adpressa</surname><given-names>D.A.</given-names></name>
<name><surname>Stalheim</surname><given-names>K.J.</given-names></name>
<name><surname>Proteau</surname><given-names>P.J.</given-names></name>
<name><surname>Loesgen</surname><given-names>S.</given-names></name>
</person-group><article-title>Unexpected Biotransformation of the HDAC Inhibitor Vorinostat Yields Aniline-Containing Fungal Metabolites</article-title><source>ACS Chem. Biol.</source><year>2017</year><volume>12</volume><fpage>1842</fpage><lpage>1847</lpage><pub-id pub-id-type="doi">10.1021/acschembio.7b00268</pub-id><pub-id pub-id-type="pmid">28530797</pub-id></element-citation></ref><ref id="B333-pharmaceutics-14-01837"><label>333.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>S.L.</given-names></name>
<name><surname>Zhou</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>H.P.</given-names></name>
<name><surname>Liu</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Sesquiterpenes with diverse skeletons from histone deacetylase inhibitor modified cultures of the basidiomycete <italic toggle="yes">Cyathus stercoreus</italic> (Schwein.) de Toni HFG134</article-title><source>Phytochemistry</source><year>2022</year><volume>195</volume><fpage>113048</fpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2021.113048</pub-id><pub-id pub-id-type="pmid">34890889</pub-id></element-citation></ref><ref id="B334-pharmaceutics-14-01837"><label>334.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chettri</surname><given-names>P.</given-names></name>
<name><surname>Dupont</surname><given-names>P.-Y.</given-names></name>
<name><surname>Bradshaw</surname><given-names>R.E.</given-names></name>
</person-group><article-title>Chromatin-level regulation of the fragmented dothistromin gene cluster in the forest pathogen Dothistroma septosporum</article-title><source>Mol. Microbiol.</source><year>2018</year><volume>107</volume><fpage>508</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1111/mmi.13898</pub-id><pub-id pub-id-type="pmid">29240271</pub-id></element-citation></ref><ref id="B335-pharmaceutics-14-01837"><label>335.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Niehaus</surname><given-names>E.-M.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>von Bargen</surname><given-names>K.W.</given-names></name>
<name><surname>Kummer</surname><given-names>W.</given-names></name>
<name><surname>Humpf</surname><given-names>H.-U.</given-names></name>
<name><surname>Reuter</surname><given-names>G.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Sound of silence: The beauvericin cluster in <italic toggle="yes">Fusarium fujikuroi</italic> is controlled by cluster-specific and global regulators mediated by H3K27 modification</article-title><source>Environ. Microbiol.</source><year>2016</year><volume>18</volume><fpage>4282</fpage><lpage>4302</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.13576</pub-id><pub-id pub-id-type="pmid">27750383</pub-id></element-citation></ref><ref id="B336-pharmaceutics-14-01837"><label>336.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Janevska</surname><given-names>S.</given-names></name>
<name><surname>Baumann</surname><given-names>L.</given-names></name>
<name><surname>Sieber</surname><given-names>C.M.K.</given-names></name>
<name><surname>Munsterkotter</surname><given-names>M.</given-names></name>
<name><surname>Ulrich</surname><given-names>J.</given-names></name>
<name><surname>Kamper</surname><given-names>J.</given-names></name>
<name><surname>Guldener</surname><given-names>U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Elucidation of the Two H3K36me3 Histone Methyltransferases Set2 and Ash1 in <italic toggle="yes">Fusarium fujikuroi</italic> Unravels Their Different Chromosomal Targets and a Major Impact of Ash1 on Genome Stability</article-title><source>Genetics</source><year>2018</year><volume>208</volume><fpage>153</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1534/genetics.117.1119</pub-id><pub-id pub-id-type="pmid">29146582</pub-id></element-citation></ref><ref id="B337-pharmaceutics-14-01837"><label>337.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Janevska</surname><given-names>S.</given-names></name>
<name><surname>G&#x000fc;ldener</surname><given-names>U.</given-names></name>
<name><surname>Sulyok</surname><given-names>M.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
</person-group><article-title>Set1 and Kdm5 are antagonists for H3K4 methylation and regulators of the major conidiation-specific transcription factor gene ABA1 in <italic toggle="yes">Fusarium fujikuroi</italic></article-title><source>Environ. Microbiol.</source><year>2018</year><volume>20</volume><fpage>3343</fpage><lpage>3362</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.14339</pub-id><pub-id pub-id-type="pmid">30047187</pub-id></element-citation></ref><ref id="B338-pharmaceutics-14-01837"><label>338.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adpressa</surname><given-names>D.A.</given-names></name>
<name><surname>Connolly</surname><given-names>L.R.</given-names></name>
<name><surname>Konkel</surname><given-names>Z.M.</given-names></name>
<name><surname>Neuhaus</surname><given-names>G.F.</given-names></name>
<name><surname>Chang</surname><given-names>X.L.</given-names></name>
<name><surname>Pierce</surname><given-names>B.R.</given-names></name>
<name><surname>Smith</surname><given-names>K.M.</given-names></name>
<name><surname>Freitag</surname><given-names>M.</given-names></name>
<name><surname>Loesgen</surname><given-names>S.</given-names></name>
</person-group><article-title>A metabolomics-guided approach to discover <italic toggle="yes">Fusarium graminearum</italic> metabolites after removal of a repressive histone modification</article-title><source>Fungal Genet. Biol.</source><year>2019</year><volume>132</volume><fpage>103256</fpage><pub-id pub-id-type="doi">10.1016/j.fgb.2019.103256</pub-id><?supplied-pmid 31344458?><pub-id pub-id-type="pmid">31344458</pub-id></element-citation></ref><ref id="B339-pharmaceutics-14-01837"><label>339.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gu</surname><given-names>Q.</given-names></name>
<name><surname>Ji</surname><given-names>T.</given-names></name>
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>Huang</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Lu</surname><given-names>X.</given-names></name>
<name><surname>Wu</surname><given-names>L.</given-names></name>
<name><surname>Huo</surname><given-names>R.</given-names></name>
<name><surname>Wu</surname><given-names>H.</given-names></name>
<name><surname>Gao</surname><given-names>X.</given-names></name>
</person-group><article-title>Histone H3 lysine 9 methyltransferase FvDim5 regulates fungal development, pathogenicity and osmotic stress responses in <italic toggle="yes">Fusarium verticillioides</italic></article-title><source>FEMS Microbiol. Lett.</source><year>2017</year><volume>364</volume><pub-id pub-id-type="doi">10.1093/femsle/fnx184</pub-id></element-citation></ref><ref id="B340-pharmaceutics-14-01837"><label>340.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fan</surname><given-names>A.</given-names></name>
<name><surname>Mi</surname><given-names>W.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Zeng</surname><given-names>G.</given-names></name>
<name><surname>Zhang</surname><given-names>P.</given-names></name>
<name><surname>Hu</surname><given-names>Y.</given-names></name>
<name><surname>Fang</surname><given-names>W.</given-names></name>
<name><surname>Yin</surname><given-names>W.B.</given-names></name>
</person-group><article-title>Deletion of a Histone Acetyltransferase Leads to the Pleiotropic Activation of Natural Products in <italic toggle="yes">Metarhizium robertsii</italic></article-title><source>Org. Lett.</source><year>2017</year><volume>19</volume><fpage>1686</fpage><lpage>1689</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.7b00476</pub-id><?supplied-pmid 28301168?><pub-id pub-id-type="pmid">28301168</pub-id></element-citation></ref><ref id="B341-pharmaceutics-14-01837"><label>341.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qadri</surname><given-names>M.</given-names></name>
<name><surname>Nalli</surname><given-names>Y.</given-names></name>
<name><surname>Jain</surname><given-names>S.K.</given-names></name>
<name><surname>Chaubey</surname><given-names>A.</given-names></name>
<name><surname>Ali</surname><given-names>A.</given-names></name>
<name><surname>Strobel</surname><given-names>G.A.</given-names></name>
<name><surname>Vishwakarma</surname><given-names>R.A.</given-names></name>
<name><surname>Riyaz-Ul-Hassan</surname><given-names>S.</given-names></name>
</person-group><article-title>An Insight into the Secondary Metabolism of Muscodor yucatanensis: Small-Molecule Epigenetic Modifiers Induce Expression of Secondary Metabolism-Related Genes and Production of New Metabolites in the Endophyte</article-title><source>Microb. Ecol.</source><year>2017</year><volume>73</volume><fpage>954</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1007/s00248-016-0901-y</pub-id><pub-id pub-id-type="pmid">27924400</pub-id></element-citation></ref><ref id="B342-pharmaceutics-14-01837"><label>342.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ramesha</surname><given-names>K.P.</given-names></name>
<name><surname>Chandra Mohana</surname><given-names>N.</given-names></name>
<name><surname>Chandra Nayaka</surname><given-names>S.</given-names></name>
<name><surname>Satish</surname><given-names>S.</given-names></name>
</person-group><article-title>Epigenetic Modifiers Revamp Secondary Metabolite Production in Endophytic Nigrospora sphaerica</article-title><source>Front. Microbiol.</source><year>2021</year><volume>12</volume><fpage>730355</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.730355</pub-id><pub-id pub-id-type="pmid">34925254</pub-id></element-citation></ref><ref id="B343-pharmaceutics-14-01837"><label>343.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El-Hawary</surname><given-names>S.S.</given-names></name>
<name><surname>Sayed</surname><given-names>A.M.</given-names></name>
<name><surname>Mohammed</surname><given-names>R.</given-names></name>
<name><surname>Hassan</surname><given-names>H.M.</given-names></name>
<name><surname>Zaki</surname><given-names>M.A.</given-names></name>
<name><surname>Rateb</surname><given-names>M.E.</given-names></name>
<name><surname>Mohammed</surname><given-names>T.A.</given-names></name>
<name><surname>Amin</surname><given-names>E.</given-names></name>
<name><surname>Abdelmohsen</surname><given-names>U.R.</given-names></name>
</person-group><article-title>Epigenetic Modifiers Induce Bioactive Phenolic Metabolites in the Marine-Derived Fungus Penicillium brevicompactum</article-title><source>Mar. Drugs</source><year>2018</year><volume>16</volume><elocation-id>253</elocation-id><pub-id pub-id-type="doi">10.3390/md16080253</pub-id><?supplied-pmid 30061488?><pub-id pub-id-type="pmid">30061488</pub-id></element-citation></ref><ref id="B344-pharmaceutics-14-01837"><label>344.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guzman-Chavez</surname><given-names>F.</given-names></name>
<name><surname>Salo</surname><given-names>O.</given-names></name>
<name><surname>Samol</surname><given-names>M.</given-names></name>
<name><surname>Ries</surname><given-names>M.</given-names></name>
<name><surname>Kuipers</surname><given-names>J.</given-names></name>
<name><surname>Bovenberg</surname><given-names>R.A.L.</given-names></name>
<name><surname>Vreeken</surname><given-names>R.J.</given-names></name>
<name><surname>Driessen</surname><given-names>A.J.M.</given-names></name>
</person-group><article-title>Deregulation of secondary metabolism in a histone deacetylase mutant of <italic toggle="yes">Penicillium chrysogenum</italic></article-title><source>MicrobiologyOpen</source><year>2018</year><volume>7</volume><fpage>e00598</fpage><pub-id pub-id-type="doi">10.1002/mbo3.598</pub-id><pub-id pub-id-type="pmid">29575742</pub-id></element-citation></ref><ref id="B345-pharmaceutics-14-01837"><label>345.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gubiani</surname><given-names>J.R.</given-names></name>
<name><surname>Wijeratne</surname><given-names>E.M.K.</given-names></name>
<name><surname>Shi</surname><given-names>T.</given-names></name>
<name><surname>Araujo</surname><given-names>A.R.</given-names></name>
<name><surname>Arnold</surname><given-names>A.E.</given-names></name>
<name><surname>Chapman</surname><given-names>E.</given-names></name>
<name><surname>Gunatilaka</surname><given-names>A.A.L.</given-names></name>
</person-group><article-title>An epigenetic modifier induces production of (10&#x02032;S)-verruculide B, an inhibitor of protein tyrosine phosphatases by <italic toggle="yes">Phoma</italic> sp. nov. LG0217, a fungal endophyte of <italic toggle="yes">Parkinsonia microphylla</italic></article-title><source>Bioorganic Med. Chem.</source><year>2017</year><volume>25</volume><fpage>1860</fpage><lpage>1866</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2017.01.048</pub-id></element-citation></ref><ref id="B346-pharmaceutics-14-01837"><label>346.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>T.</given-names></name>
<name><surname>Shao</surname><given-names>C.L.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Zhao</surname><given-names>D.L.</given-names></name>
<name><surname>Cao</surname><given-names>F.</given-names></name>
<name><surname>Fu</surname><given-names>X.M.</given-names></name>
<name><surname>Yu</surname><given-names>J.Y.</given-names></name>
<name><surname>Wu</surname><given-names>J.S.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.K.</given-names></name>
<name><surname>Wang</surname><given-names>C.Y.</given-names></name>
</person-group><article-title>Terpenoids from the Coral-Derived Fungus Trichoderma harzianum (XS-20090075) Induced by Chemical Epigenetic Manipulation</article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><fpage>572</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.00572</pub-id><pub-id pub-id-type="pmid">32318046</pub-id></element-citation></ref><ref id="B347-pharmaceutics-14-01837"><label>347.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jeon</surname><given-names>J.</given-names></name>
<name><surname>Kwon</surname><given-names>S.</given-names></name>
<name><surname>Lee</surname><given-names>Y.-H.</given-names></name>
</person-group><article-title>Histone acetylation in fungal pathogens of plants</article-title><source>Plant Pathol. J.</source><year>2014</year><volume>30</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.5423/PPJ.RW.01.2014.0003</pub-id><pub-id pub-id-type="pmid">25288980</pub-id></element-citation></ref><ref id="B348-pharmaceutics-14-01837"><label>348.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gacek</surname><given-names>A.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
</person-group><article-title>The chromatin code of fungal secondary metabolite gene clusters</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2012</year><volume>95</volume><fpage>1389</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1007/s00253-012-4208-8</pub-id><?supplied-pmid 22814413?><pub-id pub-id-type="pmid">22814413</pub-id></element-citation></ref><ref id="B349-pharmaceutics-14-01837"><label>349.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lan</surname><given-names>H.</given-names></name>
<name><surname>Wu</surname><given-names>L.</given-names></name>
<name><surname>Sun</surname><given-names>R.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<name><surname>Yang</surname><given-names>K.</given-names></name>
<name><surname>Ye</surname><given-names>L.</given-names></name>
<name><surname>He</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>F.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
</person-group><article-title>The HosA Histone Deacetylase Regulates Aflatoxin Biosynthesis Through Direct Regulation of Aflatoxin Cluster Genes</article-title><source>Mol. Plant-Microbe Interact.</source><year>2019</year><volume>32</volume><fpage>1210</fpage><lpage>1228</lpage><pub-id pub-id-type="doi">10.1094/MPMI-01-19-0033-R</pub-id><?supplied-pmid 30986121?><pub-id pub-id-type="pmid">30986121</pub-id></element-citation></ref><ref id="B350-pharmaceutics-14-01837"><label>350.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shwab</surname><given-names>E.K.</given-names></name>
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Tribus</surname><given-names>M.</given-names></name>
<name><surname>Galehr</surname><given-names>J.</given-names></name>
<name><surname>Graessle</surname><given-names>S.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Histone Deacetylase Activity Regulates Chemical Diversity in <italic toggle="yes">Aspergillus</italic></article-title><source>Eukaryot. Cell</source><year>2007</year><volume>6</volume><fpage>1656</fpage><lpage>1664</lpage><pub-id pub-id-type="doi">10.1128/EC.00186-07</pub-id><?supplied-pmid 17616629?><pub-id pub-id-type="pmid">17616629</pub-id></element-citation></ref><ref id="B351-pharmaceutics-14-01837"><label>351.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Price</surname><given-names>R.J.</given-names></name>
<name><surname>Weindling</surname><given-names>E.</given-names></name>
<name><surname>Berman</surname><given-names>J.</given-names></name>
<name><surname>Buscaino</surname><given-names>A.</given-names></name>
<name><surname>Pietro</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Chromatin Profiling of the Repetitive and Nonrepetitive Genomes of the Human Fungal Pathogen <italic toggle="yes">Candida albicans</italic></article-title><source>mBio</source><year>2019</year><volume>10</volume><fpage>e01376-19</fpage><pub-id pub-id-type="doi">10.1128/mBio.01376-19</pub-id><pub-id pub-id-type="pmid">31337722</pub-id></element-citation></ref><ref id="B352-pharmaceutics-14-01837"><label>352.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ho</surname><given-names>T.C.S.</given-names></name>
<name><surname>Chan</surname><given-names>A.H.Y.</given-names></name>
<name><surname>Ganesan</surname><given-names>A.</given-names></name>
</person-group><article-title>Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight</article-title><source>J. Med. Chem.</source><year>2020</year><volume>63</volume><fpage>12460</fpage><lpage>12484</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c00830</pub-id><pub-id pub-id-type="pmid">32608981</pub-id></element-citation></ref><ref id="B353-pharmaceutics-14-01837"><label>353.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Freitag</surname><given-names>M.</given-names></name>
</person-group><article-title>Histone Methylation by SET Domain Proteins in Fungi</article-title><source>Annu. Rev. Microbiol.</source><year>2017</year><volume>71</volume><fpage>413</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1146/annurev-micro-102215-095757</pub-id><pub-id pub-id-type="pmid">28715960</pub-id></element-citation></ref><ref id="B354-pharmaceutics-14-01837"><label>354.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gacek-Matthews</surname><given-names>A.</given-names></name>
<name><surname>Berger</surname><given-names>H.</given-names></name>
<name><surname>Sasaki</surname><given-names>T.</given-names></name>
<name><surname>Wittstein</surname><given-names>K.</given-names></name>
<name><surname>Gruber</surname><given-names>C.</given-names></name>
<name><surname>Lewis</surname><given-names>Z.A.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
</person-group><article-title>KdmB, a Jumonji Histone H3 Demethylase, Regulates Genome-Wide H3K4 Trimethylation and Is Required for Normal Induction of Secondary Metabolism in <italic toggle="yes">Aspergillus nidulans</italic></article-title><source>PLOS Genet.</source><year>2016</year><volume>12</volume><elocation-id>e1006222</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006222</pub-id><pub-id pub-id-type="pmid">27548260</pub-id></element-citation></ref><ref id="B355-pharmaceutics-14-01837"><label>355.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bachleitner</surname><given-names>S.</given-names></name>
<name><surname>S&#x000f8;rensen</surname><given-names>J.L.</given-names></name>
<name><surname>Gacek-Matthews</surname><given-names>A.</given-names></name>
<name><surname>Sulyok</surname><given-names>M.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
</person-group><article-title>Evidence of a Demethylase-Independent Role for the H3K4-Specific Histone Demethylases in <italic toggle="yes">Aspergillus nidulans</italic> and <italic toggle="yes">Fusarium graminearum</italic> Secondary Metabolism</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>1759</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.01759</pub-id><pub-id pub-id-type="pmid">31456754</pub-id></element-citation></ref><ref id="B356-pharmaceutics-14-01837"><label>356.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>M.A.J.</given-names></name>
<name><surname>Shilatifard</surname><given-names>A.</given-names></name>
</person-group><article-title>Reevaluating the roles of histone-modifying enzymes and their associated chromatin modifications in transcriptional regulation</article-title><source>Nat. Genet.</source><year>2020</year><volume>52</volume><fpage>1271</fpage><lpage>1281</lpage><pub-id pub-id-type="doi">10.1038/s41588-020-00736-4</pub-id><pub-id pub-id-type="pmid">33257899</pub-id></element-citation></ref><ref id="B357-pharmaceutics-14-01837"><label>357.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Giles</surname><given-names>S.S.</given-names></name>
<name><surname>Soukup</surname><given-names>A.A.</given-names></name>
<name><surname>Lauer</surname><given-names>C.</given-names></name>
<name><surname>Shaaban</surname><given-names>M.</given-names></name>
<name><surname>Lin</surname><given-names>A.</given-names></name>
<name><surname>Oakley</surname><given-names>B.R.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.C.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Cryptic <italic toggle="yes">Aspergillus nidulans</italic> Antimicrobials</article-title><source>Appl. Environ. Microbiol.</source><year>2011</year><volume>77</volume><fpage>3669</fpage><lpage>3675</lpage><pub-id pub-id-type="doi">10.1128/AEM.02000-10</pub-id><pub-id pub-id-type="pmid">21478304</pub-id></element-citation></ref><ref id="B358-pharmaceutics-14-01837"><label>358.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krogan</surname><given-names>N.J.</given-names></name>
<name><surname>Dover</surname><given-names>J.</given-names></name>
<name><surname>Khorrami</surname><given-names>S.</given-names></name>
<name><surname>Greenblatt</surname><given-names>J.F.</given-names></name>
<name><surname>Schneider</surname><given-names>J.</given-names></name>
<name><surname>Johnston</surname><given-names>M.</given-names></name>
<name><surname>Shilatifard</surname><given-names>A.</given-names></name>
</person-group><article-title>COMPASS, a histone H3 (Lysine 4) methyltransferase required for telomeric silencing of gene expression</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>10753</fpage><lpage>10755</lpage><pub-id pub-id-type="doi">10.1074/jbc.C200023200</pub-id><pub-id pub-id-type="pmid">11805083</pub-id></element-citation></ref><ref id="B359-pharmaceutics-14-01837"><label>359.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Palmer</surname><given-names>J.M.</given-names></name>
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Lee</surname><given-names>S.</given-names></name>
<name><surname>Dagenais</surname><given-names>T.R.T.</given-names></name>
<name><surname>Andes</surname><given-names>D.R.</given-names></name>
<name><surname>Kontoyiannis</surname><given-names>D.P.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Loss of CclA, required for histone 3 lysine 4 methylation, decreases growth but increases secondary metabolite production in <italic toggle="yes">Aspergillus fumigatus</italic></article-title><source>PeerJ</source><year>2013</year><volume>1</volume><fpage>e4</fpage><pub-id pub-id-type="doi">10.7717/peerj.4</pub-id><pub-id pub-id-type="pmid">23638376</pub-id></element-citation></ref><ref id="B360-pharmaceutics-14-01837"><label>360.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>Janevska</surname><given-names>S.</given-names></name>
<name><surname>Arndt</surname><given-names>B.</given-names></name>
<name><surname>Boedi</surname><given-names>S.</given-names></name>
<name><surname>Sulyok</surname><given-names>M.</given-names></name>
<name><surname>Humpf</surname><given-names>H.-U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
</person-group><article-title>Lack of the COMPASS Component Ccl1 Reduces H3K4 Trimethylation Levels and Affects Transcription of Secondary Metabolite Genes in Two Plant&#x02013;Pathogenic Fusarium Species</article-title><source>Front. Microbiol.</source><year>2017</year><volume>7</volume><fpage>2144</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2016.02144</pub-id><?supplied-pmid 28119673?><pub-id pub-id-type="pmid">28119673</pub-id></element-citation></ref><ref id="B361-pharmaceutics-14-01837"><label>361.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soukup</surname><given-names>A.A.</given-names></name>
<name><surname>Chiang</surname><given-names>Y.-M.</given-names></name>
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Reyes-Dominguez</surname><given-names>Y.</given-names></name>
<name><surname>Oakley</surname><given-names>B.R.</given-names></name>
<name><surname>Wang</surname><given-names>C.C.C.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
</person-group><article-title>Overexpression of the <italic toggle="yes">Aspergillus nidulans</italic> histone 4 acetyltransferase EsaA increases activation of secondary metabolite production</article-title><source>Mol. Microbiol.</source><year>2012</year><volume>86</volume><fpage>314</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2012.08195.x</pub-id><?supplied-pmid 22882998?><pub-id pub-id-type="pmid">22882998</pub-id></element-citation></ref><ref id="B362-pharmaceutics-14-01837"><label>362.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Roze</surname><given-names>L.V.</given-names></name>
<name><surname>Arthur</surname><given-names>A.E.</given-names></name>
<name><surname>Hong</surname><given-names>S.Y.</given-names></name>
<name><surname>Chanda</surname><given-names>A.</given-names></name>
<name><surname>Linz</surname><given-names>J.E.</given-names></name>
</person-group><article-title>The initiation and pattern of spread of histone H4 acetylation parallel the order of transcriptional activation of genes in the aflatoxin cluster</article-title><source>Mol. Microbiol.</source><year>2007</year><volume>66</volume><fpage>713</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.05952.x</pub-id><pub-id pub-id-type="pmid">17919289</pub-id></element-citation></ref><ref id="B363-pharmaceutics-14-01837"><label>363.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Niehaus</surname><given-names>E.-M.</given-names></name>
<name><surname>Kleigrewe</surname><given-names>K.</given-names></name>
<name><surname>Wiemann</surname><given-names>P.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>Sieber</surname><given-names>C.M.K.</given-names></name>
<name><surname>Connolly</surname><given-names>L.R.</given-names></name>
<name><surname>Freitag</surname><given-names>M.</given-names></name>
<name><surname>G&#x000fc;ldener</surname><given-names>U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
<name><surname>Humpf</surname><given-names>H.-U.</given-names></name>
</person-group><article-title>Genetic Manipulation of the <italic toggle="yes">Fusarium fujikuroi</italic> Fusarin Gene Cluster Yields Insight into the Complex Regulation and Fusarin Biosynthetic Pathway</article-title><source>Chem. Biol.</source><year>2013</year><volume>20</volume><fpage>1055</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2013.07.004</pub-id><?supplied-pmid 23932525?><pub-id pub-id-type="pmid">23932525</pub-id></element-citation></ref><ref id="B364-pharmaceutics-14-01837"><label>364.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Studt</surname><given-names>L.</given-names></name>
<name><surname>Schmidt</surname><given-names>F.J.</given-names></name>
<name><surname>Jahn</surname><given-names>L.</given-names></name>
<name><surname>Sieber</surname><given-names>C.M.K.</given-names></name>
<name><surname>Connolly</surname><given-names>L.R.</given-names></name>
<name><surname>Niehaus</surname><given-names>E.-M.</given-names></name>
<name><surname>Freitag</surname><given-names>M.</given-names></name>
<name><surname>Humpf</surname><given-names>H.-U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>Two Histone Deacetylases, FfHda1 and FfHda2, Are Important for <italic toggle="yes">Fusarium fujikuroi</italic> Secondary Metabolism and Virulence</article-title><source>Appl. Environ. Microbiol.</source><year>2013</year><volume>79</volume><fpage>7719</fpage><lpage>7734</lpage><pub-id pub-id-type="doi">10.1128/AEM.01557-13</pub-id><pub-id pub-id-type="pmid">24096420</pub-id></element-citation></ref><ref id="B365-pharmaceutics-14-01837"><label>365.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kong</surname><given-names>X.</given-names></name>
<name><surname>van Diepeningen</surname><given-names>A.D.</given-names></name>
<name><surname>van der Lee</surname><given-names>T.A.J.</given-names></name>
<name><surname>Waalwijk</surname><given-names>C.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>W.</given-names></name>
<name><surname>Feng</surname><given-names>J.</given-names></name>
</person-group><article-title>The <italic toggle="yes">Fusarium graminearum</italic> Histone Acetyltransferases Are Important for Morphogenesis, DON Biosynthesis, and Pathogenicity</article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><fpage>654</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.00654</pub-id><pub-id pub-id-type="pmid">29755419</pub-id></element-citation></ref><ref id="B366-pharmaceutics-14-01837"><label>366.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>R&#x000f6;sler</surname><given-names>S.M.</given-names></name>
<name><surname>Kramer</surname><given-names>K.</given-names></name>
<name><surname>Finkemeier</surname><given-names>I.</given-names></name>
<name><surname>Humpf</surname><given-names>H.-U.</given-names></name>
<name><surname>Tudzynski</surname><given-names>B.</given-names></name>
</person-group><article-title>The SAGA complex in the rice pathogen <italic toggle="yes">Fusarium fujikuroi</italic>: Structure and functional characterization</article-title><source>Mol. Microbiol.</source><year>2016</year><volume>102</volume><fpage>951</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1111/mmi.13528</pub-id><pub-id pub-id-type="pmid">27642009</pub-id></element-citation></ref><ref id="B367-pharmaceutics-14-01837"><label>367.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fischer</surname><given-names>J.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>S.Y.</given-names></name>
<name><surname>Netzker</surname><given-names>T.</given-names></name>
<name><surname>J&#x000e4;ger</surname><given-names>N.</given-names></name>
<name><surname>Gacek-Matthews</surname><given-names>A.</given-names></name>
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>Stroe</surname><given-names>M.C.</given-names></name>
<name><surname>Garc&#x000ed;a-Altares</surname><given-names>M.</given-names></name>
<name><surname>Pezzini</surname><given-names>F.</given-names></name>
<name><surname>Schoeler</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Chromatin mapping identifies BasR, a key regulator of bacteria-triggered production of fungal secondary metabolites</article-title><source>eLife</source><year>2018</year><volume>7</volume><fpage>e40969</fpage><pub-id pub-id-type="doi">10.7554/eLife.40969</pub-id><pub-id pub-id-type="pmid">30311911</pub-id></element-citation></ref><ref id="B368-pharmaceutics-14-01837"><label>368.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>N&#x000fc;tzmann</surname><given-names>H.-W.</given-names></name>
<name><surname>Reyes-Dominguez</surname><given-names>Y.</given-names></name>
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>Schroeckh</surname><given-names>V.</given-names></name>
<name><surname>Horn</surname><given-names>F.</given-names></name>
<name><surname>Gacek</surname><given-names>A.</given-names></name>
<name><surname>Sch&#x000fc;mann</surname><given-names>J.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
</person-group><article-title>Bacteria-induced natural product formation in the fungus <italic toggle="yes">Aspergillus nidulans</italic> requires Saga/Ada-mediated histone acetylation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>14282</fpage><lpage>14287</lpage><pub-id pub-id-type="doi">10.1073/pnas.1103523108</pub-id><?supplied-pmid 21825172?><pub-id pub-id-type="pmid">21825172</pub-id></element-citation></ref><ref id="B369-pharmaceutics-14-01837"><label>369.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Atanasoff-Kardjalieff</surname><given-names>A.K.</given-names></name>
<name><surname>Studt</surname><given-names>L.</given-names></name>
</person-group><article-title>Secondary Metabolite Gene Regulation in Mycotoxigenic Fusarium Species: A Focus on Chromatin</article-title><source>Toxins</source><year>2022</year><volume>14</volume><elocation-id>96</elocation-id><pub-id pub-id-type="doi">10.3390/toxins14020096</pub-id><pub-id pub-id-type="pmid">35202124</pub-id></element-citation></ref><ref id="B370-pharmaceutics-14-01837"><label>370.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>R.</given-names></name>
<name><surname>Wen</surname><given-names>M.</given-names></name>
<name><surname>Wu</surname><given-names>L.</given-names></name>
<name><surname>Lan</surname><given-names>H.</given-names></name>
<name><surname>Yuan</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
</person-group><article-title>The Fungi-specific histone Acetyltransferase Rtt109 mediates morphogenesis, Aflatoxin synthesis and pathogenicity in <italic toggle="yes">Aspergillus flavus</italic> by acetylating H3K9</article-title><source>IMA Fungus</source><year>2021</year><volume>12</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1186/s43008-021-00060-4</pub-id><?supplied-pmid 33823938?><pub-id pub-id-type="pmid">33823938</pub-id></element-citation></ref><ref id="B371-pharmaceutics-14-01837"><label>371.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferraro</surname><given-names>A.R.</given-names></name>
<name><surname>Ameri</surname><given-names>A.J.</given-names></name>
<name><surname>Lu</surname><given-names>Z.</given-names></name>
<name><surname>Kamei</surname><given-names>M.</given-names></name>
<name><surname>Schmitz</surname><given-names>R.J.</given-names></name>
<name><surname>Lewis</surname><given-names>Z.A.</given-names></name>
</person-group><article-title>Chromatin accessibility profiling in Neurospora crassa reveals molecular features associated with accessible and inaccessible chromatin</article-title><source>BMC Genom.</source><year>2021</year><volume>22</volume><elocation-id>459</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-021-07774-0</pub-id><?supplied-pmid 34147068?><pub-id pub-id-type="pmid">34147068</pub-id></element-citation></ref><ref id="B372-pharmaceutics-14-01837"><label>372.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>W.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Gao</surname><given-names>D.</given-names></name>
<name><surname>King</surname><given-names>J.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Liang</surname><given-names>F.S.</given-names></name>
</person-group><article-title>Investigating crosstalk between H3K27 acetylation and H3K4 trimethylation in CRISPR/dCas-based epigenome editing and gene activation</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><fpage>15912</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-95398-5</pub-id><pub-id pub-id-type="pmid">34354157</pub-id></element-citation></ref><ref id="B373-pharmaceutics-14-01837"><label>373.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nai</surname><given-names>Y.-S.</given-names></name>
<name><surname>Huang</surname><given-names>Y.-C.</given-names></name>
<name><surname>Yen</surname><given-names>M.-R.</given-names></name>
<name><surname>Chen</surname><given-names>P.-Y.</given-names></name>
</person-group><article-title>Diversity of Fungal DNA Methyltransferases and Their Association with DNA Methylation Patterns</article-title><source>Front. Microbiol.</source><year>2021</year><volume>11</volume><fpage>616922</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.616922</pub-id><pub-id pub-id-type="pmid">33552027</pub-id></element-citation></ref><ref id="B374-pharmaceutics-14-01837"><label>374.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pillay</surname><given-names>L.C.</given-names></name>
<name><surname>Nekati</surname><given-names>L.</given-names></name>
<name><surname>Makhwitine</surname><given-names>P.J.</given-names></name>
<name><surname>Ndlovu</surname><given-names>S.I.</given-names></name>
</person-group><article-title>Epigenetic Activation of Silent Biosynthetic Gene Clusters in Endophytic Fungi using Small Molecular Modifiers</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><fpage>815008</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2022.815008</pub-id><pub-id pub-id-type="pmid">35237247</pub-id></element-citation></ref><ref id="B375-pharmaceutics-14-01837"><label>375.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Basenko</surname><given-names>E.Y.</given-names></name>
<name><surname>Sasaki</surname><given-names>T.</given-names></name>
<name><surname>Ji</surname><given-names>L.</given-names></name>
<name><surname>Prybol</surname><given-names>C.J.</given-names></name>
<name><surname>Burckhardt</surname><given-names>R.M.</given-names></name>
<name><surname>Schmitz</surname><given-names>R.J.</given-names></name>
<name><surname>Lewis</surname><given-names>Z.A.</given-names></name>
</person-group><article-title>Genome-wide redistribution of H3K27me3 is linked to genotoxic stress and defective growth</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2015</year><volume>112</volume><fpage>E6339</fpage><lpage>E6348</lpage><pub-id pub-id-type="doi">10.1073/pnas.1511377112</pub-id><pub-id pub-id-type="pmid">26578794</pub-id></element-citation></ref><ref id="B376-pharmaceutics-14-01837"><label>376.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Freitag</surname><given-names>M.</given-names></name>
<name><surname>Hickey</surname><given-names>P.C.</given-names></name>
<name><surname>Khlafallah</surname><given-names>T.K.</given-names></name>
<name><surname>Read</surname><given-names>N.D.</given-names></name>
<name><surname>Selker</surname><given-names>E.U.</given-names></name>
</person-group><article-title>HP1 is essential for DNA methylation in neurospora</article-title><source>Mol. Cell</source><year>2004</year><volume>13</volume><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(04)00024-3</pub-id><pub-id pub-id-type="pmid">14967149</pub-id></element-citation></ref><ref id="B377-pharmaceutics-14-01837"><label>377.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.</given-names></name>
<name><surname>Cheng</surname><given-names>J.</given-names></name>
<name><surname>Xie</surname><given-names>J.</given-names></name>
<name><surname>Fu</surname><given-names>Y.</given-names></name>
<name><surname>Jiang</surname><given-names>D.</given-names></name>
<name><surname>Chen</surname><given-names>T.</given-names></name>
</person-group><article-title>Histone H3 Lysine 9 Methyltransferase DIM5 Is Required for the Development and Virulence of Botrytis cinerea</article-title><source>Front. Microbiol.</source><year>2016</year><volume>7</volume><fpage>1289</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2016.01289</pub-id><pub-id pub-id-type="pmid">27597848</pub-id></element-citation></ref><ref id="B378-pharmaceutics-14-01837"><label>378.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Djoumbou-Feunang</surname><given-names>Y.</given-names></name>
<name><surname>Fiamoncini</surname><given-names>J.</given-names></name>
<name><surname>Gil-de-la-Fuente</surname><given-names>A.</given-names></name>
<name><surname>Greiner</surname><given-names>R.</given-names></name>
<name><surname>Manach</surname><given-names>C.</given-names></name>
<name><surname>Wishart</surname><given-names>D.S.</given-names></name>
</person-group><article-title>BioTransformer: A comprehensive computational tool for small molecule metabolism prediction and metabolite identification</article-title><source>J. Cheminform.</source><year>2019</year><volume>11</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.1186/s13321-018-0324-5</pub-id><?supplied-pmid 30612223?><pub-id pub-id-type="pmid">30612223</pub-id></element-citation></ref><ref id="B379-pharmaceutics-14-01837"><label>379.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barrangou</surname><given-names>R.</given-names></name>
<name><surname>Fremaux</surname><given-names>C.</given-names></name>
<name><surname>Deveau</surname><given-names>H.</given-names></name>
<name><surname>Richards</surname><given-names>M.</given-names></name>
<name><surname>Boyaval</surname><given-names>P.</given-names></name>
<name><surname>Moineau</surname><given-names>S.</given-names></name>
<name><surname>Romero</surname><given-names>D.A.</given-names></name>
<name><surname>Horvath</surname><given-names>P.</given-names></name>
</person-group><article-title>CRISPR provides acquired resistance against viruses in prokaryotes</article-title><source>Science</source><year>2007</year><volume>315</volume><fpage>1709</fpage><lpage>1712</lpage><pub-id pub-id-type="doi">10.1126/science.1138140</pub-id><?supplied-pmid 17379808?><pub-id pub-id-type="pmid">17379808</pub-id></element-citation></ref><ref id="B380-pharmaceutics-14-01837"><label>380.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Makarova</surname><given-names>K.S.</given-names></name>
<name><surname>Wolf</surname><given-names>Y.I.</given-names></name>
<name><surname>Iranzo</surname><given-names>J.</given-names></name>
<name><surname>Shmakov</surname><given-names>S.A.</given-names></name>
<name><surname>Alkhnbashi</surname><given-names>O.S.</given-names></name>
<name><surname>Brouns</surname><given-names>S.J.J.</given-names></name>
<name><surname>Charpentier</surname><given-names>E.</given-names></name>
<name><surname>Cheng</surname><given-names>D.</given-names></name>
<name><surname>Haft</surname><given-names>D.H.</given-names></name>
<name><surname>Horvath</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Evolutionary classification of CRISPR&#x02013;Cas systems: A burst of class 2 and derived variants</article-title><source>Nat. Rev. Microbiol.</source><year>2020</year><volume>18</volume><fpage>67</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/s41579-019-0299-x</pub-id><?supplied-pmid 31857715?><pub-id pub-id-type="pmid">31857715</pub-id></element-citation></ref><ref id="B381-pharmaceutics-14-01837"><label>381.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ouedraogo</surname><given-names>J.-P.</given-names></name>
<name><surname>Tsang</surname><given-names>A.</given-names></name>
</person-group><article-title>CRISPR_Cas systems for fungal research</article-title><source>Fungal Biol. Rev.</source><year>2020</year><volume>34</volume><fpage>189</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/j.fbr.2020.10.002</pub-id></element-citation></ref><ref id="B382-pharmaceutics-14-01837"><label>382.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>C.</given-names></name>
<name><surname>Lv</surname><given-names>G.</given-names></name>
<name><surname>Tu</surname><given-names>Y.</given-names></name>
<name><surname>Cheng</surname><given-names>X.</given-names></name>
<name><surname>Duan</surname><given-names>Y.</given-names></name>
<name><surname>Zeng</surname><given-names>B.</given-names></name>
<name><surname>He</surname><given-names>B.</given-names></name>
</person-group><article-title>Applications of CRISPR/Cas9 in the Synthesis of Secondary Metabolites in Filamentous Fungi</article-title><source>Front. Microbiol.</source><year>2021</year><volume>12</volume><fpage>638096</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.638096</pub-id><pub-id pub-id-type="pmid">33643273</pub-id></element-citation></ref><ref id="B383-pharmaceutics-14-01837"><label>383.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chavez</surname><given-names>A.</given-names></name>
<name><surname>Tuttle</surname><given-names>M.</given-names></name>
<name><surname>Pruitt</surname><given-names>B.W.</given-names></name>
<name><surname>Ewen-Campen</surname><given-names>B.</given-names></name>
<name><surname>Chari</surname><given-names>R.</given-names></name>
<name><surname>Ter-Ovanesyan</surname><given-names>D.</given-names></name>
<name><surname>Haque</surname><given-names>S.J.</given-names></name>
<name><surname>Cecchi</surname><given-names>R.J.</given-names></name>
<name><surname>Kowal</surname><given-names>E.J.K.</given-names></name>
<name><surname>Buchthal</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Comparison of Cas9 activators in multiple species</article-title><source>Nat. Methods</source><year>2016</year><volume>13</volume><fpage>563</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3871</pub-id><pub-id pub-id-type="pmid">27214048</pub-id></element-citation></ref><ref id="B384-pharmaceutics-14-01837"><label>384.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wensing</surname><given-names>L.</given-names></name>
<name><surname>Sharma</surname><given-names>J.</given-names></name>
<name><surname>Uthayakumar</surname><given-names>D.</given-names></name>
<name><surname>Proteau</surname><given-names>Y.</given-names></name>
<name><surname>Chavez</surname><given-names>A.</given-names></name>
<name><surname>Shapiro</surname><given-names>R.S.</given-names></name>
</person-group><article-title>A CRISPR Interference Platform for Efficient Genetic Repression in <italic toggle="yes">Candida albicans</italic></article-title><source>mSphere</source><year>2019</year><volume>4</volume><pub-id pub-id-type="doi">10.1128/mSphere.00002-19</pub-id></element-citation></ref><ref id="B385-pharmaceutics-14-01837"><label>385.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wensing</surname><given-names>L.</given-names></name>
<name><surname>Shapiro</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Design and Generation of a CRISPR Interference System for Genetic Repression and Essential Gene Analysis in the Fungal Pathogen <italic toggle="yes">Candida albicans</italic></article-title><source>Methods Mol. Biol.</source><year>2022</year><volume>2377</volume><fpage>69</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-1720-5_4</pub-id><pub-id pub-id-type="pmid">34709611</pub-id></element-citation></ref><ref id="B386-pharmaceutics-14-01837"><label>386.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schmidtmann</surname><given-names>E.</given-names></name>
<name><surname>Anton</surname><given-names>T.</given-names></name>
<name><surname>Rombaut</surname><given-names>P.</given-names></name>
<name><surname>Herzog</surname><given-names>F.</given-names></name>
<name><surname>Leonhardt</surname><given-names>H.</given-names></name>
</person-group><article-title>Determination of local chromatin composition by CasID</article-title><source>Nucleus</source><year>2016</year><volume>7</volume><fpage>476</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1080/19491034.2016.1239000</pub-id><pub-id pub-id-type="pmid">27676121</pub-id></element-citation></ref><ref id="B387-pharmaceutics-14-01837"><label>387.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jinek</surname><given-names>M.</given-names></name>
<name><surname>Chylinski</surname><given-names>K.</given-names></name>
<name><surname>Fonfara</surname><given-names>I.</given-names></name>
<name><surname>Hauer</surname><given-names>M.</given-names></name>
<name><surname>Doudna</surname><given-names>J.A.</given-names></name>
<name><surname>Charpentier</surname><given-names>E.</given-names></name>
</person-group><article-title>A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity</article-title><source>Science</source><year>2012</year><volume>337</volume><fpage>816</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1126/science.1225829</pub-id><pub-id pub-id-type="pmid">22745249</pub-id></element-citation></ref><ref id="B388-pharmaceutics-14-01837"><label>388.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>N&#x000f8;dvig</surname><given-names>C.S.</given-names></name>
<name><surname>Nielsen</surname><given-names>J.B.</given-names></name>
<name><surname>Kogle</surname><given-names>M.E.</given-names></name>
<name><surname>Mortensen</surname><given-names>U.H.</given-names></name>
</person-group><article-title>A CRISPR-Cas9 System for Genetic Engineering of Filamentous Fungi</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0133085</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0133085</pub-id><?supplied-pmid 26177455?><pub-id pub-id-type="pmid">26177455</pub-id></element-citation></ref><ref id="B389-pharmaceutics-14-01837"><label>389.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>N&#x000f8;dvig</surname><given-names>C.S.</given-names></name>
<name><surname>Hoof</surname><given-names>J.B.</given-names></name>
<name><surname>Kogle</surname><given-names>M.E.</given-names></name>
<name><surname>Jarczynska</surname><given-names>Z.D.</given-names></name>
<name><surname>Lehmbeck</surname><given-names>J.</given-names></name>
<name><surname>Klitgaard</surname><given-names>D.K.</given-names></name>
<name><surname>Mortensen</surname><given-names>U.H.</given-names></name>
</person-group><article-title>Efficient oligo nucleotide mediated CRISPR-Cas9 gene editing in Aspergilli</article-title><source>Fungal Genet. Biol.</source><year>2018</year><volume>115</volume><fpage>78</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2018.01.004</pub-id><?supplied-pmid 29325827?><pub-id pub-id-type="pmid">29325827</pub-id></element-citation></ref><ref id="B390-pharmaceutics-14-01837"><label>390.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verwaal</surname><given-names>R.</given-names></name>
<name><surname>Buiting-Wiessenhaan</surname><given-names>N.</given-names></name>
<name><surname>Dalhuijsen</surname><given-names>S.</given-names></name>
<name><surname>Roubos</surname><given-names>J.A.</given-names></name>
</person-group><article-title>CRISPR/Cpf1 enables fast and simple genome editing of Saccharomyces cerevisiae</article-title><source>Yeast</source><year>2018</year><volume>35</volume><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1002/yea.3278</pub-id><pub-id pub-id-type="pmid">28886218</pub-id></element-citation></ref><ref id="B391-pharmaceutics-14-01837"><label>391.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fonfara</surname><given-names>I.</given-names></name>
<name><surname>Richter</surname><given-names>H.</given-names></name>
<name><surname>Bratovi&#x0010d;</surname><given-names>M.</given-names></name>
<name><surname>Le Rhun</surname><given-names>A.</given-names></name>
<name><surname>Charpentier</surname><given-names>E.</given-names></name>
</person-group><article-title>The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA</article-title><source>Nature</source><year>2016</year><volume>532</volume><fpage>517</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1038/nature17945</pub-id><?supplied-pmid 27096362?><pub-id pub-id-type="pmid">27096362</pub-id></element-citation></ref><ref id="B392-pharmaceutics-14-01837"><label>392.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zetsche</surname><given-names>B.</given-names></name>
<name><surname>Heidenreich</surname><given-names>M.</given-names></name>
<name><surname>Mohanraju</surname><given-names>P.</given-names></name>
<name><surname>Fedorova</surname><given-names>I.</given-names></name>
<name><surname>Kneppers</surname><given-names>J.</given-names></name>
<name><surname>DeGennaro</surname><given-names>E.M.</given-names></name>
<name><surname>Winblad</surname><given-names>N.</given-names></name>
<name><surname>Choudhury</surname><given-names>S.R.</given-names></name>
<name><surname>Abudayyeh</surname><given-names>O.O.</given-names></name>
<name><surname>Gootenberg</surname><given-names>J.S.</given-names></name>
<etal/>
</person-group><article-title>Multiplex gene editing by CRISPR&#x02013;Cpf1 using a single crRNA array</article-title><source>Nat. Biotechnol.</source><year>2017</year><volume>35</volume><fpage>31</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1038/nbt.3737</pub-id><pub-id pub-id-type="pmid">27918548</pub-id></element-citation></ref><ref id="B393-pharmaceutics-14-01837"><label>393.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bandyopadhyay</surname><given-names>A.</given-names></name>
<name><surname>Kancharla</surname><given-names>N.</given-names></name>
<name><surname>Javalkote</surname><given-names>V.S.</given-names></name>
<name><surname>Dasgupta</surname><given-names>S.</given-names></name>
<name><surname>Brutnell</surname><given-names>T.P.</given-names></name>
</person-group><article-title>CRISPR-Cas12a (Cpf1): A Versatile Tool in the Plant Genome Editing Tool Box for Agricultural Advancement</article-title><source>Front. Plant Sci.</source><year>2020</year><volume>11</volume><fpage>584151</fpage><pub-id pub-id-type="doi">10.3389/fpls.2020.584151</pub-id><pub-id pub-id-type="pmid">33214794</pub-id></element-citation></ref><ref id="B394-pharmaceutics-14-01837"><label>394.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zetsche</surname><given-names>B.</given-names></name>
<name><surname>Gootenberg</surname><given-names>J.S.</given-names></name>
<name><surname>Abudayyeh</surname><given-names>O.O.</given-names></name>
<name><surname>Slaymaker</surname><given-names>I.M.</given-names></name>
<name><surname>Makarova</surname><given-names>K.S.</given-names></name>
<name><surname>Essletzbichler</surname><given-names>P.</given-names></name>
<name><surname>Volz</surname><given-names>S.E.</given-names></name>
<name><surname>Joung</surname><given-names>J.</given-names></name>
<name><surname>van der Oost</surname><given-names>J.</given-names></name>
<name><surname>Regev</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System</article-title><source>Cell</source><year>2015</year><volume>163</volume><fpage>759</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.09.038</pub-id><pub-id pub-id-type="pmid">26422227</pub-id></element-citation></ref><ref id="B395-pharmaceutics-14-01837"><label>395.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Song</surname><given-names>R.</given-names></name>
<name><surname>Zhai</surname><given-names>Q.</given-names></name>
<name><surname>Sun</surname><given-names>L.</given-names></name>
<name><surname>Huang</surname><given-names>E.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Zhu</surname><given-names>Y.</given-names></name>
<name><surname>Guo</surname><given-names>Q.</given-names></name>
<name><surname>Tian</surname><given-names>Y.</given-names></name>
<name><surname>Zhao</surname><given-names>B.</given-names></name>
<name><surname>Lu</surname><given-names>H.</given-names></name>
</person-group><article-title>CRISPR/Cas9 genome editing technology in filamentous fungi: Progress and perspective</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2019</year><volume>103</volume><fpage>6919</fpage><lpage>6932</lpage><pub-id pub-id-type="doi">10.1007/s00253-019-10007-w</pub-id><pub-id pub-id-type="pmid">31332488</pub-id></element-citation></ref><ref id="B396-pharmaceutics-14-01837"><label>396.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H.K.</given-names></name>
<name><surname>Song</surname><given-names>M.</given-names></name>
<name><surname>Lee</surname><given-names>J.</given-names></name>
<name><surname>Menon</surname><given-names>A.V.</given-names></name>
<name><surname>Jung</surname><given-names>S.</given-names></name>
<name><surname>Kang</surname><given-names>Y.M.</given-names></name>
<name><surname>Choi</surname><given-names>J.W.</given-names></name>
<name><surname>Woo</surname><given-names>E.</given-names></name>
<name><surname>Koh</surname><given-names>H.C.</given-names></name>
<name><surname>Nam</surname><given-names>J.W.</given-names></name>
<etal/>
</person-group><article-title>In vivo high-throughput profiling of CRISPR-Cpf1 activity</article-title><source>Nat. Methods</source><year>2017</year><volume>14</volume><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4104</pub-id><pub-id pub-id-type="pmid">27992409</pub-id></element-citation></ref><ref id="B397-pharmaceutics-14-01837"><label>397.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jacobsen</surname><given-names>T.</given-names></name>
<name><surname>Ttofali</surname><given-names>F.</given-names></name>
<name><surname>Liao</surname><given-names>C.</given-names></name>
<name><surname>Manchalu</surname><given-names>S.</given-names></name>
<name><surname>Gray</surname><given-names>B.N.</given-names></name>
<name><surname>Beisel</surname><given-names>C.L.</given-names></name>
</person-group><article-title>Characterization of Cas12a nucleases reveals diverse PAM profiles between closely-related orthologs</article-title><source>Nucleic Acids Res.</source><year>2020</year><volume>48</volume><fpage>5624</fpage><lpage>5638</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa272</pub-id><pub-id pub-id-type="pmid">32329776</pub-id></element-citation></ref><ref id="B398-pharmaceutics-14-01837"><label>398.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gasiunas</surname><given-names>G.</given-names></name>
<name><surname>Barrangou</surname><given-names>R.</given-names></name>
<name><surname>Horvath</surname><given-names>P.</given-names></name>
<name><surname>Siksnys</surname><given-names>V.</given-names></name>
</person-group><article-title>Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>E2579</fpage><lpage>E2586</lpage><pub-id pub-id-type="doi">10.1073/pnas.1208507109</pub-id><?supplied-pmid 22949671?><pub-id pub-id-type="pmid">22949671</pub-id></element-citation></ref><ref id="B399-pharmaceutics-14-01837"><label>399.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Komor</surname><given-names>A.C.</given-names></name>
<name><surname>Kim</surname><given-names>Y.B.</given-names></name>
<name><surname>Packer</surname><given-names>M.S.</given-names></name>
<name><surname>Zuris</surname><given-names>J.A.</given-names></name>
<name><surname>Liu</surname><given-names>D.R.</given-names></name>
</person-group><article-title>Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage</article-title><source>Nature</source><year>2016</year><volume>533</volume><fpage>420</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1038/nature17946</pub-id><?supplied-pmid 27096365?><pub-id pub-id-type="pmid">27096365</pub-id></element-citation></ref><ref id="B400-pharmaceutics-14-01837"><label>400.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yamano</surname><given-names>T.</given-names></name>
<name><surname>Nishimasu</surname><given-names>H.</given-names></name>
<name><surname>Zetsche</surname><given-names>B.</given-names></name>
<name><surname>Hirano</surname><given-names>H.</given-names></name>
<name><surname>Slaymaker</surname><given-names>I.M.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Fedorova</surname><given-names>I.</given-names></name>
<name><surname>Nakane</surname><given-names>T.</given-names></name>
<name><surname>Makarova</surname><given-names>K.S.</given-names></name>
<name><surname>Koonin</surname><given-names>E.V.</given-names></name>
<etal/>
</person-group><article-title>Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA</article-title><source>Cell</source><year>2016</year><volume>165</volume><fpage>949</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.003</pub-id><?supplied-pmid 27114038?><pub-id pub-id-type="pmid">27114038</pub-id></element-citation></ref><ref id="B401-pharmaceutics-14-01837"><label>401.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cofsky</surname><given-names>J.C.</given-names></name>
<name><surname>Karandur</surname><given-names>D.</given-names></name>
<name><surname>Huang</surname><given-names>C.J.</given-names></name>
<name><surname>Witte</surname><given-names>I.P.</given-names></name>
<name><surname>Kuriyan</surname><given-names>J.</given-names></name>
<name><surname>Doudna</surname><given-names>J.A.</given-names></name>
</person-group><article-title>CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks</article-title><source>eLife</source><year>2020</year><volume>9</volume><fpage>e55143</fpage><pub-id pub-id-type="doi">10.7554/eLife.55143</pub-id><pub-id pub-id-type="pmid">32519675</pub-id></element-citation></ref><ref id="B402-pharmaceutics-14-01837"><label>402.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qi</surname><given-names>L.S.</given-names></name>
<name><surname>Larson</surname><given-names>M.H.</given-names></name>
<name><surname>Gilbert</surname><given-names>L.A.</given-names></name>
<name><surname>Doudna</surname><given-names>J.A.</given-names></name>
<name><surname>Weissman</surname><given-names>J.S.</given-names></name>
<name><surname>Arkin</surname><given-names>A.P.</given-names></name>
<name><surname>Lim</surname><given-names>W.A.</given-names></name>
</person-group><article-title>Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression</article-title><source>Cell</source><year>2013</year><volume>152</volume><fpage>1173</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.02.022</pub-id><pub-id pub-id-type="pmid">23452860</pub-id></element-citation></ref><ref id="B403-pharmaceutics-14-01837"><label>403.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smith</surname><given-names>J.D.</given-names></name>
<name><surname>Suresh</surname><given-names>S.</given-names></name>
<name><surname>Schlecht</surname><given-names>U.</given-names></name>
<name><surname>Wu</surname><given-names>M.</given-names></name>
<name><surname>Wagih</surname><given-names>O.</given-names></name>
<name><surname>Peltz</surname><given-names>G.</given-names></name>
<name><surname>Davis</surname><given-names>R.W.</given-names></name>
<name><surname>Steinmetz</surname><given-names>L.M.</given-names></name>
<name><surname>Parts</surname><given-names>L.</given-names></name>
<name><surname>St. Onge</surname><given-names>R.P.</given-names></name>
</person-group><article-title>Quantitative CRISPR interference screens in yeast identify chemical-genetic interactions and new rules for guide RNA design</article-title><source>Genome Biol.</source><year>2016</year><volume>17</volume><fpage>45</fpage><pub-id pub-id-type="doi">10.1186/s13059-016-0900-9</pub-id><pub-id pub-id-type="pmid">26956608</pub-id></element-citation></ref><ref id="B404-pharmaceutics-14-01837"><label>404.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malzahn</surname><given-names>A.A.</given-names></name>
<name><surname>Tang</surname><given-names>X.</given-names></name>
<name><surname>Lee</surname><given-names>K.</given-names></name>
<name><surname>Ren</surname><given-names>Q.</given-names></name>
<name><surname>Sretenovic</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Chen</surname><given-names>H.</given-names></name>
<name><surname>Kang</surname><given-names>M.</given-names></name>
<name><surname>Bao</surname><given-names>Y.</given-names></name>
<name><surname>Zheng</surname><given-names>X.</given-names></name>
<etal/>
</person-group><article-title>Application of CRISPR-Cas12a temperature sensitivity for improved genome editing in rice, maize, and Arabidopsis</article-title><source>BMC Biol.</source><year>2019</year><volume>17</volume><elocation-id>9</elocation-id><pub-id pub-id-type="doi">10.1186/s12915-019-0629-5</pub-id><pub-id pub-id-type="pmid">30704461</pub-id></element-citation></ref><ref id="B405-pharmaceutics-14-01837"><label>405.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Wu</surname><given-names>J.</given-names></name>
<name><surname>Zhao</surname><given-names>G.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
</person-group><article-title>CRISPR-Cas12a-Assisted Genome Editing in <italic toggle="yes">Amycolatopsis mediterranei</italic></article-title><source>Front. Bioeng. Biotechnol.</source><year>2020</year><volume>8</volume><fpage>698</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2020.00698</pub-id><pub-id pub-id-type="pmid">32671053</pub-id></element-citation></ref><ref id="B406-pharmaceutics-14-01837"><label>406.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Q.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>F.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Sun</surname><given-names>W.</given-names></name>
<name><surname>Tian</surname><given-names>C.</given-names></name>
</person-group><article-title>Upgrading of efficient and scalable CRISPR&#x02013;Cas-mediated technology for genetic engineering in thermophilic fungus <italic toggle="yes">Myceliophthora thermophila</italic></article-title><source>Biotechnol. Biofuels</source><year>2019</year><volume>12</volume><fpage>293</fpage><pub-id pub-id-type="doi">10.1186/s13068-019-1637-y</pub-id><pub-id pub-id-type="pmid">31890021</pub-id></element-citation></ref><ref id="B407-pharmaceutics-14-01837"><label>407.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lightfoot</surname><given-names>J.D.</given-names></name>
<name><surname>Fuller</surname><given-names>K.K.</given-names></name>
</person-group><article-title>CRISPR/Cas9-Mediated Gene Replacement in the Fungal Keratitis Pathogen <italic toggle="yes">Fusarium solani</italic> var</article-title><source>petroliphilum. Microorganisms</source><year>2019</year><volume>7</volume><elocation-id>457</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms7100457</pub-id></element-citation></ref><ref id="B408-pharmaceutics-14-01837"><label>408.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fuller</surname><given-names>K.K.</given-names></name>
<name><surname>Chen</surname><given-names>S.</given-names></name>
<name><surname>Loros</surname><given-names>J.J.</given-names></name>
<name><surname>Dunlap</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Development of the CRISPR/Cas9 System for Targeted Gene Disruption in <italic toggle="yes">Aspergillus fumigatus</italic></article-title><source>Eukaryot. Cell</source><year>2015</year><volume>14</volume><fpage>1073</fpage><lpage>1080</lpage><pub-id pub-id-type="doi">10.1128/EC.00107-15</pub-id><?supplied-pmid 26318395?><pub-id pub-id-type="pmid">26318395</pub-id></element-citation></ref><ref id="B409-pharmaceutics-14-01837"><label>409.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pachlinger</surname><given-names>R.</given-names></name>
<name><surname>Mitterbauer</surname><given-names>R.</given-names></name>
<name><surname>Adam</surname><given-names>G.</given-names></name>
<name><surname>Strauss</surname><given-names>J.</given-names></name>
</person-group><article-title>Metabolically independent and accurately adjustable <italic toggle="yes">Aspergillus</italic> sp. expression system</article-title><source>Appl. Environ. Microbiol.</source><year>2005</year><volume>71</volume><fpage>672</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1128/AEM.71.2.672-678.2005</pub-id><?supplied-pmid 15691916?><pub-id pub-id-type="pmid">15691916</pub-id></element-citation></ref><ref id="B410-pharmaceutics-14-01837"><label>410.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weber</surname><given-names>J.</given-names></name>
<name><surname>Valiante</surname><given-names>V.</given-names></name>
<name><surname>N&#x000f8;dvig</surname><given-names>C.S.</given-names></name>
<name><surname>Mattern</surname><given-names>D.J.</given-names></name>
<name><surname>Slotkowski</surname><given-names>R.A.</given-names></name>
<name><surname>Mortensen</surname><given-names>U.H.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
</person-group><article-title>Functional Reconstitution of a Fungal Natural Product Gene Cluster by Advanced Genome Editing</article-title><source>ACS Synth. Biol.</source><year>2017</year><volume>6</volume><fpage>62</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.6b00203</pub-id><?supplied-pmid 27611015?><pub-id pub-id-type="pmid">27611015</pub-id></element-citation></ref><ref id="B411-pharmaceutics-14-01837"><label>411.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>J.</given-names></name>
<name><surname>Cook</surname><given-names>D.E.</given-names></name>
</person-group><article-title>CRISPR-Cas12a ribonucleoprotein-mediated gene editing in the plant pathogenic fungus <italic toggle="yes">Magnaporthe oryzae</italic></article-title><source>STAR Protoc.</source><year>2022</year><volume>3</volume><fpage>101072</fpage><pub-id pub-id-type="doi">10.1016/j.xpro.2021.101072</pub-id><?supplied-pmid 35005648?><pub-id pub-id-type="pmid">35005648</pub-id></element-citation></ref><ref id="B412-pharmaceutics-14-01837"><label>412.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van Leeuwe</surname><given-names>T.M.</given-names></name>
<name><surname>Arentshorst</surname><given-names>M.</given-names></name>
<name><surname>Ernst</surname><given-names>T.</given-names></name>
<name><surname>Alazi</surname><given-names>E.</given-names></name>
<name><surname>Punt</surname><given-names>P.J.</given-names></name>
<name><surname>Ram</surname><given-names>A.F.J.</given-names></name>
</person-group><article-title>Efficient marker free CRISPR/Cas9 genome editing for functional analysis of gene families in filamentous fungi</article-title><source>Fungal Biol. Biotechnol.</source><year>2019</year><volume>6</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/s40694-019-0076-7</pub-id><pub-id pub-id-type="pmid">31559019</pub-id></element-citation></ref><ref id="B413-pharmaceutics-14-01837"><label>413.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schuster</surname><given-names>M.</given-names></name>
<name><surname>Kahmann</surname><given-names>R.</given-names></name>
</person-group><article-title>CRISPR-Cas9 genome editing approaches in filamentous fungi and oomycetes</article-title><source>Fungal Genet. Biol.</source><year>2019</year><volume>130</volume><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2019.04.016</pub-id><pub-id pub-id-type="pmid">31048007</pub-id></element-citation></ref><ref id="B414-pharmaceutics-14-01837"><label>414.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chavez</surname><given-names>A.</given-names></name>
<name><surname>Scheiman</surname><given-names>J.</given-names></name>
<name><surname>Vora</surname><given-names>S.</given-names></name>
<name><surname>Pruitt</surname><given-names>B.W.</given-names></name>
<name><surname>Tuttle</surname><given-names>M.</given-names></name>
<name><surname>Iye</surname><given-names>E.P.R.</given-names></name>
<name><surname>Lin</surname><given-names>S.</given-names></name>
<name><surname>Kiani</surname><given-names>S.</given-names></name>
<name><surname>Guzman</surname><given-names>C.D.</given-names></name>
<name><surname>Wiegand</surname><given-names>D.J.</given-names></name>
<etal/>
</person-group><article-title>Highly efficient Cas9-mediated transcriptional programming</article-title><source>Nat. Methods</source><year>2015</year><volume>12</volume><fpage>326</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3312</pub-id><pub-id pub-id-type="pmid">25730490</pub-id></element-citation></ref><ref id="B415-pharmaceutics-14-01837"><label>415.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hall</surname><given-names>D.B.</given-names></name>
<name><surname>Struhl</surname><given-names>K.</given-names></name>
</person-group><article-title>The VP16 Activation Domain Interacts with Multiple Transcriptional Components as Determined by Protein-Protein Cross-linking in Vivo</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>46043</fpage><lpage>46050</lpage><pub-id pub-id-type="doi">10.1074/jbc.M208911200</pub-id><pub-id pub-id-type="pmid">12297514</pub-id></element-citation></ref><ref id="B416-pharmaceutics-14-01837"><label>416.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hinz</surname><given-names>J.M.</given-names></name>
<name><surname>Laughery</surname><given-names>M.F.</given-names></name>
<name><surname>Wyrick</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Nucleosomes Inhibit Cas9 Endonuclease Activity in Vitro</article-title><source>Biochemistry</source><year>2015</year><volume>54</volume><fpage>7063</fpage><lpage>7066</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.5b01108</pub-id><pub-id pub-id-type="pmid">26579937</pub-id></element-citation></ref><ref id="B417-pharmaceutics-14-01837"><label>417.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thakore</surname><given-names>P.I.</given-names></name>
<name><surname>D&#x02019;Ippolito</surname><given-names>A.M.</given-names></name>
<name><surname>Song</surname><given-names>L.</given-names></name>
<name><surname>Safi</surname><given-names>A.</given-names></name>
<name><surname>Shivakumar</surname><given-names>N.K.</given-names></name>
<name><surname>Kabadi</surname><given-names>A.M.</given-names></name>
<name><surname>Reddy</surname><given-names>T.E.</given-names></name>
<name><surname>Crawford</surname><given-names>G.E.</given-names></name>
<name><surname>Gersbach</surname><given-names>C.A.</given-names></name>
</person-group><article-title>Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements</article-title><source>Nat. Methods</source><year>2015</year><volume>12</volume><fpage>1143</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3630</pub-id><pub-id pub-id-type="pmid">26501517</pub-id></element-citation></ref><ref id="B418-pharmaceutics-14-01837"><label>418.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Klann</surname><given-names>T.S.</given-names></name>
<name><surname>Black</surname><given-names>J.B.</given-names></name>
<name><surname>Chellappan</surname><given-names>M.</given-names></name>
<name><surname>Safi</surname><given-names>A.</given-names></name>
<name><surname>Song</surname><given-names>L.</given-names></name>
<name><surname>Hilton</surname><given-names>I.B.</given-names></name>
<name><surname>Crawford</surname><given-names>G.E.</given-names></name>
<name><surname>Reddy</surname><given-names>T.E.</given-names></name>
<name><surname>Gersbach</surname><given-names>C.A.</given-names></name>
</person-group><article-title>CRISPR&#x02013;Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome</article-title><source>Nat. Biotechnol.</source><year>2017</year><volume>35</volume><fpage>561</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1038/nbt.3853</pub-id><pub-id pub-id-type="pmid">28369033</pub-id></element-citation></ref><ref id="B419-pharmaceutics-14-01837"><label>419.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Mahata</surname><given-names>B.</given-names></name>
<name><surname>Escobar</surname><given-names>M.</given-names></name>
<name><surname>Goell</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>K.</given-names></name>
<name><surname>Khemka</surname><given-names>P.</given-names></name>
<name><surname>Hilton</surname><given-names>I.B.</given-names></name>
</person-group><article-title>Programmable human histone phosphorylation and gene activation using a CRISPR/Cas9-based chromatin kinase</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>896</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-21188-2</pub-id><?supplied-pmid 33563994?><pub-id pub-id-type="pmid">33563994</pub-id></element-citation></ref><ref id="B420-pharmaceutics-14-01837"><label>420.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lickwar</surname><given-names>C.R.</given-names></name>
<name><surname>Mueller</surname><given-names>F.</given-names></name>
<name><surname>Hanlon</surname><given-names>S.E.</given-names></name>
<name><surname>McNally</surname><given-names>J.G.</given-names></name>
<name><surname>Lieb</surname><given-names>J.D.</given-names></name>
</person-group><article-title>Genome-wide protein&#x02013;DNA binding dynamics suggest a molecular clutch for transcription factor function</article-title><source>Nature</source><year>2012</year><volume>484</volume><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1038/nature10985</pub-id><?supplied-pmid 22498630?><pub-id pub-id-type="pmid">22498630</pub-id></element-citation></ref><ref id="B421-pharmaceutics-14-01837"><label>421.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>R.</given-names></name>
<name><surname>Xie</surname><given-names>A.</given-names></name>
</person-group><article-title>Target binding and residence: A new determinant of DNA double-strand break repair pathway choice in CRISPR/Cas9 genome editing</article-title><source>J. Zhejiang Univ.&#x02014;Sci. B</source><year>2021</year><volume>22</volume><fpage>73</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1631/jzus.B2000282</pub-id><pub-id pub-id-type="pmid">33448189</pub-id></element-citation></ref><ref id="B422-pharmaceutics-14-01837"><label>422.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>G.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>T.</given-names></name>
</person-group><article-title>Computational approaches for effective CRISPR guide RNA design and evaluation</article-title><source>Comput. Struct. Biotechnol. J.</source><year>2020</year><volume>18</volume><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.csbj.2019.11.006</pub-id><pub-id pub-id-type="pmid">31890142</pub-id></element-citation></ref><ref id="B423-pharmaceutics-14-01837"><label>423.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>H.</given-names></name>
<name><surname>Xiao</surname><given-names>T.</given-names></name>
<name><surname>Chen</surname><given-names>C.H.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Meyer</surname><given-names>C.A.</given-names></name>
<name><surname>Wu</surname><given-names>Q.</given-names></name>
<name><surname>Wu</surname><given-names>D.</given-names></name>
<name><surname>Cong</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>F.</given-names></name>
<name><surname>Liu</surname><given-names>J.S.</given-names></name>
<etal/>
</person-group><article-title>Sequence determinants of improved CRISPR sgRNA design</article-title><source>Genome Res.</source><year>2015</year><volume>25</volume><fpage>1147</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1101/gr.191452.115</pub-id><pub-id pub-id-type="pmid">26063738</pub-id></element-citation></ref><ref id="B424-pharmaceutics-14-01837"><label>424.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>J.</given-names></name>
<name><surname>Bae</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>J.-S.</given-names></name>
</person-group><article-title>Cas-Designer: A web-based tool for choice of CRISPR-Cas9 target sites</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><fpage>4014</fpage><lpage>4016</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv537</pub-id><pub-id pub-id-type="pmid">26358729</pub-id></element-citation></ref><ref id="B425-pharmaceutics-14-01837"><label>425.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mendoza</surname><given-names>B.J.</given-names></name>
<name><surname>Trinh</surname><given-names>C.T.</given-names></name>
</person-group><article-title>Enhanced guide-RNA design and targeting analysis for precise CRISPR genome editing of single and consortia of industrially relevant and non-model organisms</article-title><source>Bioinformatics</source><year>2017</year><volume>34</volume><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btx564</pub-id></element-citation></ref><ref id="B426-pharmaceutics-14-01837"><label>426.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Zhang</surname><given-names>D.</given-names></name>
<name><surname>Xiong</surname><given-names>X.</given-names></name>
<name><surname>Yan</surname><given-names>B.</given-names></name>
<name><surname>Xie</surname><given-names>W.</given-names></name>
<name><surname>Sheen</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>J.-F.</given-names></name>
</person-group><article-title>A potent Cas9-derived gene activator for plant and mammalian cells</article-title><source>Nat. Plants</source><year>2017</year><volume>3</volume><fpage>930</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1038/s41477-017-0046-0</pub-id><pub-id pub-id-type="pmid">29158545</pub-id></element-citation></ref><ref id="B427-pharmaceutics-14-01837"><label>427.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hwang</surname><given-names>G.-H.</given-names></name>
<name><surname>Song</surname><given-names>B.</given-names></name>
<name><surname>Bae</surname><given-names>S.</given-names></name>
</person-group><article-title>Current widely-used web-based tools for CRISPR nucleases, base editors, and prime editors</article-title><source>Gene Genome Ed.</source><year>2021</year><volume>1</volume><fpage>100004</fpage><pub-id pub-id-type="doi">10.1016/j.ggedit.2021.100004</pub-id></element-citation></ref><ref id="B428-pharmaceutics-14-01837"><label>428.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Guo</surname><given-names>F.</given-names></name>
<name><surname>Yan</surname><given-names>W.</given-names></name>
<name><surname>Dai</surname><given-names>Z.</given-names></name>
<name><surname>Dong</surname><given-names>W.</given-names></name>
<name><surname>Zhou</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Xin</surname><given-names>F.</given-names></name>
<name><surname>Jiang</surname><given-names>M.</given-names></name>
</person-group><article-title>Recent Advances of CRISPR/Cas9-Based Genetic Engineering and Transcriptional Regulation in Industrial Biology</article-title><source>Front. Bioeng. Biotechnol.</source><year>2020</year><volume>7</volume><fpage>459</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2019.00459</pub-id><?supplied-pmid 32047743?><pub-id pub-id-type="pmid">32047743</pub-id></element-citation></ref><ref id="B429-pharmaceutics-14-01837"><label>429.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>H.</given-names></name>
<name><surname>Tu</surname><given-names>L.-C.</given-names></name>
<name><surname>Naseri</surname><given-names>A.</given-names></name>
<name><surname>Huisman</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Grunwald</surname><given-names>D.</given-names></name>
<name><surname>Pederson</surname><given-names>T.</given-names></name>
</person-group><article-title>CRISPR-Cas9 nuclear dynamics and target recognition in living cells</article-title><source>J. Cell Biol.</source><year>2016</year><volume>214</volume><fpage>529</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1083/jcb.201604115</pub-id><pub-id pub-id-type="pmid">27551060</pub-id></element-citation></ref><ref id="B430-pharmaceutics-14-01837"><label>430.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Palermo</surname><given-names>G.</given-names></name>
<name><surname>Miao</surname><given-names>Y.</given-names></name>
<name><surname>Walker</surname><given-names>R.C.</given-names></name>
<name><surname>Jinek</surname><given-names>M.</given-names></name>
<name><surname>McCammon</surname><given-names>J.A.</given-names></name>
</person-group><article-title>CRISPR-Cas9 conformational activation as elucidated from enhanced molecular simulations</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>7260</fpage><lpage>7265</lpage><pub-id pub-id-type="doi">10.1073/pnas.1707645114</pub-id><?supplied-pmid 28652374?><pub-id pub-id-type="pmid">28652374</pub-id></element-citation></ref><ref id="B431-pharmaceutics-14-01837"><label>431.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mekler</surname><given-names>V.</given-names></name>
<name><surname>Minakhin</surname><given-names>L.</given-names></name>
<name><surname>Semenova</surname><given-names>E.</given-names></name>
<name><surname>Kuznedelov</surname><given-names>K.</given-names></name>
<name><surname>Severinov</surname><given-names>K.</given-names></name>
</person-group><article-title>Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3&#x02032;-terminal segment of guide RNA</article-title><source>Nucleic Acids Res.</source><year>2016</year><volume>44</volume><fpage>2837</fpage><lpage>2845</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw138</pub-id><pub-id pub-id-type="pmid">26945042</pub-id></element-citation></ref><ref id="B432-pharmaceutics-14-01837"><label>432.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raper</surname><given-names>A.T.</given-names></name>
<name><surname>Stephenson</surname><given-names>A.A.</given-names></name>
<name><surname>Suo</surname><given-names>Z.</given-names></name>
</person-group><article-title>Functional Insights Revealed by the Kinetic Mechanism of CRISPR/Cas9</article-title><source>J. Am. Chem. Soc.</source><year>2018</year><volume>140</volume><fpage>2971</fpage><lpage>2984</lpage><pub-id pub-id-type="doi">10.1021/jacs.7b13047</pub-id><pub-id pub-id-type="pmid">29442507</pub-id></element-citation></ref><ref id="B433-pharmaceutics-14-01837"><label>433.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Strohkendl</surname><given-names>I.</given-names></name>
<name><surname>Saifuddin</surname><given-names>F.A.</given-names></name>
<name><surname>Rybarski</surname><given-names>J.R.</given-names></name>
<name><surname>Finkelstein</surname><given-names>I.J.</given-names></name>
<name><surname>Russell</surname><given-names>R.</given-names></name>
</person-group><article-title>Kinetic Basis for DNA Target Specificity of CRISPR-Cas12a</article-title><source>Mol. Cell</source><year>2018</year><volume>71</volume><fpage>816</fpage><lpage>824.e3</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.06.043</pub-id><pub-id pub-id-type="pmid">30078724</pub-id></element-citation></ref><ref id="B434-pharmaceutics-14-01837"><label>434.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sundaresan</surname><given-names>R.</given-names></name>
<name><surname>Parameshwaran</surname><given-names>H.P.</given-names></name>
<name><surname>Yogesha</surname><given-names>S.D.</given-names></name>
<name><surname>Keilbarth</surname><given-names>M.W.</given-names></name>
<name><surname>Rajan</surname><given-names>R.</given-names></name>
</person-group><article-title>RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a</article-title><source>Cell Rep.</source><year>2017</year><volume>21</volume><fpage>3728</fpage><lpage>3739</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.11.100</pub-id><pub-id pub-id-type="pmid">29281823</pub-id></element-citation></ref><ref id="B435-pharmaceutics-14-01837"><label>435.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Swarts</surname><given-names>D.C.</given-names></name>
<name><surname>van der Oost</surname><given-names>J.</given-names></name>
<name><surname>Jinek</surname><given-names>M.</given-names></name>
</person-group><article-title>Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a</article-title><source>Mol. Cell</source><year>2017</year><volume>66</volume><fpage>221</fpage><lpage>233.e4</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.03.016</pub-id><pub-id pub-id-type="pmid">28431230</pub-id></element-citation></ref><ref id="B436-pharmaceutics-14-01837"><label>436.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dong</surname><given-names>D.</given-names></name>
<name><surname>Ren</surname><given-names>K.</given-names></name>
<name><surname>Qiu</surname><given-names>X.</given-names></name>
<name><surname>Zheng</surname><given-names>J.</given-names></name>
<name><surname>Guo</surname><given-names>M.</given-names></name>
<name><surname>Guan</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>N.</given-names></name>
<name><surname>Zhang</surname><given-names>B.</given-names></name>
<name><surname>Yang</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>The crystal structure of Cpf1 in complex with CRISPR RNA</article-title><source>Nature</source><year>2016</year><volume>532</volume><fpage>522</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1038/nature17944</pub-id><pub-id pub-id-type="pmid">27096363</pub-id></element-citation></ref><ref id="B437-pharmaceutics-14-01837"><label>437.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mekler</surname><given-names>V.</given-names></name>
<name><surname>Kuznedelov</surname><given-names>K.</given-names></name>
<name><surname>Severinov</surname><given-names>K.</given-names></name>
</person-group><article-title>Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences</article-title><source>J. Biol. Chem.</source><year>2020</year><volume>295</volume><fpage>6509</fpage><lpage>6517</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA119.012239</pub-id><pub-id pub-id-type="pmid">32241913</pub-id></element-citation></ref><ref id="B438-pharmaceutics-14-01837"><label>438.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chung</surname><given-names>C.H.</given-names></name>
<name><surname>Allen</surname><given-names>A.G.</given-names></name>
<name><surname>Sullivan</surname><given-names>N.T.</given-names></name>
<name><surname>Atkins</surname><given-names>A.</given-names></name>
<name><surname>Nonnemacher</surname><given-names>M.R.</given-names></name>
<name><surname>Wigdahl</surname><given-names>B.</given-names></name>
<name><surname>Dampier</surname><given-names>W.</given-names></name>
</person-group><article-title>Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency</article-title><source>Mol. Ther.</source><year>2020</year><volume>28</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.ymthe.2019.10.008</pub-id><pub-id pub-id-type="pmid">31672284</pub-id></element-citation></ref><ref id="B439-pharmaceutics-14-01837"><label>439.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Daer</surname><given-names>R.M.</given-names></name>
<name><surname>Cutts</surname><given-names>J.P.</given-names></name>
<name><surname>Brafman</surname><given-names>D.A.</given-names></name>
<name><surname>Haynes</surname><given-names>K.A.</given-names></name>
</person-group><article-title>The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells</article-title><source>ACS Synth. Biol.</source><year>2017</year><volume>6</volume><fpage>428</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.5b00299</pub-id><?supplied-pmid 27783893?><pub-id pub-id-type="pmid">27783893</pub-id></element-citation></ref><ref id="B440-pharmaceutics-14-01837"><label>440.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verkuijl</surname><given-names>S.A.N.</given-names></name>
<name><surname>Rots</surname><given-names>M.G.</given-names></name>
</person-group><article-title>The influence of eukaryotic chromatin state on CRISPR&#x02013;Cas9 editing efficiencies</article-title><source>Curr. Opin. Biotechnol.</source><year>2019</year><volume>55</volume><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2018.07.005</pub-id><?supplied-pmid 30189348?><pub-id pub-id-type="pmid">30189348</pub-id></element-citation></ref><ref id="B441-pharmaceutics-14-01837"><label>441.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Isaac</surname><given-names>R.S.</given-names></name>
<name><surname>Jiang</surname><given-names>F.</given-names></name>
<name><surname>Doudna</surname><given-names>J.A.</given-names></name>
<name><surname>Lim</surname><given-names>W.A.</given-names></name>
<name><surname>Narlikar</surname><given-names>G.J.</given-names></name>
<name><surname>Almeida</surname><given-names>R.</given-names></name>
</person-group><article-title>Nucleosome breathing and remodeling constrain CRISPR-Cas9 function</article-title><source>eLife</source><year>2016</year><volume>5</volume><fpage>e13450</fpage><pub-id pub-id-type="doi">10.7554/eLife.13450</pub-id><?supplied-pmid 27130520?><pub-id pub-id-type="pmid">27130520</pub-id></element-citation></ref><ref id="B442-pharmaceutics-14-01837"><label>442.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sternberg</surname><given-names>S.H.</given-names></name>
<name><surname>Redding</surname><given-names>S.</given-names></name>
<name><surname>Jinek</surname><given-names>M.</given-names></name>
<name><surname>Greene</surname><given-names>E.C.</given-names></name>
<name><surname>Doudna</surname><given-names>J.A.</given-names></name>
</person-group><article-title>DNA interrogation by the CRISPR RNA-guided endonuclease Cas9</article-title><source>Nature</source><year>2014</year><volume>507</volume><fpage>62</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1038/nature13011</pub-id><pub-id pub-id-type="pmid">24476820</pub-id></element-citation></ref><ref id="B443-pharmaceutics-14-01837"><label>443.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clarke</surname><given-names>R.</given-names></name>
<name><surname>Heler</surname><given-names>R.</given-names></name>
<name><surname>MacDougall</surname><given-names>M.S.</given-names></name>
<name><surname>Yeo</surname><given-names>N.C.</given-names></name>
<name><surname>Chavez</surname><given-names>A.</given-names></name>
<name><surname>Regan</surname><given-names>M.</given-names></name>
<name><surname>Hanakahi</surname><given-names>L.</given-names></name>
<name><surname>Church</surname><given-names>G.M.</given-names></name>
<name><surname>Marraffini</surname><given-names>L.A.</given-names></name>
<name><surname>Merrill</surname><given-names>B.J.</given-names></name>
</person-group><article-title>Enhanced Bacterial Immunity and Mammalian Genome Editing via RNA-Polymerase-Mediated Dislodging of Cas9 from Double-Strand DNA Breaks</article-title><source>Mol. Cell</source><year>2018</year><volume>71</volume><fpage>42</fpage><lpage>55.e8</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.06.005</pub-id><pub-id pub-id-type="pmid">29979968</pub-id></element-citation></ref><ref id="B444-pharmaceutics-14-01837"><label>444.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Hou</surname><given-names>X.-M.</given-names></name>
<name><surname>Guo</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>F.</given-names></name>
<name><surname>Bi</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>H.-H.</given-names></name>
<name><surname>Wen</surname><given-names>F.</given-names></name>
<name><surname>Xi</surname><given-names>X.-G.</given-names></name>
<etal/>
</person-group><article-title>Dynamics of Staphylococcus aureus Cas9 in DNA target Association and Dissociation</article-title><source>EMBO Rep.</source><year>2020</year><volume>21</volume><fpage>e50184</fpage><pub-id pub-id-type="doi">10.15252/embr.202050184</pub-id><pub-id pub-id-type="pmid">32790142</pub-id></element-citation></ref><ref id="B445-pharmaceutics-14-01837"><label>445.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jeon</surname><given-names>Y.</given-names></name>
<name><surname>Choi</surname><given-names>Y.H.</given-names></name>
<name><surname>Jang</surname><given-names>Y.</given-names></name>
<name><surname>Yu</surname><given-names>J.</given-names></name>
<name><surname>Goo</surname><given-names>J.</given-names></name>
<name><surname>Lee</surname><given-names>G.</given-names></name>
<name><surname>Jeong</surname><given-names>Y.K.</given-names></name>
<name><surname>Lee</surname><given-names>S.H.</given-names></name>
<name><surname>Kim</surname><given-names>I.-S.</given-names></name>
<name><surname>Kim</surname><given-names>J.-S.</given-names></name>
<etal/>
</person-group><article-title>Direct observation of DNA target searching and cleavage by CRISPR-Cas12a</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>2777</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-05245-x</pub-id><pub-id pub-id-type="pmid">30018371</pub-id></element-citation></ref><ref id="B446-pharmaceutics-14-01837"><label>446.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Wen</surname><given-names>F.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Jin</surname><given-names>J.</given-names></name>
<name><surname>Bi</surname><given-names>L.</given-names></name>
<name><surname>Lu</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>M.</given-names></name>
<name><surname>Xi</surname><given-names>X.-G.</given-names></name>
<name><surname>Huang</surname><given-names>X.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>The post-PAM interaction of RNA-guided spCas9 with DNA dictates its target binding and dissociation</article-title><source>Sci. Adv.</source><year>2019</year><volume>5</volume><fpage>eaaw9807</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aaw9807</pub-id><pub-id pub-id-type="pmid">31763447</pub-id></element-citation></ref><ref id="B447-pharmaceutics-14-01837"><label>447.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hsu</surname><given-names>P.D.</given-names></name>
<name><surname>Scott</surname><given-names>D.A.</given-names></name>
<name><surname>Weinstein</surname><given-names>J.A.</given-names></name>
<name><surname>Ran</surname><given-names>F.A.</given-names></name>
<name><surname>Konermann</surname><given-names>S.</given-names></name>
<name><surname>Agarwala</surname><given-names>V.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Fine</surname><given-names>E.J.</given-names></name>
<name><surname>Wu</surname><given-names>X.</given-names></name>
<name><surname>Shalem</surname><given-names>O.</given-names></name>
<etal/>
</person-group><article-title>DNA targeting specificity of RNA-guided Cas9 nucleases</article-title><source>Nat. Biotechnol.</source><year>2013</year><volume>31</volume><fpage>827</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1038/nbt.2647</pub-id><pub-id pub-id-type="pmid">23873081</pub-id></element-citation></ref><ref id="B448-pharmaceutics-14-01837"><label>448.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>K&#x000fc;nne</surname><given-names>T.</given-names></name>
<name><surname>Swarts</surname><given-names>D.C.</given-names></name>
<name><surname>Brouns</surname><given-names>S.J.</given-names></name>
</person-group><article-title>Planting the seed: Target recognition of short guide RNAs</article-title><source>Trends Microbiol.</source><year>2014</year><volume>22</volume><fpage>74</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2013.12.003</pub-id><?supplied-pmid 24440013?><pub-id pub-id-type="pmid">24440013</pub-id></element-citation></ref><ref id="B449-pharmaceutics-14-01837"><label>449.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>X.</given-names></name>
<name><surname>Scott</surname><given-names>D.A.</given-names></name>
<name><surname>Kriz</surname><given-names>A.J.</given-names></name>
<name><surname>Chiu</surname><given-names>A.C.</given-names></name>
<name><surname>Hsu</surname><given-names>P.D.</given-names></name>
<name><surname>Dadon</surname><given-names>D.B.</given-names></name>
<name><surname>Cheng</surname><given-names>A.W.</given-names></name>
<name><surname>Trevino</surname><given-names>A.E.</given-names></name>
<name><surname>Konermann</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells</article-title><source>Nat. Biotechnol.</source><year>2014</year><volume>32</volume><fpage>670</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1038/nbt.2889</pub-id><?supplied-pmid 24752079?><pub-id pub-id-type="pmid">24752079</pub-id></element-citation></ref><ref id="B450-pharmaceutics-14-01837"><label>450.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Walton</surname><given-names>R.T.</given-names></name>
<name><surname>Christie</surname><given-names>K.A.</given-names></name>
<name><surname>Whittaker</surname><given-names>M.N.</given-names></name>
<name><surname>Kleinstiver</surname><given-names>B.P.</given-names></name>
</person-group><article-title>Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants</article-title><source>Science</source><year>2020</year><volume>368</volume><fpage>290</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1126/science.aba8853</pub-id><?supplied-pmid 32217751?><pub-id pub-id-type="pmid">32217751</pub-id></element-citation></ref><ref id="B451-pharmaceutics-14-01837"><label>451.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kleinstiver</surname><given-names>B.P.</given-names></name>
<name><surname>Prew</surname><given-names>M.S.</given-names></name>
<name><surname>Tsai</surname><given-names>S.Q.</given-names></name>
<name><surname>Topkar</surname><given-names>V.V.</given-names></name>
<name><surname>Nguyen</surname><given-names>N.T.</given-names></name>
<name><surname>Zheng</surname><given-names>Z.</given-names></name>
<name><surname>Gonzales</surname><given-names>A.P.W.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Peterson</surname><given-names>R.T.</given-names></name>
<name><surname>Yeh</surname><given-names>J.-R.J.</given-names></name>
<etal/>
</person-group><article-title>Engineered CRISPR-Cas9 nucleases with altered PAM specificities</article-title><source>Nature</source><year>2015</year><volume>523</volume><fpage>481</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1038/nature14592</pub-id><?supplied-pmid 26098369?><pub-id pub-id-type="pmid">26098369</pub-id></element-citation></ref><ref id="B452-pharmaceutics-14-01837"><label>452.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kleinstiver</surname><given-names>B.P.</given-names></name>
<name><surname>Prew</surname><given-names>M.S.</given-names></name>
<name><surname>Tsai</surname><given-names>S.Q.</given-names></name>
<name><surname>Nguyen</surname><given-names>N.T.</given-names></name>
<name><surname>Topkar</surname><given-names>V.V.</given-names></name>
<name><surname>Zheng</surname><given-names>Z.</given-names></name>
<name><surname>Joung</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition</article-title><source>Nat. Biotechnol.</source><year>2015</year><volume>33</volume><fpage>1293</fpage><lpage>1298</lpage><pub-id pub-id-type="doi">10.1038/nbt.3404</pub-id><pub-id pub-id-type="pmid">26524662</pub-id></element-citation></ref><ref id="B453-pharmaceutics-14-01837"><label>453.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>T&#x000f3;th</surname><given-names>E.</given-names></name>
<name><surname>Varga</surname><given-names>&#x000c9;.</given-names></name>
<name><surname>Kulcs&#x000e1;r</surname><given-names>P.I.</given-names></name>
<name><surname>Kocsis-Jutka</surname><given-names>V.</given-names></name>
<name><surname>Krausz</surname><given-names>S.L.</given-names></name>
<name><surname>Nyeste</surname><given-names>A.</given-names></name>
<name><surname>Welker</surname><given-names>Z.</given-names></name>
<name><surname>Husz&#x000e1;r</surname><given-names>K.</given-names></name>
<name><surname>Ligeti</surname><given-names>Z.</given-names></name>
<name><surname>T&#x000e1;las</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases</article-title><source>Nucleic Acids Res.</source><year>2020</year><volume>48</volume><fpage>3722</fpage><lpage>3733</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa110</pub-id><pub-id pub-id-type="pmid">32107556</pub-id></element-citation></ref><ref id="B454-pharmaceutics-14-01837"><label>454.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kleinstiver</surname><given-names>B.P.</given-names></name>
<name><surname>Sousa</surname><given-names>A.A.</given-names></name>
<name><surname>Walton</surname><given-names>R.T.</given-names></name>
<name><surname>Tak</surname><given-names>Y.E.</given-names></name>
<name><surname>Hsu</surname><given-names>J.Y.</given-names></name>
<name><surname>Clement</surname><given-names>K.</given-names></name>
<name><surname>Welch</surname><given-names>M.M.</given-names></name>
<name><surname>Horng</surname><given-names>J.E.</given-names></name>
<name><surname>Malagon-Lopez</surname><given-names>J.</given-names></name>
<name><surname>Scarf&#x000f2;</surname><given-names>I.</given-names></name>
<etal/>
</person-group><article-title>Engineered CRISPR&#x02013;Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing</article-title><source>Nat. Biotechnol.</source><year>2019</year><volume>37</volume><fpage>276</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1038/s41587-018-0011-0</pub-id><pub-id pub-id-type="pmid">30742127</pub-id></element-citation></ref><ref id="B455-pharmaceutics-14-01837"><label>455.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kleinstiver</surname><given-names>B.P.</given-names></name>
<name><surname>Pattanayak</surname><given-names>V.</given-names></name>
<name><surname>Prew</surname><given-names>M.S.</given-names></name>
<name><surname>Tsai</surname><given-names>S.Q.</given-names></name>
<name><surname>Nguyen</surname><given-names>N.T.</given-names></name>
<name><surname>Zheng</surname><given-names>Z.</given-names></name>
<name><surname>Joung</surname><given-names>J.K.</given-names></name>
</person-group><article-title>High-fidelity CRISPR&#x02013;Cas9 nucleases with no detectable genome-wide off-target effects</article-title><source>Nature</source><year>2016</year><volume>529</volume><fpage>490</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1038/nature16526</pub-id><pub-id pub-id-type="pmid">26735016</pub-id></element-citation></ref><ref id="B456-pharmaceutics-14-01837"><label>456.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsai</surname><given-names>S.Q.</given-names></name>
<name><surname>Zheng</surname><given-names>Z.</given-names></name>
<name><surname>Nguyen</surname><given-names>N.T.</given-names></name>
<name><surname>Liebers</surname><given-names>M.</given-names></name>
<name><surname>Topkar</surname><given-names>V.V.</given-names></name>
<name><surname>Thapar</surname><given-names>V.</given-names></name>
<name><surname>Wyvekens</surname><given-names>N.</given-names></name>
<name><surname>Khayter</surname><given-names>C.</given-names></name>
<name><surname>Iafrate</surname><given-names>A.J.</given-names></name>
<name><surname>Le</surname><given-names>L.P.</given-names></name>
<etal/>
</person-group><article-title>GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases</article-title><source>Nat. Biotechnol.</source><year>2015</year><volume>33</volume><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1038/nbt.3117</pub-id><pub-id pub-id-type="pmid">25513782</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="pharmaceutics-14-01837-f001"><label>Figure 1</label><caption><p>Workflow for genome mining assisted BGC prediction and verification. The order and interplay of prediction tools, databases, and scientist is depicted. In orange letters, we point out pitfalls that could lead to incorrect predictions and can easily be overlooked. The correct order is depicted by the arrows and follows the numbered bold headlines. The light-yellow arrow represents a re-prediction of an outdated BGC annotation. Explanations regarding point 5. &#x0201c;Experimental verification&#x0201d;: The top part is the genomic locus with the putative BGC surrounded by a dotted outline; genes are numbered from 1&#x02013;6, BB stands for &#x0201c;backbone- gene&#x0201d; (gene No. 3; orange) and TF stands for &#x0201c;pathway-specific transcription factor&#x0201d; (gene No. 4, green). Yellow lightning bolt symbols represent genetic manipulation (i.e., gene deletion in case of BB or overexpression in case of TF). The colors represent the three different samples/transformants: The control (&#x0201c;C&#x0201d;) represents the wildtype (wt) or recipient strain and is illustrated by a grey flask, expression bars, and HPLC spectra (i.e., wt-like synthesis of the investigated secondary metabolite. In this case it is produced but in case of a silent BGC, the peak on the far right would be absent). Transformant 1 (&#x0201c;T1&#x0201d;) has the backbone gene deleted and is represented by an orange flask, gene expression bars and HPLC peaks (orange flat line; i.e., no synthesis of the secondary metabolite); Transformant 2 (&#x0201c;T2&#x0201d;) has the TF of the BGC overexpressed. It is depicted by a green flask, green gene expression bars and a green HPLC peak (i.e., overproduction of the secondary metabolite). Diagrams have either the expression level (&#x0201c;Expr.&#x0201d;) or the absorption value (&#x0201c;Abs.&#x0201d;) as the y-axis and time (&#x0201c;min&#x0201d;) as the x-axis. The setup of 5. Experimental verification represents one possibility of linking a putative BGC to its metabolite. After deposition into a database (6.), the gathered information about the BGC can be utilized for the prediction of BGCs in other genomes (2.).</p></caption><graphic xlink:href="pharmaceutics-14-01837-g001" position="float"/></fig><fig position="float" id="pharmaceutics-14-01837-f002"><label>Figure 2</label><caption><p>Molecular biology methods for BGC activation. Silent genes are depicted as grey or black arrows while active genes are green. Yellow thunder bolts represent genetic manipulation. Genetic manipulation that results in overexpression or deletion of a gene is abbreviated as &#x0201c;OE&#x0201d; or &#x0201c;KO&#x0201d; respectively. (<bold>a</bold>) The exchange of one (i.e., pathway-specific TF) or several promoter regions of the BGC of interest leads to gene activation. (<bold>b</bold>) Overexpression of a global regulator can lead to the activation of several BGCs all over the genome. (<bold>c</bold>) Heterologous expression of a BGC of interest in an expression host followed by cultivation, extraction and structure elucidation of the compound encoded within the BGC. (<bold>d</bold>) Genetic manipulation of a chromatin remodeler can lead to the de-repression or silencing of a BGC that is regulated by the respective remodeler. Silencing and expression-promoting histone modifications are depicted as grey and green pins respectively.</p></caption><graphic xlink:href="pharmaceutics-14-01837-g002" position="float"/></fig><fig position="float" id="pharmaceutics-14-01837-f003"><label>Figure 3</label><caption><p>Maturation of guide RNAs and Cas mediated Gene editing. (<bold>a</bold>) Methods for release of mature sgRNAs with Cas9. <bold>Top</bold>: the ~100 bp long sgRNA is flanked by the 37 bp Hammerhead (HH) and the 68 bp HDV ribozyme. Upon transcription by RNA polymerase II (RNA POL II), the sgRNA is released by the formation of secondary structure and autocleavage of the ribozymes. <bold>Bottom</bold>: Cas9 sgRNAs can be matured and released by flanking it by ~72 bp long tRNAs (i.e., glycine). Upon transcription by RNA polymerase III (RNA POL III), the tRNAs are cleaved by the endogenous RNAse P and RNAse Z and the mature sgRNA is released which then can form a functional complex with Cas9. Arrays of sgRNA and tRNAs can be cloned and expressed in vivo for multiplexing purposes. (<bold>b</bold>) Cas12a can process the CRISPR transcript itself. The expression fragment contains an only ~19 bp direct repeat followed by the approximately 25 bp long protospacer sequence. Due to its small size, it is easy to clone several guide RNAs in sequence for multiplexing purposes. After expression by RNA polymerase III (RNA POL III), the transcript is processed by Cas12a and the mature sgRNAs are released which can form a functional complex with Cas12a. (<bold>c</bold>) two options for gene editing with CRISPR/Cas technology. After the successful introduction of the double-strand break, the DNA can either be repaired via the non-homologous end joining pathway (NHEJ) or, if an oligo or gene with complementary regions (orange) is provided (i.e., HDR Substrate), the homology directed repair mechanism can be activated (HDR) and the provided genetic material is introduced into the target locus.</p></caption><graphic xlink:href="pharmaceutics-14-01837-g003" position="float"/></fig><fig position="float" id="pharmaceutics-14-01837-f004"><label>Figure 4</label><caption><p>Targeted gene activation approaches via CRISPR/Cas technology. (<bold>a</bold>) targeted chromatin remodeling via a chromatin active domain (CAD). DNA is depicted in dotted black lines, nucleosomes are cyan, heterochromatic histone modifications are grey pins while euchromatic histone modifications are green pins. A fusion protein of dCas and a CAD is targeted into a nucleosome-free region (NFR) in a heterochromatic area where it modifies the local histones. This leads to an increase in DNA accessibility and promotes transcription. (<bold>b</bold>) Targeted gene activation by dCas fused to a trans-activating domain (TAD; e.g., VPR). DNA is depicted as a black bar, genes are either grey (inactive) or green (active) arrows. The colored bars in front of the genes are target sites for dCas-TAD (i.e., protospacer sequence). dCas-TAD is sent into accessible promoter regions of target genes. The TAD recruits components of the transcriptional machinery which leads to the transcription of the target gene. By using multiple guide RNAs, several genes/promoters can be targeted simultaneously.</p></caption><graphic xlink:href="pharmaceutics-14-01837-g004" position="float"/></fig><table-wrap position="float" id="pharmaceutics-14-01837-t001"><object-id pub-id-type="pii">pharmaceutics-14-01837-t001_Table 1</object-id><label>Table 1</label><caption><p>List of platforms and databases used for BGC prediction. Ordered by the most recent update. Status March 2022.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="6" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Tools and Database Used for BGC Predictions</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tool/<break/>Database</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Purposes</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Last Update</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Link <break/>(Accessed on 15 March 2022)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EMBL-EBI/ENA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">uncurated Database (large repository: DNA, RNA, genome annotations)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">regular updates</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>ebi.ac.uk</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-pharmaceutics-14-01837" ref-type="bibr">87</xref>,<xref rid="B88-pharmaceutics-14-01837" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GenBank</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">uncurated Database (large repository: DNA, RNA, genome annotations)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">every 2 month</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>ncbi.nlm.nih.gov/genbank</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-pharmaceutics-14-01837" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GNPS </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0201c;Global Natural Products Social Molecular Networking&#x0201d; <break/>community-curated mass spectrometry database</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2022</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>gnps.ucsd.edu</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-pharmaceutics-14-01837" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">fungiSMASH</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gold standard for BGC prediction. Allrounder with an extensive variety of integrated tools and algorithms, web-application or stand-alone; Rule-based and rule-independent algorithms. Versions for fungi, bacteria and plants available. Fungal version has additional BGC border detection based on TF-binding sites </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri xlink:href="https://fungismash.secondarymetabolites.org/#!/start">https://fungismash.secondarymetabolites.org/#!/start</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B78-pharmaceutics-14-01837" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP-atlas 2.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">curated community database of microbially-derived SMs<break/>compounds from marine macro algae and diatoms are excluded</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>npatlas.org/</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B91-pharmaceutics-14-01837" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TIGRFAMs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">curated database of protein families (mainly prokaryotic)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>ncbi.nlm.nih.gov/genome/annotation_prok/tigrfams/</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-pharmaceutics-14-01837" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PFAM v35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">partly curated database protein domains and families</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>pfam.xfam.org/</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B93-pharmaceutics-14-01837" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FunOrder</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">detection of essential genes within a BGC by a co-evolutionary approach</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>github.com/gvignolle/FunOrder</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B72-pharmaceutics-14-01837" ref-type="bibr">72</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ARTS 2.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibiotics cluster prediction by detection of resistance genes; web application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>arts.ziemertlab.com</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-pharmaceutics-14-01837" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HMMER</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DNA based Homology search via pHMM; <break/>as source code or as web application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>hmmer.org/</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B94-pharmaceutics-14-01837" ref-type="bibr">94</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CO-OCCUR </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">genome-wide co-occurence of BGC-related gene pairs; source code available</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>github.com/egluckthaler/co-occur</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-pharmaceutics-14-01837" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TOUCAN </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC prediction via phylogeny, function, composition at amino acid level (k-mers, Pfam protein domains, and GO terms); <break/>source code (python/perl) available</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>github.com/bioinfoUQAM/TOUCAN</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B95-pharmaceutics-14-01837" ref-type="bibr">95</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antiSMASH Database v3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">high-quality genomes and BGCs of bacteria, archaea, and fungi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>antismash-db.secondarymetabolites.org/</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-pharmaceutics-14-01837" ref-type="bibr">96</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NORINE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">manually curated DB for NRPS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>bioinfo.lifl.fr/norine/</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B97-pharmaceutics-14-01837" ref-type="bibr">97</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FRIGG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibiotics BGC prediction based on presence of resistance gene; Pipeline that combines different tools; Python and R-based script available</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>zenodo.org/record/2560245#.YjlMHepBw5s</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B85-pharmaceutics-14-01837" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BIG-SCAPE + CORASON</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Output refinement</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">takes output of antismash and generates phylogenic BGC family networks; software application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>git.wageningenur.nl/medema-group/BiG-SCAPE</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B98-pharmaceutics-14-01837" ref-type="bibr">98</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MiBIg 2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">curated database (community effort and institute curation) of known BGCs and their products</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>mibig.secondarymetabolites.org/</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-pharmaceutics-14-01837" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IMG-ABC v5.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">predicted BGCs with environmental metadata (prediction via antiSMASH v5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>img.jgi.doe.gov/abc-public</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B100-pharmaceutics-14-01837" ref-type="bibr">100</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deep-BGC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deep learning strategy to determine BGC product classes and chemical activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>github.com/Merck/deepbgc</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-pharmaceutics-14-01837" ref-type="bibr">101</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RiPPMiner</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RiPPs; web-application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>nii.ac.in/rippminer.html</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B102-pharmaceutics-14-01837" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SBSPKSv2 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PKS/NRPS (structure/ substrate/ product)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>nii.ac.in/sbspks2.html</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B103-pharmaceutics-14-01837" ref-type="bibr">103</xref>,<xref rid="B104-pharmaceutics-14-01837" ref-type="bibr">104</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SEMPI 2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">genome-based PKS I modular product prediction; web-application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>pharmaceutical-bioinformatics.de/SeMPI/</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B105-pharmaceutics-14-01837" ref-type="bibr">105</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CASSIS and SMIPS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Promoter base- BGC prediction focused around SM-key enzymes, online or as application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>sbi.hki-jena.de/cassis</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B106-pharmaceutics-14-01837" ref-type="bibr">106</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FunGene-ClusterS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Transcriptome and genome-assisted BGC prediction; standalone and web application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>fungiminions.shinyapps.io/FunGeneClusterS</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B107-pharmaceutics-14-01837" ref-type="bibr">107</xref>,<xref rid="B108-pharmaceutics-14-01837" ref-type="bibr">108</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2metDB/SecmetDB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PKS/NRPS-prediction tool; software application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>sourceforge.net/projects/secmetdb/</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B109-pharmaceutics-14-01837" ref-type="bibr">109</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GNP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Structure prediction and LC-MS data peak identification; web-application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>magarveylab.ca/gnp/</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-pharmaceutics-14-01837" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Smiles2Mono-mers (s2m)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">predict monomers from polymeric structure; webserver and standalone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>bioinfo.lifl.fr/norine/smiles2monomers.jsp</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-pharmaceutics-14-01837" ref-type="bibr">111</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ClusterFinder</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC detection via Pfam domain occurrence in genome and metagenomic data;<break/>software application and integrated into <break/>antiSMASH and IMG-ABC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>github.com/petercim/ClusterFinder</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-pharmaceutics-14-01837" ref-type="bibr">82</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MIPS-CG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clusters of BGC-related Pfam-domains outside of syntenic blocks; web-application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><uri>fung-metb.net/</uri><break/>(currently offline)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B47-pharmaceutics-14-01837" ref-type="bibr">47</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MIDDAS-M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Motif-Independent transcriptome and genome-assisted BGC prediction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><uri>133.242.13.217/MIDDAS-M</uri><break/> (currently offline)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-pharmaceutics-14-01837" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ClusterMine-360</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">crowd-source, semi and auto-curated database of microbial NRPS and PKS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><uri>clustermine360.ca/</uri><break/>(currently offline)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B112-pharmaceutics-14-01837" ref-type="bibr">112</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NRPS-predictor2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">predict bacterial and fungal NRPS adenylation domain substrate specificity; web-application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><uri>nrps.informatik.uni-tuebingen.de/</uri><break/>(currently offline)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B113-pharmaceutics-14-01837" ref-type="bibr">113</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SMURF </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rule-based-backbone gene search via HMMs in genome data; web-application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>jcvi.org/smurf/</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-pharmaceutics-14-01837" ref-type="bibr">79</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CLUSEAN</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PKS/NRPS-prediction tool; software application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<uri>bitbucket.org/tilmweber/clusean</uri>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B114-pharmaceutics-14-01837" ref-type="bibr">114</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: Database (DB), Prediction Tool (PT).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pharmaceutics-14-01837-t002"><object-id pub-id-type="pii">pharmaceutics-14-01837-t002_Table 2</object-id><label>Table 2</label><caption><p>Successful application of BGC induction by mimicking environmental conditions or by genetic manipulation of global regulators.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">BGC Activation by Natural Triggers and Manipulation of Their Global Regulators</th></tr><tr><th colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Section 1: <italic toggle="yes">Aspergillus</italic> and <italic toggle="yes">Penicillium</italic></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trigger</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organism</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Observation</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">ApyapA&#x02206;</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus parasiticus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">ApyapA&#x02206;</italic>: increased aflatoxin production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B173-pharmaceutics-14-01837" ref-type="bibr">173</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">csnE&#x02206;</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">csnE&#x02206;</italic>: production of orsellinic acid-related metabolites: orcinol, diorcinol, <break/>cordyol C, violaceol I and violaceol II; activation of DHMBA cluster</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B181-pharmaceutics-14-01837" ref-type="bibr">181</xref>,<xref rid="B182-pharmaceutics-14-01837" ref-type="bibr">182</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">mcRA&#x02206;</italic> (TF)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
<break/>
<italic toggle="yes">Aspergillus terreus</italic>
<break/>
<italic toggle="yes">Penicillium canescens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">mcRA&#x02206;</italic>: Upregulation of secondary metabolites in all three organisms <break/><italic toggle="yes">A. nidulans</italic> dereplication strain: two new metabolites from the cichorine pathway, production of felinone A<break/>new compounds of other organisms not identified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B175-pharmaceutics-14-01837" ref-type="bibr">175</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">sumO&#x02206;</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">sumO&#x02206;</italic>: production of Asperthecin, decrease of austinol/dehydroaustinol and sterigmatocystin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B183-pharmaceutics-14-01837" ref-type="bibr">183</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Addditives <break/>(supernatant extract)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
<break/>
<italic toggle="yes">Streptomyces rapamycinicus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">a novel a guanidine containing macrolide named polaramycin B, produced by <italic toggle="yes">S. rapamycinicus</italic>, is responsible for the derepression of the ors- cluster and its derivates in <italic toggle="yes">A. nidulans</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B184-pharmaceutics-14-01837" ref-type="bibr">184</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Additives</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium citrinum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cultivation in presence of rare earth metals (i.e., scandium chloride) and isolation of three new peptide derivatives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B185-pharmaceutics-14-01837" ref-type="bibr">185</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C-source <break/>&#x02206;/OE of <italic toggle="yes">creA</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus flavus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">creA&#x02206;</italic> (Carbon catabolite repressor)<break/>Growth defects, impaired conidia production, increased amount of sclerotia, near abolishment of aflatoxin production, impaired virulence<break/>OE of <italic toggle="yes">creA</italic>: similar to wild type</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B122-pharmaceutics-14-01837" ref-type="bibr">122</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C-source</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carbon source dependent BGC expression</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B186-pharmaceutics-14-01837" ref-type="bibr">186</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C-source<break/><italic toggle="yes">laeA&#x02206;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium expansum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">sucrose decreases both patulin and <italic toggle="yes">laeA</italic> levels and increases <italic toggle="yes">creA</italic> expression<break/>LaeA regulates patulin BGC, <italic toggle="yes">laeA</italic><italic toggle="yes">&#x02206;</italic> results in less virulence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B144-pharmaceutics-14-01837" ref-type="bibr">144</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cultivation (chemostat)<break/>N starvation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Production of antiproliferative compounds sanghaspirodins A and B<break/>Convergence of two BGCs pathways (anthraquinone and orsellinic acid-derived)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B128-pharmaceutics-14-01837" ref-type="bibr">128</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/>Temperature<break/><italic toggle="yes">veA&#x02206;</italic><break/><italic toggle="yes">laeA&#x02206;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus fumigatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Connection between temperature and light regulation of 11 BGCs<break/>Involvement of VeA at 37 &#x000b0;C and LaeA at 30 &#x000b0;C and 37 &#x000b0;C in BGC regulation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B157-pharmaceutics-14-01837" ref-type="bibr">157</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/><italic toggle="yes">velB&#x02206;</italic><break/><italic toggle="yes">veA&#x02206;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">velvet complex VelB/VeA/LaeA regulates developmental regulation and secondary metabolism in a light-dependent manner.<break/><italic toggle="yes">velB&#x02206;</italic> or <italic toggle="yes">veA&#x02206;</italic>: defects in sexual fruiting-body formation and secondary metabolite production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B138-pharmaceutics-14-01837" ref-type="bibr">138</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/><italic toggle="yes">laeA&#x02206;, veA&#x02206;, velB&#x02206;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus ochraceus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">laeA&#x02206;</italic>/<italic toggle="yes">veA&#x02206;</italic>/<italic toggle="yes">velB&#x02206;</italic>: differential regulation of 66% of all BGC backbone genes (majority downregulated)<break/>drastic reduction of Ochratoxin A production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B136-pharmaceutics-14-01837" ref-type="bibr">136</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/>Velvet: <break/><italic toggle="yes">&#x02206;Apc.LaeA&#x02206; Apc.VeA&#x02206;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus pachycristatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Apc.LaeA&#x02206;</italic> or <italic toggle="yes">Apc.VeA</italic><italic toggle="yes">&#x02206;</italic> reduce production of echinocandin B and sterigmatocystin<break/>Impact of deletions on aerial hyphae, pigmentation, development of conidiophores, conidial germination rate, and ascospore maturation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B134-pharmaceutics-14-01837" ref-type="bibr">134</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media<break/>Mimicking of plant and rhizosphere environment<break/>Nitrogen, Metals, Amino acids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus terreus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(independent) signals for terrain production: methionine, nitrogen limitation, iron starvation (=host rhizosphere)<break/>Global regulators AreA and AtfA essential for terrain production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B119-pharmaceutics-14-01837" ref-type="bibr">119</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media composition<break/>Carbon source<break/>Amino acids<break/>CreA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus terreus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">discovery of isoflavipucine and dihydroisoflavipucine<break/>production only in the presence of certain amino acids, alkaline pH, and strictly repressed in the presence of glucose (CreA).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B167-pharmaceutics-14-01837" ref-type="bibr">167</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media<break/>C-source</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium citrinum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased production of citrinin on glucose compared to sucrose</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B187-pharmaceutics-14-01837" ref-type="bibr">187</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media<break/>HDACi<break/>DNMTi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus awamori</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media: MEA, rice, nutrient, triptone soya agar<break/>HDACi: valproic acid, nicotinamide, trichostatin A<break/>DNMTi: 5-azacytidine<break/>Different metabolic profiles between media and epigenetic modifiers<break/>Nicotinamide was found to be the best epigenetic inducer <break/>Rice grains were the best medium for SM induction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B188-pharmaceutics-14-01837" ref-type="bibr">188</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metals and Trace elements</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus fumigatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xanthocillin BGC-derived isocyanides help accumulate copper and exhibit antimicrobial activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B166-pharmaceutics-14-01837" ref-type="bibr">166</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metals and Trace elements</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus fumigatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HapX and SreA, which oppositely regulate iron homeostasis also control an iron-dependent secondary metabolite network comprising the virulence factor hexadehydroastechrome (tryptophan-derived iron (III)-complex) which causes an iron starvation phenotype upon overexpression</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B165-pharmaceutics-14-01837" ref-type="bibr">165</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metals and Trace elements<break/>Oxidative stress<break/><italic toggle="yes">sidC&#x02206;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NRPS SidC involved in iron regulation (excess and starvation)<break/>Upregulated by oxidative stress<break/><italic toggle="yes">sidC&#x02206;</italic>: bad iron utilization (reduced growth under iron-starvation and higher iron demand), delayed germination under iron-depleted conditions, higher sensitivity of conidia to oxidative stress, no cleistothecia formation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B169-pharmaceutics-14-01837" ref-type="bibr">169</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metals and Trace elements</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium brasilianum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CuSO4 and MnSO<sub>4</sub> alter the SM-profile<break/>production of a series of cyclodepsipeptides<break/>repression of verruculogen biosynthesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B163-pharmaceutics-14-01837" ref-type="bibr">163</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metals and Trace elements</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium urticae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eight metal ions tested<break/>manganese dependent conversion of 6-methylsylicylic acid to patulin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B164-pharmaceutics-14-01837" ref-type="bibr">164</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE <italic toggle="yes">laeA</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">overexpression of <italic toggle="yes">laeA</italic>: activation of the Terrequinone (tdi) cluster and production of terrequinone A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B189-pharmaceutics-14-01837" ref-type="bibr">189</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Osmotic &#x00026; <break/>Saline stress</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus aculeatus</italic><break/>Three ex-type strains from three different collections</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Osmotic (glycerol) and saline stress had different impacts on SM profile of fungal strains. Also strain-source specific chemotypes.<break/>Same morphology across all treatments</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B159-pharmaceutics-14-01837" ref-type="bibr">159</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxidative stress<break/>Carbon source</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus flavus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Strains that produce less aflatoxin are more prone to oxidative stress and have more differentially regulated genes (also SM genes) under oxidative stress conditions<break/>carbon source affects BGC expression and production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B190-pharmaceutics-14-01837" ref-type="bibr">190</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxidative stress<break/><italic toggle="yes">ApyapA&#x02206;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus ochraceus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">ApyapA&#x02206;</italic> shows missing redox balance which triggers aflatoxin synthesis and an involvement of oxidative stress in ochratoxin A regulation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B174-pharmaceutics-14-01837" ref-type="bibr">174</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxidative stress<break/><italic toggle="yes">veA&#x02206;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus parasiticus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">transcription factor AtfB regulates conidial tolerance towards oxidative stress<break/>AtfB binds to promoters with CRE sites in the aflatoxin cluster under inducing conditions. <italic toggle="yes">veA&#x02206;</italic> abolishes these interactions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B171-pharmaceutics-14-01837" ref-type="bibr">171</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pH</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">A. nidulans</italic>
<break/>
<italic toggle="yes">A. parasiticus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sterigmatocystin/aflatoxin expressed at higher levels at acidic pH than on neutral or alkalic pH<break/>Constitutive active PacC in <italic toggle="yes">A. nidulans</italic> reduced sterigmatocystin production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B150-pharmaceutics-14-01837" ref-type="bibr">150</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pH<break/>Acidic stress</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acid-Tolerant Fungi <italic toggle="yes">Penicillium</italic><break/><italic toggle="yes">Aspergillus</italic><break/><italic toggle="yes">Talaromyces</italic><break/><italic toggle="yes">Cladosporium</italic><break/><italic toggle="yes">Allophoma</italic><break/><italic toggle="yes">Alternaria</italic><break/><italic toggle="yes">Trichoderma</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Supernatant extracts: &#x000be; shows cytotoxic activity,<break/>&#x0003c;&#x000bc; show antimicrobial or anti-H1N1 activity<break/>pH-related chemical diversity of <italic toggle="yes">P. oxalicum</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B149-pharmaceutics-14-01837" ref-type="bibr">149</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pH<break/><italic toggle="yes">AcpacC&#x02206;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus carbonarius</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PacC involved in pathogenicity and Ochratoxin A production<break/><italic toggle="yes">AcpacC&#x02206;</italic>: impaired fungal growth at neutral/alkaline pH, diminished gluconic and citric acid production, reduced virulence toward grapes and nectarine fruits</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B148-pharmaceutics-14-01837" ref-type="bibr">148</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pH<break/>Light<break/>Temperature</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus flavus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aflatoxin production:<break/>5x increase of in darkness<break/>pH 4 media produces 30 times more than pH 7.4<break/>strongly reduced production at 18 or 40 &#x000b0;C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B191-pharmaceutics-14-01837" ref-type="bibr">191</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pH<break/><italic toggle="yes">pacC</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Penicillin highest at alkaline pH and in mutated <italic toggle="yes">pacC</italic> (mimics alkaline conditions)<break/>Production was lowest at acid pH and in strains that mimic acid pH</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B151-pharmaceutics-14-01837" ref-type="bibr">151</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solid-state vs. submerged fermentation<break/>Media</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus oryzae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solid-state: Increase of coumarins and oxylipins, higher antimicrobial activities<break/>submerged: Terpenoids abundant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B178-pharmaceutics-14-01837" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solid-state vs. submerged fermentation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium expansum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Submerged fermentation: strongly increased production of polyketide metabolites (agonodepside B, rotiorin, verrucosidin, and ochrephilone)<break/>Solid-state fermentation: exclusive production of meroterpenoid compounds (andrastin A and C)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B177-pharmaceutics-14-01837" ref-type="bibr">177</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Temperature</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus fumigatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Temperature affects stress tolerance, pigmentation, and trypacidin accumulation in conidia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B192-pharmaceutics-14-01837" ref-type="bibr">192</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Temperature</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus fumigatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endocrocin biosynthesis in spores is temperature-dependent and endocrine is connected to pathogenicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B193-pharmaceutics-14-01837" ref-type="bibr">193</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Temperature</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium oxalicum</italic>
<break/>
<italic toggle="yes">P. citrinum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unique metabolite profile under temperature stress</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B194-pharmaceutics-14-01837" ref-type="bibr">194</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Temperature Oxidative stress<break/>Culture conditions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus flavus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Float culture method<break/>Stress conditions:<break/>aflatoxin is downregulated under stress<break/>secondary metabolites with antioxidant properties (e.g., kojic acid and imizoquins) were upregulated under stress</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B118-pharmaceutics-14-01837" ref-type="bibr">118</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Velvet:<break/><italic toggle="yes">&#x00394;laeA</italic><break/><italic toggle="yes">laeA-OE</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">laeA&#x02206;</italic>: abolishment of sterigmatocystin, penicillin, and lovastatin<break/><italic toggle="yes">laeA-OE</italic>: increased penicillin and lovastatin production<break/><italic toggle="yes">laeA</italic> expression is negatively regulated by AflR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B142-pharmaceutics-14-01837" ref-type="bibr">142</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">mpkA&#x02206;</italic><break/>(kinase knockout library)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">mpkA&#x02206;</italic>: activation of the pkf-cluster and production of aspernidine A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B195-pharmaceutics-14-01837" ref-type="bibr">195</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Section 2: <italic toggle="yes">Fusarium</italic></bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Trigger</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Organism</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Observation</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Ref.</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02206;/OE <italic toggle="yes">lae1</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x00394;lae1</italic>: downregulation of unknown NRPS4 cluster<break/><italic toggle="yes">OE-lae1</italic> induced beauvericin cluster and STC7-cluster (product not identified)<break/>generally LaeA has a substantial impact on many SMs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B147-pharmaceutics-14-01837" ref-type="bibr">147</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x02206;areA</italic>, <italic toggle="yes">&#x02206;areB</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">deletions have an impact on &#x0003e;50% of BGCs<break/><italic toggle="yes">&#x02206;areB</italic>: upregulation of cryptic clusters PKS09, NRPS04, NRPS21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-pharmaceutics-14-01837" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x02206;areA</italic>, <italic toggle="yes">areB</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AreA and <italic toggle="yes">AreB</italic> are required for gibberellic acid production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B196-pharmaceutics-14-01837" ref-type="bibr">196</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">&#x02206;pacC</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">pacC</italic> deletion de-represses bikaverin cluster-complementation with active <italic toggle="yes">pacC</italic> variant represses bikaverin cluster</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-pharmaceutics-14-01837" ref-type="bibr">153</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Global regulator of development<break/><italic toggle="yes">&#x00394;csm1</italic> (<italic toggle="yes">NsdD</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x00394;csm1</italic>: elevated conidiation in wt and also in non-sporulating <italic toggle="yes">&#x00394;veA</italic> strain. Induction of BGC for bikaverin and fusarubins<break/>Impact on 19 of 47 BGCs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B176-pharmaceutics-14-01837" ref-type="bibr">176</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/>N-source<break/><italic toggle="yes">&#x02206;veA</italic>, <italic toggle="yes">&#x02206;laeA</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium oxysporum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">velvet complex and nitrate metabolism intertwined<break/><italic toggle="yes">&#x02206;veA</italic> or <italic toggle="yes">&#x02206;laeA</italic>: growth impaired on nitrate/nitrite<break/><italic toggle="yes">AREA</italic> involved in chromatin accessibility of two velvet-regulated BGCs (beauvericin and siderophore ferricrocin)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B131-pharmaceutics-14-01837" ref-type="bibr">131</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/>N- source<break/>pH<break/><italic toggle="yes">&#x02206;areA</italic>, <italic toggle="yes">&#x02206;areB</italic><break/><italic toggle="yes">&#x02206;vel1</italic>, <italic toggle="yes">&#x02206;lae1</italic><break/><italic toggle="yes">&#x02206;pacC</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x02206;areA</italic>: reduces fusaric acid production<break/><italic toggle="yes">&#x02206;areB</italic>: abolished fusaric acid production<break/><italic toggle="yes">&#x02206;vel1</italic> and <italic toggle="yes">&#x02206;lae1</italic>: significant reduction of fusaric acid<break/><italic toggle="yes">&#x02206;pacC</italic>: abolishment of fusaric acid cluster expression</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B197-pharmaceutics-14-01837" ref-type="bibr">197</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/><italic toggle="yes">&#x02206;fgwc-1</italic>
<break/><italic toggle="yes">&#x02206;fgwc-2</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium graminearum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x02206;fgwc-1</italic>/<italic toggle="yes">&#x02206;fgwc-2</italic>:<break/>impaired carotenogenesis, photoreactivation and maturity of perithecia<break/>mutants produced more aurofusarin and trichothecenes independent from light and have derepressed conidiation during constant light</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B198-pharmaceutics-14-01837" ref-type="bibr">198</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/><italic toggle="yes">&#x02206;vel1, &#x02206;vel2, &#x02206;lae1</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x02206;ffvel1</italic> and <italic toggle="yes">&#x02206;fflae1</italic>: velvet positively regulates gibberellic acid, fumonisins and fusarin C, velvet negatively regulates bikaverin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B141-pharmaceutics-14-01837" ref-type="bibr">141</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N-source <break/>pH<break/>Host infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
<break/>
<italic toggle="yes">F. circinatum</italic>
<break/>
<italic toggle="yes">F. mangiferae</italic>
<break/>
<italic toggle="yes">F. oxysporum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PKS19 cluster is induced on rice but not maize<break/>Gibberelic acid cluster only expressed in <italic toggle="yes">F. fujikuroi</italic><break/>Different conditions for different metabolites necessary: fusarins: high nitrogen, bikaverin and fusarubins: acidic low nitrogen or alkaline low nitrogen, Fumonisin B1: acidic low nitrogen</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B125-pharmaceutics-14-01837" ref-type="bibr">125</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N-source<break/><italic toggle="yes">&#x02206;areA</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium graminearum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">asparagine was found to be a preferential nitrogen source. <break/><italic toggle="yes">&#x02206;areA</italic> led to poor growth on NaNO<sub>3</sub>
<break/>Utilization of aspartic acid, histidine, isoleucine, leucine, threonine, tyrosine, and valine as nitrogen sources was shown to depend of a functional AREA. <break/>AREA is required for the production of deoxynivalenol (DON), zearalenone, and fusarielin H regardless of the medium</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B129-pharmaceutics-14-01837" ref-type="bibr">129</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N-source<break/><italic toggle="yes">&#x02206;areA</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Gibberella fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02206;areA: significantly reduced gibberellin production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B199-pharmaceutics-14-01837" ref-type="bibr">199</xref>],<break/>[<xref rid="B200-pharmaceutics-14-01837" ref-type="bibr">200</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N-source/starvation<break/>&#x02206; of N-pathway regulators</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium Fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Effect of N-source (glutamine, nitrate) and starvation in different mutants<break/><italic toggle="yes">&#x00394;niaD, &#x00394;nrtA, &#x00394;nirA</italic> and <italic toggle="yes">&#x00394;areA</italic><break/>expression of backbone genes of gibberellic acid and bikaverin BGC after 72 h in starvation in wt and all mutants except for gibberellic acid in <italic toggle="yes">&#x00394;areA</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B124-pharmaceutics-14-01837" ref-type="bibr">124</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pH<break/><italic toggle="yes">PAC1</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium graminearum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pac1 negatively regulates trichothecene BGC; induction under acidic pH<break/>&#x00394;fgpac1: reduced development under neutral and alkaline pH, increased sensitivity to H<sub>2</sub>O<sub>2</sub> and early onset of Tri expression and product synthesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B155-pharmaceutics-14-01837" ref-type="bibr">155</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Temperature</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium langsethiae</italic>
<break/>
<italic toggle="yes">F. sporotrichioides</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Impact of temperature and time on spore amount and T-2, HT-2 toxin production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B201-pharmaceutics-14-01837" ref-type="bibr">201</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Section 3: Other Species</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Trigger</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Organism</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Observation</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Ref.</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Additives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Colletotrichum gloeosporioides</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Triggering silent BGCs by natural dietry components: Grape skin and turmeric extracts resulted in 20 and 14 additional compounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B202-pharmaceutics-14-01837" ref-type="bibr">202</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C-source</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Spicaria elegans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">starch vs. glucose<break/>novel spicochalasin A and five new aspochalasins (M&#x02013;Q)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B203-pharmaceutics-14-01837" ref-type="bibr">203</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Co-cultivation<break/>Additives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Isaria felina</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">potassium bromide and cocultivation with <italic toggle="yes">Aspergillus sulphureus:</italic><break/>discovery of Isariketide B and Oxirapentyn L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B204-pharmaceutics-14-01837" ref-type="bibr">204</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cultivation optimization for SM production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Phomopsis</italic> sp. <italic toggle="yes">Hant25</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Optimization of different media and cultivation parameters for overproduction of mycoepoxydiene<break/>Parameters: combination of stationary and agitated, solid support (cellulose paper disc), different medias, cultivation time</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B179-pharmaceutics-14-01837" ref-type="bibr">179</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/><italic toggle="yes">&#x02206;lreA</italic><break/>(=<italic toggle="yes">WC-1</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Alternaria alternata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Opposite light regulation of mycotoxin and spore production<break/>spores decreased under light and<break/>production of alternariol increased two to three times<break/>altertoxin production was strictly dependent on light.<break/>&#x02206; white-collar 1 (<italic toggle="yes">WC-1</italic>) gene (<italic toggle="yes">lreA</italic>):<break/>derepression of spore formation in dark and in light.<break/>altertoxin formation strongly induced in the dark<break/>alternariol formation partially dependent on LreA<break/>still able to partially respond to blue light</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B205-pharmaceutics-14-01837" ref-type="bibr">205</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/>Velvet<break/><italic toggle="yes">&#x02206;velB</italic><break/><italic toggle="yes">&#x02206;veA</italic><break/><italic toggle="yes">&#x02206;laeA</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Cuetootiopsis microspora</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Velvet Complex involved in the development, stress tolerance, and secondary metabolism<break/><italic toggle="yes">&#x02206;velB</italic>: hypersensitive to osmotic stress and congo red<break/>pestalotiollide B production requires <italic toggle="yes">velB</italic> and <italic toggle="yes">laeA</italic>.<break/><italic toggle="yes">veA</italic> inhibits pestalotiollide B biosynthesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B132-pharmaceutics-14-01837" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/>Velvet<break/>Iron starvation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Neurospora crassa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Velvet controls development, secondary metabolism, and light-dependent carotenoid production<break/>Heterotrimeric velvet complex (VE-1/VE-2/LAE-1) suppresses the production of the siderophore coprogen under iron starvation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B133-pharmaceutics-14-01837" ref-type="bibr">133</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/>C-source<break/><italic toggle="yes">&#x02206;CRE1</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Trichoderma reesei</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intertwined regulation of light and carbon pathways<break/>CRE1- regulated cluster is responsible for light-dependent production of dihydrotrichotetronin<break/>Biosynthesis of the antibiotic paracelsin was influenced</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B135-pharmaceutics-14-01837" ref-type="bibr">135</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light<break/><italic toggle="yes">&#x02206;SUB1</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Trichoderma reesei</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">SUB1</italic> is light-regulated<break/>SUB1 affects growth and is required for female fertility<break/>SM is regulated by SUB1 in a light- and nutrient-dependent manner</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B206-pharmaceutics-14-01837" ref-type="bibr">206</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media<break/>Salts<break/>Cultivation type</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Nigrospora</italic> sp. <italic toggle="yes">MA75</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Discovery of 2,3-didehydro-19a-hydroxy-14-epicochlioquinone B, 6-O-desmethyldechlorogriseofulvin 6&#x02032;-hydroxygriseofulvin<break/>Media: NaCl vs. NaI, static/solid vs. agitated/liquid, rice-based vs. yeast extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B207-pharmaceutics-14-01837" ref-type="bibr">207</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media<break/>HDACi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Drechslera</italic> sp.,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi: SAHA, valproate, octanoylhydroxamic acid<break/>2 new metabolites: chromanone and prenylhydroxybenzoic acid <break/>different metabolome between MEA and minimal media<break/>biotransformation of the inhibitors occurred</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B208-pharmaceutics-14-01837" ref-type="bibr">208</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media<break/>HDACi<break/>DNMTi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Cladosporium resinae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media. Czapek-DOX, YES, PDA, starch, liquid vs. solid<break/>HDACi: SAHA<break/>DNMTi: 5-AZA<break/>Czapek yeast extract broth: more total secondary metabolites<break/>DNMTi and HDACi: expressions of silent genes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B209-pharmaceutics-14-01837" ref-type="bibr">209</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N-source<break/><italic toggle="yes">&#x02206;AcareA</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Acremonium chrysogenum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
AcareA is required for nitrogen metabolism and cephalosporin production
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B130-pharmaceutics-14-01837" ref-type="bibr">130</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">OE-laeA</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Chaetomium globosum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">overexpression of <italic toggle="yes">laeA</italic>: activation of the chaetoglobosin gene cluster and production of chaetoglobosin Z</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B145-pharmaceutics-14-01837" ref-type="bibr">145</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pH<break/><italic toggle="yes">&#x00394;pacC</italic><break/><italic toggle="yes">pacC<sup>c</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Trichoderma virens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x00394;pacC</italic>: decreased competitiveness against <italic toggle="yes">Rhizoctonia solani</italic> and <italic toggle="yes">Sclerotium rolfsii</italic><break/>Constitutive PacC: wt like overgrowth of <italic toggle="yes">R. solani</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B152-pharmaceutics-14-01837" ref-type="bibr">152</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant Hormones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Arthrinium sacchari</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">discovery of the polyketides kinetin, 6-benzylaminopurine, and forchlorfenuron</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B210-pharmaceutics-14-01837" ref-type="bibr">210</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salinity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47 marine fungi isolates</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NaCl and KCl had growth-promoting effect on most marine fungi and 15% of isolates showed increased antifungal activity against Candida albicans,<break/>NaCl had impact on the metabolite profile</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B160-pharmaceutics-14-01837" ref-type="bibr">160</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salinity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Spicaria elegans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Different secondary metabolites on different saline conditions (3% and 10%)<break/>Four metabolites, only at 10% salinity: (2E,2&#x02019;Z)-3,3&#x02019;-(6,6&#x02019;-dihydroxybiphenyl-3,3&#x02019;-diyl) (new compound), diacrylic acid, aspulvinone E, aspochalasin E and trichodermamide B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B162-pharmaceutics-14-01837" ref-type="bibr">162</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solid vs. liquid fermentation<break/>Solid growth support</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Cylindrocarpon</italic> sp.<break/><italic toggle="yes">Acremonium</italic> sp.<break/><italic toggle="yes">Penicillium</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Addition of inert absorbent polymeric attachment supports in solid state and submerged fermentation leading to distinct metabolite profiles<break/>Impact on culture morphology and relative metabolite yields<break/>Solid agar with moist polyester-cellulose paper:<break/><italic toggle="yes">Cylindrocarpon</italic> sp. (pyrrocidines A and B), <italic toggle="yes">Acremonium</italic> sp. (acremonidins A&#x02013;E)<break/>Agitated submerged cultures:<break/>Complex HPLC metabolome, decrease in target compounds<break/>Liquid fermentation with various inert growth supports (polypropylene, polypropylene cellulose, polyester-cellulose, or polyurethane): production of<break/>rugulosin, skyrin, flavomannin, and the new compound WF159-A (bisanthracene)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B180-pharmaceutics-14-01837" ref-type="bibr">180</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Temperature</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 polar fungal isolates</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45% of fungal strains showed antimicrobial activity<break/>Different fungal metabolite profiles dependent on temperature (4, 10, 15, 28 &#x000b0;C)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B158-pharmaceutics-14-01837" ref-type="bibr">158</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">&#x00394;vmlaeA</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Valsa mali</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">
&#x00394;vmLaeA
</italic>
: reduced virulence and differential regulated secondary metabolism profile (31/60).
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B143-pharmaceutics-14-01837" ref-type="bibr">143</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>The table is separated into three sections: Section 1 contains studies that were conducted on fungi of the genus Aspergillus or Penicillium, Section 2 comprises fungi from the genera Fusarium and Section 3 presents studies with filamentous fungi of other genera. The sections themselves are ordered alphabetically by the trigger that was applied. Signs and Abbreviations: &#x00394;: deletion of a gene; OE: overexpression of a gene; TF: transcription factor.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pharmaceutics-14-01837-t003"><object-id pub-id-type="pii">pharmaceutics-14-01837-t003_Table 3</object-id><label>Table 3</label><caption><p>Discovery of new secondary metabolites by co-cultivation. Ordered by Set-up type.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">BGC Activation by Co-Cultivation</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Setup</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Method</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organism</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Observation</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Co-cultivation of two developmental stages (morphs) of a marine alga-derived fungus<break/>Pre-grow both morphs on agar plates (2&#x02013;3 weeks) &#x02192; small liquid pre-cultures &#x02192; combine mono-cultures after 14 days &#x02192; cultivate for 15&#x02013;20 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus alliaceus</italic> and its teleomorph <italic toggle="yes">Petromyces alliaceus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Production of the cytotoxic chlorinated bianthrone allianthrone A (only liquid)<break/>Morphs develop new phenotype in co-culture under liquid but not solid fermentation <break/>Restreaks after co-culture keep phenotype and can produce bianthrones on liquid and solid media</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B218-pharmaceutics-14-01837" ref-type="bibr">218</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Submerse co-culture and membrane-separated culture<break/>5 mL of pre-culture (A. flavipes and Streptomyces sp. in a ratio of 1:4 (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>)) were added to 200 mL medium 8 days of cultivation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus flavipes</italic> marine actinomycete <italic toggle="yes">Streptomyces</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Production of five aspochalasins and rosellichalasin by fungus with cytotoxic effects against Streptomyces. Physical interaction necessary</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B219-pharmaceutics-14-01837" ref-type="bibr">219</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 media (ISP2, GYE, F) inoculated with 3d old pre-cultures. 4L culture, fungal preculture was incubated 2 d earlier, 6 h before harvest 50 g/L Diaion HP-20 resin was added</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus fumigatus</italic> MR2012 (marine)<break/><italic toggle="yes">Streptomyces leeuwenhoekii</italic> (C34 and C58) (desert)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fungus: production of luteoride D (luteoride derivative), pseurotin G (pseurotin derivative), terezine D, 11-O-methylpseurotin A<break/>Bacteria C34: Chaxapeptin C58: Chaxapeptin doubled, pentalenic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B220-pharmaceutics-14-01837" ref-type="bibr">220</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 h old mycelia of <italic toggle="yes">A. fumigatus</italic> were washed and placed in fresh AMM with 1/20 vol of the <italic toggle="yes">streptomyces</italic> culture or with 1/20 filtered supernatant. Harvest after 12 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus fumigatus</italic>
<break/>
<italic toggle="yes">Streptomyces rapamycinicus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">induction of fungal PKS FgnA, the discovery of bacteria-specific germination inhibitor fumigermin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B221-pharmaceutics-14-01837" ref-type="bibr">221</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 day 30 &#x000b0;C liquid agitated co-culture (93 mL London + 32 mL GYM medium). simultaneous inoculation of both MOs (equal amounts of spores)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
<break/>
<italic toggle="yes">Streptomyces mobaraensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">bacterial glycopeptide (antibiotic) triggers antibacterial and iron-chelating tropolonesanhydrosepedonin and antibiotic C (<italic toggle="yes">A. nidulans</italic>), polyketide tripyrnidone (novel structure)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B222-pharmaceutics-14-01837" ref-type="bibr">222</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solid rice medium </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus versicolor</italic>
<break/>
<italic toggle="yes">Bacillus subtilis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">two new tetralones; aspvanicin A and aspvanicin B<break/>several other cryptic SMs; cytotoxic activity against mouse lymphoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B223-pharmaceutics-14-01837" ref-type="bibr">223</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Confrontation assay on ISP2 agar<break/>MALDI-TOF straight from agar<break/>Inoculation for 48 h at 30 &#x000b0;C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus fumigatus</italic><break/><italic toggle="yes">Aspergillus niger</italic><break/><italic toggle="yes">Bacillus</italic><break/><italic toggle="yes">amyloliquefaciens</italic> (GA40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The coral-derived bacteria GA40 produced an antifungal iturin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B224-pharmaceutics-14-01837" ref-type="bibr">224</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Precultures on rice media 1 week then co-culture for 2 weeks. Axenic cultivation with potassium bromide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus sulphureus</italic> KMM 4640<break/><italic toggle="yes">Isaria feline</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">discovery of Isariketide B (rice media with KBr) and Oxirapentyn L (Co-cultivation)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B204-pharmaceutics-14-01837" ref-type="bibr">204</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fungal bacterial stepwise liquid co-culture. Addition of bacterial broth (1/1000) to fungal culture on day 3. Further cultivation for 2 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Emericella</italic> sp. <break/>(CNL-878; marine fungus)<break/><italic toggle="yes">Salinispora arenicola</italic> (CNH-665; ascomycete)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Emericellamides A and B synthesis by <italic toggle="yes">Emericella</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B225-pharmaceutics-14-01837" ref-type="bibr">225</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solid agar confrontation assay (5 days)<break/>Submerged fermentation (2 mL of each pre-culture and cultivation for 5 days in broth)<break/>Co-cultivation of MF028 with five other strains<break/>time-course</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Chaunopycnis</italic> sp. (CMB-MF028)<break/><italic toggle="yes">Trichoderma hamatum</italic> (CMB-MF030)<break/>Co-isolated from mollusc <italic toggle="yes">Siphonaria</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chaunopyran A production<break/>Cultivation on sterilized mycelia showed no induction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B226-pharmaceutics-14-01837" ref-type="bibr">226</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Extraction of confrontation zone (Agar)<break/>Incubation of several weeks<break/>Dereplication via monocultures<break/>Method development:<break/>~600 cultures by confrontation assay on agar<break/>UHPLC&#x02013;TOF-MS fingerprints of mono and cocultures have been prepared to filter out new peaks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Fusarium</italic> isolates (clinical, soil<break/>or plant-derived)<break/><italic toggle="yes">Aspergillus clavatus, Trichophyton rubrum, Acremonium, Cladosporium</italic> sp. <italic toggle="yes">Hohenbuehelia reniformis</italic><break/><italic toggle="yes">Bionectria ochroleuca Eutypa lata</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chemical novel MS spectra have been recorded<break/>Results indicate that a large portion of fungi produce new metabolites in co-culture</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B213-pharmaceutics-14-01837" ref-type="bibr">213</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solid state confrontation cultivation<break/>17 basidiomycetes, 136 co-cultures<break/>Molecular network analysis<break/>Liquid co-cultivation for 5&#x02013;30 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Ganoderma</italic>
<break/>
<italic toggle="yes">applanatum</italic>
<break/>
<italic toggle="yes">Trametes versicolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">discovery of novel xylosides <break/>3-phenyllactic acid and orsellinic acid<break/>in <italic toggle="yes">G. applanatum</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B227-pharmaceutics-14-01837" ref-type="bibr">227</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Addition of bacterial broth (1/1000) to fungal culture on day 3. Harvest after 24 h. Screen of 50 fungal strains</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Libertella</italic> sp. <break/>(CNL-523)<break/><italic toggle="yes">&#x003b1;-proteobacterium</italic> (CNJ-328)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Discovery of Libertellenones A&#x02013;D, produced by the addition of marine &#x003b1;-proteobacterium to a 3-day <italic toggle="yes">Libertella</italic> sp. culture.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B228-pharmaceutics-14-01837" ref-type="bibr">228</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Submerged fermentation<break/>Different pre-grow times before co-cultivation. Optimal: addition of fungal culture to 2-day bacterial culture and further incubation for 7 days. Other setups showed metabolome of either bacterial or fungal axenic culture</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Penicillium</italic> sp. <break/><italic toggle="yes">(WC-29-5) Streptomyces fradiae</italic> (007)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Production of five phenolic polyketides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B229-pharmaceutics-14-01837" ref-type="bibr">229</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solid rice media, Cultivation parameters <break/>Optimal: inoculation of Penicillium sp mycelium plug. and seed medium of <italic toggle="yes">Bacillus</italic> sp. simultaneously at the center of petri dish 15d culture</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Penicillium</italic> sp. <break/>(DT-F29)<break/><italic toggle="yes">Bacillus</italic> sp. (B31)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ten bioactive 2,5-diketopiperazines by <italic toggle="yes">Penicillium</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B230-pharmaceutics-14-01837" ref-type="bibr">230</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Co-cultivation on solid rice medium</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Penicillium strains</italic> (IO1 and IO2) isolated from sponge</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Accumulation of norlichexanthone and monocerin, biotransformation of the antifungal pyridoxatin to methyl-pyridoxatin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B231-pharmaceutics-14-01837" ref-type="bibr">231</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liquid co-culture with seawater-based marine<break/>nutrient medium. After 24 h, bacterial culture is added to fungal cultivation following further 6d cultivation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Pestalotia</italic><break/>(marine fungus)<break/>CNJ-328 <break/>(marine bacterium)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Discovery of pestaolne (antibiotic)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B216-pharmaceutics-14-01837" ref-type="bibr">216</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Submerged fermentation and sea water agar, inoculation of flasks with spores of both fungi, cultivation for 9 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Talaromyces aculeatus</italic>
<break/>
<italic toggle="yes">Penicillium variabile</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Four new polyketides (penitalarins A/ B/C and nafuredin B)<break/>cytotoxicity against some human cancer cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B232-pharmaceutics-14-01837" ref-type="bibr">232</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mycelia from <italic toggle="yes">A nidulans</italic> o/n preculture was combined with 1/20 (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) <italic toggle="yes">Sreptomyces</italic> preculture in fresh AMM medium. Further cultivation at 37 &#x000b0;C for 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus nidulans</italic> with a collection of 58 soil-dwelling actinomycetes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Physical interaction between the fungus and <italic toggle="yes">Streptomyces hygroscopicus.</italic> Induction of orsellinic acid and derivatives (lecanoric acid, yellow polyketides)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B215-pharmaceutics-14-01837" ref-type="bibr">215</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Co-culture in Warkingsman&#x02019;s agar (Confrontation assay) and liquid medium (5 days) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Fusarium graminearum</italic><break/>vs. <break/>12.000 bacteria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">reduced virulence of <italic toggle="yes">F. graminearum</italic> due to <italic toggle="yes">Pseudomonas piscium</italic><break/>(FgGcn5 inhibitor phenazine-1-carboxamide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B214-pharmaceutics-14-01837" ref-type="bibr">214</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">treatment of <italic toggle="yes">Aspergillus</italic> with<break/>extracts of <italic toggle="yes">Streptomyces</italic> cultures </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
<break/>
<italic toggle="yes">Streptomyces rapamycinicus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">a guanidine containing macrolide, polaramycin B that is constitutively produced by the bacteria triggers the production of the ORS BGC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B184-pharmaceutics-14-01837" ref-type="bibr">184</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">analytical scale microbial cultivations in a 24-well plate<break/>cultivation in presence of metabolites from other cultivation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus</italic> sp.<break/><italic toggle="yes">Streptomyces</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">bacteriostatic cyclo-(L-Phe-trans-4-hydroxy-L-Pro) from <italic toggle="yes">Aspergillus</italic> stimulates nitric oxide production by <italic toggle="yes">Streptomyces</italic> which triggers silent BGC of <italic toggle="yes">Aspergillus</italic>: fungistatic heronapyrrole B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B233-pharmaceutics-14-01837" ref-type="bibr">233</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="pharmaceutics-14-01837-t004"><object-id pub-id-type="pii">pharmaceutics-14-01837-t004_Table 4</object-id><label>Table 4</label><caption><p>Successful application of overexpression methods for induction of BGCs. Entries are ordered alphabetically by organism.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Targeted BGC Activation by Overexpression</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Method</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Target/Parameter</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organism</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Observation</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">fsqA</italic> (TF)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus fumigatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE of <italic toggle="yes">fsqA</italic> (fsq gene cluster) <break/>production of pyrido [1,2-b]isoquinolines fumisoquin A and fumisoquin B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B249-pharmaceutics-14-01837" ref-type="bibr">249</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">xanC</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus fumigatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE of <italic toggle="yes">xanC</italic>: Activation of xan cluster and production of xanthocillin derivatives, the sulfated xanthocillin derivative BU-4704 and xanthocillin X monomethyl ether</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B250-pharmaceutics-14-01837" ref-type="bibr">250</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CRISPRa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AN8506 AN8507 <italic toggle="yes">mdpE</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Method establishment: upregulation of putative BGC genes (AN8506, AN8507) and the silent mdP cluster via nucleosome map assisted targeting of inducible VPR-dCas9 into accessible chromatin in promoter </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B251-pharmaceutics-14-01837" ref-type="bibr">251</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CRISPRa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">breF, fuml, fwnA</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Method establishment: fusion of different chromatin active enzymes/domains to dCas9, activation of <italic toggle="yes">breF</italic> and <italic toggle="yes">fuml</italic> via p300-dCas9 (HAT), <break/>repression of <italic toggle="yes">breF</italic> by HAT GcnE-dCas9 and HDAC HosA-dCas9 and RpdA-dCas9 <break/>activation of <italic toggle="yes">fwnA</italic> by HosA-dCa9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B252-pharmaceutics-14-01837" ref-type="bibr">252</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CRISPRa (multiplex)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mic- BGC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">method establishment: activation of mic cluster by dCas12a-VPR (multigene <break/>CRISPRa): dehydromicroperfuranone production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B253-pharmaceutics-14-01837" ref-type="bibr">253</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hybrid Activator</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Asperlin cluster</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">fusion of the DNA binding domain of AlnR (pathway-specific TF) and the trans-activation domain of AfoA lead to the activation of the (+)-Asperlin cluster</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B246-pharmaceutics-14-01837" ref-type="bibr">246</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">aspyridone cluster (asp)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">overexpression of the pathway-specific TF <italic toggle="yes">apdR</italic>: activation of the silent BGC and production of aspyridone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B237-pharmaceutics-14-01837" ref-type="bibr">237</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">ctnR</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">overexpression of the TF ctnR: Cluster activation (7 genes) and asperfuranone biosynthesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B238-pharmaceutics-14-01837" ref-type="bibr">238</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">TFBB gene</td><td align="center" valign="middle" rowspan="1" colspan="1">several BGCs</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Chicorine cluster activation<break/>pkg cluster activation: alternariol, citreoisocoumarin, analogs of citreoisocoumarin<break/>pki cluster: 6-Hydroxy-7-methyl-3-nonylisoquinoline-5,8-dione<break/>pkhB /pkhA: 2,4-dihydroxy-6-[(3E,5E,7E)-2-oxonona-3,5,7-trienyl]benzaldehyde<break/>Pkd: 2-ethyl-4,6-dihydroxy-3,5-dimethylbenzaldehyde</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B243-pharmaceutics-14-01837" ref-type="bibr">243</xref>]</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">pbcR</italic>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">overexpression of <italic toggle="yes">pbcR</italic> resulted in upregulation of a 7-gene cluster and the production of ent-pimara-8(14),15-diene</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B254-pharmaceutics-14-01837" ref-type="bibr">254</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BB gene<break/>Het. Expr.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">micro-perfuranone (micA, BGC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">promoter exchange or heterologous expression (<italic toggle="yes">A. niger</italic>) of backbone gene <italic toggle="yes">micA</italic> was sufficient to produce microperfuranone </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B255-pharmaceutics-14-01837" ref-type="bibr">255</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BB gene<break/>Het. Expr.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">asqK</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE of BB gene and heterologous expression for stepwise pathway elucidation: <break/>Products: 4&#x02032;-methoxylated 6,7-benzodiazepinediones and 4&#x02032;-methoxyviridicatin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B256-pharmaceutics-14-01837" ref-type="bibr">256</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple<break/>genes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inpE cluster</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">promoter replacement of seven genes (inpC-inpB):<break/>production of protease inhibitor fellutamide B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B248-pharmaceutics-14-01837" ref-type="bibr">248</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple<break/>genes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ivo cluster</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE of <italic toggle="yes">ivoA</italic>, <italic toggle="yes">B</italic> and <italic toggle="yes">C</italic> (and combinations): production of a dark pigment with the precursors N-acetyltryptophan and N-acetyl-6-hydroxytryptophan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B247-pharmaceutics-14-01837" ref-type="bibr">247</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple<break/>genes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">sgdA, D, C, F</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">promoter replacements (4 genes): production of aspernidgulene&#x02005;A1 and A2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B257-pharmaceutics-14-01837" ref-type="bibr">257</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">azaR</italic> (TF)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus niger</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">overexpression of <italic toggle="yes">azaR</italic>: Activation of aza cluster and production of azanigerones A&#x02013;F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B258-pharmaceutics-14-01837" ref-type="bibr">258</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">aflR</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus parasiticus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">overexpression of <italic toggle="yes">aflR</italic> lead to the production of aflatoxin under repressing conditions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B259-pharmaceutics-14-01837" ref-type="bibr">259</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF of pgm BGC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus terreus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE of pgm cluster TF (ATEG_06205) led to the production of naphthoquinones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B260-pharmaceutics-14-01837" ref-type="bibr">260</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resistance gene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">neomycin resistance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus versicolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The introduction of neomycin resistance leads to production of the new anti-tumor bioactive compounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B261-pharmaceutics-14-01837" ref-type="bibr">261</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NRPS31 BGC (APS-like) PKS19- BGC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">overexpression of pathway-specific TF (<italic toggle="yes">APS2</italic>) and complementation of enzyme (<italic toggle="yes">F. semitectum APS8</italic>) resulted in production of ApicidinF<break/>OE of TF and PKS19 resulted in production of four novel compounds (Fujikurin A&#x02013;D)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B125-pharmaceutics-14-01837" ref-type="bibr">125</xref>,<xref rid="B262-pharmaceutics-14-01837" ref-type="bibr">262</xref>,<xref rid="B263-pharmaceutics-14-01837" ref-type="bibr">263</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">APF2</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">overexpression of <italic toggle="yes">APF2</italic> increases apicidin F synthesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B262-pharmaceutics-14-01837" ref-type="bibr">262</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Whole BGC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">BIK2</italic> or <italic toggle="yes">BIK3</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Separate OE of <italic toggle="yes">BIK2</italic> and <italic toggle="yes">BIK3</italic>: revelation of precursor oxo-pre-bikaverin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B264-pharmaceutics-14-01837" ref-type="bibr">264</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BB gene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">DMATS1</italic>, FFUJ_09179</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE of <italic toggle="yes">DMATS1</italic> yielded a reversely N-prenylated tryptophan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B265-pharmaceutics-14-01837" ref-type="bibr">265</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">TF22</italic><break/>(PKS-NRPS1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tet-on activation of <italic toggle="yes">TF22</italic> (FFUJ_02222): <break/>cluster activation and trichosetin production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B239-pharmaceutics-14-01837" ref-type="bibr">239</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">FSL7</italic> (TF)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium graminearum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">overexpression of the TF <italic toggle="yes">FSL7</italic>: activation of the FSL cluster (<italic toggle="yes">PKS9</italic>) and production of fusarielins, F, G, and H</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B266-pharmaceutics-14-01837" ref-type="bibr">266</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BB gene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">PKS8</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium graminearum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">activation of Gibepyrones and Prolipyrone B production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B33-pharmaceutics-14-01837" ref-type="bibr">33</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">FGM4</italic> (fg3_54 BGC; NRPS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium graminearum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE triggers the production of fusaoctaxin A. Deletion compromises plant infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B267-pharmaceutics-14-01837" ref-type="bibr">267</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BB gene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">FSDS</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium heterosporum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE of backbone gene resulted in novel Tyrosine-Derived 2,4-Pyrrolidinedione</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B268-pharmaceutics-14-01837" ref-type="bibr">268</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">PEXANC</italic> (TF)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium expansum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE of <italic toggle="yes">PEXANC</italic> resulted in the activation of the Citrinin cluster via the TF CtnA and production of Citrinin (evolutionary TF repurposing)<break/>The theoretical cluster responsible for xanthocillin remained silent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B269-pharmaceutics-14-01837" ref-type="bibr">269</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resistance gene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">neomycin resistance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium purpurogenum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Introduction of neomycin resistance results in the production of the new cyclic dipeptide penicimutide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B270-pharmaceutics-14-01837" ref-type="bibr">270</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CRISPRa (TF)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">macR</italic> (TF)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium rubens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">induction of macrophorin pathway-specific TF <italic toggle="yes">macR</italic>: production of macrophorin A, D and 4&#x02032;-oxomacrophorin D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B271-pharmaceutics-14-01837" ref-type="bibr">271</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: Heterologous expression (Het. Expr.), backbone gene (BB gene), pathway-specific Transcription factor (TF).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pharmaceutics-14-01837-t005"><object-id pub-id-type="pii">pharmaceutics-14-01837-t005_Table 5</object-id><label>Table 5</label><caption><p>Successful examples of heterologous expression of single genes and BGCs. Ordered by organism.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">BGC Activation by Heterologous Expression</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Target/Parameter</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organisms</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Observation</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">high throughput <break/>BGC activation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 Species (Donors)<break/>S. cerevisiae (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">method establishment: Hex<break/>Expression of 22/41 fungal BGCs resulted in detectable compounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B285-pharmaceutics-14-01837" ref-type="bibr">285</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">156 FACs with random genome fragments</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus aculeatus</italic> (Donor) <break/><italic toggle="yes">Aspergillus terreus</italic> (Donor) <break/><italic toggle="yes">Aspergillus wentii</italic> (Donor)<break/><italic toggle="yes">Aspergillus nidulans</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">method establishment: FAC-MS, Identification of 15 new substances <break/>Clusters/metabolites: A. terreus: ATEG_07067, ATEG_07500, sesterterpenoid, valactamide A, benzomalvin A/D<break/>A. aculeatus: AACU_51108, AACU_59515,<break/>A. wentii: ASPWE_027400, ASPWE_034272, ASPWE_042595, ASPWE_044725, ASPWE_085322, ASPWE_151732, ASPWE_163793</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B284-pharmaceutics-14-01837" ref-type="bibr">284</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">diketomorpholine BGC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergilllus aculeatus</italic> (Donor)<break/><italic toggle="yes">Aspergillus nidulans</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elucidation of the biosynthetic pathway of acu-dioxomorpholine, featuring a new type of condensation domain, by FAC-MS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B287-pharmaceutics-14-01837" ref-type="bibr">287</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">ftmA</italic> (NRPS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus fumigatus</italic> (Donor/Host)<break/><italic toggle="yes">Aspergillus nidulans</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE of the NRPS <italic toggle="yes">ftmA</italic>: Production of Brevianamide F (Product of NRPS, product of cluster is putatively fumitremorgin) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B288-pharmaceutics-14-01837" ref-type="bibr">288</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pyr Cluster</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus fumigatus</italic> (Donor)<break/><italic toggle="yes">Aspergillus. oryzae</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">successive expression of the pyr cluster: Characterization of pyr cluster and isolation of the meroterpenoid pyripyropene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B289-pharmaceutics-14-01837" ref-type="bibr">289</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">micro-perfuranone (<italic toggle="yes">micA</italic>, BGC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus nidulans</italic> (Donor)<break/><italic toggle="yes">Aspergillus niger</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">promoter exchange or heterologous expression of backbone gene <italic toggle="yes">micA</italic> was sufficient to produce microperfuranone </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B255-pharmaceutics-14-01837" ref-type="bibr">255</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">asqJ</italic>
<break/>
<italic toggle="yes">asqE-L</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus nidulans</italic> (Donor)<break/><italic toggle="yes">Escherichia coli</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OE of <italic toggle="yes">asqE-L</italic> in host and elucidation of AsqJ function by expression in <italic toggle="yes">E. coli</italic>
<break/>Final products: 4&#x02032;-methoxylated 6,7-benzodiazepinediones and 4&#x02032;-methoxyviridicatin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B256-pharmaceutics-14-01837" ref-type="bibr">256</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">wA</italic> (NWA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus nidulans</italic> (Donor) <break/><italic toggle="yes">Aspergillus oryzae</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">expression of the WA-PKS: identification of the YWA1 compound</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B290-pharmaceutics-14-01837" ref-type="bibr">290</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">terreazepine BGC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus terreus</italic> (Donor)<break/><italic toggle="yes">Aspergillus nidulans</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">production of terreazepine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B291-pharmaceutics-14-01837" ref-type="bibr">291</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39 BGCs from various species </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Donors:<break/><italic toggle="yes">Colletotrichum gloeosporioides</italic><break/><italic toggle="yes">Alternaria alternata</italic>
<break/><italic toggle="yes">Fusarium graminearum</italic><break/><italic toggle="yes">Trichoderma viride</italic><break/><italic toggle="yes">Aspergillus flavipes</italic><break/>Host: <italic toggle="yes">Aspergillus oryzae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">method establishment: genome mining assisted automated and high-throughput (auto-HTP) biofoundry workflow<break/> refactoring of 39 BGCs and production of 185 distinct terpenoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B292-pharmaceutics-14-01837" ref-type="bibr">292</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">STC5</italic>, <italic toggle="yes">STC3</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Fusarium fujikuroi</italic> (Donor)<break/><italic toggle="yes">E. coli</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Use of homologues<break/><italic toggle="yes">STC3</italic>: (+)-eremophilene <break/><italic toggle="yes">STC5</italic>:(&#x000a2;)-guaia-6,10(14)-diene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-pharmaceutics-14-01837" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">carotenoid BGC of <italic toggle="yes">Fusarium fujikuroi</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Fusarium fujikuroi</italic> (Donor)<break/><italic toggle="yes">Aspergillus nidulans</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">method establishment: <italic toggle="yes">aflR</italic> scaffold as heterologous expression matrix; successful production of &#x003b2;-carotene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B286-pharmaceutics-14-01837" ref-type="bibr">286</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">STC1</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Fusarium fujikuroi</italic> (Donor)<break/><italic toggle="yes">E. coli</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heterologous Expression of <italic toggle="yes">STC1</italic> identification of (&#x02013;)-germacrene D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B176-pharmaceutics-14-01837" ref-type="bibr">176</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FgJ03939 BGC </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Fusarium graminearum</italic> (Donor)<break/><italic toggle="yes">Saccharomyces cerevisiae</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">stepwise synthesis of several new sesquiterpene synthase-derived metabolites such as fusariumdiene, fusagramineol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B293-pharmaceutics-14-01837" ref-type="bibr">293</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">part of the fusarubin gene cluster</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Fusarium solani</italic> (Donor)<break/><italic toggle="yes">S. cerevisiae</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Expression of <italic toggle="yes">F</italic><italic toggle="yes">VPPT</italic>, fsr1, fsr2, and fsr3 in <italic toggle="yes">S. cerevisiae</italic> (galactose inducible promoter) and biosynthesis of bostrycoidin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B294-pharmaceutics-14-01837" ref-type="bibr">294</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">pvhA-E</italic> (BGC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium variabile (Donor)</italic>
<break/>
<italic toggle="yes">Aspergillus nidulans (Host)</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heterologous expression of genes <italic toggle="yes">pvhA-e</italic>: production of varicidin A and B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B295-pharmaceutics-14-01837" ref-type="bibr">295</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">psilocybin BGC </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Psilocybe carpophores</italic> (Donor)<break/><italic toggle="yes">Aspergillus nidulans</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">method establishment: Successful Expression of whole BGC as polycistronic RNA piconavirus assisted expression of the whole basidiomycete derived psilocybin BGC </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B296-pharmaceutics-14-01837" ref-type="bibr">296</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TESG_6702 to 6705</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Trichophyton tonsurans</italic> (Donor)<break/><italic toggle="yes">Aspergillus nidulans</italic> (Host)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Expression of the whole cluster resulted in the production of neosartoricins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B297-pharmaceutics-14-01837" ref-type="bibr">297</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="pharmaceutics-14-01837-t006"><object-id pub-id-type="pii">pharmaceutics-14-01837-t006_Table 6</object-id><label>Table 6</label><caption><p>Untargeted BGC activation by interference with global chromatin regulatory mechanisms. Ordered alphabetically by organism.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">BGC Activation by Interference of Chromatin-Regulation</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Method</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organism</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Observation</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi<break/>DNMTi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">162 mangrove endophytic Fungi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi: sodium butyrate, DNMTi: 5-azacytidine<break/>Activity against ESKAPE MOs and <italic toggle="yes">Mycobacterium tuberculosis</italic> and <italic toggle="yes">Leishmania donovani</italic>:<break/>254/ 1608 extracts showed bioactivity, HDACi or DNMTi: 72 fungi produced active extracts, 40 fungi were active only in the control</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B320-pharmaceutics-14-01837" ref-type="bibr">320</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media<break/>HDACi<break/>DNMTi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus awamori</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media: MEA, rice, nutrient, triptone soya agar<break/>HDACi: valproic acid, nicotinamide, trichostatin A, DNMTi: 5-azacytidine <break/>Different metabolic profiles between media and epigenetic modifiers<break/>Nicotinamide was found to be the best epigenetic inducer Rice grains was the best medium for SM induction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B188-pharmaceutics-14-01837" ref-type="bibr">188</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">HDACi<break/>DNMTi</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus calidoustus</italic>, <break/><italic toggle="yes">Aspergillus westerdijkiae</italic><break/><italic toggle="yes">Aspergillus bombycis Aspergillus carbonarius</italic><break/><italic toggle="yes">Aspergillus fischeri</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">HDACi: SAHA, DNMTi: 5-azacytidine<break/>significant changes in secondary metabolite profile with examples of both induction and repression. </td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B321-pharmaceutics-14-01837" ref-type="bibr">321</xref>]</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HDACi<break/>DNMTi</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus clavatus</italic>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HDACi: valproic acid, trichostatin A, butyrate<break/>DNMTi: 5-azacytidine. N-acetyl-d-glucosamine<break/>Source of peptone strongly influences the SM profile, epigenetic modifier effects SM profile which is metabolite-specific and dependent on growth media and incubation time</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B322-pharmaceutics-14-01837" ref-type="bibr">322</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">cclA&#x02206;</italic> (Bre2; H3K4me): <break/>activation of mdp cluster: production of monodictyphenone, emodin, and emodin derivatives<break/>activation of anti-osteoporosis polyketides cluster: F9775A and F9775B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B323-pharmaceutics-14-01837" ref-type="bibr">323</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HepA occupancy decreases during sterigmatocystin activation<break/><italic toggle="yes">hepA&#x02206;</italic>/<italic toggle="yes">clrD&#x02206;</italic> (H3K9me): upregulation of sterigmatocystin, isopenicillin A, terraquinone A<break/>LaeA involved in reversing heterochromatic marks at ST BGC, </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B305-pharmaceutics-14-01837" ref-type="bibr">305</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">hosA&#x02206;</italic> (HDAC): impact on H4ac, SM, carbohydrate metabolism, virulence, defense</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B324-pharmaceutics-14-01837" ref-type="bibr">324</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Knockdown</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus nidulans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">knockdown of <italic toggle="yes">rpdA</italic> (HDAC): production of aspercryptin A1 and A2 and fellutamides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B325-pharmaceutics-14-01837" ref-type="bibr">325</xref>,<xref rid="B326-pharmaceutics-14-01837" ref-type="bibr">326</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus niger</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi: SAHA, discovery of nygerone A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B327-pharmaceutics-14-01837" ref-type="bibr">327</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus niger</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">gcnE&#x02206;</italic> (SAGA/Ada; acetylation): activation of 12 silent clusters (1 novel compound): nigerpyrone, carbonarone A, pestalamide A, funalenone, aurasperone E, aurasperone A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B328-pharmaceutics-14-01837" ref-type="bibr">328</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi<break/>DNMTi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi: suberohydroxamic acid, DNMTi: 5-azacytidine<break/>discovery of diphenylether-O-glycoside (diorcinol 3-O-&#x003b1;-D-ribofuranoside)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B329-pharmaceutics-14-01837" ref-type="bibr">329</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Botryosphaeria mamane</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi: SAHA, Valporate, production of five unknown compounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B330-pharmaceutics-14-01837" ref-type="bibr">330</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Calcarisporium arbuscula</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02206;<italic toggle="yes">hdaA</italic> (HDAC): upregulation of 75% of BGC genes: isolation of 10 new compounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B331-pharmaceutics-14-01837" ref-type="bibr">331</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi<break/>DNMTi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Chalara</italic> sp. <italic toggle="yes">6661</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi: sodium butyrate, suberobishydroxamic acid, vorinostat; DNMTi: 5-azacytidine<break/>vorinostat: four new modified xanthones, only one out of four inhibitors showed effect<break/>Biotransformation of vorinostat</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B332-pharmaceutics-14-01837" ref-type="bibr">332</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media<break/>HDACi<break/>DNMTi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Cladosporium resinae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media: Czapek-DOX, YES, PDA, starch, liquid vs. solid; HDACi: SAHA; DNMTi: 5-AZA<break/>Czapek, yeast extract broth: more total secondary metabolites<break/>DNMTi and HDACi: expressions of silent genes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B209-pharmaceutics-14-01837" ref-type="bibr">209</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi<break/>DNMTi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Cyathus stercoreus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">nine previously undescribed sesquiterpenes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B333-pharmaceutics-14-01837" ref-type="bibr">333</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Dothistroma septosporum</italic>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x00394;DsKmt1</italic> (H3K9me) or <italic toggle="yes">&#x00394;DsKmt6</italic> (H3K27me): Substantial decrease of H3K9me3 or H3K27me3. Increase of production of dothistromin in both cases</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B334-pharmaceutics-14-01837" ref-type="bibr">334</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Media<break/>HDACi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Drechslera</italic> sp.,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi: SAHA, valproate, octanoylhydroxamic acid; 2 new metabolites: chromanone and prenylhydroxybenzoic acid; different metabolome between MEA and minimal media<break/>biotransformation of the inhibitors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B208-pharmaceutics-14-01837" ref-type="bibr">208</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Epichloe festucae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x00394;clrD</italic> (H3K9me) and/or <italic toggle="yes">&#x00394;ezhB</italic> (H3K27me): reduction of H3K9me3 and/or H3K27me3<break/>activation of bioprotective lolitrems (ltm) and ergot alkaloids (eas)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B307-pharmaceutics-14-01837" ref-type="bibr">307</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x00394;hda1</italic>(<italic toggle="yes">hdaA</italic>; HDAC): production of beauvericin (BEA-cluster; NRPS22)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B335-pharmaceutics-14-01837" ref-type="bibr">335</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x00394;set2</italic> and <italic toggle="yes">&#x00394;ash1</italic> (H3K36me): upregulation of PKS-NRPS9 and NRPS4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B336-pharmaceutics-14-01837" ref-type="bibr">336</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02206;<italic toggle="yes">set1</italic> (H3K4me): activation of PKSNRPS9, PKS type III, NRPS4, NRPS23, and DMATS3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B337-pharmaceutics-14-01837" ref-type="bibr">337</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium graminearum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x00394;kmt6</italic> (PRC2, H3K27me): Differential regulation of many SM genes, <break/>upregulation of: NRPS9, NRPS14, NRPS16, NRPS19, PKS2, PKS3, PKS13, PKS22, PKS28, PKS29, STC5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B312-pharmaceutics-14-01837" ref-type="bibr">312</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Fusarium graminearum</italic> (dereplication strain)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02206;<italic toggle="yes">kmt6</italic> (H3K27me): discovery of Protofusarin and N-ethyl anthranilic acid, N-phenethylacetamide, N-acetyltryptamine<break/>&#x02206;kmt6 and &#x02206;fus1: tricinolone, tricinolonic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B338-pharmaceutics-14-01837" ref-type="bibr">338</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium mangiferae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02206;<italic toggle="yes">fmkmt1</italic> (H3K9me): increased beauvericin biosynthesis, nearly abolished fusapyrone production; revelation of fusapyrone BGC (FmPKS40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B308-pharmaceutics-14-01837" ref-type="bibr">308</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium verticillioides</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x00394;fvdim5</italic> (H3K9me): increase of fumonisin B1 and melanin biosynthesis, reduced virulence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B339-pharmaceutics-14-01837" ref-type="bibr">339</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Metarhizium robertsii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x00394;hat1</italic>: activation of 11 orphan BGCs<break/>Meromuside A&#x02013;I, Meromutides A and B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B340-pharmaceutics-14-01837" ref-type="bibr">340</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi<break/>DNMTi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Muscodor yucatanensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi: SAHA, DNMTi: 5-azacytidine <break/>different morphology, cultural characteristics, metabolites</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B341-pharmaceutics-14-01837" ref-type="bibr">341</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi<break/>DNMTi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Nigrospora sphaerica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi: SAHA, sodium butyrate, valproic acid, quercetin<break/>DNMTi: 5-azacytidine, hydralazine hydrochloride<break/>induction of cryptic metabolites by all modifiers used</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B342-pharmaceutics-14-01837" ref-type="bibr">342</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium brevicompactum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi: nicotinamide, sodium butyrate<break/>total phenolic compounds increased drastically upon HDACi treatment<break/>Nicotinamide: p-anisic acid, p-anisic acid methyl ester, benzyl anisate, syringic acid, sinapic acid, acetosyringone, phenyl acetic acid, gentisaldehyde and p-hydroxy benzaldehyde<break/>Sodium butyrate enhanced the productivity of anthranilic acid and ergosterol peroxide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B343-pharmaceutics-14-01837" ref-type="bibr">343</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Penicillium chrysogenum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02206;<italic toggle="yes">hdaA</italic> (HDAC): new compound. Maybe crosstalk with sorbicillinoids cluster</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B344-pharmaceutics-14-01837" ref-type="bibr">344</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Phoma</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SAHA triggers the production of (10&#x02019;S)-verruculide B, vermistatin and dihydrovermistatin<break/>Absence of SAHA: discovery of (S,Z)-5-(3&#x02032;,4&#x02032;-dihydroxybutyldiene)-3-propylfuran-2(5H)-one</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B345-pharmaceutics-14-01837" ref-type="bibr">345</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Trichoderma harzianum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDACi: sodium butyrate; diterpenoids changed into cyclonerane sesquiterpenoids.<break/>3 new compounds: cleistanthane diterpenoid, harzianolic acid A, harziane diterpenoid, harzianone E, cyclonerane sesquiterpenoid, 3,7,11-trihydroxy-cycloneran</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B346-pharmaceutics-14-01837" ref-type="bibr">346</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Knockdown</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium fujikuroi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Knockdown of <italic toggle="yes">KMT6</italic> (H3K27me; PRC2): differential regulation of SM-clusters, <break/>upregulated SM genes: <italic toggle="yes">NRPS22</italic>, <italic toggle="yes">STC4</italic>, tetraterpene cyclase-encoding gene <italic toggle="yes">TETC1</italic>, <break/><italic toggle="yes">PKS-NRPS1, STC5, STC8, DMATS3, NRPS4, PKS2</italic>)<break/>detection of six yet unidentified cluster-products: STC5: guaia-6,10(14)-diene, STC3: (+)-eremophilene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-pharmaceutics-14-01837" ref-type="bibr">55</xref>,<xref rid="B315-pharmaceutics-14-01837" ref-type="bibr">315</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: HDACi (inhibition of histone deacetylases by chemical inhibitors), DNMTi (inhibition of DNA methyltransferases by chemical inhibitors), SAHA (vorinostat), 5-AZA (azacitidine).</p></fn></table-wrap-foot></table-wrap></floats-group></article>